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Abstract 
     Cell migration is essential for the development of multicellular organisms; with 
disruptions in this process contributing to diseases such as cancer, neurological disorders 
and musculoskeletal diseases. The LINC (Linker of Nucleoskeleton and Cytoskeleton) 
complex is an evolutionary conserved proteinaceous structure, critical for maintaining 
proper cellular migration. This multifunctional complex provides a physical connection 
between the nuclear interior and the cytoskeleton, with disruptions stimulating loss of 
directed cell migration, compromised nuclear structure and abnormal cellular signalling. 
As it is also noted that the nucleus in many cells is the stiffest cellular component, it is 
suggested that LINC complex disruptions may be key in increasing the migration potential 
of cells through both in vivo and in vitro 3D environments.  
     This project aimed to investigate the roles of LINC complex disruptions on keratinocyte 
morphological and migratory behaviours in 2D, and both non-restrictive and space-
restrictive 3D culture environments, through the application of dominant negative SUN1 
mutants. Through extensive analysis, it was identified that these mutants exhibited altered 
cell-cell and cell-substratum attachment phenotypes, alongside increased nuclear heights. 
It was also demonstrated that the LINC disrupted mutants displayed a migration 
advantage in space-restricted 3D environments, which was attributed to a decrease in 
nuclear stiffness. Through fibroblast incorporation to the 3D scaffolds used, it was further 
shown that LINC disrupted keratinocytes displayed increased levels of differentiation 
markers, alongside increased cellular stacking phenotypes across scaffolds surface 
regions, potentially attributed to alterations in Hippo pathway signalling.  
     The migratory phenotypes observed in DN mutants closely resemble that of high-grade 
cancer cells, able to migrate through space-restrictive environments during metastasis. 
Comprehensive protein expression and localisation analysis across a range of breast 
cancer cell lines and tissues suggested that several LINC complex components display 
altered expression levels closely linked to cancer progression, most significantly a down-
regulation of lower nesprin-1/-2 isoforms was identified. As following investigations later 
suggested Nup88 as an upstream regulator of nesprin-2, able to bind C-terminal regions, 
it’s suggested that these phenotypes link closely to that observed in high-grade cancers.  
      Together, the data presented suggests that LINC complex disruptions increase 
migration potential of cells through restrictive 3D environments due to a decrease in 
nuclear stiffness, comparable to that observed across high-grade breast cancer cell lines.   
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1. Introduction 
 
1.1    The LINC complex. 
      
       The maintenance of cell and nuclear architecture is key in maintaining normal cellular 
function. One key element which contributes to the maintenance of cell architecture is the 
cytoskeletal network, able to provide a physical link between the extra cellular matrix 
(ECM) and the genome through associated nuclear envelope (NE) proteins. The 
maintenance of nuclear architecture however is influenced heavily by its NE, consisting of 
a double lipid bilayer separating the nuclear interior from the cytoplasm. This 
compartmentalisation of the nuclear interior enables the separation of transcription and 
translation within eukaryotic systems, allowing the formation of a highly regulated 
mechanism to control gene expression [1]. The NE is an extension of the endoplasmic 
reticulum (ER), consisting of an inner (INM) and outer nuclear membrane (ONM), 
uniformly separated by the perinuclear space (PNS) of a ~50 nm width. Both the INM and 
ONM are fused at the nuclear pore complexes (NPC), through which macromolecular 
trafficking between the nuclear and cytoplasmic regions occurs [2, 3]. Further evidence is 
also available suggesting NPCs are not the only methods for the transport of cargoes in 
and out of the nucleus, with some exceptionally large nuclear cargoes able to move 
across the PNS through vesicular transport methods, similar to the nuclear egresses 
employed by herpes viruses.  [4, 5].  
     Communication between nuclear and cytoplasmic compartments has long been known 
as a crucial cellular function [6]; however, understanding the mechanisms by which this 
physical connection enables cellular feedback is currently a growing area of interest. 
Mechanical coupling of the nucleus to the cytoskeleton can influence multiple cellular 
processes, including nuclear positioning, force transduction and cell signalling pathways 
[7, 8, 9]. The correct positioning of nuclei is of vital importance, especially in neuronal and 
muscle cell types, suggesting that this nuclear-cytoskeleton link could provide a 
mechanism to push and pull nuclei [10]. Forming a physical connection between the 
nuclear and cytoplasmic regions provide further potential for mechanotransduction across 
the NE, in which signal transduction from plasma membranes as a result of external 
stimuli can elicit a change in gene activation levels [11]. Due to this wide ranging 
functionality, potential roles of this nucleoskeleton-cytoskeleton coupling has been further 
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investigated in the onset of disease development, including muscular dystrophies, 
premature aging and laminopathies [12, 13].   
     These described connections between nucleoskeletal and cytoskeletal components 
are formed through Linker of Nucleoskeleton and Cytoskeleton (LINC) complexes [14, 15], 
characterised by SUN-KASH perinuclear interactions. The INM-resident Sad1 and UNC-
84 (SUN) protein spans the perinuclear space, interacting with ONM-resident Klarsicht 
ANC-1 and SYNE-Nesprin-1/-2 homology (KASH) proteins, helping to establish a physical 
bridge between INM and ONM.  
 
1.1.1    Components of the LINC complex. 
 
     The LINC complex is widely recognised as the major NE component able to provide 
the mechanical links between the nucleus and cytoskeletal network, comprising of ONM 
KASH domain proteins and INM SUN proteins (Figure 1.1). The KASH domain projects 
into the NE lumen, where it interacts with SUN domains. This SUN-KASH interaction 
helps to anchor KASH proteins to the NE, preventing them from diffusing into the 
adjoining ER. The ONM KASH proteins interact with a range of cytoskeletal components, 
physically tethering the nucleus to the cytoplasmic compartment [15, 16], whereas the 
SUN proteins physically interact with INM proteins networks such as the nuclear lamina 
and chromatin components [17, 18]. This complex of proteins therefore establishes a 
physical bridge between the cytoskeletal and nucleoskeletal networks. The formation of 
this two membrane adhesive assembly of proteins is capable of transmitting force across 
the NE, providing function in maintaining centrosome-nuclear interactions, nuclear 
architecture, signal transduction, DNA repair and chromosome migration [14]. This 
therefore suggests that the LINC complex must be a dynamic protein network of highly 
ordered protein interactions, allowing the transmission of multiple signal transductions 
from a variety of cytoskeletal components to the nuclear interior.  
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1.1.1.1    The nuclear lamina. 
 
    To efficiently position and move the nucleus through the cell, the LINC complex must be 
anchored so that the force exerted by cytoskeletal components can be transmitted directly 
to the nucleus. This anchoring is established through SUN interactions across the INM 
with nuclear lamins, composed of type V intermediate filaments (IFs), able to self-
associate to form parallel coiled-coil homodimers. These homodimers then cross link, 
forming a higher ordered filament network across the INM (the nuclear lamina). The major 
components of this nuclear lamina are the A- and B-type lamin proteins, sharing similar 
structural homology including a central α-helical rod domain, flanked by non-helical, 
globular domains situated at each terminus [19].  
     B-type lamins, including lamin B1 and lamin B2, are encoded by the LMNB1 and 
LMNB2 genes respectively. It is interesting to note that limited mutations in B-type lamins 
are observed across a range of diseases, however, with implications in the development 
of adult onset autosomal dominant leukodystrophy (ADLD) and more recently the 
Figure 1.1: The LINC complex bridge across the NE; comprising of SUN and KASH 
interactions within the perinuclear space, alongside associated cytoskeletal and 
nucleoskeletal networks. [15]. 
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development of neural tubes in spina bifida patients [20, 21], it is becoming increasingly 
evident that these proteins do in fact play critical roles in cellular functions. Of further 
interest is current evidence implicating a potential role for B-type lamins in the 
development of a number of cancers [22, 23]. In breast cancer for example, the 
decreased expression of LMNB1 has been associated to poor patient prognosis [24], and 
further evidence suggests that overexpression of lamin B1 is associated with low grade 
differentiation in pancreatic cancers [25]. Of importance in this final study however, is the 
suggestion of lamin B1 for use as a potential therapeutic target against cancer 
progression. It was shown that the activity of the anti-cancer drug betulinic acid appears to 
down regulate lamin B1 as part of its anti-cancer effects. However thus far it is not known 
whether the down regulation of lamin B1 was a direct result of the anti-cancer effects, or a 
resulting side effect of drug action.     
     A-type lamins however, are encoded by a single gene, LMNA, which undergoes 
alternative splicing to generate the major lamins, types A and C, which are both 
ubiquitously expressed and developmentally regulated [26]. As lamin A/C are considered 
key in the maintenance of nuclear architecture across many cell types [27], mutations in 
the LMNA gene resulting in altered expression patterns of lamin A/C have been implicated 
across a wide range of human diseases, collectively known as ‘laminopathies’ [28]. 
     These variable lamin sub-types have been shown as contributing factors in 
nucleoplasmic anchorage of LINC complex components through multiple methods. Initial 
investigations were able to discern that the carboxyl terminus of lamin A was able to bind 
with SUN1 through yeast two hybrid systems, whereas binding affinity with lamin B and C 
sub-types were shown to be very weak [29]. Further to this, Östlund et al. helped identify 
that SUN1 and SUN2 mobility across the INM was increased in fibroblast cells derived 
from lamin A knock-out mice [30]. Using LMNA knockout mice (LMNA-/-), further 
investigations into actin-dependant nuclear movement in mouse embryonic fibroblasts 
(MEFs) suggested that upon lamin A loss across the INM, Nesprin-2G-SUN dependant 
transmembrane actin-associated nuclear (TAN) line orientation and anchoring was 
impaired [31]. This suggests that the loss of A-type lamin proteins stimulated a decreased 
actin binding potential across the NE through the potential loss of LINC connections. 
     Interestingly, it is suggested that lamin A binding is not essential for the correct 
localisation of SUN proteins to the INM, suggesting that further protein interactions must 
be involved in LINC complex anchoring to the nucleoplasmic network [32]. It was shown 
that limited localisation defects of SUN1 were present in COS7 cells lacking A-type, or 
A/B-type lamins [32]. Alongside this, SUN2 localisation was seen to be minimally miss 
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localised to the ER in lamin A and C deficient HeLa cells [33], suggesting alternate protein 
interactions aside from those displayed by lamins are contributing to LINC anchorage 
across the NE. Further mouse models have supported this claim that lamin associations 
are not crucial to the maintenance of LINC NE anchoring, by which it was observed that 
lamin A deficient mice were able to develop normally through early stages of development 
[34]. Subsequent postnatal growth however, was severely retarded, displaying the 
development of muscular dystrophy [34].  
     Potential suggestions as to alternate protein interactions involved in LINC complex 
anchoring to the NE comes from further mouse models, suggesting that B-type lamins, 
despite their weak interactions with SUN proteins, may be a key component. It was shown 
that lamin B1, lamin B2, nesprin-1/-2 and SUN1/2 deficient mice all expressed similar 
defects in neuronal migration [35, 36, 37], suggesting roles for lamin B in anchoring LINC 
complex components during neuronal development. These findings further suggest 
differential roles for lamin proteins in maintaining NE functionality, whereby A-type lamin 
components may provide the physical connections between the nucleoskeleton and the 
cytoskeleton, whereas B-type lamins may contribute to maintaining more specific LINC 
complex functions, such as maintaining nuclear stiffness [38].  
     Alongside lamin interactions with SUN proteins, further evidence suggests direct 
interactions also exist with nesprin-1 and nesprin-2 across two conserved spectrin repeats 
(SRs) localised to nesprin C-terminal regions [39, 40]. This direct interaction however is 
not suggested to influence the anchoring of LINC components to the nucleus, as nesprin-
2G localisation across the ONM is not seen to be disrupted upon A-type lamin absence 
[41]. This however, does suggest further potential roles for smaller nesprin isoforms 
situated across the INM in lamin associated roles, such as chromatin organisation and 
maintaining nuclear integrity [42].  
 
1.1.1.2    Lamin associated proteins. 
 
     Alongside the wide ranging functionality of lamin proteins, their interactions with further 
associated proteins provide a high degree of complex functionality within the cell. Of these 
associated proteins, the A-type lamin associated emerin and samp1 (NET5) have been 
implicated in LINC anchoring to the NE. Through analysing the localisation of samp1 
deletion mutants, it has been shown that the samp1 localises to the INM through its 
cysteine rich N-terminal domain, comprising of four conserved CxxC motifs with the 
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potential to form Zinc fingers [43]. Its INM localisation has been shown to depend upon A-
type lamin presence [44]. Initially, it was shown that samp1 displayed binding affinity to 
SUN1 and emerin across the INM, with post-translational silencing of samp1 in HeLa cells 
displaying a loss of emerin localisation across the INM, suggesting roles form samp1 in 
emerin localisation at the NE [43]. Subsequent investigations further displayed interacting 
potential with SUN2, lamin A and lamin C across the INM, however, correct localisation of 
these proteins was not dependent on samp1.  
     It was further highlighted that for correct TAN line formation to occur, samp1 was 
required across the NE, mediated through the further interacting potential with nesprin-2G 
and SUN2 during MEF migration [44]. In this study, it was suggested that samp1 helped to 
reinforce TAN line anchorage across the NE through providing further binding sites for 
SUN2 alongside A-type lamins.  
     Emerin is a further lamin associated protein with implicated roles in LINC complex 
anchoring. Emerin consists of an N-terminal nucleoplasmic domain and a C-terminal 
transmembrane domain, found localised to the INM and the ONM (where it binds MRS 
and the centrosome). Upon synthesis of the completed emerin protein, its small size 
allows it to freely diffuse into the nucleus through NPCs whilst remaining membrane 
anchored [45]. Once inside the nucleus, emerin binds to A-type lamins, shown to be 
crucial to the efficient localisation of emerin to the INM, as cells lacking A-type lamins 
express increased emerin mobility through the NE and the ER [46]. The ubiquitous 
expression of emerin across multiple cell types has been linked to its role in numerous cell 
functions, including regulating gene expression, cell signalling and nuclear architecture 
[47, 48, 49]. This ranging functionality, linked with suggestive interactions with SUN1 and 
SUN2 across their nucleoplasmic domains, suggests potential roles of emerin in 
maintaining LINC function across the NE. Depletion of emerin in polarising NIH3T3 
fibroblasts has been shown to lead to abnormal nuclear migration and loss of TAN line 
organisation across the nuclear surface [50]. Thus, emerin, alongside its associated 
interacting partners A-type lamins and samp1, may function in maintaining LINC complex 
connections between nucleoskeletal and cytoskeletal compartments.  
 
1.1.1.3    SUN proteins. 
       
     Forming close associations with the INM nuclear lamina, SUN proteins form the 
physical link between INM and ONM regions through their associations with nesprins, 
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enabling the establishment of LINC complex interactions across the NE. These 
Sad1/UNC-84 (SUN) proteins were originally described in fission yeast [51] and C. 
elegans (UNC-84) [52], with subsequent BLAST searches using the highly conserved C-
terminal domain (SUN-domain) revealing the mammalian homologues SUN1 and SUN2. 
Mammalian SUN proteins consist of five family members (SUN1-5), whereas SUN1 and 
SUN2 are ubiquitously expressed across a range of tissues [52, 33, 53], SUN 3-5 are 
expressed exclusively in the testis [54, 55]. Both SUN1 and SUN2 are type II membrane 
proteins [56], expressing a single pass transmembrane domain, anchored to the INM 
through their signal-anchor sequence localised to their C-terminal region. Aside this, both 
SUN1 and SUN2 further express high degrees of similarity, sharing 64% homology, 
containing an N-terminal region localised to the nucleoplasm [29] followed by a single 
transmembrane domain which spans the INM [57]. The core of both SUN1 and SUN2 is 
comprised of the stalk region spanning the PNS, made up from coiled-coil repeats, which 
are essential for protein trimerisation [58, 59]. Following the coiled-coil is the most highly 
conserved region of SUN proteins, the C-terminal SUN-domain, composed of ~175 aa, 
forming the core protein region responsible for KASH interactions. Interestingly, recent 
studies have found 6 potential splice isoforms for SUN1 alone expressed in murine heart 
tissue using RT-PCR [60], through which all isoforms were shown to retain the conserved 
SUN-domain, coiled-coil stalk and INM transmembrane domain, but expressed varying 
lengths of N-terminal nucleoplasmic protrusions. This helps to suggests that through these 
multiple splice variants, SUN1 could display a range of tissue specific functionalities, 
however, it is currently unknown whether these described splice variants are actually 
translated into protein. For SUN2 however, there is currently no experimental evidence for 
isoform variants as a result of splicing [61].  
     Both SUN1 and SUN2 have been shown to display direct interacting potential with 
nuclear lamins [33, 29]. Investigations overexpressing HA-tagged SUN1 displayed co-
immunoprecipitation potential with GFP-conjugated lamin A in U2OS cells, alongside 
further work showing that in vitro transcribed/translated N-terminal region of SUN1 
displayed further interacting potential with in vitro transcribed/translated lamin A, but not 
lamin C, B1 or B2 [29]. Further biochemical analysis has also increased our 
understanding of SUN-lamin interactions through evidence suggesting that GST-bound N-
terminal regions of SUN1 display preferential binding with pre-lamin A over mature lamin 
A, alongside further weak interacting potential with lamin C and lamin B1 subtypes [33]. 
Interestingly, the retention of this lamin-SUN interaction appears to be evolutionary 
conserved, as the localisation of both SUN1 and SUN2 homologues within C. elegans to 
the NE appears to be dependent on lamin expression [62]. Further in vitro work however, 
8 | P a g e  
 
highlighted that SUN retention at the NE was not solely dependent on lamin. In both lamin 
A/C deficient MEFs and lamin A/C or lamin B deficient HeLa cells, it was shown that 
SUN1 was still able to localise to the NE [63]. This therefore suggests that further SUN1 
interactions must be present across the NE, enabling SUN retention across this region. In 
contrast, SUN2 does display some dependence on lamin A/C for NE retention, as SUN2 
displayed the inability to localise to the NE within mouse embryonic fibroblast cells lacking 
lamin A/C, expressing diffuse staining through the ER [33].  
     As displayed above, much of the early research implicates lamin A/C dependant 
localisation of SUN proteins to the NE. However, mouse models used in these studies 
must be taken with caution  in light of recent investigations showing that LMNA -/- mice 
were still able to produce truncated lamin A, which may retain its SUN interacting potential 
[64]. In the study conducted by Crisp et al. above, in which MEFs expressing lamin A/C 
absence showed retention of SUN1 across the NE, it is possible that the truncated lamin 
A/C retained in these cells expressed the SUN1 binding site. Upon closer inspection, it 
was shown that regions of lamin A proposed to bind SUN1 maps to residues 389 – 664 
[29] and the truncated lamin A produced within the lamin A/C null MEF’s retained 78 of 
these 275 aa’s. It is therefore possible that the remaining 78 aa’s in the truncated lamin 
A/C null mice may infer the SUN1 binding to truncated lamin A.  
     Alongside these potential lamin interactions across the NE, further lamin independent 
mechanisms also exist to localise both SUN1 and SUN2 to the INM. In C. elegans, UNC-
84 requires a combination of two nuclear localisation signals (NLS) to retain its INM 
positioning, an INM-sorting motif and NE-localisation signal (NELS), found to be 
evolutionary conserved within its mammalian SUN1 homolog [56]. Alongside this, it has 
been further demonstrated that in addition to lamin A/C, SUN2 requires a further 
combination of its NLS, Golgi-retrieval sequence and the transmembrane domain for its 
maintained localisation across the INM [65]. Aside the requirement of classic NLS 
sequences for SUN retention across the NE, further evidence suggests that interactions 
with emerin and short nesprin isoforms may also be contributing factors to SUN 
localisation [66], however, it is clear that further work is required to increase our 
understanding of SUN interactions responsible for retaining their localisation across the 
NE.   
     As can be seen, SUN1/SUN2 localisation and connection to the nucleoskeleton 
requires a complex combination of protein interactions. In contrast to this, connections 
with cytoskeletal components are well documented, known to mediate through 
interactions with nesprin family members through SUN-KASH domain interactions [58, 67, 
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59]. Deriving the crystal structure of SUN2 revealed that it forms a trimer [58, 67], 
essential for the recruitment of KASH domains of nesprin-1 and nesprin-2 [59] (Figure 
1.2). 
 
 
 
 
 
 
 
 
Figure 1.2: (A) Overview of the SUN2 protomer isolated whilst not bound to KASH binding 
partners.  (B) Top view of the SUN2 protomer displayed in (A) (facing the outer nuclear 
membrane). The apo-protomer of SUN2 is superimposed in red, with the only region displaying 
significant conformational changes being the KASH-lid. (C) Top view of the trimeric SUN2-
KASH complex. SUN2 domains are coloured in blue and the KASH peptide in orange. (D) 
Same view as (C), but SUN2 in surface representation, highlighting how each bound KASH 
peptide is clamped between two SUN2 protomers. (E) Side view of the SUN2-KASH complex, 
illustrating the deep binding pocket on SUN2 into which the terminal four residues of the KASH 
peptide bind. (F) Sedimentation equilibrium ultracentrifugation analysis of apo-SUN2 at two 
concentrations overlaid over primary data (red and black) for the two speeds. In the upper 
panel, the mass of the complete SUN2 trimer was calculated at 138 kDa. [505] 
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     It is envisioned that three SUN domains form a hexametric complex with three KASH 
domains, coordinating them through a combination of hydrogen bonds, a KASH ‘lid’ (a 
~20 aa extension emanating from the central β-sandwich motif) and disulphide bridges. 
Interestingly, the KASH lid region of SUN domains was found in an unstructured, 
monomeric form when not bound to KASH peptides during observations by Zhao et al. 
[57], but incorporated an alpha helix in the later Sosa et al. study [68]. These findings 
suggest that the KASH lid is a dynamic structure until bound to KASH peptides. Its ability 
to display varying structural conformations may further reflect the ability of SUN proteins 
to connect to other ONM proteins aside from the KASH proteins. The incorporation of this 
KASH lid appears to resemble an evolutionary locking mechanism, whereby interactions 
between SUN domains and KASH peptides are further reinforced. This extensive 
arrangement of connections between the SUN and KASH domains across the perinuclear 
space is suggested to make up the core of LINC complex, able to transmit signals and 
force between the nucleoskeleton and cytoskeleton [69, 70].  
 
1.1.1.4    KASH proteins. 
 
     LINC components have been identified in a wide range of organisms including plants, 
yeast, amoebae, worms, flies and vertebrates [71, 72, 73, 14, 74, 32]. The core of this 
LINC connection between nucleoskeletal and cytoskeletal components is formed through 
SUN-KASH perinuclear interactions. The KASH (Klarsicht, ANC-1 and Syne Homology) 
component is situated across the ONM, forming both direct and indirect connections 
between NE and cytoskeletal elements. The C-terminal KASH domain of these proteins is 
encompassed by a single transmembrane segment, followed by an evolutionary 
conserved PNS-situated short peptide, which associated directly with the luminal SUN 
domain [75, 14]. In contrast to their highly conserved C-terminal domains, N-terminal 
regions are highly variable, displaying considerable variation in both length; due to their 
differing SR copy numbers and domain composition; resulting in differential interacting 
potential with cytoskeletal structures [76, 77, 14]. For most KASH proteins, especially the 
large isoforms, their most prominent structural features can be found in their N-terminal 
cytoplasmic extensions, containing predicted regions of SRs or coiled-coil domains 
(Figure 1.3). 
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     To date, five KASH domain-containing proteins have been identified in humans, 
termed nesprin 1-4 (nuclear envelope spectrin repeat proteins) and KASH5 (encoded by 
SYNE1, SYNE2, SYNE3, SYNE4 and CCDC155 respectively). Each of these proteins 
expresses unique numbers of SRs across the length of these molecules [78, 79], whereas 
KASH5 contains a large coiled-coil region. Alongside the range of KASH containing 
proteins, associated genes also contain multiple exon splice sites, forming multiple splice 
variants. These multiple splice variants contain variable spectrin repeat numbers, 
Figure 1.3: Schematic of the major KASH proteins across mammals and C. elegans. Lines 
under the KASH proteins indicate known binding partners. The calponin homology domain 
(CH) situated across GIANT isoforms bind F-actin, and signalling protein interactions 
(displayed in blue) have also been identified in nesprin isoforms lacking the C-terminal 
KASH domain. [15]. 
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alongside some isoforms missing the KASH domain completely [80], suggesting potential 
roles for further nesprin isoforms in alternate functions than maintaining LINC connections 
across the NE. Across this wide range of nesprin isoforms, N-terminal regions display 
interacting capabilities with cytoplasmic filament systems. This interacting potential 
supports early beliefs that nesprins localised to ONM regions of the NE, alongside many 
nesprin isoforms (i.e. giant, >800 kDa) being too large to migrate through outer NPC 
channels into the nucleus. However, shorter nesprin isoforms have now been implicated 
in INM functionality, suggesting a nucleoplasmic localisation [81]. More specifically, in 
muscle, the small-tissue specific expression of nesprin-1α and nesprin-2α have been 
implicated in retaining nuclear integrity, through nucleoplasmic interactions with lamin A, 
emerin and SUN1 [37, 82].  
     The cytoplasmic regions of nesprin-1G and nesprin-2G isoforms express a range of 
cytoplasmic binding potentials, able to directly interact with actin networks through their 
tandem calponin homology (CH) N-terminal domains, alongside indirectly to microtubule 
networks through kinesin and dynein interactions. These interactions with kinesin occur 
via a conserved LEWD motif comprising of a four residual tryptophan-acidic [83], which 
are essential for the maintenance of correct nuclear positioning in myotubes [84]. These 
LEWD motifs have also been identified across the short nesprin-1α and nesprin-2α 
isoforms, suggesting potential roles for these proteins in microtubule interactions via 
kinesin light chain 1 (KLC1). Further support for this microtubule (MT) interacting potential 
came from Schneider et al. [77], through which yeast two-hybrid screens and GST-
pulldowns highlighted a direct interacting potential between KLC1 and nesprin-2. These 
investigations therefore provide strong support to suggestions that nesprins play key roles 
in recruiting both actin and MT networks to the NE.  
     It is further suggested that nesprin-4 and KASH5 also plays roles in recruiting MT 
networks to the NE. Nesprin-4 has been shown to interact with kinesin [78], through which 
experimentation shown that nesprin-4 overexpression in HeLa cells stimulated significant 
changes in cellular organisation, including relocation of Golgi and centrosome 
components away from the NE. KASH5 however, is located specifically to germ cells, 
where interactions have been displayed with the dynein-dynactin complex [85].  
     In contrast to nesprin proteins described thus far, nesprin-3 displays interactions with 
plectin, noted for its roles in connecting intermediate filament networks throughout the cell. 
Notably, plectin is further shown to mediate connections between the three major 
cytoskeletal networks [86]. Thus, this vast diversity of KASH proteins making up the LINC 
complex presents interacting potential between the NE and all three cytoskeletal 
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networks. Further to this, the varying isoforms of nesprin infer unique properties to the NE 
due to their associated interacting potentials and binding partners, suggesting that their 
relative expression could confer unique properties to the NE-cytoplasmic filament 
interactions.   
     Thus far, it has been described how interactions between SUN domains and KASH 
peptides across the PNS produce a physical connection between INM and ONM regions 
of the NE. Through associated binding of KASH proteins to cytoskeletal components and 
SUN interactions with the nuclear lamina, this connection is able to physically connect 
nucleoskeletal and cytoskeletal components, allowing a bridge for cross talk between the 
two subcellular compartments.  
     The importance of this physical bridge across the NE can be seen through its high 
conservation through evolution. At least one pair of SUN- and KASH- domain proteins is 
found across all higher eukaryotes, and although homologues are not as readily apparent 
in lower eukaryotes, current in-depth research is beginning to uncover these conserved 
protein bridges [87]. It has been identified that during evolution, multicellular eukaryotes 
have amplified both SUN and KASH components, but not necessarily in equal 
proportions. For example, mammals tend to have 4-6 KASH and 4-6 SUN domain 
containing proteins, whereas fish display double the number of KASH-domain containing 
proteins and only half the number of SUN proteins. When combined with current 
understanding of LINC associated proteins, this conservation suggests strong evidence 
for potential unique LINC functionalities, specific to different tissues, developmental 
stages and organisms [88]. In support of this suggestion, investigations by Göb et al. 
highlighted the existence of two distinct LINC complex connections established during 
mouse sperm development [54]. These include the spermatogenesis specific SUN3-
nesprin-1, and SUN1η (a novel SUN1 isoform) -nesprin-3 interactions. Interestingly, it was 
shown that each LINC connection localised to opposite spermatid poles, likely providing 
sperm-specific interactions with cytoskeletal components. These investigations therefore 
highlights that not only are LINC connections required to connect the nuclear interior with 
cytoplasmic components, but may also infer unique region specific cytoskeletal 
interactions across the NE, aiding in the formulation of cell polarisation, and subsequent 
differentiation.  
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1.1.1.5    LINC mediated NE - cytoskeletal connections. 
 
     Further to KASH protein interactions with SUN proteins, forming the physical 
connections between INM and ONM, cytoplasmic extensions of the KASH proteins also 
infer connections between the NE and cytoskeletal filaments. Through these connections, 
the NE is linked to the cytoskeleton and its associated interactions with the extra-cellular 
matrix (ECM). This cytoplasmic filament system consists of three major protein networks 
defined by size; microfilaments (actin) (7 nm), intermediate filaments (IFs) (10 nm) and 
microtubules (MTs) (25 nm) (Figure 1.4).  
 
 
 
 
  
    Each filament network works in close association to define cell shape and structural 
integrity, but also maintain specific cellular functions such as maintaining cytokinesis, 
intracellular transport, cell signalling and cell migration [89]. Some assemblies of these 
filament networks display further tissue specificity, such as the formation of Z-bands in 
muscle between actin and desmin, the formation of actin in acrosomes or spermatozoa, 
alongside cilia/flagella formation in many biological systems [89, 90].   
     Microfilaments are formed through the oligomerisation of actin, forming two strands 
which further wrap around each other forming a right handed spiral, whereas MTs form 
through the assembly of α- and β-tubulin heterodimers, able to form linear protofilaments 
which in turn are able to interact laterally to form a sheet that circularises into a 25 nm 
Figure 1.4: Schematic of the major cytoskeletal filament networks in mammalian systems. 
(A) Shows actin filament arrangement into a right handed spiral comprised of oligermerized 
actin subunits, (B) displays intermediate filaments, made up from head-to-tail assembly of 
subunits, and (C) displays microtubule filaments, comprised of α- and β-tubulin heterodimers 
formed into hollow tubular structures. [506]. 
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wide hollow tube [89]. In contrast to other cytoskeletal filament networks, IFs display very 
different properties, both through their coiled-coil rod domain making them insoluble, and 
through their dimers assembling into head to tail linear arrays, which further layer forming 
a ~10 nm diameter filament comprising of 32 molecules [91]. IF networks further differ in 
their cellular dynamics. Both actin and tubulin networks display dynamic assembly and 
disassembly in response to environmental stimuli, are stabilised by tension and are highly 
polarised to facilitate directional movement by associated motor proteins. In contrast, IFs 
are much less dynamic, confer cell stability through resistance to tension and have no 
polarity [89]. This helps to highlight that each filament network is able to provide unique 
functionality to cellular systems, through its physical properties, associated binding 
partners or NE connections, able to link the nucleus to various cytoplasmic functions and 
ECM components.  
     The association of actin filaments to the NE is mediated through the giant KASH 
proteins nesprin-1G, nesprin-2G in vertebrates and ANC-1 in C. elegans through their 
paired CH domains which closely resemble those displayed by known actin associating 
proteins like actinin. It has been well documented that these CH domains, situated across 
KASH N-terminal regions are sufficient to bind actin filaments to the NE, enabling actin 
dependant nuclear movement and positioning [92, 93]. However, recent studies indicate 
that these CH domains alone are not sufficient to resist the mechanical strain exhorted by 
the actin cytoskeleton during nuclear movement [94].  Polarising fibroblast cells re-position 
their nucleus towards the rear of the cell, resulting in re-orientation of the centrosome [95]. 
This movement is enabled through coupling retrograde moving actin cables to the NE 
through SUN2-nesprin-2G LINC connections, arranged into linear arrays known as 
transmembrane associated nuclear (TAN) lines [96]. Kutscheidt et al. [94] were able to 
show that nesprin-2G was necessary for the formation of TAN lines and resulting nuclear 
movement, however, required a further interaction with the formin FHOD1 actin binding 
proteins to perform this function. FHOD1 contains a typical formin domain structure 
alongside a unique second actin binding site which, in conjunction with an adjacent site 
that binds to SR11-13 of nesprin-2G, is able to sufficiently cross link nesprin-2G and actin 
across the NE. These FHOD1 interacting domains found in nesprin-2G are not present in 
nesprin-1G, suggesting a unique role played by nesprin-2G in resisting mechanical stress 
upon nuclear movement.  
     Aside from actin connections across the NE mediating nuclear movement, MT filament 
networks are also tethered to the NE through interactions with KASH proteins including 
nesprin-1, nesprin-2, nesprin-4 and KASH5 in mammalian systems [97]. In most cases, 
this interaction is mediated through association of KASH proteins with the motor proteins 
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kinesins or dynein or both. One exception however, comes from the KASH-less p50nesp1 
isoform, containing SRs 48-51 of nesprin-1. This isoform has been shown to display direct 
interacting potential with MTs through co-sedimentation assays [98]. The impact of this 
finding could suggest that all nesprin-1 isoforms containing SRs 48-51 could also display 
direct MT interactions, however, to date this hypothesis has not yet been tested. Nesprin-
1, nesprin-2 and KASH5 have been shown to bind with specific subunits of the motor 
proteins dynein. For KASH5, this binding with dynein and dynein regulators occurs in 
close proximity to its KASH domain [99], whereas the interaction sites for nesprin-1/2 and 
dynein have not yet been resolved.  Several KASH proteins also display interacting 
potential with kinesin-1 motors, including nesprin-2 [77] and nesprin-4 [78], mediated 
through direct binding between kinesin-1 light chain (KLC) tetraticopeptide repeats and 
sites close to the KASH domain.  
    Of further emerging interest are suggestions that KASH proteins are able to interact 
with multiple motor proteins or cytoskeletal elements. For example, across its N-terminal 
region, nesprin-2G display interacting potential with actin through CH domains and 
FHOD1 interaction sites, whereas interaction potential with kinesin is inferred at its other 
end. This suggests potential dual functions played by individual KASH proteins across the 
NE, able to confer specific functionalization based on environmental requirements. For 
example, nesprin-2G is involved in actin dependent nuclear movement in fibroblast cells 
[93], alongside MT and dynein dependant nuclear movement in developing neurones 
[100]. This suggests that further regulatory mechanisms must be in place to allow 
selection of one mechanism for nuclear movement over another dependant on the 
situational requirements.  
     The engagement of KASH proteins with MTs across the NE has also been shown to 
facilitate centrosome movement in number of mammalian systems. These proteins 
include nesprins-1-3, and KASH5, all of which have been shown to play roles in retaining 
close positioning between centrosomes and nuclei [99, 100]. In contrast, Roux et al. 
showed that overexpression of GFP-tagged nesprin-4 constructs into HeLa cells 
stimulated a detachment of centrosomes from the NE, resulting in a fivefold increase in 
nuclear to centrosome distance [78]. This again helps to support suggestions that a 
complex interplay between KASH proteins exists across the NE to maintain normal 
cellular function.  
     Nesprin-3α is the only KASH protein to date known to interact with cytoplasmic IF 
through a unique region situated across its N-terminal domain. This region interacts with 
the ABD domain of plectin, which in turn, binds IFs through its plakin domain [86]. It is also 
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interesting to note that further binding has been suggested between nesprin-3α and N-
terminal ABD domains of nesprin-1G and nesprin-2G. This interaction has been 
hypothesised to control nuclear size through the formation of a nuclear cage situated 
across the ONM [101]. Integration between NE and IFs (mediated through nesprin-3α) 
has also been implicated in regulating cellular responses to shear stress, force 
transmission and flow induced cell polarisation [102, 103].   
     The described ability of KASH proteins to confer variable NE interacting potential with 
multiple cytoskeletal components both individually, or at the same time, highlights the 
complex mechanisms by which the LINC complex is able to relay mechanical and signal 
induced responses from the NE to cytoplasmic regions. Therefore providing a subtle 
regulatory mechanism, through which cells can dictate responses to environmental 
stimuli.  
 
1.2    Roles of the LINC complex in normal cell function. 
 
1.2.1    LINC complex roles in maintaining nuclear architecture 
and correct nuclear movement. 
 
     The maintenance of nuclear architecture is of great importance to the maintained 
functionality of many cell types due to its suggested roles as an anchoring site for many 
cytoskeletal components [104]. In this recent evidence, it was shown that nuclear shape 
changes result from peripheral cell boundary dynamics, as a result of variations in 
mechanical stress and strain mediated through the cytoskeleton. The nuclei of most cells 
display a nuclear shape of either round or oval morphology, with alterations in this nuclear 
shape being implicated as an important factor in the development of many disease 
phenotypes. Moreover, in certain specialised cell types, altered nuclear shape is important 
to their function, such as that found neutrophils, in which, protein composition across the 
NE is adapted to increase nuclear malleability, allowing increased cellular migration in and 
out of numerous tissue systems [105]. 
     An essential LINC complex component shown to play roles in maintaining nuclear 
architecture is the nuclear lamina. The importance of this protein network in maintaining 
nuclear shape has been well characterised, with analysis of lamin A/C deficient MEFs and 
LMNA1 RNA interference (RNAi) in C. elegans shown to lead to alterations in nuclear 
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shape [106, 107]. Further to this, many laminopathies are characterised by altered nuclear 
shapes, most notably presented in the development of the premature aging disease 
Hutchinson-Gilford progeria syndrome (HGPS). The mutation stimulating the formation of 
HGPS was mapped to the LMNA gene [108], stimulating the activation of a cryptic splice 
site, which in turn, results in the generation of an aberrant form of lamin A, called progerin 
which is constitutively lipid-modified across the INM [109]. It is hypothesised that this 
constitutive lipid-modification of lamin A stimulates the observed alterations in nuclear 
shape, as treatment of cells from HGPS patients with the farnesyl transferase inhibitor 
rac-R115777 (designed to inhibit farnesylation), reverses the abnormalities in nuclear 
shape [110]. More recent investigations into roles of lamin proteins in maintaining nuclear 
architecture have suggested further functions in maintaining the structural integrity of the 
nucleus, as well as conferring its sensitivity to mechanical stress. For example, lamin A/C 
have been shown to play key roles in defining the nuclear lamina’s elastic properties; 
through which lamin A/C deficient HeLa cells, displayed increased numbers of misshapen 
nuclei and a decreased nuclear stiffness [111]. Further to this, when wildtype or mutant  
lamin A is overexpressed within Xenopus oocyte nuclei, nuclear stiffness is shown to 
increase proportionally to the lamin A concentration inserted [112]. 
     Further to roles for lamin A/C in maintaining nuclear architecture, current investigations 
further implicate roles for lamin B in maintaining the integrity of the NE. Current 
investigations suggest that lamin B1 absence in MEFs results in no changes to the elastic 
properties of the nucleus, however stimulates severe abnormalities in nuclear morphology 
[113]. More recently, Ferrera et al. investigated the effects of lamin B1 overexpression 
associated with autosomal dominant leukodystrophy (ADLD) on nuclear function and 
mechanics [114]. It was shown that transient transfection of lamin B1 into both HEK293 
and neuronal N2a cells stimulated an increased nuclear stiffness, similar to that found 
within ADLD cells. More importantly however, in ADLD fibroblasts, reducing lamin B1 
levels through shRNA knockdowns was shown to restore elasticity values 
indistinguishable from those of control fibroblast cells. It was shown that isolated nuclei 
from ADLD fibroblasts displayed reduced nuclear ion channel open probability in voltage-
step application, suggesting that the increased lamin B1 levels associated with ADLD also 
contribute to altered nuclear signalling cascades in somatic cells. These findings therefore 
help to highlight the complex roles played by lamin components of the LINC complex in 
regulating nuclear architecture.  
     Of further importance in maintaining nuclear architecture are the KASH proteins 
situated across the ONM. It has been shown that the maintenance of LINC connections 
across the NE, specifically those mediated through nesprin-2 interactions are required to 
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maintain normal nuclear size and shape [115].  Further work conducted by Kandert et al. 
[116] suggested that nesprin-2G is responsible for maintaining nuclear shape when 
correctly localised to the NE. In this investigation, it was observed that p.S143F progeria 
fibroblast cells (LMNA mutant cells) exhibited dysmorphic nuclei containing nuclear blebs 
and lobulations, which increased in number during cell aging in culture (Figure 1.5). On 
closer observations, it was shown that nesprin-1 displayed a slight increase in cytoplasmic 
distributions in mutant cells, whereas nesprin-2 appeared to be mostly reduced or absent 
from the NE. Interestingly however, through immunofluorescence analysis against nesprin 
2 N- and C-terminal regions, it was shown that mutant fibroblast cells expressing even low 
levels of nesprin-2G across the NE displayed normal nuclear shapes, with significant 
reductions in nuclear blebs and lobulations. Observations from this work were therefore 
able to suggest that correct nesprin-2G localisation across the NE was able to safe-guard 
the nuclear architecture within LMNA mutant cells. Alongside this, further investigations 
have described the combined roles of nesprin-1G, nesprin-2G and nesprin-3 in the 
maintenance of nuclear shape, suggesting the complex interactions displayed across the 
range of nesprin proteins forms a cage across the ONM, able to control nuclear size and 
shape [101].    
 
 
 
 
Figure 1.5: p.S143F progeria fibroblasts display normal nuclear morphology when expressing 
nesprin-2G. (A) Displays indirect immunofluorescence analysis of nesprin-2 C-terminal (pAbK1), 
and N-terminal (K20-478) staining. Arrows present mutants expressing low C-terminal levels and 
asterisks display cell lacking N-terminal staining.  (B) Displays histogram data of nuclear 
deformations in cells positive for nesprin-2 N-terminal regions, showing reduced nuclear 
deformations observed in both young and aged mutant cells positive for nesprin-2G. (C) Displays 
western blot data against nesprin-2 N- and C-terminal regions across control and mutant 
fibroblasts, indicating a slight reduction in nesprin-2G in mutant fibroblasts. [116]   
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     Aside roles in maintaining nuclear shape, size and mechanical properties, LINC 
components have been further suggested to influence the distance between INM and 
ONM regions of the NE [58]. However, literature views are mixed on this issue. In HeLa 
cells for example, disrupting the SUN-KASH interaction across the PNS with dominant 
negative versions of SUN/KASH, or siRNA knockdowns alters spacing between the two 
membranes [33]. However, disruptions of the SUN homologue UNC-84 in C. elegans only 
affect membrane spacing when nuclei are actively under force such as in wall muscle 
cells, and further deleting a large portion of the luminal domain does not appear to change 
the spacing [117]. As the nuclei in HeLa cells, like many other adherent cells, are under 
constant tension, these studies suggest the LINC complex may only contribute to INM and 
ONM spacing when the nucleus is under stress. Current views have now clarified these 
prevailing models, suggesting that across many cells, the SUN protein component of LINC 
complex interactions is necessary to maintain the even spacing between INM and ONM in 
cells under high mechanical strain [118]. However, these interactions are not required in 
cells not undergoing nuclear strain.  
     Alongside the maintenance of nuclear architecture, nuclear positioning is also an 
important cellular process, leading to the establishment of cell migration, cellular polarity, 
cell division and zygote formation. It is thought that three main protein families play roles 
in maintaining correct nuclear movement; the cytoskeleton, motor proteins and KASH 
proteins, which are all key components of the LINC complex.  
     The involvement of MT and MT-associated proteins in nuclear migration has been 
documented across a range of organisms. Dynein and its activator complex dynactin have 
been shown to control nuclear migration events in budding yeast and Drosophila [119] 
[120], with further LIS1 loss (a dynein and MT-binding protein) shown to affect neuronal 
migration in humans during cerebral cortex development, leading to the development of 
lissencephaly [121]. Alongside roles for cytoskeletal components to act alone in nuclear 
movement, the combined action of both MT and actin networks has also been implicated 
in nuclear migration [122]. In Xenopus for example, the MT and actin binding Myo10 
facilitates nuclear anchorage and spindle assembly [123].  
     This coordinated action of multiple cytoskeletal components in nuclear migrations has 
been attributed to LINC connections across the NE. It has been shown that ANC-1 loss in 
C. elegans stimulates nuclear clumping, preventing the correct nuclear migration to their 
assigned destinations [92]. In mammalian systems, extensive mouse models have been 
used to demonstrate that nuclear anchorage is mediated by nesprins in vivo. Transgenic 
mice overexpressing a dominant negative nesprin-1 KASH domain under the regulation of 
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a muscle specific promoter display a loss of nuclear anchorage beneath neuromuscular 
junctions in skeletal muscle [124]. It was also suggested nesprin-1 -/-KASH domain knockout 
mice display synaptic nuclei displacement alongside extensive branching of phrenic 
nerves, suggesting that nesprin-1 mediated synaptic nuclear anchorage may be essential 
in maintaining neuronal innervation sites. In contrast, nesprin-2 -/-KASH domain knockout mice 
display no abnormalities in nuclear anchorage.  
     Interestingly, when all actin connections are abolished across the NE in nesprin-1/-2 -/-
KASH domain knockout mice, a lethal phenotype is observed [125], suggesting the existence 
of a potential redundancy mechanism between these KASH proteins. It is not considered 
in these experiments however, the potential impact of these knockouts on other KASH 
isoforms across the NE. These animal models may additionally disrupt the function of 
KASH proteins which do not display direct actin interactions. For example, nesprin-1 and 
nesprin-2 both display interacting potential with dynein and kinesin-1, coupling the 
centrosome to the NE in neurons of the developing mouse brain. In the nesprin-1/-2 
knockout mouse described above, the centrosome was shown to un-couple from the NE 
resulting in severe nucleokinesis and interkinetic nuclear migration defects [100]. As the 
binding motifs for these motor proteins have not yet been mapped across nesprin-1 or 
nesprin-2 proteins, they could interact with one or multiple SRs across the N-terminal 
regions or truncated KASH domain variants. This therefore suggests further investigation 
is required to understand the complex interplay between LINC components across the NE 
during nuclear migration and subsequent cellular processes.  
     Due to these observed roles of LINC components in maintaining correct nuclear 
positioning and migration, it is not surprising that the LINC complex is further implicated in 
the development of cell polarity, a crucial process responsible for directing correct cellular 
differentiation and tissue formation across many organisms. Nesprin-3 for example has 
been implicated in the establishment of flow induced polarity of human aortic endothelial 
cells (HAECs) through regulating nuclear-MTOC connectivity [103]. Through the 
application of nesprin-3 siRNA, it was shown that not only was this silencing sufficient to 
sever connections between the NE and MTOC, but also the HAECs ability to correctly 
polarise in response to environmental flow. Alongside nesprin-3, nesprin-4 has been 
further implicated in regulating kinesin mediated cell polarisation [78], through the 
regulation of both centrosome and Golgi positioning in the cell.  
     With more current investigations now implicating the LINC complex as having key 
functional roles in maintaining cell polarity in both fibroblast and myoblast cells [126, 127],  
it can be suggested that the complex interplay of protein interactions across the NE, 
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mediated by the LINC complex components, is able to infer a further regulatory 
component facilitating nuclear migration and the maintenance of nuclear architecture.  
 
1.2.2    LINC roles in force transmission and 
mechanotransduction across the NE. 
 
     Investigating the processes by which cells are able to transmit force from peripheral 
cellular regions to the NE, and subsequently induce a response through alterations in 
signalling pathways or gene expression is an area of great interest in current cell biology 
fields. Initial evidence suggesting the nucleus of a cell is under tension came from Sims et 
al. in 1992 [128], through which it was shown that disrupting the actomyocin forces 
exerted across the nuclear surface altered both cell and nuclear shape. Further work from 
this research group later showed that the tugging of integrin receptors situated across the 
plasma membrane stimulated direct distortions across the NE [129], displaying the first 
indication as to direct physical links existing between the NE and plasma membrane. This 
established the concept that forces applied externally to the cell, such as those from the 
surrounding ECM, are propagated to the nuclear surface, which links closely to 
mechanical models suggesting physical interactions exist between cytoskeletal networks 
and the NE [130, 131, 132]. Current investigations further support these suggestions, 
showing that external cellular forces are able to induce clearly detectable nuclear 
deformations across a range of cells [102, 133, 8].  
     In recent years, the LINC complex has been highlighted as the only known structure by 
which cytoskeletal stresses can be directly transferred to the nuclear surface (Figure 1.6). 
Since the cytoskeleton has been shown to directly connect with focal adhesions and cell-
cell junctions across the plasma membrane [134, 135], subsequent connections with LINC 
components across the NE therefore enable a mechanism by which the nucleus, 
cytoskeleton and ECM can be physically connected [14, 136]. In support of this, current 
understanding suggests LINC complex components are required for correct nuclear 
positioning, cell polarisation, propagation of cytoskeletal forces [137] and the efficient 
transfer of force between the nucleus and cytoskeleton [102, 138].    
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     It has been demonstrated that forces applied to the apical surface of living cells are 
able to propagate through the cytoskeleton and induce a response to the nucleus in 
emerin deficient MEFs [69], alongside integrin manipulation able to invoke direct motion in 
cellular organelles in bovine capillary endothelial cells [129, 133]. It was recently shown 
that nesprin-1 knockdowns in human umbilical vein endothelial cells (HUVECs) through 
siRNA-mediated silencing were able to significantly increase the nuclear height [139], 
suggesting potential roles for nesprin-1 in flattening the nucleus in endothelial cells. 
Following this, Chancellor et al. was further able to show that inhibiting myosin activity in 
HUVECs induced similar phenotypes [140], leading to their proposed model in which 
actomyocin force pulls laterally on the nucleus, stimulating the observed flattened disk 
phenotype. In this proposed model, the nucleus is suggested to act as a scaffold to 
balance the actin and microtubule forces internally, whilst the extracellular substrate 
balances them externally. Through their investigations, the absence of nesprin-1 
Figure 1.6: LINC mediated mechanotransduction from the ECM to the nucleus. (A) The 
actin cytoskeleton links focal adhesions at the plasma membrane to the LINC connections 
across the NE. (B) Focal adhesions are sites of integrin clustering and adhesion to the ECM. 
(C) Actin filaments connect to LINC complex components situated across the ONM, 
stimulating signal transduction to the INM. [134]  
24 | P a g e  
 
substantially reduces the pulling forces exerted across the nuclear surface, leading the 
nucleus to ‘relax’ vertically, forming a more rounded shape, whilst excess forces are 
balanced through an increased number of adhesion sites with the substratum.  
     Following from this, a series of recent papers were able to show that dorsal actin 
bundles situated across the top of the nucleus interacted with the NE through TAN line 
formation, mediated by nesprin-2G and SUN2 [93]. It was suggested that these TAN lines 
act in a similar fashion to focal adhesions situated across the plasma membrane due to 
both assemblies able to anchor actin cables to each respective membrane and transmit 
mechanical force [93, 94]. Aside this, it has been suggested that further unique actin 
organisations across the NE surface are also present, comprising of distinct apical stress 
fibres forming across the top of the nucleus, able to manipulate nuclear shape [141]. 
These ‘Actin Caps’ link to the peripheral plasma membrane through specialised focal 
adhesions, which have been shown to be larger than conventional focal adhesions as well 
as displaying faster turnover dynamics [142]. These actin caps alongside associated focal 
adhesions have been proposed to provide fast and efficient, physical pathways for 
mechano-transduction by providing a stabile connection between the ECM and nuclear 
regions of the cell [143, 144].  
     Further to actin, MTs have also been implicated in the generation of tension across the 
NE, mediated through LINC connections. It was shown that through binding the NE via 
cargo ends, dynein and kinesin are able to pull the nucleus either towards or away from 
centrosomes respectively [145]. Further work by Wu et al. highlighted roles for these 
interactions in eliciting nuclear rotation in response to environmental stimuli, alongside 
producing a computational model describing how this process occurs [146].  
     It is therefore evident that the physical links between the NE and surrounding ECM 
mediated by LINC complex components is of great importance in the maintenance of 
normal cell function. However, to date the exact mechanisms by which cells sense and 
subsequently respond to environmental stimuli is still unclear. One potential mechanism 
by which mechanotransduction through LINC components could elicit a cellular response 
to environmental stimuli comes from evidence suggesting that nuclear forces could 
potentially regulate gene expression [147]. In response to cyclic strain, lamin A/C deficient 
and emerin deficient mouse embryonic fibroblasts (MEFs) display impaired expression of 
the genes lex-1 and Egr-1 [106] alongside impaired nuclear translocation of MKL-1 
transcription factor [148].  
      It can therefore be suggested that although the precise mechanisms by which nuclear 
coupling to the ECM through LINC associations is able to elicit a cellular responses to 
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external stimuli remains unknown, evidence is emerging that LINC components are critical 
in maintaining efficient mechanotransduction and force transmission across the NE.  
 
1.2.3    The LINC complex displays functions in regulating 
signalling and chromatin anchorage across the NE.  
 
     As growing evidence suggests roles for LINC complex in maintaining 
mechanotransduction through the cell, further research has presented propositions as to 
roles of LINC connections in regulating cellular signalling pathways. Early investigations 
were able to show that nesprin-1 interacts with both muscle specific tyrosine kinase and 
muscle A kinase anchoring protein (mAKAP) [79, 15], known to complex signal 
transduction molecules such as cAMP-dependent protein kinase A and protein 
phosphatase 2A. More recently however, nesprin-2 has been shown to display interacting 
potential with α-catenin alongside the NE protein emerin [149]. Through these 
interactions, it was shown that nesprin-2 was able to positively regulate the nuclear 
localisation of active β-catenin alongside Wnt signalling [149]. Interestingly however, it has 
been further documented that emerin is able to bind with β-catenin and negatively 
regulate Wnt signalling by restricting nuclear accumulation of β-catenin [9]. When collated 
together with knowledge that emerin and α-catenin bind to the same region of nesprin-2, it 
can be suggested that both proteins compete for nesprin-2 binding, inferring roles for 
nesprin-2 within the regulation of Wnt signalling (Figure 1.7).  
     Of further interest is that this role of KASH proteins in the regulation of Wnt signalling 
may be evolutionary conserved. ANC-1 in C. elegans has been shown to interact with 
Regulator of Presynaptic Morphology 1 (RPM-1), a regulator of neuronal development and 
regulation [150]. Further genetic studies suggested that RPM-1, ANC-1 and β-catenin 
work together to regulate the formation of synapses in motor neurons and axon 
termination sites in mechanosensory neurons. To maintain this function, it was shown that 
ANC-1 retention to the NE is required, with emerin displaying a negative regulatory role 
similar to that found within mammalian systems [151]. This evidence supports current 
hypothesis that the retention of KASH proteins across the NE contributes to Wnt signalling 
through enhancing the perinuclear concentration of active β-catenin.  
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     Aside strong evidence for roles of LINC components in the regulation of Wnt signalling, 
further implications have been made between the LINC complex and rapid 
mechanochemical signalling in the nucleus [152]. It has been well documented that the 
nucleus responds to mechanical force sourced from extracellular regions, and that LINC 
complex components are necessary for this force transmission. However, it has proven 
difficult to determine whether LINC complex components are able to convert these 
mechanical stimuli into chemical signals in the nucleus. The first evidence for direct roles 
Figure 1.7: Model of nesprin-2 and α-catenin roles in Wnt signalling. (A) α- and β-catenin 
localise to adherence junctions and the cell periphery, forming links with the actin cytoskeleton. 
Nesprin-2 and emerin are localised to the NE, where emerin across the INM supports β-catenin 
nuclear export. (B) α-catenin can be dislodged from the plasma membrane through reduction in 
cell contacts, where it then moves to the NE. (C) During Wnt pathway activation, cytoplasmic β-
catenin levels increase. A quaternary complex of nespri-2, emerin, α- and β-catenin can be 
formed across the ONM. When this complex dismantles, β-catenin then enters the nucleus. (D) 
Upon loss of nesprin-2, reduced β-catenin is observed in the nucleus, hypothesised due to a 
loss of α- and β-catenin quaternary complexes forming at the NE. [9] 
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of LINC components in mechanosensing came from Guilluy et al. [153], in which magnetic 
tweezers were used to pull on nesprin-1 antibody coated beads attached to the surface of 
isolated endothelial and fibroblast nuclei. This pulling force was shown to stimulate a 
stiffening response in the nucleus, through which increased accumulation of A-type 
lamins, activation of Src and tyrosine phosphorylation of emerin were observed. This 
helped to identify the first instance of direct correlation of KASH proteins and nuclear 
mechanotransduction responses.   
     Alongside documented interactions between LINC complex components and signalling 
molecules across the NE, further roles of the LINC complex in meiotic chromatin 
anchorage have also been speculated. During meiosis, the LINC complex is mobile 
across the NE, tethered to defined regions of chromosomes (telomeres in mice and 
pairing centres in C. elegans) [85]. This tethering is required for chromosome movement 
and is mediated through interactions between meiotic proteins that link regions of the 
chromosomal site and SUN proteins, and subsequently the cytoskeleton through LINC 
associations. In mammalian systems, associated interactions with KASH5 enable 
telomere associated SUN1 to engage dynactin and dynein, mediating meiotic 
chromosome movement [99, 154]. SUN2 has been further implicated in telomere 
tethering, but may not be required for meiosis [155]. 
     The mechanism by which the LINC complex is modified in meiotic cells to enable force 
transmission directly to the chromosomes is still unclear. However, one possibility is that 
during meiosis, LINC components are post-translationally regulated. Suggestive evidence 
for this comes from Penkner et al. and Wynne et al. [156], through which it was shown in 
C. elegans that specific phosphorylation of Ser/Thr residues in the nucleoplasmic tail of 
SUN1/Matefin occurs during meiosis, which is essential for meiotic movement. Further to 
this, these modifications may also contribute to an increase in LINC complex mobility 
across the NE, which have been observed during the onset of meiosis [157].  
     A further potential mechanism by which LINC modifications may enable chromosome 
migration could reside in the formation of the nuclear lamina itself. In mammalian germ 
cells, a meiotic specific A-type lamin (lamin C2) is expressed, localised to sites of LINC 
mediated telomere tethering [158, 159]. This lamin sub-type lacks the amino-terminal 
head, alongside the central α-helical rod domain required to allow filament formation [158]. 
The expression of lamin C2 in somatic cells has been shown to alter the localisation of 
SUN proteins and lamin B1, suggesting potential roles for lamin C2 in modifying the 
anchoring mechanisms of LINC associated proteins. However, it was further shown that 
tethering of meiotic telomeres to LINC components was not altered in the absence of 
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lamin C2, but detachment of the telomere-LINC connection was affected, suggesting that 
the presence of lamin C2 may only be required for the efficient separation of 
chromosomes after migration.  
     It is further suggested that the LINC complex functions in DNA damage repair. It has 
been shown across both budding yeast and fission yeast systems that LINC components 
Mps3 and Sad1/Kms1 respectively are able to localise to sites of DNA double-stranded 
breaks and participate in repair [160, 161]. In mammalian systems, SUN1 and SUN2 are 
seen to interact with DNA-dependant protein kinase, which function in DNA repair, with 
loss of either SUN1 or SUN2 perturbing this process [161]. Further to SUN proteins, 
nesprin-1 has been shown to interact with DNA damage response proteins MSH2 and 
MSH6 through N-terminal CH domains [162], suggesting strong evidence that LINC 
components play roles in anchoring regions of damaged DNA in order to facilitate efficient 
repair across the NE.  
     It can therefore be seen that the LINC complex functions across a wide range of 
cellular activities, contributing to nuclear architecture, chromatin organisation and 
mechanotransduction events across the NE. This wide ranging functionality is further 
supported through the high degree of conservation across many LINC proteins, 
suggesting that the inferred functions of the LINC complex connections are fundamental in 
maintaining cellular homeostasis.   
 
1.3    Roles of the LINC complex in disease development. 
 
     Due to wide ranging cell functionality displayed by the LINC complex, it is of no 
surprise that LINC complex components have been implicated in the development of 
numerous disease phenotypes. With extensive reviews covering the broad range of 
laminopathies deriving from mutations in both LMNA and LMNB2 genes [163, 164, 165] 
we will focus herein on roles for KASH and SUN proteins in the development of multiple 
disease phenotypes. 
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1.3.1    LINC complex roles in neurodegenerative and 
musculoskeletal disease development. 
 
     As SYNE-1, SYNE-2 and SYNE-4 genes display a wide range of splice variants 
leading to the extensive range of nesprin protein isoforms, the roles of nesprins in the 
development of diseases has become an area of great interest over recent years. Current 
evidence suggests strong links between mutations in SYNE-1 and the development of a 
number of neurodegenerative diseases including late onset ARCA1 (autosomal recessive 
cerebellar ataxia type 1) [166] and cerebellar ataxia [167]. Interestingly, although ARCA1 
has been linked to nonsense mutations scattered along the SYNE-1 gene in a range of 
populations [168, 169], little is known about the molecular etiology of its debilitating late 
onset phenotype. In recent work however, it has been shown that nesprin-1 expression is 
specific to the CNS, with an abundant expression of a KASH’less nesprin-1G isoforms 
(KLnes1g) highlighted in the cerebellum [170]. This KLnes1g isoform was shown to 
express noncanonical localisation at glomeruli of cerebellar neurons, whereas nesprin-2 
retained specific staining across the NE in all tissues. Due to the specific nature of 
KLnes1g expression in the CNS, it was proposed that these nonsense mutations along 
the SYNE-1 gene may stimulate dysfunction in KLnes1g isoforms. As KLnes1g is found 
most abundantly expressed in the cerebellum, this may explain why ARAC1 mutations 
mostly target cerebellar function and integrity. Aside alterations to the regulation of 
KLnes1g, further abnormal SYNE-1 splicing or translational modification events could lead 
to the development of truncated or shortened nesprin-1 protein variants, which in turn, 
stimulate the late onset phenotypes of ARAC1 due to disruptions to the LINC complex 
[171]. With evidence also available to suggest that SUN1 deficiency may be a leading 
cause to the development to multiple cerebellar ataxia conditions [172], it is becoming 
evident that disruptions to the SUN-KASH NE interactions may be a causative factor in its 
onset.  
     As the maintenance of KASH proteins have been identified as a key factor in brain 
development, further links have also been made between this protein family and the 
development of a number of disorders associated with the brain, including schizophrenia, 
bipolar disorder, depression and autism spectrum disorders (ASD). Recent evidence has 
identified the SYNE-1 gene as a potential candidate gene in the development of ASD 
through the application of whole-exome sequencing, through which it was shown that 
biallelic mutations in SYNE-1 across both consanguineous and nonconsanguineous 
families were displayed [173, 174]. In further genome-wide association studies, links 
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between SYNE-1 and both bipolar disorder and recurrent major depression were made 
[175] through which significant correlations in SYNE-1 polymorphisms and disease onset 
were made. This helps to provide further support for the roles of nesprins in the 
development of numerous neurodegenerative diseases.    
     Over recent years, the LINC complex has been further implicated in the development 
of Emery Dreifuss muscular dystrophy (EDMD), characterised by progressive skeletal 
muscle wasting and potentially fatal cardiomyopathies. Much of the literature accredits its 
development to mutations in emerin (X-EDMD, EDMD1) and lamin A/C (EDMD2, AD-
EDMD), however, increasing evidence is developing suggesting roles of further LINC 
complex components in its onset [37]. For example, in fibroblasts extracted from DMD 
suffering patients, distribution and abundance of nesprin-1 and -2 were seen to be altered 
compared to controls [176]. Through the use of both immunofluorescence and western 
blotting analysis, it was seen that nesprin-1 and -2 displayed decreased expressions 
across the NE of patients suffering from DMD, with the lower C-terminal containing 
isoforms of nesprin-1 displaying the largest decrease. Further studies also support these 
propositions in which lower isoforms of nesprin-1/-2 may be the leading nesprin 
contributor to EDMD, through evidence highlighting missense mutations residing in 
nesprin-1α and nesprin-2β, two small ONM and INM positioned, KASH- and SR-
containing variants of SYNE-1 and SYNE-2 [82, 177]. It is believed that due to binding 
sites of nesprin-1 and nesprin-2 to emerin and lamin A/C overlapping, that disruptions to 
nesprin/emerin/lamin A/C interactions within the LINC complex lead to the development of 
EDMD [42]. 
     With further links also suggesting roles for nesprin-1/-2 in the development of 
Duchenne muscular dystrophy (DMD) [176] and autosomal recessive myogenic 
arthrogryposis multiplex congenita (AMC) [178], it can be suggested that nesprins play 
key roles in the development of neuromuscular disorders. However, the exact 
mechanisms by which nesprins are able to stimulate the development of these disorders 
are still unclear due to the complex nature of SYNE genes and multiple nesprin isoform 
variants.   
     Of further interest was the identification of a down regulation of SUN2 in patient 
fibroblasts expressing DMD and EDMD-CMT phenotypes [176]. Upon closer inspection, 
the proteome of EDMD-CMT patient fibroblasts was significantly altered to that of healthy 
controls (Figure 1.8), displaying altered SUN2 interacting potential through the application 
of GST pulldown techniques. These findings further help to support suggestions that 
alterations in nesprin and SUN protein interactions across a range of EDMD patients may 
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be a contributing factor to disease onset, however, it is not yet known whether the 
observed differences in protein expression profiles are causative or resulting phenotypes 
from disease development.  
 
 
 
 
 
 
 
 
 
Figure 1.8: SUN2 proteome from control and EDMD/CMT patients. (A) Displays 
Commassie blue staining from SDS gel electrophoresis of pulldowns using GST-SUN2Nt as 
bait. Ctrl 1 represents GST-SUN2Nt incubated with PBS, Ctrl 2 and 3 represent GST beads 
alone incubated with control and EDMD/CMT lysates respectively. Input Ctrl and Input 
EDMD/CMT represent GST-SUN2Nt incubation with the appropriate lysate. Red arrows 
display proteins only precipitated in control lysates, dark grey only the EDMD/CMT lysates 
and light grey controls (B) graphical representation of observed SUN2 binding partners in 
control and EDMD/CMT patients. (C) Pull down experiment using GST and GST-SUN2Nt, 
displaying precipitation of tubulin and lamin A/C [176].   
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1.3.2    Roles of the LINC complex in premature aging. 
 
     The onset of accelerated aging diseases such as progeria has been well characterised 
over recent years, suggested to arise from defects in A-type lamin expression [179]. In 
many lamin A/C mediated progeria symptoms, further abnormalities have also been 
reported in LINC complex proteins such as SUNs and nesprins, in which increased 
expression of SUN1 alongside severe down regulation of nesprin-2G is observed [41]. 
Coupled with further mouse model and cell line data presented by Chi et al. [180], 
suggesting that SUN1 deletion in LMNA deficient mice and HGPS derived cells reduced 
progeric and dystrophic phenotypes, it was suggested the complex interplay between 
LINC complex proteins was central to the development of premature aging. Following 
from this research, Chen et al. was then able to verify the potential mechanism by which 
this SUN1 depletion reversed progeric effects of the LMNA mutations [181]. Through the 
use of light and electron microscopy techniques, it was shown that SUN1 contributes to 
the progerin-elicited structural defects arising across the NE and ER. Further to this, it was 
shown that the farnesylation of progerin enhanced its binding with SUN1, reducing SUN1s 
mobility across the NE. This reduced mobility resulted in the accumulation of SUN1 
across the NE, resulting in the aberrant recruitment of progerin to the ER during post-
mitotic re-assembly of the NE, which subsequently lead to the  accumulation of SUN1 and 
progerin over consecutive cell divisions. It is therefore suggested that this de-regulation of 
SUN1 through progerin farnesylation leads to the accumulation of SUN1 across the NE, 
often a hallmark of Hutchinson-Guilford progeria syndrome (HGPS). This further provides 
an explanation as to why the observed deletion of SUN1 in progeric mice conducted by 
Chi et al. was able to revert some of the phenotypic symptoms.  
 
1.3.3    Roles of nesprin-3/-4 in disease development. 
 
     SYNE-3 is known to code for at least two protein isoforms, termed nesprin-3α and 
nesprin-3β [182, 58], with nesprin-3α displaying high binding affinity to the ABD domains 
of plectin, MACF1 and MACF2 (MT-Actin Cross-linking Factor 1 and 2, respectively) 
inferred through its first unique SR. It was shown through In vitro siRNA silencing studies 
in vascular epithelium that nesprin-3 is required for the correct induction of flow induced 
polarity, and correct regulation of cytoskeletal-NE interactions [103]. However due to 
similar functionality also displayed by nesprin-2 [77], a potential redundancy mechanism 
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may also exist for systems displaying a loss of nesprin-3, which could explain why to date, 
no disease mutations have been linked directly to nesprin-3 in humans. In support of this 
suggestion, it was shown that in nesprin-3 knockout mice, nesprin-3 was not required for 
the maintenance of cell polarisation and migration in MEFs, nor the testicular morphology 
and efficient spermatogenesis [183], suggesting that the further mechanisms are acting to 
retain IF connections across the NE.  
     In contrast, SYNE-4 encodes a single protein, the smallest nesprin family member 
nesprin 4. Unlike nesprin-1/-2/-3, nesprin 4 is found expressed exclusively in secretory 
epithelial cells and mechanosensory hairs of the cochlea, within which it is able to mediate 
NE-kinesin-1 binding across the ONM [184], dependent on SUN1 for its correct 
localisation. The binding function displayed by nesprin-4 and kinesin-1 has been further 
shown to regulate kinesin-mediated cell polarisation [185], through which overexpression 
of nesprin-4 leads to dramatic changes in centrosome and Golgi positioning in relation to 
nuclei.  
     It has been further suggested that nesprin-4 plays critical roles in the development of 
hearing due to its observed localisation across the NE of outer hair cells (OHC) [186]. It 
was shown by Horn et al. [184], that mice lacking nesprin-4 or SUN1 develop OHCs 
normally, however, as hearing matures, these cells begin to degrade. Further to this, it 
was shown that the OHC cells were unable to retain their basal nuclear positioning (Figure 
1.9), potentially due to the loss of kinesin-1 mediated MT associations across the NE 
through nesprin-4 interactions. OHC cells act to amplify sound within the cochlea, through 
a variety of mechanisms, one of which is through the hyperpolarisation and depolarisation 
events, suggesting that these cells are highly mobile [187, 188]. It is believed that through 
an ATP dependent motility mechanism involving the modification of cytoskeletal proteins 
[189, 190], OHCs are able to tune and amplify large decibel sound input, whilst preventing 
overstimulation, which could potentially lead to cell stress and subsequent cell death 
[191]. As the nucleus is implicated in playing a cytoskeletal organising role in many 
tissues [192], it can be suggested that the inherent loss of nesprin-4 dependant coupling 
of MTs to the NE may result in alterations in MT dependant nuclear positioning [185], 
leading to the eventual loss of MT organisation and resulting ability to withstand 
mechanical stresses stimulated through sound input, leading to OHC death overtime and 
subsequent hearing loss [191].          
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Figure 1.9: (A) Whole mount cochlea P14 displaying nuclear localisation in WT and nesprin 
4 knockout OHCs. Nuclei (blue), OHC membrane (green) and actin (red) are stained within 
each sample; clearly highlighting the nuclei in nesprin-4 knockout OHC’s displaying a more 
apical localisation. (B) 3D confocal stacks depicting nuclear miss-localisation in nesprin-4 
and sun1 knockout cochlea whole mounts. Staining’s present include nuclei (blue), 
cytoplasmic membrane (red) and actin (yellow), helping to display that nuclei are miss 
localised in both OHC and inner hair cells (IHCs). Scale bars = 15 µm [184].  
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1.3.4    Roles of the LINC complex in cancer development. 
 
     Due to our increasing understanding of the role played by the LINC complex in the 
maintenance of nuclear architecture, cell migration, mechanotransduction and cytoskeletal 
organisation [192, 127, 193, 194], current research is investigating whether LINC 
components play further roles in the development of cancer. Interestingly, whole 
genome/exome analysis has identified nesprin proteins as candidate cancer genes [195], 
with both SYNE-1 and SYNE-2 mutations implicated in the development of many cancer 
forms including breast [196, 197, 198], lung [199], pancreatic [195] and colorectal [200] 
cancers.         
     Although a wide range of cancers display high frequency of mutations in the SYNE 
genes, the exact mechanism by which nesprins could contribute to cancer development is 
still unknown. Based on current understanding that nuclei are the stiffest organelle in most 
cells [201] and that nesprins regulate nuclear architecture/stiffness, it can be suggested 
that these mutations lead to a loss of nesprin across the NE and subsequent reduction in 
nuclear stiffness. This increased nuclear malleability may then aid in the transmigration of 
cancerous cells from the primary tumour source to surrounding tissues, similar to that 
displayed by the highly malleable neutrophils which express very few LINC components 
[202]. This view is supported through current work by Matsumoto et al. [203], providing 
evidence suggesting that the LINC components lamin A/C, SUN1, SUN2 and nesprin-2 
are all seen to be down regulated in breast cancer biopsies.  
     More recently, nesprins have been implicated in providing functional connections 
between non-muscle myosin IIB (NMIIB) and the NE, aiding in nuclear translocation 
during 3D MDA-MB-231 cell migration. NMIIB is a motor protein which is differentially 
expressed in a tissue specific and developmentally regulated fashion [204], implicated in 
both cell polarisation events and 2D/3D migration [205, 206]. During 2D migration, NMIIA 
is found at the sites of protrusions in the migratory edge, helping to stabilise nascent focal 
adhesions [207]. As the NMIIA filaments move rearward through actin retrograde flow, 
NMIIB co-assembles with the NMIIA filament and becomes the dominant isoform 
expressed in the cells posterior [208]. Interestingly, as mammary gland epithelial cells are 
driven through EMT, NMIIB expression is seen to be robustly upregulated [209]. This 
increased expression during EMT is suggested to contribute to the invasive behaviour of 
the newly formed mesenchymal like cells through its suggested roles in nuclear 
positioning [50]. It is now suggested however that NMIIB transmits force to the nucleus 
mediated through nesprin-2 interactions across the NE, which in turn aids in the nuclear 
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translocation required for cell migration during 3D invasion [210]. With further evidence 
now emerging implicating nesprins in the regulation of cell shape, malleability and 
migration [16, 211] it is increasingly evident that the roles of LINC complex in maintaining 
nuclear architecture, and more importantly NE integrity, is a critical factor in the 
development of cancer metastasis.  
 
1.4    Current 3D culture models are becoming 
increasingly more relevant to the in vivo situation. 
 
          Over recent years, there has been ongoing work into the development of 3D culture 
models which more accurately capture aspects of the in vivo environment, such as the 
diffusion of molecules through tissues, or the effect of interstitial fluid flow on the 
concentration of secreted proteins [212]. Current applications of 3D materials are wide 
ranging, applied to the development of in vitro 3D tissue systems, drug screens and 3D 
models to study cancer development [213, 214].  
 
1.4.1    Standard 2D cell culture imparts changes in gene 
expression, different to that found in vivo. 
 
     Alongside the emergence and subsequent expansion of applied 3D culture 
technologies, increasing evidence has been presented demonstrating the potential cellular 
changes associated with conventional 2D culture systems, leading to protein and genetic 
profiles distant from the in vivo situation. Alterations in 2D gene expression patterns 
across a range of cell lines has been increasingly noted in a wide variety of cellular 
functions, including proliferation and metabolism when compared back to their tissue of 
origin [215].  
     Investigations into the 3D morphology of breast cancer cell lines helps to demonstrate 
that there was a significant alteration in protein expression associated with signal 
transduction when 2D and 3D cultures were compared in addition to cells grown across 
different 3D growth environments [216]. Alongside these changes, it was further shown 
that when cultured in 3D, the cells adopted one of four distinct cell morphologies, which 
did not correlate to that observed under 2D growth conditions on tissue culture plastic. 
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Aside this, further investigations culturing hepatocellular carcinoma cells within a 3D gel 
also elicited changes in gene expression, shown to induce an upregulation of a range of 
matrix metalloproteinase (MMPs) and the focal adhesion proteins paxillin and focal 
adhesion kinase (FAK) [217]. This evidence demonstrated the altered localisation and 
expression profiles of both genes and proteins across a range of cells when compared 
between conventional 2D and 3D culture systems, highlighting the need for 3D culture 
systems.  
 
1.4.2    Current 3D culture models are becoming increasingly 
more biologically relevant. 
 
     As the development of 3D culture technologies has expanded, the introduction of in 
vivo like environments has become a clear aim for these materials, with aims to provide a 
material able to accurately replicate a cells natural in vivo environment, leading to the cells 
displaying comparable gene and protein expression profiles. As multiple materials have 
been developed, the most impactful to date appear to be formed through the application of 
ECM hydrogel and synthetic scaffold systems.  
 
1.4.2.1    ECM hydrogel cultures. 
 
          One current system that uses biological ECM reagents to develop novel 3D growth 
environments is the hydrogel. These polymeric materials have been seen to produce 
structures with a water content, biocompatibility and mechanical properties similar to that 
found within natural biological systems [218, 219].  Through adding cells to the hydrogel 
precursor prior to gelling, cells can be distributed homogeneously throughout the gel, 
leading to close cellular associations from the point of seeding. Alongside this, hydrogels 
are easily adapted to incorporate soluble or immobilised signalling molecules such as 
transforming growth factor β (TGF-β) and bone morphogenetic protein (BMP-2). This 
allows for the production of targeted environments that provide a supporting structure for 
specific cell growth and function. Numerous polymers, including natural and synthetic 
polymers are currently used to form hydrogels. Such natural polymers include collagen, 
hyaluronic acid and fibrin [220], and synthetic polymers include poly(ethylene glycol) 
(PEG) [221].  
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     Whilst many of these systems can be formed through the polymerisation of a single 
ECM component, such as those found in the development of collagen gel systems, the 
microenvironment produced does not reflect the complexity of that found in normal 
biological systems. In contrast, systems incorporating a wide array of proteins such as in 
Matrigel® [220] have also been developed. However, even though the complexity of these 
systems is increased, closer to that of normal biological systems, they still lack the correct 
protein organisation as seen in the in vivo situation, leading to conflicting environmental 
cues.  
     A major drawback to the use of hydrogel systems as a platform to study cell migration 
is the weak structural rigidity exhibited by the gels. This mechanically weak polymer 
network may not withstand the forces exerted by the cells in order to migrate through 
restrictive environments. 
 
1.4.2.2    Synthetic scaffold systems. 
 
     In addition to hydrogel systems, a wide range of porous and fibrous polymer scaffolds 
have also been applied to the development of novel 3D culture environments. These 
materials have been synthesized from a wide range of natural and synthetic polymers by 
a variety of fabrication techniques [222], and can be adapted to suit a range of system 
through tuning of the mechanical and/or chemical properties of the polymer network [223] 
[224]. These systems therefore provide a biologically inert environment, providing the 
opportunity to assess the effects of dimensionality within the 3D culturing environment in 
the absence of signalling cues which may arise from ECM hydrogel based systems.  
     Some examples of tailored scaffolds to suit the specific needs of cells grown within 
them include the reinforcement of skin equivalents using hyaluronic acid [225], human 
stem cell differentiation using poly(L-lactic-co-glycolic acid) (PLGA) [226], or ontogenesis 
on mPEG/hydroxyapatite scaffolds [227]. Alongside the components of the scaffold 
material, the fabrication methods used also introduce further functionality to the designed 
system. Current synthetic scaffold systems employ the numerous fabrication methods, 
including 3D printing, electrospinning and emulsion templating, each able to produce 
unique environmental conditions within which cells can adapt and respond [228].    
     Together, these systems help to demonstrate that over recent years, the desire for 
more in vivo like cell culturing techniques has led to the development of a wide range of 
3D scaffold systems, each conferring unique properties to their biological systems. 
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Unfortunately however, one common trend with each system described is that as the 
biological relevance of the system increases, the ability to extract relevant data from the 
system appears to decrease.  
 
1.5    Hypothesised Outcomes. 
 
     From the literature reviewed here, the following experimental outcomes are 
hypothesised: 
 Chapter 3 - Disruptions to LINC complex connection spanning the NE will elicit NE 
and cellular phenotypic changes. 
 Chapter 3 - The disruptions in this SUN-KASH bridge spanning the PNS may 
result in phenotypic differences emerging in migration across both 2D and 3D 
environments.  
 Chapter 3 - LINC-disrupted mutant cells may exhibit increased migratory potential 
through challenging 3D migratory environments due to loss of NE integrity. 
 Chapter 4 - Severing the connections between nuclear and cytoskeletal 
compartments through LINC complex disruptions may elicit changes in 
keratinocyte colony formation and subsequent differentiation potential, due to a 
loss of mechanotransduction between the nucleus and extracellular regions.   
 Chapter 5 - Variability in LINC complex protein expression may be present across 
ranging breast cancer cell lines, of which nesprins would be suggested to display 
expression patterns which closely correlate to the cancer grade and aggression. 
 Chapter 6 - Nesprins may further functionally interact with Nup88, a NPC protein 
with known links to increased cancer aggression. 
 
1.6    Thesis Overview. 
 
     Work within this project aims to investigate the effects of LINC complex disruptions 
across the NE in both 2D and 3D culture environments. These investigations will aim to 
further our understandings as to roles of the LINC complex in maintaining directed cell 
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migration, cell-cell interactions and cell-substratum adhesion. Further characterisation of 
LINC complex components will then be conducted with aims to investigate whether 
correlation can be seen between protein expression patterns and the development of 
cancer aggression.  
     Chapter 3 will look at fully characterising the effects of disruptions to SUN-KASH 
perinuclear interactions, in relation to both 2D and 3D migration, cell colony formation, 
cell-substratum attachment and nuclear malleability. Further work will then be conducted 
to investigate whether differences in migration potential are evident between LINC 
disrupted and WT cells through both non-restrictive Alvetex® Scaffold and space-
restrictive Alvetex® Strata 3D materials.  
     Following on from Chapter 3, work in Chapter 4 will aim to fully characterise both LINC 
protein localisation and expression patterns across a range of breast cancer cell lines, 
with aims to assess if correlations in expression profiles and cancer progression exist. 
Further work will then aim to assess migratory behaviours of representative control, low- 
and high-grade breast cancer cell lines within space-restrictive Alvetex® Strata scaffolds 
used in Chapter 3. With aims to assess whether any phenotypic similarities in migratory 
behaviour can be observed between the LINC disrupted keratinocytes characterised in 
Chapter 3 and high-grade breast cancer cells. In concluding sections of this chapter, 
immunofluorescence analysis of the key LINC complex protein nesprin-2 will be assessed 
across control, low- and high-grade primary breast biopsies, to investigate whether 
localisation or expression profiles appear to alter between the specimens. 
     Chapter 5 will aim to expand on findings from both Chapter 3 and 4, with two specified 
aims. The first to investigate whether LINC disrupted keratinocytes described in Chapter 3 
displays migration advantages when co-cultured in both non-restrictive and space-
restrictive 3D culture environments pre-seeded with fibroblast cells.  And secondly, to 
assess whether the DN mutants display increased cell stacking in fibroblast co-culture 
conditions compared to both WT and single cultured conditions in Chapter 3. Assessment 
as to whether further differences exist between WT and DN HaCaT cells in their 
differentiation ability when lifted to the air-liquid interface will also be conducted, as the 
LINC disruptions may result in altered differentiation potential. 
     Finally, Chapter 6 aims to follow on from work conducted through each chapter thus 
far, aiming to assess whether nesprin-2 display interacting potential with the hypothesised 
binding partner Nup88 (component of the NPC). This theorised link between nesprin-2 
and Nup88 can be implicated in the development of many forms of cancer, in which 
increased Nup88 levels, aside mutations in SYNE-1/-2 are associated with increased 
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metastatic properties. To further our understanding of this interacting potential, 
assessment as to whether any functional relationships exist between nesprin-2 and 
Nup88 will also be conducted.  
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2. Materials and Methods 
 
2.1    Routine 2D cell culture. 
2.1.1    Cell Lines: COS-7, WT HaCaT, HDF, SW480, SW620 and 
HeLa. 
     The monkey derived kidney fibroblast cell line COS-7 (ATCC® CRL-1651™), human 
keratinocyte cell line HaCaT (AddexBio, T0020001), primary human dermal fibroblasts 
isolated from neonatal foreskin (HDF) (Life Technologies, C-004-5C), human 
adenocarcinoma cell lines SW480/SW620 (ATCC®, CCL-228™/ATCC®, CCL-2), and 
human cervical adenocarcinoma cell line HeLa (ATCC®, CCL-2) required the same 
culturing conditions. Cells were maintained in high glucose Dulbecco’s modified Eagle’s 
medium (DMEM, Sigma) supplemented with 10% v/v foetal bovine serum (FBS, Sigma), 2 
mM L-glutamine (Sigma) and 100 U/ml penicillin/streptomycin (Sigma). Culturing was 
performed on CELLSTAR® plastic ware (Greiner Bio-one) at 37 °C in a 5% CO2 
environment and enzymatically passaged as outlined in 2.1.5, upon cells reaching 70% 
confluence.  
 
2.1.2    Cell Line: DN SUN1 expressing clonal HaCaT. 
     Modified human keratinocyte cell line expressing luminal regions of SUN1-GFP [77] 
was maintained in high glucose DMEM supplemented with 10% v/v FBS, 2 mM L-
glutamine, 100 U/ml penicillin/streptomycin and 400 µg/ml G418 (Geneticin, Sigma).  
Culturing was performed on CELLSTAR® plasticware at 37 °C in a 5% CO2 environment 
and enzymatically passaged as outlined in 2.1.5, upon cells reaching 70% confluence. 
 
2.1.3    Cell Lines: MCF 10A and MCF 12A.  
     The human derived mammary gland/breast cell lines MCF 10A and MCF 12A (ATCC) 
were maintained in DMEM: F12 (Sigma) containing 15 mM HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid) (Sigma) and NaHCO3 (Sigma). Media was supplemented 
with 5% v/v horse serum (Invitrogen), 1 mg/ml hydrocortisone (Sigma), 100 µg/ml 
epidermal growth factor (EGF, Sigma), 1 mg/ml cholera toxin (Sigma), 10 mg/ml insulin 
(Sigma), 2 mM L-glutamine and 100 U/ml penicillin/streptomycin. Culturing was performed 
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on CELLSTAR® plasticware at 37 °C in a 5% CO2 environment and enzymatically 
passaged as outlined in 2.1.6, upon cells reaching 70% confluence. 
 
2.1.4    Cell Lines: MCF7, MDA-MB-231, T-47D and HCC-38. 
     The human mammary gland/breast adenocarcinoma cell lines MCF7 and MDA-MB-
231, human mammary gland ductal carcinoma cell line T-47D and human mammary 
gland TNM stage IIb ductal carcinoma cell line HCC-38 (ATCC and Newcastle University), 
required the same culturing conditions. Cells were maintained in high glucose DMEM 
without phenol red (Sigma), supplemented with 10% v/v FBS, 2 mM L-glutamine and 100 
U/ml penicillin/streptomycin. Culturing was performed on CELLSTAR® plasticware at 37 
°C in a 5% CO2 environment and enzymatically passaged as outlined in 2.1.5, upon cells 
reaching 70% confluence. 
 
2.1.5    Routine passaging and propagation of cells. 
     All cell lines were enzymatically passaged by removing growth media, washing the 
adhered cells with sterile versene (phosphate buffered saline + [0.02%] EDTA 
(ethylenediaminetetraacetic acid) and incubating with 10% v/v trypsin (Lonza) in 
phosphate buffered saline (PBS, Sigma) at 37 °C. Incubation was conducted for 2 min 
(MCF7 and MDA-MB-231 cell lines), 5 min (COS-7, SW480, SW620, T-47D and HCC38 
cell lines) and 10 min (WT HaCaT and DN HaCaT cell lines). Trypsin neutralisation was 
then performed with complete culturing media, followed by returning cells to the culture 
flask.  
 
2.1.6    Passaging of MCF 10A and MCF 12A cell lines. 
     Enzymatic passaging of MCF10A and MCF 12A in a T-75 cell culture flask required 
more care due to increased sensitivity to trypsin. Growth media was removed followed by 
washing of the cells with cell culture grade PBS (Sigma). 2 ml of 10% v/v trypsin in PBS 
was then distributed evenly across the surface, and 1.5 ml subsequently removed leaving 
a thin film of trypsin. Once cells were dislodged, forming a single cell suspension, 5 ml of 
re-suspension media (DMEM: F12 supplemented with 20% horse serum and 100 U/ml 
penicillin/streptomycin) was added to neutralise the trypsin. The resulting cell suspension 
was then centrifuged for 5 min at 1000 rpm at 4 °C. The pellet was then re-suspended in 
fresh growth media and returned a T-75 culture flask.   
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2.1.7    Cryopreservation of cells. 
     All cell lines were cryopreserved at -150 °C in 1.5 ml Nunc cryovials (Thermo 
Scientific) following trypsinisation as described in 2.1.5, centrifugation of cell suspension 
at 1000 rpm for 5 min at 4 °C, and subsequent pellet re-suspension in freezing media at a 
density of one 70% confluent T-75 flask per 5 ml freezing media. Freezing media 
comprised of 10% v/v dimethyl sulfoxide (DMSO, Sigma) diluted in the specific culturing 
media for that cell line.  
     Cells were retrieved from cryopreservation by defrosting at 37 °C and diluting the 
freeze media in complete growth media. The suspension was centrifuged at 1000 rpm for 
5 min maintained at 4 °C. The resulting supernatant was removed and the cell pellet re-
suspended in fresh complete culture media. The suspension was then placed into a T-25 
culture flask and incubated to obtain a monolayer culture.   
 
2.2    Scratch wound assay. 
2.2.1    Growth in 2D culture. 
     Cell lines were seeded into CELLSTAR® 24 well plates (Greiner Bio-one) and left to 
grow to 95% confluency with media changes every 2 days.  
 
2.2.2    Scratch wound assay. 
     Upon obtaining 95% confluence, cells were serum starved (Incubated in normal culture 
media minus FBS) for 6 h, scratched using a 20-200 µl pipette tip (Greiner) and washed 3 
times in cell culture grade PBS. Complete cell culture medium was then added to each 
well and cells were returned to an incubator at 37 °C with 5% CO2 environment for 48 h.  
 
2.2.3    Scratch wound assay analysis. 
     Phase contrast images of the wound were taken at the time of wounding, as well as 24 
h and 48 h post wounding using the Leica DM1 3000 B light microscope with a Leica 
DFC310 FX camera attached using a 10x objective lens. Wound closure was analysed 
using ImageJ (v1.49s) to measure distances between the leading edge of cells across 
each side of the wound. At 24 h and 48 h time points, cells were fixed as described in 
2.8.1 and stained with DAPI (4',6-diamidino-2-phenylindole) and phalloidin as described in 
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2.11.2. Fluorescence images were obtained using the Leica DM1 3000 B light microscope 
with a Leica DFC310 FX camera.  
 
2.3    3D cell culture. 
2.3.1    Scaffolds utilised. 
     We utilised two scaffolds: 12 well Alvetex® Scaffold and Alvetex® Strata inserts 
(Reinnervate, AVP002 and STP005). These polystyrene scaffolds were used in order to 
provide non-restrictive and space-restrictive 3D migratory environments respectively due 
to their varying void diameters.  
     For short term culturing (<14 days) scaffold inserts were placed into Greiner 12 well 
plates, with 4 mL of complete culture media. For longer term culturing (>14 days), three 12  
welled inserts were placed into a triplet well insert holder in a deep well petri dish 
(Reinnervate, AVP015) alongside 50 mL of complete culture media.  
 
2.3.2    Scaffold pre-treatment. 
     To ensure surface hydrophobicity Alvetex® Scaffolds were pre-treated with an oxygen 
plasma for 5 min at 40 W using the Emitech K1050X Plasma Asher. Alvetex® Strata 
scaffolds were subjected to oxygen plasma for 30 min at 10 W. Following treatment, 
scaffolds were left to cool for 10 min, then they were ready for use.  
 
2.3.3    Preparation of cell suspensions for seeding scaffolds. 
     Cells cultured in 2D were trypsinised and counted as described in 2.1.5 and 2.5.1 
respectively, followed by centrifugation at a 1000 rpm for 5 min at 4 °C. The resulting cell 
pellet was re-suspended at a cell density of 2.5 x 106 cells/mL.  
 
2.3.4    Seeding cells to the scaffolds. 
     To seed the cells to the Alvetex® scaffold and Alvetex® Strata, 100 µl of cell suspension 
(2.3.3) containing 250,000 cells was applied directly to the centre of each pre-treated 
scaffold. The scaffolds were then placed in their respective culture dishes and moved into 
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a cell culture incubator for 20 min to allow cell attachment to the scaffold surface. 
Complete culture media was added. 
 
2.3.5    Media changes. 
     To change the media during 3D culture, old media was removed through aspiration 
between the gaps in the insert (highlighted in Figure 2.1), ensuring the cells situated 
across the surface of the scaffold are not disturbed. New media was then place in the 
same gap between the insert and the culture dish.  
     For short-term culturing (<14 days), cell culture medium was replaced every 2-3 days 
in 12 well dishes. For long-term culturing (>14 days) in the deep well dishes described 
previously, media was replaced every 4-5 days. In addition, at 7, 14 and 21 days of 
culturing, cell culture dishes were replaced due to cellular build-up across the bottom of 
the dish.  
 
 
 
2.3.6    Co-culture of fibroblasts and keratinocytes. 
     For the co-culture observations, 500,000 HDF cells at a T-75 confluence of 60% were 
placed onto plasma-treated scaffolds alongside complete culture medium and cultured in 
12 well plates for 7 days. The scaffolds were transferred into triplet well insert holders in a 
deep well petri dish for a further 7 days. Either WT or DN HaCaT cells were then seeded 
as described in section 2.3.4, then cultured for a further 14 days. For both WT and DN cell 
lines, culture media described in 2.1.1 was used, as we have shown that DN HaCaT 
retain their phenotypic expression of DN SUN1 even after several months of drug 
removal.  
Figure 2.1: Example images of Alvetex
®
 scaffolds housed in their inserts. Arrows 
can be seen to highlight gaps in the insert to allow media flow across the scaffolds 
surface. 
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2.4    2D culture scaffolds. 
2.4.1    Rhombic micro-pillar materials. 
     To assess the nuclear deformity potential, a poly(L-lactic acid) (PLLA) micro-pillared 
polymer matrix containing protrusions of 7 µm width which extend from the surface to a 
height of 6 µm, was utilised [229]. The spacing between each pillar was 7 µm, and so 
nuclear deformity would be required for cells to settle fully within the material. These 
materials were kindly donated by Dr. Katrine Anselme of the Institute de Science des 
Materiaux de Mulhouse. Initially, cells were enzymatically passaged as described in 
section 2.1.5, producing a single cell suspension. 50,000 cells were then seeded onto the 
materials surface and cultured under normal growth conditions for 5 days. 
 
2.4.2    Polycarbonate inserts. 
     To further test the migration potential of WT and DN HaCaT cell lines through 
restrictive void sizes of <4 µm, a commercially available polycarbonate scaffold (Corning® 
Costar®, Transwell™ insert) was used. This material contains a monolayer of 3 µm voids 
across a 24 mm diameter. Cells were enzymatically passaged as described in section 
2.1.5 to produce a single cell suspension. Following this, 500,000 cells were placed onto 
the materials surface and maintained under normal culture conditions for 3 days.   
 
2.5    Cell counting. 
2.5.1    Neubauer Improved Haemocytometer.  
     To determine cell numbers for seeding within 3D cell culture experiments, 2D cultures 
were trypsinised into a single cell suspension as described in 2.1.5 and counted using a 
Neubauer improved haemocytometer (Marienfeld-Superior). To ensure consistency and 
accuracy of results, cell suspensions with a density between 0.5-1.5 x 106 were used to 
count the cells.  
 
48 | P a g e  
 
2.6    Plasmid preparation. 
2.6.1    Bacterial transformation. 
     Plasmids used were amplified and purified by the following method: DH5α bacteria 
were thawed from -80 °C and a 50 µl aliquot of these competent cells was incubated with 
2 µg/ml of the desired plasmid on ice for 15 min. The competent cell/DNA mixture was 
then heat shocked at 42 °C for 1 min and placed back on ice for a further 2 min. 500 µl of 
LB (lysogeny broth) broth solution (FORMEDIUM™, LMM0102) was then added to the 
competent cells, and the suspension was left to incubate for 1 h at 37 °C with periodic 
shaking. Once incubated, the suspension was then placed onto a 10 cm LB agar plate 
(FORMEDIUM™, LMM0203) containing the antibiotics the plasmid confers resistance to. 
Colonies were isolated and inoculated into 500 ml LB broth solution and incubated 
overnight at 37 °C with periodic shaking.  
 
2.6.2    Plasmid purification. 
     To purify plasmids from the transformed bacteria described in 2.6.1, the competent 
cells were taken from an overnight incubation and purified using a PureYield™ plasmid 
midiprep system (Promega, A2492) according to manufacturer instructions. Upon plasmid 
purification, plasmid concentrations were calculated using a Genova spectrophotometer 
(Jenway, 736501). Concentration was measured at an absorbance of 260 nm followed by 
further measurements at 320 nm (adjustment measurement for turbidity), the output was 
then multiplied by the dilution factor, and using the relationship that A260 of 1.0 = 50 µg/ml 
pure dsDNA the concentration was obtained;  
Concentration (µg/ml) = (A260 reading – A320 reading) x dilution factor x 50 µg/ml 
 
2.7    Plasmid transfections. 
2.7.1    Cellular transfection. 
     Purified plasmids were incorporated into the desired cells by transfections via 
electroporation using an Amaxa® Nucleofector™ device, plasmids used within our 
investigation can be seen displayed in Table 2.1. Cells at a 70% confluence in a T-75 
flask were dislodged from the culture flask as described in section 2.1.5, to obtain a single 
cell suspension. This cell suspension was then centrifuged at 1000 rpm for 5 min at 4 °C. 
The cell culture media was then aspirated off, and the pellet re-suspended with pre-
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Table 2.1: Plasmids used throughout our experimentation, detailing vectors/source of the 
plasmid, alongside the inferred antibiotic resistance. 
warmed, cell culture grade PBS. The resulting suspension was then re-centrifuged and re-
pelleted as before. Transfections were then conducted using an Amaxa® Cell Line 
Nucleofector™ Kit V (Lonza), at a working plasmid concentration of 2 µg/µl. The Amaxa® 
Nucleofector™ device contains pre-programmed settings for each of the cell line used 
(COS7 – A-024, HaCaT – U-020, MCF7 – P-020, MDA-MB-231 – X013). Upon plasmid 
transfection, cells were quickly re-suspended in normal cell culture media and incubated 
for up to 4 days before processing. For transient transfections, protein expression 
deteriorates post 4 days in culture for most cell lines.  
     To maintain ectopic protein expression for periods >4 days, plasmids used encoded a 
resistance gene against a targeted drug. To establish effective drug concentrations to 
select for plasmid expression, kill curves were produced for each cell line, in which 
different drug concentrations were tested to establish the concentration required to kill 
100% of cell within 1 week. This drug concentration (described in Chapter 4) was added 
24 h after transfection, resulting in selection cells expressing the desired plasmid. Cells 
expressing the drug resistance were then selected from single colonies.   
 
 
Plasmid Vector/Source 
Associated antibiotic 
resistance 
pEGFP See ref. [101] N/A 
pEGFP-Nup88 
Kindly donated by Dr Birthe 
Fahrenkrog [230] 
Neomycin 
Nesprin-2-SR See ref. [9] G418, Geneticin® 
Nesprin-2 siRNA See ref. [101] N/A 
Control Nesprin-2 siRNA See ref. [101] N/A 
Nup88 siRNA Santa Cruz, SC-75980 N/A 
Nesprin-2 mini See ref. [77] G418, Geneticin® 
DN SUN1 See ref. [9] G418, Geneticin® 
SR-KASH See ref. [9] G418, Geneticin® 
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2.8    Sample Fixation. 
2.8.1    2D monolayer cultures. 
     2D monolayers were fixed by growing them on glass coverslips or micro-pillar 
materials [229], washed for 5 min with PBS three times, and incubated for 15 min in 4% 
w/v paraformaldehyde (PFA, Sigma) in PBS at pH 7.4. Samples were then washed twice 
in PBS and stored at 4 °C for no longer than 3 days.  
     For the fixation of 2D monolayer cells on polycarbonate inserts, cells were washed for 
5 min in cell culture grade PBS three times, and the polycarbonate membrane removed 
from the insert with a razor blade. The membrane was then immersed in 4% PFA in PBS, 
pH 7.4, and left to fix overnight at 4 °C. After fixation, the membranes were washed for 5 
min in PBS twice and then stored at 4 °C until use.  
 
2.8.2    3D cultures. 
     Cells cultured within Alvetex® scaffold and Alvetex® Strata were fixed as follows: 
inserts were rinsed once with cell culture grade PBS and carefully unclipped from the 
insert holder. Upon removal, scaffolds were washed a further two times in PBS for 5 min, 
submerged within 4% PFA in PBS, pH 7.4 and left at 4 °C overnight. After fixation, 
scaffolds were washed another two times in PBS and stored at 4 °C until used.  
 
2.9    Histological processing. 
2.9.1    Dehydration and Embedding. 
     Histological processing of Alvetex® scaffold and Alvetex® Strata materials was carried 
as described previously [231]. Briefly, samples fixed as described in 2.8.2 were washed in 
PBS for 5 min twice. Washing was then followed by 15 min incubations in varying ethanol 
concentrations of 30%, 50%, 70%, 80%, 90%, 95% and 100% v/v at room temperature. 
Scaffolds were subsequently removed from their housing inserts, cut in half across their 
diameter using sterilised surgical scissors and incubated for 15 min in Histoclear (Fisher, 
12358637) at 60 °C. An equal volume of liquid paraffin wax (Fisher, 12624077) was 
added, and the scaffolds were incubated for 15 min at 60 °C. The Histoclear/liquid paraffin 
solution was then replaced with fresh paraffin wax, and the scaffolds were incubated for 1 
h at 60 °C. Vertical embedding was then performed in which the scaffold sections were 
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placed into embedding moulds (Cellpath Ltd, GAD-5302-02A) with the cut side facing 
down. These were then topped with a labelled embedding cassette (SLS, HIS0029), and 
filled with fresh paraffin wax.  
 
2.9.2    Sectioning. 
     Wax blocks were sectioned using a Leica RM2125RT microtome with MB Dynasharp 
microtome blades (Fisher, 12056679). For all cell lines, sections were cut to a thickness of 
10 µm for conventional haematoxylin and eosin (H&E) staining, with subsequent 7 µm 
sections for antibody staining. Sections were then floated on a 42 °C water bath, mounted 
onto Superfrost+ microscope slides (Fisher, 10149870) and left to dry overnight on a 32 
°C heated slide dryer.  
 
2.10    Pathological samples. 
     Slides containing pre-paraffin embedded and sectioned pathological samples were 
obtained from Breast Cancer Now’s tissue bank. Ethical approval was sought and 
approved from Breast Cancer Now’s board of governance and from Durham University 
School of Biological and Biomedical Sciences Human Tissue Board (HTB). Samples were 
selected from a variety of patient sources based on their pathological phenotypes and 
defined grades in accordance with standard breast cancer grading systems. Approval for 
this work was received on 13/04/15, with a materials transfer agreement subsequently 
signed. Materials were received and recorded in line with legislation requirements on 
16/05/15. A total of 324 sections were received. A third of which represented 18 serial 
sections of 6 patients derived from healthy premenopausal breast tissue obtained via 
breast reduction mammoplasty in pre-menopausal women. The second third was derived 
from ER+ (oestrogen receptor), PR- (progesterone receptor) tumours in pre-menopausal 
women and the final third from triple negative (ER-, PR- and HER2-) tumours in pre-
menopausal women. These samples were intended for use within immuno-fluorescence 
analysis of LINC complex components. 
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2.11    Staining. 
2.11.1    Haematoxylin and Eosin (H&E) staining. 
     Paraffin wax was cleared from the slides by washing with histoclear for 5 min at room 
temperature. Gradual sample rehydration was conducted through washes in 100% 
ethanol for 2 min, 95% and 70% ethanol for 1 min, and distilled water for a further 1 min. 
Nuclei were then stained via a 5 minute incubation in Mayer’s haematoxylin (Sigma, 
H1532) (0.1% v/v haematoxylin, 0.02% v/v sodium iodate, 5% v/v aluminium potassium 
sulphate, 5% v/v chloral hydrate and 0.1% v/v citric acid in dH2O), followed by a 1 min 
wash in distilled water and incubation in alkaline alcohol (3% ammonia in 70% ethanol) for 
30 sec to stain nuclei. Samples were subsequently dehydrated by 30 sec incubations in 
70% and 95% ethanol. Once dehydrated, cytoplasmic staining in 0.5% eosin (Sigma, 
E4009) in 95% ethanol for 1 min was carried out. The samples then underwent two 10 sec 
washes in 95% ethanol, followed by two washes in 100% ethanol, the first for 15 sec and 
second for 30 sec. Slides were then cleared via 2x 3 min washes in Histoclear, prior to 
mounting with DPX mounting media (Fisher, 10050080) and covering with a 50 x 22 mm 
coverslip (Fisher, 12383138). 
     Slides were left to dry at 4°C overnight and then imaged using a Leica DM500 light 
microscope with attached ICC50 HD camera at 10x and 20x magnifications utilising the 
LAS EZ software (Leica).  
 
2.11.2    Immunofluorescence staining of 2D monolayers. 
     Cells were initially placed onto 10 mm glass coverslips (SLS) and grown to a 
confluence of 70% across the surface. Samples were then fixed as described in 2.8.1 and 
subsequently permeabilised in 0.5% v/v Triton X-100 (Fisher) in PBS for 10 min. Cells 
were washed for 5 min in PBS followed by 15 min blocking in 0.2% (w/v) cold water fish 
gelatine (Sigma), 0.5% (w/v) BSA (bovine serum albumin) in PBS (PBG). Primary 
antibodies were diluted in blocking buffer (PBG) to the dilutions stated in Table 2.2 and 
incubated for 1 h. Samples were then washed three times in PBS for 5 min, followed by a 
further 1 h incubation in secondary antibodies alongside DAPI (4',6-diamidino-2-
phenylindole) [20 mg/ml] (1 in 1000 dilution). The samples were then protected from light 
and diluted in blocking buffer to the dilutions displayed in Table 2.3. Post incubation, cells 
were washed five times in PBS for 3 min followed by mounting on Superfrost+ microscope 
slides (Fisher, 10149870) using Gelvatol mounting media (4.8 g Gelvatol, 24 ml glycerol, 
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Table 2.2: Primary antibodies used for 2D immunofluorescence staining with suppliers and 
working concentrations. 
24 ml 0.2 M Tris-HCl pH8.5 and 1.3 g DABCO [1,4-Diazabicyclo(2,2,2)octane]). Images 
were then obtained using a Leica SP5 confocal microscope with Leica LAS AF software.  
 
 
 
Antibody Host Supplier 
Catalogue 
Number 
Working 
dilution 
Pan-Cytokeratin X Mouse Millipore MAB3412 1 in 500 
TRITC-conjugated 
Phalloidin 
N/A Sigma P1951 1 in 600 
β-tubulin Mouse Sigma T8328 1 in 100 
Nup88 Mouse BD Transduction 611896 1 in 2000 
Nesprin-1 (ABD) Rabbit See ref. [232] N/A 1 in 500 
Nesprin-1 (SPECII) Rabbit See ref. [232] N/A 1 in 100 
Nesprin-2 (pAbk1) Rabbit See ref. [233] N/A 1 in 300 
Nesprin-2 (K20) Mouse See ref. [234] N/A 1 in 1 
Nesprin-3 Rabbit 
In house 
unpublished reagent 
Ab123031 1 in 5 
Nesprin-4 Rabbit See ref. [78] N/A 1 in 100 
Mab414 Mouse Covance MMS-120R 1 in 500 
SUN1 (282) Rabbit abcam Ab124770 1 in 300 
SUN1 (K71) Rabbit abcam ab74758 1 in 250 
SUN2 Rabbit GeneTex GTX63578 1 in 50 
Lamin A/C Mouse ImmuQuest IQ608 1 in 10 
Lamin B1 Goat abcam Ab16048 1 in 50 
Lamin B1 + B2 Rabbit Santa Cruz B1913 1 in 50 
Vinculin Mouse Sigma V9131 1 in 100 
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Table 2.3: Secondary antibodies for 2D immunofluorescence staining with suppliers and 
working concentrations. 
 
 
 
2.11.3    Immunofluorescence staining of 3D paraffin embedded 
scaffolds. 
     Paraffin embedded scaffold sections were prepared as described in 2.9.1. Sections 
were then deparaffinised in Histoclear for 10 min, followed by gradual hydration through 5 
min incubations in 100% ethanol, 70% ethanol and PBS. Antigen retrieval was then 
performed through microwave heating the samples three times for 5 min in citrate buffer 
(10 mM citric acid, 0.05% Tween 20, pH 6.0) with cooling at room temperature for 30 sec 
between each 5 min heating. The sections were then cooled to room temperature for 15 
minutes, then treated with permeabilisation/blocking solution (20% normal goat serum 
(Sigma) in 0.4% Triton X-100 PBS) for 45 min. Primary antibody incubation was then 
performed overnight at 4 °C in a humidified chamber, with antibodies diluted in 
permeabilisation/blocking solution (20% v/v FCS and 0.4% triton x100 v/v in PBS). 
Antibodies used for paraffin embedded 3D scaffold sections are displayed in Table 2.4, 
alongside source and working concentrations. 
 
 
 
Antibody Supplier 
Catalogue 
Number 
Working 
dilution 
Donkey anti mouse 
conjugated Alexa Fluor 488 
Molecular probes, Invitrogen A21202 1:3000 
Goat anti mouse conjugated 
Alexa Fluor 568 
Molecular probes, Invitrogen A11001 1:3000 
Chicken anti rabbit 
conjugated Alexa Fluor 488 
Molecular probes, Invitrogen A21001 1:1500 
Goat anti rabbit conjugated 
Alexa Fluor 568 
Molecular probes, Invitrogen A11011 1:1500 
Chicken anti goat 
conjugated Alexa Fluor 568 
Molecular probes, Invitrogen A11041 1:3000 
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Table 2.4: Primary antibodies utilised for 3D immunofluorescence staining with suppliers and 
working concentrations. 
Table 2.5: Secondary antibodies utilised for 3D immunofluorescence staining with suppliers 
and working concentrations. 
 
  
     Once stained with primary antibodies, the samples were then washed three times in 
PBS for 5 min, followed by incubation with a secondary antibody, diluted in 
permeabilisation/blocking solution, for 1 h at room temperature in a humidified chamber. 
Secondary antibody sources and working concentrations can be seen in Table 2.5.  
 
 
 
     Following incubation, sections were washed a further three times in PBS for 5 min and 
mounted onto Superfrost+ microscope slides in Vectashield/DAPI hard set mounting 
media (Vector Labs H-1400). Slides were then left to set overnight at 4 °C and 
subsequently imaged using a Leica SP5 confocal microscope with Leica LAS AF 
software.  
Antibody Host Supplier 
Catalogue 
Number 
Working 
dilution 
E-Cadherin Rat Sigma U3254 1 in 100 
Keratin 14 Rabbit abcam Ab7800 1 in 100 
YAP1 Mouse Novus biologicals NB110-58358 1 in 100 
Keratin 10 Rabbit abcam Ab76318 1 in 100 
Vimentin Rabbit 
Kindly donated by Prof. 
R. Quinlan [235] 
N/A 1 in 100 
Antibody Supplier 
Catalogue 
number 
Working dilution 
Donkey anti mouse 
conjugated Alexa Fluor 488 
Sigma A21202 1 in 1700 
Donkey anti mouse 
conjugated  Alexa Fluor 568 
Sigma A21203 1 in 1700 
Donkey anti rabbit 
conjugated Alexa Fluor 488 
Sigma A21207 1 in 1000 
Donkey anti rabbit 
conjugated Alexa Fluor 568 
Sigma A21208 1 in 1000 
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Table 2.6: Primary antibodies utilised for 3D immunofluorescence staining of pathological 
samples, with suppliers and working concentrations. 
2.11.4    Immunofluorescence of pathological sectioned breast 
tissue samples. 
     Pathological samples were stained utilising a modified version of the protocol 
described in 2.11.3. Sections were deparaffinised overnight in Histoclear, followed by two 
10 min washes in Histoclear. Samples were hydrated by 5 min incubations in 100% 
ethanol, 70% ethanol and PBS. Antigen retrieval was performed using citrate buffer (10 
mM citric acid, 0.05% Tween 20, pH 6.0) pre-heated in a water bath at 95 °C. The 
samples were incubated in the heated citrate buffer for 20 min, then left to cool to room 
temperature. Once cooled, permeabilisation/blocking solution (20% normal goat serum in 
0.4% triton X-100 PBS) was added. The samples were then incubated in a humidified 
chamber for 45 min. Primary antibodies, diluted in permeabilisation/blocking solution, 
were then added and the samples were left to incubate overnight at 4 °C in a humidified 
chamber. Details of the antibodies used for staining pathological samples are displayed in 
Table 2.6.  
 
 
 
       Following primary antibody incubation, samples were washed three times in PBS for 
10 min, then incubated for 1 h in secondary antibodies diluted in permeabilisation/blocking 
solution (secondary antibodies, and dilutions used were the same as those detailed in 
Table 2.5). Samples were washed three times in PBS for 10 min, and then mounted on 
Superfrost+ microscope slides using Vectashield/DAPI hard set mounting media. The 
slides were then left to set at 4 °C overnight and imaged using a Leica SP5 confocal 
microscope.  
 
Antibody Host Supplier Catalogue Number 
Working 
dilution 
Nesprin-2 (pAbK1) Rabbit See ref. [233] N/A 1 in 100 
Actin Mouse Sigma A5316 1 in 100 
p63 Mouse abcam ab53039 1 in 50 
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2.11.5    Super resolution microscopy staining. 
     Cells were initially passaged and seeded onto (22 x 22) mm square coverslips (Fisher, 
12898715), as described in 2.1.5, and then left to grow to 70% confluence. This 
monolayer of cells was then processed as described in 2.11.2. One difference in the 
protocol occurs post-incubation in secondary antibody. At this stage, cells were washed 
for 5 min with PBS and incubated for 15 min in a 1:1000 dilution of Hoechst (Molecular 
Probes, 33342) to stain the nuclei. Samples were washed a further four times in PBS for 3 
min followed by mounting on Superfrost+ microscope slides using non setting Vectashield 
without DAPI. Coverslips were then sealed with nail varnish and left to set overnight at 4 
°C. Images were collected using a DeltaVision OMX Blaze V4 (Ge healthcare, Applied 
precision) super resolution microscope under 3D SIM settings. Image analysis was 
conducted using ImageJ v1.49. 
 
2.12    Western Blotting. 
2.12.1    Sample preparation: from cell culture to cell lysates. 
2.12.1.1    2D Lysate production. 
     To produce sample lysates form a single T-75 flask at 70% confluence, cells were 
washed three times for 1 min in cell culture grade PBS. The PBS was removed and 500 µl 
RIPA (Radioimmunoprecipitation assay buffer) buffer (50 mM Tris-HCl (Sigma), pH 7.5, 
150 mM NaCl (Sigma), 0.1% SDS (sodium dodecyl sulphate, Sigma), 1% Nonidet P-40 
(Sigma), 0.5% sodium-deoxycholate (Sigma)) containing 1% protease inhibitor cocktail 
(PIC, Sigma) was added and the flask cooled to 4 °C. All following procedures were 
conducted on ice to prevent autolysis. Cells were dislodged using a cell scraper, collected 
in the RIPA buffer, and transferred to a pre-cooled Eppendorf tube. The Eppendorf tube 
was then incubated on ice for 15 min. During the 15 min incubation, mechanical 
breakdown of cellular components was performed using a sterile 1 ml syringe fitted with a 
24G x ¾ inch disposable hypodermic needle. Samples were syringed 15 times to ensure 
lysate homogenization, efficient protein extraction and genomic DNA sheering. The 
resulting solution was then centrifuged at 4 °C for 15 min at 12 000 x g to pellet the 
remaining cell debris. The resulting supernatant was then extracted and combined with 
120 µl of 5x concentrated Laemmli sample buffer (0.25 M Tris-HCl, pH 6.8, 20% glycerol 
(Sigma), 4% SDS, 1.43 M β-mercaptoethanol (Sigma) and 0.2% bromophenol blue 
(Sigma)) and heated to 99 °C for 4 min. Samples were then stored at -20 °C until use. 
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2.12.1.2    3D lysate production. 
     To produce sample lysates from restrictive Alvetex® Strata scaffolds, cells were washed 
three times for 2 min in cell culture grade PBS. Scaffolds were then removed from their 
inserts and cut into small (~1 mm) square pieces with sterilised scissors. Scaffold pieces 
were then combined with 500 µl RIPA buffer containing 5 µl protease inhibitor cocktail in a 
pre-cooled Eppendorf and incubated on ice for 15 min. All following procedures were 
conducted on ice. During the 15 min incubation, the Eppendorf was vortexed every 3 min 
for 30 sec to dislodge cells. Following incubation, samples were sonicated for 1 min using 
the MSE soniprep 150 sonicator, then centrifuged at 4 °C for 15 min at 12 000 x g to pellet 
the remaining cell and scaffold debris. The resulting supernatant was then extracted and 
combined with 120 µl of 5x concentrated Laemmli sample buffer and boiled at 99 °C for 4 
min. Samples were then stored at -20 °C until use. 
 
2.12.2    Sodium Dodecyl Sulphate Polyacrylamide Gel 
Electrophoresis (SDS-PAGE). 
     For 10% polyacrylamide gels, we combined 9 ml of 10% polyacrylamide stock solution 
(375 mM Tris HCL pH 8.8, 10% v/v Protogel Acrylamide (PAA, Fisher), 0.1% w/v SDS), 
with 22 µl 10% ammonium persulfate (APS, Sigma) and 10 µl tetramethylethylenediamine 
(TEMED, Sigma). This solution was then poured into a gel caster (Hoefer Inc.) topped 
with isobutanol and left for 45 min to set.    
     For gradient gels, we used a gradient mixer system (VWR, 700-7104) to produce gels 
with a range of 3-15% acrylamide concentrations. 5.5 ml of 3% polyacrylamide stock 
solution (25 mL of 1.5 M Tris-HCl pH 8.8, 10 mL [30%] acrylamide, 1 mL of [10%] SDS 
and 64 mL H2O) was mixed with a 15% polyacrylamide stock solutions (25 mL of 1.5 M 
Tris-HCl pH 8.8, 50 mL [30%] acrylamide, 1 mL [10%] SDS and 24 mL H2O) as it was 
drawn into the gel caster. This resulted in a gradient gel, with a 15% base, decreasing in 
polyacrylamide concentration towards the top of the gel. The solution was topped with 
isobutanol after pouring, and left for 45 min to set.  
     Once set, the isobutanol was removed and a 4% polyacrylamide stock solution (1.7 M 
Tris-HCl pH 6.8, 4% v/v PAA and 1.72% w/v SDS) was combined with 30 µl APS and 16 
µl TEMED, was then poured over the surface of the resolving gel. The comb was then 
inserted to form the wells and left for 10 min to set. Once set, sample lysates produced by 
the method described in 2.12.1 were thawed and loaded in equal protein concentrations 
alongside a standard protein ladder. Samples were then electrophoresed at a constant 
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voltage of 100 V for 20 min, followed by an increase in voltage to 120 V until the dye front 
reached the base of the gel. Glass plates were then separated, and the gel was 
equilibrated in transfer buffer (25 mM Tris-Base, 190 mM glycine, 0.1% SDS, 10% 
ethanol) for 1 min.   
 
2.12.3    Tank (wet) western blot electro-transfer. 
     Following SDS-PAGE, wet electro transfer of proteins from the gel to a more stable 
membrane platform was carried out. Within a transfer compression cassette (VWR, 
CLEVSB10C), a fibre pad (VWR) was placed across the negative electrode region, 
followed by two layers of Whatman paper wetted with transfer buffer. The SDS-PAGE gel 
was then placed on top of this Whatman paper layer, followed by the activated PVDF 
(Polyvinylidene fluoride) membrane. The PVDF membrane was activated by washing in 
methanol (15 sec), distilled water (2 min), and transfer buffer (5 min). Two layers of 
transfer buffer wetted Whatman paper and a fibre pad layer were then placed on top of 
the SDS-PAGE gel, and then the compression cassette closed. The complete 
compression cassette was then placed into the electrophoretic transfer tank (VWR, 700-
7131) filled with 2 L western blot transfer buffer ([10%] ethanol, 25 mM Tris and 190 mM 
glycine in H2O) and set to a constant voltage of 10 V for 18 h, followed by an increase in 
voltage to 45 V for a further 2 h.   
 
2.12.4    Membrane blocking and immuno-blotting. 
     Following protein transfer, the compression cassette was disassembled and protein 
standard positioning was labelled on the PVDF membrane for future reference. The 
membrane was then washed for 10 sec in methanol and left to dry sandwiched in 
Whatman paper for 15 min. Following this, membrane blocking was conducted through 
incubation in blocking solution (5% skim milk powder (Sigma) in PBS) at ambient temp for 
30 min. The membrane was then rinsed twice for 15 sec in a solution of 0.1% Tween-20 in 
PBS, followed by a single 5 min wash in a fresh portion of the 0.1% Tween-20 in PBS 
solution. Primary antibody, diluted in blocking solution, was then added to the membrane 
and shaken overnight at 4 °C using a rocking shaker. The primary antibodies used are 
described in Table 2.7.    
    Following the overnight incubation in primary antibody, the membrane was washed 
three times for 10 min in a solution of 0.1% Tween-20 in PBS, followed by a further 1 h 
incubation in secondary antibody, diluted in blocking buffer, at ambient temp, on a rocking 
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Table 2.7: Primary antibodies utilised for western blot detection, with suppliers and working 
concentrations. 
shaker. Details of secondary antibodies used, alongside working concentrations can be 
seen in Table 2.8.  
     After secondary antibody incubation, membranes were washed three times, for 5 min 
in a solution of 0.3% Tween-20 in PBS, followed by three 5 min wash in a solution of 0.1% 
Tween-20 in PBS.. The washing solution was then removed from the membrane, and 
excess liquid removed with a paper towel. Freshly made ECL (enhanced 
chemiluminescence) detection solution (2.51 mM luminol (Sigma), 413.58 μM p-coumaric 
Acid (Sigma), 1 M Tris HCl pH 8.5 (Fisher) and 0.01% v/v hydrogen peroxide (Sigma)) 
was then added to the membrane and left for 1 minute. The excess ECL was then 
removed and membranes exposed to high performance photographic film (GE Healthcare 
Life Sciences), followed by film development 
 
  
Antibody Host Supplier 
Catalogue 
Number 
Working 
dilution 
Pan-Cytokeratin X Mouse Millipore MAB3412 1 in 500 
β-actin Mouse Sigma A5316 1 in 1000 
β-tubulin Mouse Sigma T8328 1 in 2000 
λ-tubulin Mouse Sigma T6557 1 in 100 
YL ½ tubulin Mouse Abcam Ab6160 1 in 1000 
Acetylated Tubulin Mouse Sigma T7451 1 in 100 
GAPDH Mouse Millipore 6C5 1 in 3000 
Nup88 Mouse BD Transduction 611896 1 in 500 
Nesprin-1 (ABD) Rabbit See ref. [232] N/A 1 in 300 
Nesprin-1 (SPECII) Rabbit See ref. [232] N/A 1 in 500 
Nesprin-2 (pAbk1) Rabbit See ref. [233] N/A 1 in 1000 
Nesprin-2 (K20) Mouse See ref. [234] N/A 1 in 500 
Nesprin-3 Rabbit Abcam Ab123031 1 in 500 
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Nesprin-4 Rabbit See ref. [78] N/A 1 in 400 
E-Cadherin Rat Sigma U3254 1 in 1000 
Emerin Mouse Abcam Ab49499 1 in 500 
Mab414 Mouse Covance MMS-120R 1 in 400 
SUN1 (282) Rabbit Abcam Ab124770 1 in 1000 
SUN1 (K71) Rabbit Abcam Ab74758 1 in 1000 
SUN2 Rabbit GeneTex GTX63578 1 in 1000 
Lamin A/C Mouse ImmuQuest IQ608 1 in 350 
Lamin B1 Goat Abcam Ab16048 1 in 4000 
Lamin B1 + B2 Rabbit Santa Cruz B1913 1 in 500 
Lap2α Mouse BD Transduction 611000 1 in 200 
Centrin Rabbit Santa Cruz sc-27793-R 1 in 500 
Peri-Centrin Rabbit Abcam Ab4448 1 in 500 
Vimentin Rabbit 
Kindly donated by Prof. R. 
Quinlan [235] 
N/A 1 in 400 
p53 Mouse Abcam Ab7757 1 in 1000 
JNK Mouse Cell signalling 9258S 1 in 1000 
Phosphorylated JNK Mouse Cell signalling 4668S 1 in 1000 
p38 total Mouse Cell signalling 9212S 1 in 2000 
Phosphorylated p38 Mouse Cell Signalling 28B10 1 in 1000 
82F-HSP27 Mouse 
Kindly donated by Prof. R. 
Quinlan [236] 
N/A 1 in 100 
3270-GFAP Rabbit 
Kindly donated by Prof. R. 
Quinlan [237] 
N/A 1 in 250 
ACD5-HSP27 Rabbit 
Kindly donated by Prof. R. 
Quinlan [236] 
N/A 1 in 250 
2D2B5-CRYAB Mouse 
Kindly donated by Prof. R. 
Quinlan [237] 
N/A 1 in 100 
3148-CRYAB Rabbit 
Kindly donated by Prof. R. 
Quinlan [237] 
N/A 1 in 200 
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Table 2.8: Secondary antibodies utilised western blot detection, with suppliers and working 
concentrations. 
 
 
 
2.13    Electron microscopy imaging. 
2.13.1    Transmission electron microscopy (TEM) of 2D cultured 
samples. 
     For a single T-75 culture flask at 70% confluence, fixation was performed by aspirating 
off the culture media and rinsing the surface with PBS. Following this, a 30 min incubation 
in 2% glutaraldehyde in NaHCa buffer (30 mM HEPES, 100 mM NaCl, pH adjusted to 7.4 
with NaOH, followed by addition of 2 mM CaCl2) was conducted. Cells were then washed 
a further two times for 5 min in NaHCa buffer (30 mM HEPES, 100 mM NaCl, pH’ed with 
NaOH followed by addition of 2 mM CaCl2 in dH2O), before a further 15 min incubation in 
a solution of 1% tannic acid and 0.075% saponin at room temp. The tannic acid solution 
was removed, and cells rinsed a further two times in NaHCa buffer for 5 min. Following 
this, the cells were washed twice in 0.1 M cacodylate buffer (10 ml 0.2 M sodium 
cacodylate pH 7.4 in 10 ml H2O) for 10 min. Cells were then rinsed with 1.5 ml cacodylate 
buffer and then scraped off the surface of the flask using a cell scraper, and transferred to 
a 1.5 ml centrifuge tube. The cell suspension was then centrifuged at 1000 g for 4 min. 
The supernatant was then removed, and the resulting pellet incubated for 1 h in a solution 
of 0.5% osmium tetroxide in 0.1 M cacodylate buffer in a rotating mixer. A further two 5 
min washes in 0.1 M cacodylate buffer then followed.  
Antibody Supplier Catalogue Number Working dilution 
Goat anti rabbit 
conjugated POD 
Sigma A6154 1 in 3000 
Goat anti mouse 
conjugated POD 
Sigma P4416 1 in 4000 
Goat anti rat 
conjugated POD 
Sigma A9037 1 in 1500 
Rabbit anti goat 
conjugated POD 
Sigma A5420 1 in 2500 
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    The cell pellet was then dehydrated by washing for 5 min, three times in 50%, 70% and 
95% ethanol solutions, followed by three 10 min washes in 100% ethanol. The cell pellet 
was then transferred to a glass vial and infiltrated with a 1:1 mixture of 100% alcohol and 
propylene oxide for 10 min. The infiltration process was then repeated, followed by two 10 
min incubations with propylene oxide. The cell pellet was then incubated for 30 min in a 
1:1 mixture of propylene oxide and epoxy resin (EPON™ 828) at 60 °C. This mixture was 
then replaced through two 30 min washes in 100% epoxy resin at 60 °C. Finally, the 
pellets were orientated in embedding moulds (Agar scientific), and incubated in fresh 
epoxy resin at 60 °C for 24-48 h to allow the resin to polymerise.  
     Ultra-thin sections were cut using a Leica EM UC6 microtome. Sections were cut at 70 
nm, and mounted onto Formvar coated copper grids. The grids were dried by blotting on 
filter paper, and then incubated in a drop of uranyl acetate for 10 min. The grids were then 
rinsed twice for 20 sec in distilled water, followed by 10 min incubation in lead citrate 
(0.4% lead citrate w/v, 0.5% sodium citrate in 0.1 N NaOH). The grids were then left to dry 
for 20 min and imaged using a Hitachi TEM-H7600 transmission electron microscope.  
 
2.13.2    Transmission electron microscopy (TEM) of 3D cultured 
samples. 
     Cells were prepared as described in section 2.3 scaffolds were removed from inserts 
and washed three times for 5 min in PBS at room temperature. Scaffolds were then cut in 
half and fixed at room temp for 1 h using Karnovsky’s double strength fixative (5% 
glutaraldehyde, 4% paraformaldehyde, 0.1 M cacodylate buffer and 50 mg CaCl2/100ml). 
Following fixation, scaffolds were incubated in 1% Osmium tetroxide for 1 h, dehydrated 
through three 5 min washes in 50%, 70% and 95% ethanol solutions, and then washed 
three times in 100% ethanol for 10 min each time. The scaffolds were then infiltrated with 
1:1 mixture of 100% ethanol: propylene oxide for three times for 10 min each time. The 
infiltrated scaffolds were then washed three times with propylene oxide for 10 min. Once 
washed, the scaffolds were cut into smaller pieces and incubated in 1:1 mixture of 
propylene oxide: epoxy resin overnight. Following the overnight incubation, the scaffolds 
were then incubated for 30 min in epoxy resin (11.75 g epon 812, 6.25 g dodecenyl 
succinic anhydride (DDSA), 7 g methyl nadic anhydride (MNA) and 0.375 ml benzyle 
dimethylamine (BDMA) twice. The scaffolds were then transferred to resin moulds with 
fresh epoxy resin and left to set for a further 24-48 h. Once set, samples were sectioned 
as described in 2.13.1 and imaged using a Hitachi TEM-H7600 transmission electron 
microscope.  
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2.13.3    Scanning electron microscopy (SEM) imaging. 
     Cells were cultured as described in section 2.3, and the scaffolds removed from their 
inserts and incubated in BRB80 buffer (80 mM PIPES, 1 mM MgCl2, 1 mM EGTA, pH 6.8 
with KOH) + 0.001% digitonin for 10 min. Fixation was then conducted by a 2 h incubation 
in a solution of 2% glutaraldehyde and 0.1% tannic acid in PHEM buffer (5 mM HEPES, 
60 mM PIPES, 10 mM EGTA, 2 mM MgCl2, pH 7 with KOH)). The scaffolds were then 
incubated in 0.1 % Osmium tetroxide for 30 min, and then dehydrated through 5 min 
washes in 10%, 20%, 40%, 60%, 80% ethanol, and then washed twice for 5 min in 100% 
ethanol. Scaffolds were then critical point dried using a Balzers CPD 030 and sputter 
coated with 10 nm platinum using a 328 Cressington sputter coater. The scaffolds were 
then fractured and placed onto silicon chips using double sided tape. Sample imaging was 
conducted using a Hitachi S5200 scanning electron microscope.  
 
2.14    Atomic force microscopy (AFM) imaging.  
2.14.1    AFM under non-biological conditions. 
     Cells were passaged as described in 2.1.5 and seeded onto glass coverslips until 70% 
confluence was achieved. Cells were then washed three times for 5 min in PBS, then left 
to air dry for 1 h at room temp. Once dried, single cells were imaged using a Bruker MM8 
AFM fitted with a 70 kHz Scanasyst cantilever, expressing a 0.4 N/m spring constant and 
triangular tip (radios 2-12 nm, height 2.5 – 8 nm) (Bruker, Scanasyst-Air) within a (15 x 15 
x 5) µm grid. Image analysis was then conducted using NanoScope Analysis 1.5 software. 
 
2.14.2    AFM under biological conditions. 
      Cells were passaged as described in 2.1.5 and seeded onto 35 mm plastic petri 
dishes (TPP). Analysis was then performed when cells reached 60% confluence. 30 min 
before analysis, cells were washed three times for 1 min with sterile PBS, and 5 ml of 
sterile filtered CO2 independent culture media (Fisher) was added. Cells were then 
analysed using a Nanowizard® 3 Bioscience AFM (JPK) using a (D)NP silicon nitride 
probe cantilever, expressing a spring constant of 0.06 - 0.7 N/m (Bruker, DNP-10) over a 
(100 x 100 x 10) µm grid. Cells were maintained at a constant temperature of 37 °C 
throughout image collection. Young’s modulus values were then assessed across different 
cell regions using the Gwyddion image analysis software.  
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2.15    GST Pull-down. 
2.15.1    GST-SR purification. 
     Initially, DH5α bacteria expressing the last four spectrin repeats across the C-terminal 
region of nesprin-2 bound to GST [77] (glutathione sepharose transferase) were 
inoculated into 5 ml LB broth (Formedium™) and 50 µg/ml ampicilin, and grown overnight 
at 37 °C with moderate shaking. 500 ml of fresh LB broth was inoculated with 4 ml of the 
overnight culture, and incubated for 2-4 h, until the OD at 600nm was >0.5. Protein 
expression was then induced through 0.5 mM IPTG (Isopropyl β-D-1-
thiogalactopyranoside) addition to the culture overnight at 20 °C. Following overnight 
induction, the bacterial culture was centrifuged at 1500 x g for 10 min. The resulting pellet 
was then rinsed in STE buffer (10 mM Tris pH 8, 150 mM NaCl and 1 mM EDTA) and 
centrifuged at 3,500 rpm for a further 10 min. The pellet was then re-suspended in ice cold 
7 ml STE buffer and 1% protease inhibitor cocktail containing 100 µm/ml Lysozyme 
(Sigma) and transferred to a Dounce homogenizer (Fisher) on ice. All following 
procedures were performed on ice. Cells were homogenized 10-20 times for 15 min, 
followed by the addition of sarkosyl [1.5%] v/v final concentration. The resulting solution 
was vortexed for 30 sec, then sonicated for 1 min. Sample was then centrifuged at 25,000 
x g rpm for 30 min, and the resulting supernatant transferred to a separate tube, whilst the 
pellet was re-suspended in equal volumes of STE buffer and mixed with SDS-loading 
buffer (as described in 2.12.1), ready for loading as a control. To 8 ml of the transferred 
supernatant, 3.2 ml 10% Triton X-100 in STE buffer was added in 0.3 ml aliquots and 
mixed ready for GST bead incubation. To ensure successful protein purification, samples 
from both the pellet and supernatant were run on SDS-PAGE as described in 2.12.2 and 
subsequently stained using coomassie blue.   
 
2.15.2    SR attachment to GST beads. 
     Following SR purification, GST beads (GE healthcare, 17, 5279-01) were cleaned 
through four 3 min washes in PBS, with centrifugation and supernatant removal after each 
wash. Incubation with 1:1 v/v ratios of GST bead slurry and isolated SR protein overnight 
at 4°C on a rotary shaker was then carried out. The beads were then washed a further two 
times for 5 min in STE buffer and stored at -20 °C until needed. A 20 µl aliquot was taken 
prior to storage of the beads and added to 5 µl SDS loading buffer as a control for GST-
SR before cellular incubation.  
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2.15.3    Cell lysate production and GST-Pulldown. 
     To assist in protein isolation, COS7 cells were transfected as described in section 2.7 
with pEGFP Nup88 in order to increase Nup88 levels, and increase protein availability for 
interactions with the GST-SR beads. Cells were cultured as described in section 2.1.1 
until a confluence of 80% was reached in a T-75 flask. Cells were then rinsed twice, for 1 
min each time, with PBS then incubated in 5 ml PBS containing a 1:100 dilution of PIC 
(protease inhibitor cocktail) (Sigma), 1 mM DTT (dithiothreitol) (Sigma), 1 mM 
benzamidine (Sigma), 1mM EGTA (Sigma) and 1 mM PMSF 
(phenylmethanesulfonylfluoride) (Sigma), and then scraped off the surface using a cell 
scraper. The cell suspension was centrifuged for 5 min at 2500 x g, and the pellet was 
then re-suspended in 1 ml lysis buffer (50 mM Tris-HCl pH7.5, 150 mM NaCl, 1% Nonidet 
P-40 and 0.5% Na-deoxycholate) and placed on ice for 15 min. During this incubation, 
mechanical breakdown was performed five times using a sterile 1 ml syringe fitted with a 
24G x ¾ inch disposable hypodermic needle. The samples was then sonicated five times 
for 10 sec each time, followed by centrifugation at 16000 x g for 10 min at 4 °C. The 
resulting supernatant was then extracted and incubated with the GST-SR beads 
described in 2.14.2 for 2 h at 4 °C with moderate shaking. Following lysate incubation with 
the GST-SR beads, the beads were centrifuged at low speeds and washed six times for 1 
min each with lysis buffer. The resulting solution was then centrifuged at 14000 x g for 2 
min, and the supernatant removed and prepared as a control. The GST-SR beads were 
then re-suspended in 1:5 ratio of 5x concentrated Laemmli sample buffer to GST-SR 
beads. Samples were then run and assessed using western blotting as described in 
2.12.3.  
 
2.16    Förster resonance energy transfer (FRET) / 
fluorescence lifetime imaging microscopy (FLIM). 
     HaCaT cells were cultured and fixed onto glass coverslips as described in 2.1.2 and 
2.8.1 respectively, followed by immunofluorescence staining for Nup88 and Nesprin-2’s C-
terminal (pAbK1) as described in 2.11.2. Within this experiment, the anti-mouse 488 
secondary was used for Nup88 staining, and was considered the donor, whereas the anti-
rabbit 568 secondary was used for Nesprin and considered the acceptor.  
     Initially, a sample of HaCaT cells stained only for Nup88 using the anti-mouse 488 
secondary antibody was assessed to gain an average reading for the fluorophore’s 
lifetime between excitation and emission without the presence of an acceptor. Once this 
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baseline was established, a PicoQuant event timer and TCSPC module attached to the 
Leica SP5 confocal microscope was used to assess the fluorescence lifetime of the anti-
mouse 488 fluorophore with the acceptor present. It is widely accepted that if an 
fluorescence lifetime reduction greater than 0.5 ps is observed, then an association 
between the donor and acceptor fluorophores is suggested [238, 239], meaning that the 
two proteins of interest are in close association.  
 
2.17    Statistical analysis. 
     Statistical analysis of data produced was carried out using Microsoft Excel and the R 
programming language. Where two experimental groups were directly compared, a 
Student’s t-test was performed. For more than two experimental groups, we used a 
Univariate Analysis of Variance (ANOVA) to determine trends within the data. The type of 
statistical test performed can be seen stated in each experiment, with statistical 
significance between the groups highlighted on graphical figures as * for differences 
where p ≤ 0.05 and ** for differences where p ≤ 0.005. All error bars presented in figures 
represent ± standard deviation of the mean unless otherwise stated.  
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Figure 3.1: Insertion of DN SUN1 results in the loss of KASH-SUN domain 
interactions. The loss of these interactions results in dilation of the nuclear membrane. 
DN SUN 1 constructs included the entire luminal SUN1 domain fused with GFP. 
3. The characterisation of LINC complex roles 
within 2D and 3D growth and migration.  
3.1   Introduction. 
 
     The LINC complex spans the double membrane of the nuclear envelope (NE), 
physically connecting nuclear structures to the cytoskeletal network. This protein bridge 
acts as a force transduction element within the cell [102, 240], facilitating cellular 
processes such as nuclear migration [241], cell polarity, [127] and chromatin organisation 
[99] in response to environmental cues. Alongside roles in maintaining cellular function, 
LINC components have been shown to maintain nuclear architecture [41, 101], which in 
turn influences both nuclear and cellular stiffness. Current understanding of LINC roles in 
nuclear and cellular stiffness are not well understood, however both nuclear and 
extracellular matrix stiffness have been shown to be key factors in influencing migratory 
behaviour, cellular function such as YAP signalling, and differentiation [242, 243, 244, 
245]. To characterise potential LINC complex roles in cellular growth and migration, we 
employed stably transfected HaCaT lines expressing a DN SUN1 construct [77]. This 
mutant overexpressed the luminal domain of SUN1, which encompasses the coiled-coil 
region and SUN domain fused to GFP, which in turn, outcompetes endogenous full length 
SUN1 for KASH binding. Thus, endogenous SUN1 is no longer able to connect to the 
ONM due to the oversaturation of KASH domains by the DN-GFP fusion.  This mutant 
therefore represents a severance of the link between INM and ONM, shown in Figure 3.1.   
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3.1.1    LINC components function in maintaining directed cell 
migration, proliferation and cell signalling. 
3.1.1.1    The KASH-SUN perinuclear interactions are crucial for maintaining 
cell polarity. 
 
     The LINC complex is a double membrane adhesive assembly, formed by interactions 
between inner NE SUN proteins and outer nuclear envelope KASH proteins across the 
perinuclear space. This connection is capable of transmitting mechanical force and 
signals across the NE, functioning in a wide range of cellular processes.   
     Cell polarisation via centrosome positioning is underpinned by SUN-KASH interactions 
across the NE helping to maintain directed cell migration, differentiation and tissue 
formation in many systems [246, 100]. It has been shown that the KASH protein nesprin-4 
can influence cell polarity through Golgi and centrosome re-organisation via kinesin-1 
mediated microtubule associations across the NE [78]. It was shown by Roux et al. that 
expression of nesprin-4 in non-polarised HC11 cells lead to kinesin mediated  detachment 
of the centrosome from NE regions. These finding suggest nesprin-4-kinesin 1 
interactions mediate the localisation and attachment of centrosomes across the NE. 
Further KASH containing proteins of the LINC complex have also been shown to play 
roles in the maintenance of cell polarity [103]. It was shown that loss of nesprin-3 
functionality through siRNA knockdowns in human aortic endothelial cells (HAECs) 
caused miss-localisation of the microtubule-organising centre (MTOC), resulting in the 
development of abnormal cell shapes. Nesprin-2 and KLC1 depletion in the human 
keratinocyte HaCaT line have also been shown to alter normal centrosome positioning at 
the NE, resulting in loss of directed cell migration [77]. These results suggest that LINC 
components are crucial for the maintenance of cell polarity due to their role in connecting 
the nucleus and cytoskeleton.  
 
3.1.1.2    LINC complex components control nuclear positioning. 
 
     Nuclear positioning plays key roles in organ physiology, tissue formation  and directed 
cell migration [247] aiding in cellular responses to developmental and extracellular cues 
(Figure 3.2). It has been suggested that nuclear positioning is maintained through LINC 
mediated associations with the cytoskeleton, through which regulation of multiple cell 
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signalling pathways can be maintained including the mitogen activated protein (MAP) 
kinase pathway [97]. LINC components, such as nesprins, have been shown to regulate 
nuclear positioning by associating with kinesin and dynein motor proteins at the NE [84]. 
Microtubule dependent nuclear movement, required for skeletal muscle development in 
mice was shown to be impaired upon loss of Kinesin-1, leading to nuclear clustering both 
in vivo and in vitro. This phenotype was shown to be reversible through the accumulation 
of active Kinesin-1 motors at the NE via a ligand inducible dimerization system between 
FKBP-EGFP-KASH (FK506 binding protein chaperone fused to EGFP-KASH) embedded 
in the ONM and HA-Kif5B-FRB (FKBP-rapamycin binding domain fused to Kif5B-HA). 
This then formed a system by which the heterodimerisation of FKBP and FRB domains is 
induced by the cell permanent ligand rapalog. These investigations suggest strong 
evidence for the localisation of Kinesin-1 motor proteins across the NE to be responsible 
for maintaining normal nuclear migration. Nesprin-1 has been further shown to regulate 
nuclear anchorage within mouse skeletal muscle, with nesprin-1 loss stimulating abnormal 
nuclear positioning, resulting in decreased tissue stiffness and a reduction in tissue strain 
resistance [248, 249].  
     Alongside this microtubule dependent nuclear positioning, actin cytoskeletal elements 
are also crucial to nuclear movement. Transmembrane actin-associated nuclear (TAN) 
lines, comprising of nesprin-2G and SUN proteins anchored by A-type lamins have been 
suggested to influence nuclear positioning within cells [96]. Further evidence suggests the 
interactions between nesprin-2G and FHOD1 (FH1/FH2 domain containing protein 1) 
allows the formation of these TAN lines across the NE. Disruptions in either A-type lamins, 
nesprin-2G or SUN proteins have been further shown to stimulate TAN line loss, resulting 
in abnormal nuclear positioning due to disruptions in centrosome positioning in polarising 
fibroblasts.  [7, 94].  
     Alongside the nesprin family of KASH proteins, SUN proteins, located at the INM, have 
also been shown to affect nuclear positioning. SUN1 and SUN1/SUN2 double knockout 
mice display abnormal nuclear positioning within skeletal muscle [250], suggesting that 
the maintenance of the SUN-KASH bridge spanning the NE is crucial in maintaining 
correct nuclear positioning.   
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Figure 3.2: A. Nuclear positioning in dividing cells and developing epithelium. Arrows indicate 
direction of nuclear movement. The nucleus is positioned relative to division plane in yeast and 
fertilised eggs. The diagram of insect optic epithelium represents a longitudinal section of a 
larval eye disc; two nuclei are shown. Nuclei anterior (A) to the morphogenetic furrow (mf), 
which moves anteriorly, move basally. Nuclei posterior (P) to the furrow move apically as cells 
are recruited into clusters comprising ommatidium (white cells, cones; grey cells, R-cells). The 
diagram of vertebrate neuroepithelium represents a longitudinal section of the developing 
cerebral cortex. Nuclei move basally during G1 and apically during G2. Mitosis (M) occurs near 
the apical surface. (B) Left highlights schematic of a cell with a protruding leading edge, actin 
filaments are highlighted in red. Right, montage of cells with the front-back dimensions 
normalised. Dotted line represents the midpoint between the front and back of each cell 
displaying nuclei are maintained at the back of the cell during migration. (C) Cross section of 
kidney cortex displaying nuclear positioning in the centre of each cell. In skeletal muscle, nuclei 
are positioned at the periphery.   [97].  
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3.1.1.3    LINC components play roles in proliferation and cellular signalling. 
 
     LINC complex proteins are involved in a wide variety of cellular functions. In addition to 
those highlighted above, nesprin-2G has been shown to play a role in both cell 
proliferation and wound healing [251]. Primary cells from nesprin-2G knockout (KO) mice 
display reduction in proliferation, and altered differentiation of keratinocytes, along with 
reduced cellular migration during wound healing. In addition, it was further shown that in 
nesprin-2 knockdown HaCaT cells (through shRNAs induced sequence specific silencing), 
the rate at which TGF-β induced SMAD was localised to the nucleus was reduced, 
suggesting that nesprins play further roles in cellular signalling. 
     Nesprins have been further suggested to play important roles in signalling pathways 
such as the ERK1/2 (Extracellular signal-regulated kinase) and Wnt pathways [252, 9]. It 
was shown that nesprin-2, ERK1/2 and PML (promyelocytic leukemia protein) co-localise 
at the NE. With nesprin 2 functionality in this pathway discerned through siRNA/DN 
nesprin construct insertion, stimulating an increase in ERK1/2 function, leading to 
increased cellular proliferation. 
 
3.1.2    The growing field of 3D cell culture. 
 
     Recently, 3D cell culture technologies and methods have expanded, incorporating the 
use of new materials that aim to replicate in vivo environments. It has been shown that in 
conventional 2D cultures, the extracellular matrix components, cell-cell and cell-matrix 
interactions, that are important for differentiation, proliferation and cellular functions in vivo 
are disrupted [253]. In contrast to this, 3D culture technologies have been shown to 
display increased expression and deposition of in vivo extracellular matrix components 
compared to their 2D monolayer counterparts [254], alongside integrated cellular 
signalling between cells due to their closer associations [255].  
     For use within this investigation, a material that provides both restrictive and non-
restrictive growth environments was required in order to allow for the assessment of cell 
growth and migration with and without LINC complex disruptions. Materials with restrictive 
growth environments were deemed as those through which nuclear deformities would be 
required to migrate due to interconnects between material regions being narrower than 
nuclear width or height.    
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3.1.2.1    Potential 3D culture models to study cell behaviour and migration. 
 
     In an attempt to bridge the gap between current culturing techniques and real life 
systems, a wide range of biological components have been incorporated into 3D cell 
culture platforms [256, 257]. In the context of assessing migratory behaviour, the 
incorporation of features such as increased dimensionality, culture heterogeneity and 
close cellular associations are crucial. These factors can alter the cellular behaviours 
found in conventional 2D systems, directing cells to adopt migratory behaviours, which 
better resemble the in vivo phenotypes.  
     One current system that uses biological reagents to develop novel 3D growth 
environments is the hydrogel. These polymeric materials have been seen to produce 
structures with a water content, biocompatibility and mechanical properties similar to that 
found within natural biological systems [218, 219].  Through adding cells to the hydrogel 
precursor prior to gelling, cells can be distributed homogeneously throughout the gel, 
leading to close cellular associations from the point of seeding. Alongside this, hydrogels 
are easily adapted to incorporate soluble or immobilised signalling molecules such as 
transforming growth factor β (TGF-β) and bone morphogenetic protein (BMP-2). This 
allows for the production of targeted environments that provide a supporting structure for 
specific cell growth and function. Numerous polymers, including natural and synthetic 
polymers are currently used to form hydrogels. Such natural polymers include collagen, 
hyaluronic acid, fibrin and a variety of extracellular matrix proteins (Matrigel®) [220], and 
synthetic polymers include poly(ethylene glycol) (PEG) [221]. However, a major drawback 
to the use of hydrogels as a platform to study cell migration is the weak structural rigidity 
exhibited by the gels. This mechanically weak polymer network may not withstand the 
forces exerted by the cells in order to migrate through restrictive environments.  
     In addition to hydrogels, a wide range of porous and fibrous polymer scaffolds have 
been developed. These materials have been synthesized from a wide range of natural 
and synthetic polymers by a variety of fabrication techniques [222]. These materials can 
be adapted to suit a range of system through tuning of the mechanical and/or chemical 
properties of the polymer network [223]. Some examples of such tailored scaffolds include 
the reinforcement of skin equivalents using hyaluronic acid fibres [224], human stem cell 
differentiation using poly(L-lactic-co-glycolic acid) (PLGA) [225], or oncogenesis on 
mPEG/hydroxyapatite scaffolds [226]. Alongside the components of the scaffold material, 
the fabrication methods used also introduce further functionality to the designed system. 
Current synthetic scaffold systems employ the numerous fabrication methods, including 
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3D printing, electrospinning and emulsion templating, each able to produce unique 
environmental conditions within which cells can adapt and respond [227, 228, 258].   As a 
result of their increased mechanical integrity compared with hydrogels, a synthetic porous 
polymer will be used as a scaffold for 3D cell culture in this investigation.  
 
3.1.2.2    Disadvantages of 3D migration assays. 
 
     Due to the increasing complexity of many 3D culturing systems, the means of 
extracting data regarding cell penetration and viability is becoming increasingly more 
complex, often requiring sophisticated analysis methods. 2D migration assays allow for 
quick and simple analysis of cell migration using single plane microscopy on either fixed 
or live cell systems. 3D work often requires more complex methods of tracking cells 
through the x, y and z planes [259]. Many cell tracking methods in 3D systems come with 
trade-offs between ease of use methods, which may have potential to stimulate cell 
damage, and process resource or time intensive methods, which in turn are less 
disruptive to the cells [260]. Alternative systems are available to assess 3D migration 
capacity in controlled systems, such as the Transwell® systems [261], however, these 
monolayer materials are not representative of in vivo systems. These factors will all have 
to be considered throughout this investigation to obtain accurate data with limited cellular 
disruption.  
 
3.1.3    LINC complex roles in nuclear stiffness and cell migration. 
 
     Cell malleability is known to play an important role in cell migration and is partially 
underpinned by nuclear proteins such as LINC complex components [262, 263]. However, 
the fundamental role of nuclear malleability in this process is not well understood. With the 
nucleus being the largest and considered the stiffest organelle in the cell [264], it can be 
hypothesised that nuclear malleability, alongside cellular malleability could be a 
contributing factor to cellular penetration potential. Initial data suggests that in 
conventional 2D systems, cellular and nuclear malleability is affected upon cell migration 
[265]. This is also observed in many 3D migration systems. Current investigations 
highlight the nuclear lamina situated across the INM, as this protein network is seen as a 
major contributor to nuclear stiffness. Mouse embryonic fibroblasts (MEFs) derived from 
lamin A/C-deficient mice were observed to penetrate through a microfluidic system much 
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faster than their control counterparts, suggesting that the loss of lamin A/C induced a loss 
of nuclear stiffness, and increases cell migration potential [266]. It is further suggested 
that altering endogenous assemblies of A- and B-type lamins can influence migration 
potential through restrictive environments, as well as influence cellular resistance to 
migration-related stress [267]. In addition, the SUN-KASH interaction across the 
perinuclear space is also suggested to play a role in the maintenance of cell migration. It 
was shown that through incorporation of mutant SUN2, SUN-KASH interactions were 
disrupted, impairing cell migration, with subsequent WT SUN2 re-insertion able to 
promote cell migration [59]. Therefore, it can be suggested that as a complex of proteins, 
LINC components may be a major contributing factor in maintaining the mechanical 
properties of the cell, and in cell migration potential.   
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3.2   Chapter Aims. 
 
     This chapter aims to investigate the effects of LINC complex disruptions on normal 
cellular processes, such as colony formation and cellular migration in both 2D and 3D cell 
culture environments. To achieve this, multiple analysis techniques including scratch 
wound assays, western blotting, 3D scaffold technologies and atomic force microscopy 
will be used. From this it is aimed to provide insights into the potential roles of nuclear 
envelope proteins on cell migration.   
 
3.2.1   Objectives. 
 
 To assess the effects of LINC complex disruptions on the cell growth phenotypes 
of a human keratinocyte cell line. 
 
 To assess whether LINC complex disruptions affect nuclear malleability and 2D 
migration potential. 
 
 To assess whether loss of the SUN-KASH ‘bridge’ between the nucleus and 
cytoplasm affects other LINC complex associated protein levels. 
 
 To assess the effects of LINC complex disruptions on the 3D migration potential in 
two 3D scaffold models, representing both restrictive and non-restrictive growth 
environments respectively.  
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Figure 3.3: TRITC-conjugated Phalloidin (Red) and DAPI (Blue) stained WT and DN 
HaCaT cells within a 70% confluence 2D culture. Scale bar = 20 µm. 
3.3 Results. 
3.3.1   Disrupting the LINC complex stimulates altered 2D growth 
phenotypes in culture. 
3.3.1.1   DN HaCaT cells present increased cell clustering under 2D growth 
conditions.  
 
     It has been described previously [77] that DN HaCaT cells (expressing a DN SUN1 
construct, which outcompete endogenous SUN for KASH interactions), present multiple 
cellular defects. These defects include reduced proliferation and migration rates, 
alongside nuclear deformities. Through sub-culturing, initial observations when compared 
to WT HaCaT cells, suggested that the DN HaCaT’s further display more compact colony 
morphologies, as displayed through fluorescence microscopy analysis in Figure 3.3.  
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Figure 3.4: Phase contrast images of WT and DN HaCaT’s at 60% confluence under standard 
growth conditions. Squares depict the 100 µm
2
 measurement areas. Scale bar = 200 µm. 
 
     As seen in Figure 3.3, DN HaCaT cells appear to cluster in much more compacted 
colonies, displayed through TRITC-conjugated phalloidin staining, allowing visualisation of 
cytoplasmic F-actin. When collated with nuclear DAPI staining, it can be clearly seen that 
the DN HaCaT cells express specific accumulation of actin across regions of the cell 
periphery, with little space observed between each nucleus. In contrast, WT HaCaT cells 
appear to express more space between individual nuclei. 
     Quantification of this phenotype was conducted between WT and DN HaCaT cells, 
with measurements taken as highlighted in Figure 3.4. Images represent live cells at 60% 
confluence, providing a depiction of the cells in close association at the beginning of 
colony formation. Imaging of cells at high confluency was avoided due to cellular shape 
changes occurring due to the restricted space available. Multiple measurements were 
taken from 12 individual images per cell line, in order to count how many cells occupied a 
100 µm2 area. Cells situated both in and out of the analysis box were counted only if they 
were seen to situate across two sides of the box (i.e. corner regions of the square).  
     Observations show visual differences between the colony morphologies of both cell 
types. The DN HaCaT cells appear to cluster in much tighter groupings, allowing a higher 
number of cells to grow in the measured space in comparison to their WT counterparts. 
Quantification of these observations can be seen in Figure 3.5.  
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Figure 3.5 shows that DN HaCaT cells grow at a significantly higher density than WT 
using an unpaired student t-test where p ≤ 0.005 was observed, suggesting an average of 
7.4 cells counted per 100 µm2 for WT HaCaT cells, whereas for DN HaCaT cells, 15.8 
cells were observed. This suggests that the growth phenotype and resulting colony 
morphology of the HaCaT cells has been affected by the disruption of the LINC complex 
across the NE. 
     In order to assess if the increased density observed in DN HaCaT colonies was a 
result of reduced cell area, both DN and WT HaCaT cells at 70% confluence were stained 
with DAPI and TRITC-conjugated phalloidin, as shown in Figure 3.3. Cell area was then 
analysed using the Velocity® image analysis software. To obtain accurate values for each 
cell line, 200 WT and DN HaCaT cells were assessed using TRITC-conjugated phalloidin 
to identify the actin-rich cell cortex and peripheral cell regions. The results obtained can 
be seen in Figure 3.6. 
 
 
Figure 3.5: Differences in cell numbers observed between the DN and WT HaCaT 
cells in a defined 2D area of 100 µm
2
. Each bar represents collated data from 20 
analysis grids across 3 replicates for each cell line.  
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     The data presented in Figure 3.6 suggests that the DN HaCaT cells display a smaller 
cellular area of 262.33 µm2, in comparison to a calculated cell area of 472.69 µm2 for the 
WT HaCaT’s. To statistically validate our findings an unpaired student t-test was used, 
suggesting a significant difference is observed between WT and DN HaCaT cell area, 
when p ≤ 0.005. This suggests that DN HaCaT cells display a significantly smaller cell 
area to the WT counterparts, implicating further roles for the SUN-KASH interaction in 
maintaining normal cellular architecture and shape.  
 
3.3.1.2   DN HaCaT cells display an altered 3D cell shape under 2D growth 
conditions.      
 
     As suggested in section 3.3.1.1, the DN HaCaT cells appear to grow in much closer 
associated colonies, occupying less space than that of the WT controls. To further 
understand the morphological changes undertaken by the DN HaCaT cells, the cells were 
analysed in 3D through Z-stack acquisition using a LEICA SP5 confocal microscope, 
followed by subsequent 3D rendering using the Volocity® image analysis software. This 
investigations aimed to assess whether DN HaCaT cells displayed a similar cellular shape 
Figure 3.6: Calculated cell area observed between the DN and WT HaCaT cells in 
2D monolayer cultures.  
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to their WT counterparts across the Z plane, or whether they have developed a more 
cuboidal morphology similar to that of in vivo keratinocytes, providing an explanation for 
how the cells are able to grow in such close proximity.  
     To test this hypothesis, DN and WT HaCaT cells were grown to 70% confluence on 
glass coverslips, and then stained with TRITC-conjugated phalloidin and DAPI in order to 
visualise the proximity of cell-cell positioning and cell nuclei. The acquired Z-stack 3D 
reconstructions are displayed in Figure 3.7. 
 
 
  
 
     Differences in nuclear shape and volume were obtained through the use of Volocity® 
imaging software. Example data outputs can be seen displayed in Figure 3.8. For each 
cell line, the blue nuclear staining was isolated and specific cells targeted. The cell height 
could then be calculated across the ZY and ZX planes. Nuclear height and volumes were 
analysed for 150 WT and DN HaCaT cells respectively. 
Figure 3.7: Fluorescence images of WT and DN HaCaT Z-stacks. Images A and B display 
WT and DN colony morphologies. Images C and D represent WT and DN cells across the Z 
axel plane, allowing nuclear height to be calculated. Coloured arrows represent cell 
orientation across the XYZ planes. Scale bar = 10 µm. 
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     A summary of the data obtained is displayed in Figures 3.9 and 3.10.  
 
 
Figure 3.8: Example output from the Volocity
®
 image analysis software from which nuclear 
height was calculated. Images A and B represent WT and DN cells respectively stained with 
TRITC-conjugated phalloidin and DAPI. Images C and D represent WT and DN DAPI 
staining alone, allowing nuclear measurements to be calculated. Arrows represent the same 
cell across the XY plane and the ZY/ZX planes. Magnifications for each image are different; 
with scale bars for WT images represent 27 µm across the XY axis and 14 µm within DN 
images.  
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     The data presented in Figure 3.9 suggests that the DN HaCaT cells are significantly 
taller than the WT HaCaT cells across the Z axis. This measurement is consistent upon 
analysis of single cells at low (A) and high (B) magnifications using 20x and 40x objective 
lenses on a LEICA SP5 confocal microscope respectively. A statistical difference is 
observed between the WT and DN HaCaT cell lines at both magnifications using a 
student’s t-test where p ≤ 0.005. Figure 3.10 displays representative data of nuclear 
volumes between the two cell lines at low (A) and high (B) magnifications. At low 
magnification, there is no significant difference between the two cell lines. However, at 
high magnification analysis of nuclear volume, a significant difference using an unpaired 
student t-test where p ≤ 0.05 can be seen, suggesting that the DN HaCaT cells display a 
smaller nuclear volume than that of the WT HaCaT cells. This suggests that the observed 
changes in nuclear height do not directly correlate to an equal change in nuclear volume.  
Figure 3.9: Average nuclear heights of WT and DN HaCaT cells measured at low, 20x 
objective (A), and high, 40x objective (B) magnifications. 
 
Figure 3.10: Average nuclear volumes of WT and DN HaCaT cells measured at low, 20x 
objective (A), and high, 40x objective (B) magnifications. Higher magnifications elude to 
differences is calculated volume due to increased accuracy of Z-stack reconstructions. 
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3.3.1.3   LINC complex disruption affects cell-substratum adhesion. 
 
     Our experimental data collected thus far suggests the DN HaCaT’s appear grow in 
more compacted colonies compared to WT counterparts. From this, we then aimed to 
further investigate whether other phenotypic differences exist between the DN and WT 
HaCaT cells during the first few hours of cell-substratum attachment post trypsinisation. 
This investigation will help elucidate potential effects of LINC complex disruption on cell-
substratum adhesion. In order to investigate phenotypic differences between the DN and 
WT HaCaT cells, cell-substrate attachments speed was analysed in real time. Image 
collection was conducted directly after cell trypsinisation, and over a period of 18 h. 
Images were collected over a range of Z-regions every 15 min, allowing for the 
assessment of flattening alongside cell-substrate attachment. The acquired images for 
each time point across both WT and DN HaCaT cells can be seen displayed in Figure 
3.11.    
     The data presented in Figure 3.11 suggests the DN HaCaT cells display a reduction in 
cell spreading upon contact with the culture substrate to that of the WT HaCaT cells. The 
first observation of this can be seen at 3 and 6 h time points, in which the WT HaCaT cells 
appear to flatten and spread across the substrate’s surface, whereas the DN HaCaT cells 
appear to retain a more spherical phenotype. Only at later stages of cell-substrate 
attachment (between 15 - 18 hour time points) do the DN HaCaT cells begin to flatten out 
across the culture flasks surface similar to that of the WT HaCaTs. Further validation of 
this data is however required, in order to conclude that disruptions to the LINC complex do 
indeed reduce cell-substratum attachment speed.  
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Figure 3.11: Time course images of WT and DN HaCaT cells post trypsinisation, 
taken over an 18 h period. Scale bar = 25 µm. 
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3.3.1.4   LINC complex disruptions stimulate differential vinculin 
organisation upon cell-substratum attachment. 
 
     Live cell analysis of WT and DN HaCaT cells suggests that the WT HaCaTs flatten out 
much faster than their DN counterparts upon contact with the cell culture substrate. To 
increase our understanding of the potential differences between the two cell lines 
stimulating this finding, further assessment of actin and vinculin organization during early 
stage cell-substrate attachment were assessed. Vinculin is a member of the focal 
adhesion complex, responsible for the connection between integrin adhesion molecules 
and the actin cytoskeleton, enabling the subsequent formation of cell interactions with the 
extracellular environment. The formation of these focal adhesions has been well 
documented to function in cell flattening events [268], suggesting that the function of 
vinculin and subsequent focal adhesion formation may be compromised in LINC disrupted 
cells. 
     Initial experiments aimed to investigate vinculin distribution over set time points post 
trypsinisation between the WT and DN HaCaT cells, therefore assessing focal adhesion 
formation. To assess this, both WT and DN HaCaT cells were trypsinised and placed onto 
glass coverslips as described in methods section 2.11.2. Cells were then incubated under 
normal growth conditions for a period of 24 h, with cell fixation taking place at 2, 4, 6, 8, 12 
and 24 h time points. Cells were stained with DAPI to reveal nuclei and for vinculin in 
order to visualise focal adhesion sites, followed by assessment through confocal 
microscopy. Representative images for both cell lines at each time point can be seen in 
Figure 3.12. 
     From the data presented within Figure 3.12, observations suggest limited variation 
between vinculin organisation across WT and DN HaCaT cells can be seen, with potential 
differences in organisation observed at the 6 h time point. At this time point, WT HaCaT 
cells appear to begin flattening onto the culture substrate, stimulating vinculin localisation 
towards the cell periphery. At this same time point, DN mutants display no changes in 
vinculin distribution to that of 2 and 4 h time points. This observation further supports the 
previous finding that WT keratinocytes begin flattening between 3 - 6 h time points, with 
DN cells displaying a delay in cell flattening. However, at these time points, this 
observation is not fully clear, so alongside the 12 h time period, cells were also assessed 
24 h post trypsinisation. This further analysis aimed to investigate whether focal adhesion 
formation and vinculin distribution is further altered upon cell attachment over extended 
culture periods. Representative images of this time point can be seen in Figure 3.13. 
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Figure 3.12: Images of WT and DN HaCaT cells post trypsinisation. Cells are stained 
for DAPI (blue) and vinculin (red). Arrows at the 6 h time point display cells not yet 
beginning to flatten across the culture surface. Scale bar = 10 µm. 
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Figure 3.13: WT and DN HaCaT cells 24 h post trypsinisation. Cells are stained for 
DAPI (blue), phalloidin (cyan) and vinculin (red). Arrows display sites of focal 
adhesion formation across the cell periphery. Scale bar = 10 µm. 
 
 
 
     In Figure 3.13, a clear difference can be seen between the vinculin distribution of WT 
and DN HaCaT cells. It can be seen that for the WT HaCaT cell line, the majority of 
cellular vinculin is accumulated at the cell periphery at points of actin accumulation. This 
vinculin accumulation represents points of focal adhesion formation, allowing cell-
substrate interactions to be established, in turn, helping the cell spread and migrate. The 
DN HaCaT cells however, appear to lack this vinculin accumulation at the cell periphery, 
retaining the majority of expression within the central cytoplasmic regions. This helps 
provide potential suggestions as to why DN HaCaT cells display increased nuclear height 
and cell clustering, suggesting the DN HaCaT cells may express less peripheral focal 
adhesions through which cell flattening can be aided.  
     In order to further investigate these observations, actin organisation during cell-
substrate attachment was also monitored. It is known that actin plays vital roles in cell 
migration and attachment [269], thus it was hypothesized that loss of normal SUN-KASH 
interactions across the NE would affect actin organisation due to a loss of potential 
mechanotransduction and load bearing strength across the NE during the attachment 
period. Experimental set up was the same as for the vinculin investigation, with cells 
stained against DAPI and TRITC-conjugated phalloidin (Figure 3.14).  
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Figure 3.14: WT and DN HaCaT cells post trypsinisation. Cells are stained for DAPI (blue) 
and TRITC-conjugated phalloidin (red). Arrows highlight proposed actin ‘cap’ (D’) alongside 
sites of actin organisation differences between WT and DN cells. Scale bar = 10 µm.  
 
 
 
      Figure 3.14 suggests that global actin organisation between the WT and DN HaCaT 
cells does appear to alter during cell-substrate attachment. Initially it can be seen that 
when in close proximity (A- J), the DN HaCaT cells retain the highest levels of actin within 
regions in contact with other cells. This differs to that of the WT HaCaT cells, which 
display an even distribution of actin across the cells cytoplasm and NE, with much 
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localised at cell-substrate interacting regions (clearly indicated in D and I). These 
observations support previous findings, in which WT cells appear to spread and flatten 
much sooner than the DN cells across the substratum, highlighted best within images D 
and I at the 8 h time point. For isolated cells (A’- J’), further differences in actin 
organisation can be seen between the two cell types. Within both cell lines, actin 
distribution can be seen to accumulate at the cells periphery from 4 h onwards, with DN 
HaCaT cells displaying more filopodia protruding into the surrounding space. Interestingly 
however, from 6 h onwards, the WT HaCaT cells begin to accumulate actin across the 
nuclear region, forming an ‘actin cap’ around the nucleus. This ‘actin cap’ is not observed 
in the DN HaCaT cells, which display consistent actin localisation at the cell periphery. To 
further quantify this observation, 100 cells for both the WT and DN HaCaT cells were 
analysed across the 8 – 12 h time points to assess whether a difference was observed 
between cell numbers expressing this nuclear actin accumulation. Cells were considered 
to express a nuclear actin cap when a distinct covering of actin filaments could be seen 
across the nuclear surface, similar to the image displayed within Figure 3.14 (D’). The 
collated data from this assessment can be seen below in Figure 3.15.  
 
     
 
     The results presented in Figure 3.15, suggests that WT HaCaT’s do indeed display 
significantly more nuclear actin cap positive cells compared to DN HaCaT counterparts 
using a student’s t-test where p ≤ 0.005, suggesting 50% of WT cells, but only 16% of DN 
HaCaT cells were observed to display an actin cap .  
Figure 3.15: Numbers of nuclear cap positive (+ve) and negative (-ve) cells 
during cell-substratum attachment between WT and DN HaCaT cells.  
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Figure 3.16: WT and DN HaCaT at 0 h, 24 h and 48 h time points. Green phase contrast 
images display wound closure over time alongside DAPI staining. Green regions represent 
false colouring of dense cell regions either side of the wound. Scale bar = 100 µm. 
     From the data presented thus far, it can be suggested that both the rate of cell 
attachment and flattening was less in LINC-disrupted compared to WT cells. Further to 
this, it can be seen that two major protein components of cells attachment, vinculin and 
actin; express differential organisation between the WT and DN HaCaT cells at varying 
time points post trypsinisation.  
 
3.3.2   LINC complex disruption affects 2D directed cell migration. 
3.3.2.1    LINC complex disruption reduces migration speed in 2D culture. 
 
     In order to assess the impact severing the SUN-KASH perinuclear interactions in the 
rate of cell migration in 2D culture environments a scratch wound assay was carried out. 
Images of wound closure were taken at 0 h, 24 h ad 48 h time points, at which phase 
contrast microscopy was carried out, followed by fixation and DAPI staining, the results of 
which can be seen in Figure 3.16.  
 
 
 
 
     To accurately assess cell migration across the wound, 100 measurements for each cell 
line were taken at 100 µm intervals across three independent repeats, the results of which 
are shown in Figure 3.17.  
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Figure 3.17: Wound closure of WT and DN HaCaT cells over 0 h, 24 h and 48 h time points. 
 
 
 
     The data presented within Figure 3.17 suggests that the DN HaCaT cells display a 
slower migration rate in comparison to their WT counterparts. Using a student’s t-test, it 
can be seen that there is a significant difference between the WT and DN HaCaT 
migration speeds at the 24 h and 48 h time points when p ≤ 0.005. 
     The data obtained thus far suggest that when using conventional 2D culture systems, 
disrupting LINC complex connections through severance of SUN-KASH perinuclear 
interactions stimulates significant cellular abnormalities, ranging from reduced cell 
migration potential, to alterations in cell-substrate interactions. To further understand the 
effects of this LINC complex disruption in relation to more life-like settings, further 
characterisation of DN and WT HaCaT cell lines was then performed using a 3D culture 
system. This 3D environment more accurately emulated an in vivo growth environment, 
allowing observations to be made as to the effects of this SUN-KASH disruption on 
cellular behaviour/morphology in a 3D growth system.  
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3.3.3   DN HaCaT cells, but not WT HaCaT cells exhibit altered 
growth phenotypes within 3D culture to that of 2D culture. 
3.3.3.1   LINC complex disruptions stimulate decreased cellular migration 
rates within non-restrictive 3D Alvetex® Scaffolds. 
 
     When cultured on 2D substrates, WT HaCaT cells migrate significantly faster than the 
DN mutants. However, when compared to 2D cultures, true biological systems often 
display altered cellular behaviours and movement patterns in 3D environments, allowing 
for more complex interactions to occur due to the nature of cellular positioning, proximity 
and density of packing within a confined space.  
    Two commercially available 3D cell culture scaffolds were used in order to investigate 
migration behaviour of WT and DN HaCaT cells in a 3D environment. The two systems 
used were Alvetex® Scaffold and Alvetex® Strata. Both materials exhibit a synthetic 3D 
environment produced from a highly porous polystyrene matrix. This matrix provides cells 
with the support and space to grow in 3D. Both materials consist of voids, interconnecting 
windows and pores, all working in conjunction to allow cellular migration and growth to 
occur throughout the scaffold. A representation of the two scaffold types and the 
differences between them can be seen in Figure 3.18.  Both materials have been 
fabricated from the same polymer (cross-linked polystyrene), however, the manufacturing 
process has been modified for Alvetex® Strata in order to produce a material with much 
smaller voids and interconnecting windows in comparison to Alvetex® Scaffold. The 
observed void diameters in Alvetex® scaffold are between 15-45 µm in diameter, whereas 
the Alvetex® Strata scaffold void diameter is between 5-15 µm. The smaller void 
diameters associated with Alvetex® Strata create an environment that is more restrictive to 
cell migration than that of the Alvetex® Scaffold, allowing for differences in migration 
potential between the two cell lines to be assessed. 
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     It has been hypothesized that the materials’ high porosity allows cells to anchor to the 
extracellular environment, as well as migrate through the culture substrate in a manner 
that is more similar to that of their in vivo migration phenotypes. In addition, the porous 
nature of the material means that ‘wells’ of media will remain available throughout the 
scaffold, allowing for areas of the cell in contact with the scaffold surface to remain in 
contact with media. This therefore provides the ability of cells in these 3D matrices to 
uptake media across an increased surface area in comparison to their 2D culture 
counterparts.  
 
 
    
 
Figure 3.18: Differences between Alvetex
® 
Scaffold and Alvetex
® 
Strata materials. A) I) SEM 
micrograph of Alvetex Scaffold, highlighting the larger void diameters (~15-45 µm) and the 
interconnecting windows. II) SEM micrograph of Alvetex
® 
Strata material, highlighting much 
smaller void sizes (~5-15 µm). Scale bar = 40 µm. B) I) SEM micrograph material’s surface, 
demonstrating how cells use the pores as attachment points to aid migration through the 
scaffolds, with II) Representation of the microstructure of the materials surface. 
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     To test the differences in migration and penetration potential between the WT and DN 
HaCaT cell lines, 250,000 cells were seeded onto each scaffold type for an observation 
period of 14 days. Migration was analysed at 2, 4, 6, 8, 10 and 14 day time points, 
allowing sufficient time for cell penetration to occur. At each time point, cells were fixed 
and paraffin embedded, sectioned, and H & E stained (Materials and Methods). 
Micrographs of the full length of Alvetex® Scaffolds containing WT and DN HaCaTs can be 
found below in Figure 3.19. 
 
 
 
     Images in Figure 3.19 show that there is a large difference in cell packing density 
between the DN and WT cell lines after 14 days of culture. The DN HaCaT cells appear to 
pack more densely throughout the width of the material, whereas the WT HaCaT cells 
appear to form two dense cell layers, one on the side of seeding, and another on the 
opposite side of the scaffold. This result agrees with observed differences between these 
two cell lines in 2D systems, in which the DN HaCaT cells exhibit much closer 
associations.  
Figure 3.19: H & E stained Alvetex
®
 Scaffold 14 days after cell seeding. A) Alvetex
®
 scaffold 
seeded with WT HaCaT cells, B) Alvetex
®
 scaffold seeded with DN HaCaT cells. Arrows 
represent the surface of initial cell seeding. Scale bar = 300 µm.
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Figure 3.20: Analysis of cell penetration into Alvetex
®
 Scaffold. 5 sections were taken through 
varying depths to get a representation of penetration across the whole scaffold. Each section 
was then H & E stained and imaged at 100x magnification A) Full length scaffold with regions 
imaged. B) 5 measurements across the scaffold. C) Obtained output.  
     The rate at which each cell line penetrated into Alvetex® Scaffold was assessed over a 
14 day period, with sampling taking place at 2, 4, 6, 8, 10 and 14 day time points. An 
objective analysis method described in Figure 3.20, was developed in order to remove 
bias.  
 
 
 
 
     The rules used when measuring penetration into the scaffolds were deemed strict 
enough to remove as much subjectivity as possible from data collection. Across each full 
length scaffold, images were taken at intervals of 250 µm. Penetration was then measured 
at 100 µm intervals across these images. Micrographs of H & E stained scaffolds at each 
time point can be seen in Figure 3.21. 
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     The data presented in Figure 3.21 suggests that both cell lines behave differently in the 
non-restrictive 3D culture environment. The images suggest that the WT HaCaT cells 
appear to migrate through the Alvetex® scaffold faster than the DN mutants, penetrating 
through the whole 200 µm scaffold within 6 days. In addition, the DN HaCaTs appear to 
pack more densely in the voids of the material in comparison to their WT counterparts. 
The collated data from across all three repeats can be seen presented in Figure 3.22.   
Figure 3.21: H & E staining of both WT and DN HaCaT cells in Alvetex
®
 scaffolds at 2, 4, 6, 
8, 10 and 14 day time points post seeding. Scale bar = 100 µm. 
98 | P a g e  
 
Figure 3.22: Differences in Alvetex
®
 scaffold penetration between WT and DN HaCaT cells 
over a 14 day period post-seeding. 
 
 
     As shown in Figure 3.22, the WT HaCaTs migrate through the less restrictive Alvetex 
scaffolds much faster than the DN HaCaTs, showing complete penetration through the 
200 µm scaffold between 4 and 6 day time points. The DN HaCaT cells show complete 
penetration between the 6 and 8 day time points. Statistical analysis using an unpaired 
student’s t-test suggest that the differences observed between the WT and DN HaCaT 
penetrations at the 2, 4 and 6 day time points are statistically significant when p ≤ 0.005. 
The 8, 10 and 14 day time points show no significant difference between penetration rates 
of both cell lines, as both have fully penetrated through the material. Due to the use of 
multiple t-tests, a Bonferroni test was also carried out as seen through p-values of 0.005, 
in order to reduce the occurrences of type 1 errors and therefore increase the validity of 
statistical data obtained.  
     These observations suggest that disrupting the connection between the nucleus and 
the cytoplasm through this SUN-KASH bridge effects cellular packing density of these 
cells within a 3D system, similar to that found in 2D environments. In addition, the WT 
HaCaT cells migrate through the less restrictive Alvetex® Scaffold significantly faster than 
the DN mutants. 
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3.3.3.2   Disrupting the LINC complex provides cells with a migration 
advantage within physical restrictive 3D Alvetex Strata inserts. 
 
      To further investigate the roles of LINC complex disruptions on migration behaviour, 
the rate of migration of both WT and DN HaCaT cells in the space-restrictive cell culture 
environment of Alvetex® Strata was investigated. During cancer metastasis, cancerous 
cells migrate away from the source tumour via extravasation and intravasation. In order to 
migrate away from the source tumour, cancer cells must possess the ability to migrate 
through highly restrictive environments. It was envisaged that the highly restrictive nature 
of the Alvetex® Strata material would mimic this environment, providing a platform to study 
the impact of LINC complex disruptions, and hence, nuclear deformations, on cell 
migration.  
     The same preparation and analysis methods used for the Alvetex® Scaffold materials 
were employed for the Alvetex® Strata scaffolds, with cells being seeded at a density of 
250,000 cells after plasma treatment. Examples of full length H & E stained scaffolds 
containing WT and DN HaCaT cells can be seen in Figure 3.23.  
     Initial observations from Figure 3.23 suggest the DN HaCaTs appear to penetrate 
consistently across the length of the scaffold, whereas their WT counterparts display a 
more sporadic migration pattern. Further observations suggest the restrictive nature of the 
material stimulates cellular build up at the seeding site. The DN HaCaTs appear to 
produce a much denser cell layer across the scaffold’s surface, causing the scaffold to 
curl. In comparison to this, the WT HaCaTs appear to produce a much less dense layer of 
cells. Micrographs of H&E stained scaffolds at each time point are displayed in Figure 
3.24. 
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Figure 3.23: H&E stained Alvetex
®
 Strata scaffolds 14 days after cell seeding. A) Scaffold 
seeded with WT HaCaT cells, B) Alvetex
®
 Strata scaffold seeded with DN HaCaT cells. 
Arrows represent the side of initial cell seeding. Scale bar = 300 µm. 
Figure 3.24: H&E staining of both WT and DN HaCaT cells in Alvetex
®
 Strata scaffolds at 2, 4, 
6, 8, 10 and 14 day time points post seeding. Scale bar = 100 µm. 
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     The data presented within Figure 3.24 suggest that there is a large variation in growth 
patterns observed between the non-restrictive Alvetex® Scaffold and space-restrictive 
Alvetex® Strata, with neither cell line penetrating fully through the scaffold. In addition, it 
appears that the WT HaCaTs migrate up to half way through the scaffold, then plateau, 
whereas the DN HaCaTs retain their slower migration speed, migrating further into the 
scaffold by day 10. Data collated from 3 repeats is shown in Figure 3.25. 
 
 
     The data presented in Figure 3.25 suggest that both cells lines exhibit different 
penetration properties in the restrictive scaffold. As observed previously, the WT HaCaT 
cells appear to migrate faster than the DN HaCaT cells over the first 6 days of growth, 
however, upon reaching the central region of the scaffold (~100 µm) their migration 
appears to halt. In comparison, the DN HaCaTs appear to maintain a constant growth rate 
over the course of the experiment, migrating deeper into the scaffold than the WT HaCaTs 
around the 8 - 10 day time point. This suggests that the DN HaCaTs have a migration 
advantage in the highly space-restrictive Strata® environment, in which cellular and 
nuclear morphology changes will be required in order to migrate and penetrate into the 
material. Further statistical analysis between WT and DN HaCaT penetrations at each 
Figure 3.25: Differences in Alvetex
®
 Strata scaffold penetration between WT and DN HaCaTs 
over a 14 days period post-seeding. 
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time point suggests that each observed difference in cell penetration is statistically 
significant when p ≤ 0.005.   
     This initial investigation suggests that through disrupting this link between 
nucleoplasmic and cytoplasmic networks in the DN HaCaT cells, abnormalities in cell 
behaviour have occurred The properties exhibited by the DN mutants contain some 
similar migration phenotypes to that exhibited by many high grade cancer cells during 
metastasis, in which cells are able to migrate through challenging, space-restrictive 
environments, similar to that found in many tissue systems.   
 
3.3.3.3   The DN HaCaT cells exhibit a more uniform penetration phenotype 
within restrictive Strata® Scaffolds. 
 
     It can be seen that migratory behaviour differs between the WT and DN HaCaT cells in 
the restrictive Strata® scaffolds, in which the DN HaCaT cells display a more uniform 
leading edge in comparison to the WT HaCaT cells. To quantify these observed 
differences, H&E staining was performed on both cell lines in these space-restrictive 
scaffolds at the 6 day time point. This time point was selected as it represents a time point 
at which both cell lines migrate equal distance through the scaffold. Measurements were 
then taken along the leading edge of the scaffold as highlighted in Figure 3.26. The 
leading edge was measured between two set points at 200 µm apart, allowing 
comparisons to be made between the cell lines regarding their migratory behaviours. Cells 
which migrate as a uniform group will, theoretically, produce a measurement close to the 
known distance of 200 µm, whereas cells that display a less uniform migratory behaviour 
should produce a measurement larger than that of the known distance.  
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Figure 3.26: Migratory behaviour across the leading edge. H&E stained Alvetex
®
 Strata scaffold 
seeded with WT (A) and DN (B) HaCaT cells, examined 6 days post seeding. Arrows represent a 
known distance of 200 µm, and the red line across the leading migratory edge represents the 
measured distance. Scale bar = 100 µm. 
Figure 3.27: Differences observed between the WT and DN HaCaT leading 
edge migration uniformity within the space-restrictive Strata
®
 scaffolds at the 6 
day time point.  
 
 
 
 
     The data presented in Figure 3.26 suggests a difference between the penetration 
behaviours of WT and DN HaCaT cells in the space-restrictive scaffolds. Collated data 
using this technique across 25 scaffolds for both the WT and DN HaCaTs can be seen 
displayed within Figure 3.27.  
 
 
 
B
 
 A 
A
 
 A 
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     Data presented in Figure 3.27 suggests there is a significant difference between 
leading edge migration uniformity in WT and DN HaCaTs using an unpaired students t-
test where p ≤ 0.005. The WT HaCaTs appear to display a less uniform migratory 
behaviour in the restrictive Strata® Scaffold producing an average leading edge distance 
of 335.5 µm. In contrast, the average DN HaCaT leading edge was measured at 235.5 
µm, which is much closer to measurement distance of 200 µm. This data, therefore, 
suggests that the LINC complex disruptions present in DN HaCaT cells, stimulates a more 
uniform migration phenotype when faced with restrictive 3D environments.  
 
3.3.3.4   DN HaCaT cells display cell stacking, alongside shape changes 
across surface regions of space restrictive scaffolds.  
 
     In addition to leading edge morphology differences highlighted in section 3.3.3.3, 
further observations were made as to the cellular changes occurring across both the 
surface and within the centre of the space-restrictive Strata® scaffolds. 
     Initial observations were conducted on H&E stained WT and DN HaCaT cells grown for 
4 days submerged in growth media, followed by an 8 day culture period at the air-liquid 
interface. The use of this air-liquid interface is known to stimulate the differentiation of 
HaCaT cells in vitro [270]. It is therefore hypothesised that due to the cytoskeleton playing 
a key role in keratinocyte differentiation during skin development [271], alongside further 
evidence that LINC components control cytoskeletal organisation [81], the LINC-
disruptions present in DN HaCaT cells may stimulate alterations in this process.  
     From this experiment, morphological differences were observed between the WT and 
DN HaCaT cells across space-restrictive Strata® scaffolds, in which WT HaCaT cells 
appeared to produce a single cell layer across the surface of the scaffold with the 
remainder of the cells migrating and proliferating into the scaffold. The DN HaCaT cells, 
however, appeared to produce a thick layer of ~2-3 cells across the scaffolds surface. 
This observed cell stacking displayed a layer of cuboidal and/or columnar cells in direct 
contact with the scaffold, while upper layers displayed a more flattened phenotypic shape.  
These observed phenotypes resemble cellular shape changes seen during initial stages of 
cellular stratification in the epidermal layer of skin.  Images of this observed phenotype 
can be seen in Figure 3.28, with examples of keratinocyte morphology in human skin 
shown in Figure 3.29. 
105 | P a g e  
 
     The data displayed in Figure 3.28 and 3.29 suggest that DN HaCaTs appear to display 
some phenotypic similarities to that of differentiating keratinocytes in human skin. This is 
evident across the scaffolds surface, in which cell shapes change from a flattened to a 
more cuboidal phenotype. In Figure 3.29, the area of interest highlighted by X in images A 
and B, helps highlight that these cuboidal cell shape changes are present in both the DN 
HaCaT cells and human skin samples. Images C and D, however, displays the cellular 
flattening phenotypes across the surface of both the human skin sample and the surface 
layer of the Strata® Scaffolds, highlighted with XX in each image. This data suggests that 
even though the cell shape changes present within the Strata® Scaffolds seeded with DN 
HaCaTs are not as extensive as those found within the primary human skin, there are still 
some similarities in morphology.  
 
 
    
 
 
Figure 3.28: H&E staining of (A, B) WT HaCaT, and DN HaCaT cells grown at the air-liquid 
interface for 8 days in the Strata scaffold. Images obtained at both (A, C) low magnification, 
scale bar = 100 µm, and (B, D) high magnification, scale bar = 50 µm. 
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Figure 3.29: (A, C) H&E stained DN HaCaT cells grown at the air interface in restrictive Strata
®
 
Scaffolds. (B, D) H&E stained human skin samples displaying epidermal regions. X highlights the 
cuboidal cell shapes change observed in both systems. XX highlights the flattened cellular layer of 
cells positioned across the surface layer of cells. Scale bars = 50 µm. 
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Figure 3.30: Images of DN HaCaT cells in Strata scaffolds.(A) DAPI staining, (B) the 
DN GFP signal (as the DN SUN1 construct contains a GFP tag), (C) Nile Red and 
cytokeratin 1. Arrows display regions of cell stacking (A) and regions of cell 
accumulation above the scaffold (C). Scale bar = 25 µm.  
3.3.3.5   DN HaCaTs display altered nuclear and cellular phenotypes across 
the surface and within the centre of the 3D scaffolds. 
 
     Thus far, H&E staining in section 3.3.3.4 suggest that DN HaCaTs exhibit an altered 
cell shape across the surface of the space-restrictive Strata® Scaffold. However, it is not 
clear as to whether these observed differences are occurring across the surface or within 
the scaffolds. To investigate this, DN HaCaT cells grown at the air-liquid interface in 
space-restrictive Strata® scaffolds were co-stained using Nile red (to stain the scaffolds), 
cytokeratin 1 (to visualise keratinocytes) and DAPI (to observe the nuclei). This staining 
allows for the clear identification between scaffold regions and cell positioning, allowing 
the assessment of whether this cell stacking observed previously is within, or across the 
surface of the scaffold (Figure 3.30).  
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     The data displayed in Figure 3.30 suggests that the shape changes observed in DN 
HaCaT cells are occurring across the surface of the scaffold, rather than within the voids 
of the first 10-50 µm. This can be clearly observed in images A and B, showing the GFP 
and DAPI stains, highlighting a tightly associated network of cells across the scaffolds 
surface. Alongside this, C displays further scaffold and cell staining with Nile red and 
cytokeratin 1, suggesting that the layer of cells associated with the cuboidal shape 
changes in the initial H & E staining, can be seen above the scaffolds surface, in a layer 
~2-4 cells thick. 
     Due to these observations, further investigation aimed to assess whether shape 
changes between WT and DN HaCaT cells could be seen in both space-restrictive and 
non-restrictive scaffolds environments when cultured at the air-liquid interface using 
confocal microscopy analysis.  It was hypothesized that DN HaCaT cells may express 
abnormal nuclear shapes in central scaffold regions compared to both surface regions of 
the same scaffold, and their WT counterparts, due to known roles of the LINC complex in 
maintaining nuclear architecture. This inferred disruption to nuclear shape in DN mutants 
may therefore be the contributing factor to their observed surface shape changes and 
increased penetration potential into space-restrictive scaffolds. The results of this can be 
seen in Figure 3.31.  
     As seen in Figure 3.31, the cell packing densities appear to differ between the WT and 
DN HaCaT cells in central regions of the non-restrictive scaffolds (Image sequence C and 
D). It is seen that more cells are observed in close proximity across each void for the DN 
HaCaT mutants in comparison to their WT counterparts, similar to phenotypes observed 
under 2D culturing conditions (Figure 3.3). These observations further support previous 
H&E analysis (Figure 3.28), suggesting that the DN HaCaT mutants appear to colonise 
central scaffold regions in much more dense cell colonies, displaying closer cell-cell 
proximity compared to WT cells.    
     Further to this, image sequences A and B suggests differences also exist between cell 
packing density across surface scaffold regions between each cell line, in which DN 
HaCaTs appear to produce a 1-2 cell thick layer of flattened cells. In contrast, WT HaCaT 
cells appear to migrate into the scaffold without any cellular stacking occurring across the 
scaffolds surface.  
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     Cells cultured in Alvetex® Scaffolds displayed morphological differences between WT 
and DN HaCaT cells in both central and surface scaffold regions. To expand on this, 
confocal analysis was also conducted on the space-restrictive Strata® Scaffolds under the 
same air-liquid interface conditions for each cell type. The aims of this investigations was 
Figure 3.31: Fluorescence images displaying both WT (A’,A’’A’’’ and C’, C’’,C’’’) and DN 
(B’,B’’,B’’’ and D’,D’’,D’’’) HaCaTs in the Alvetex
®
 scaffold after 8 days at the air interface. 
Images A and B highlight both cell types across the surface of the scaffold. C and D highlight 
cellular morphology across the central scaffold regions at various magnifications. Staining’s 
present include DAPI (blue), Scaffold (red) and GFP (green). Scale bar = 10 µm. 
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to assess whether further differences existed in cell/nuclear morphology, alongside cell 
behaviour between WT and DN cells in central/surface scaffold regions compared to the 
non-restrictive environments, with results displayed in Figure 3.32. 
     The data presented in Figure 3.32 suggests the morphology of both cell lines appears 
to vary more than observed previously in the less restrictive Alvetex® Scaffold. Initial 
surface analysis suggests WT HaCaTs display no obvious differences to phenotypes 
observed in the Alvetex® Scaffold, in which cells appear to settle within the first 5 µm of 
the scaffold, rather than flatten across the surface. In contrast, the DN HaCaTs display 
large morphology differences to that of both the WT cells in the Strata® scaffold, and to 
that of the DN HaCaT cells grown within the Alvetex® scaffold. It can be seen that DN 
HaCaTs form a 2-3 cell thick layer across the scaffold’s surface, similar to that seen within 
the non-restrictive scaffold. However, in addition to this, the DN HaCaTs appear to 
undergo morphological changes, displaying a much more cuboidal like phenotype, not 
dissimilar to that displayed by in vivo keratinocytes. In addition to these observed cell 
shape changes, it is also evident that cells situated across the surface of this 2-3 cell thick 
layer appear to have flattened nuclei and elongated cell shapes, similar to that found in 
the differentiated epidermal layers of skin (Figure 3.29). Further to this, the distribution of 
GFP SUN1 across the surface layer of DN HaCaT cells appears to form a more defined 
structure, potentially corresponding to cytoplasmic staining of the ER (Figure 3.32 (B)). 
These observations suggest that DN HaCaT cells across these surface regions of space-
restrictive scaffolds undergo significant changes in cellular morphology compared to their 
WT counterparts.  
     Alongside cellular differences observed across surface regions of the space-restrictive 
scaffold, further variation in cellular phenotypes can also be seen in central scaffold 
regions for both cell lines, when compared to the less restrictive Alvetex® counterparts. As 
suggested in Figures 3.24 and 3.25, the WT HaCaTs appear to exhibit a reduced 
migration speed in the space-restrictive Strata® scaffold, with migration appearing to halt 
at the centre of the scaffold (~100 µm into the scaffold). Fluorescence staining in this 
central region suggests a sparse cell distribution for WT HaCaT cells compared to that 
observed for the Alvetex® scaffold. DN HaCaTs appear to exhibit similar cellular packing 
densities to that found in the Alvetex® scaffolds (Figure 3.31 (D)). However, the more 
restrictive Strata® Scaffold appears to stimulate an increased occurrence of nuclear 
morphology changes (more specifically shown in images D’’ and D’’’, with observed 
nuclear constrictions measuring at 5 µm and 2 µm respectively). These observations 
therefore suggest that for both WT and DN HaCaT migration through space-restrictive 
Strata® scaffolds, but not the Alvetex® scaffolds, nuclear deformities are required.   
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     Due to the nature of morphological changes observed between the two cell lines, and 
more specifically between the DN HaCaT cells in both scaffold types, further 
investigations into the cell/nuclear morphological changes observed were conducted using 
Figure 3.32: Fluorescence images displaying both WT (A’,A’’A’’’ and C’, C’’,C’’’) and DN 
(B’,B’’,B’’’ and D’,D’’,D’’’) HaCaTs in the Alvetex
®
 Strata after 8 days at the air interface. 
Images A and B highlight both cell types across the surface of the scaffold. C and D highlight 
cellular morphology across the central scaffold regions at various magnifications. Staining’s 
present include DAPI (blue), Scaffold (red) and GFP (green). Scale bar = 10 µm. 
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TEM and SEM techniques. With the use of these techniques, it was possible to more 
accurately assess and characterise the cellular and nuclear deformities occurring in these 
differing scaffold environments. 
     SEM imaging was used in order to investigate how both WT and DN HaCaT cells 
interact with space-restrictive scaffolds across surface and central regions.  Due to 
previous H&E observations, it was chosen to examine the cell growth patterns in a 
submerged Strata® scaffold, at a time point of 14 days. These conditions were chosen due 
to previous observations suggesting the greatest degree of difference between migration 
potential and cell morphology occurred between WT and DN HaCaT cells under these 
settings. Scaffolds were processed as described in the methods and sputter coated with a 
5 nm platinum layer to maintain image resolution whilst preventing sample charging. SEM 
micrographs of both WT and DN HaCaT cells in the restrictive Strata® scaffolds can be 
seen in Figure 3.33.  
     The data displayed in Figure 3.33 suggests that the space-restrictive 3D scaffolds 
provide a matrix in which the cells can move freely in all directions. It can also be seen 
that both cell types appear to interact with the scaffolds surface in a similar manner to that 
of 2D culture plastic, with cellular projections reaching out in multiple directions. Alongside 
these initial observations, images A and B suggest the DN HaCaT cells are more densely 
packed at the surface of the scaffold (B), whereas WT HaCaTs appear to ‘sink’ into the 
surface and integrate into the porous network, resulting in more ‘bare’ scaffold surface (A). 
This observation is in agreement with the differences observed in previous H&E and 
fluorescence staining, in which the DN HaCaTs, but not the WT HaCaTs were seen to 
stack at the scaffold’s surface.  
     The data displayed in C, D, E and F highlight the cell phenotypes observed in the 
centre of the scaffold. To gain access to these regions, scaffolds were fractured and 
imaged from the side, allowing a view of cell morphology in these central regions. It can 
be seen that in this region, cells are forced into much closer association and display 
numerous cellular protrusions reaching out to the surrounding scaffold. No obvious 
differences can be seen between WT and DN HaCaTs in this central region using this 
imaging technique, however, it does help provide a visual representation of how the cells 
interact with the 3D growth environment, which other techniques used thus far have been 
unable to show with as much clarity.   
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Figure 3.33: SEM images displaying WT (A, C and E) and DN (B, D and F) HaCaT cells within 
Alvetex
®
 Strata after 14 days of growth. A and B display surface scaffold regions. Images C, D, E 
and F highlight cell morphology in central scaffold regions. To consider cell in central scaffold 
regions, penetration must have exceeded 25 µm from the initial seeding surface. Arrows highlight 
areas of cellular projections.  
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     In addition to SEM analysis, further investigations were performed using high-powered 
TEM. Using this technique, the differences in cell ultrastructure between WT and DN 
HaCaT cells across the surface and in the centre of the space-restrictive scaffolds were 
investigated, at the 14 day time point. Cells were cultured, fixed and imaged as described 
in the methods, with resulting images seen displayed in Figure 3.34. 
     The data presented in Figure 3.34 displays WT (A) and DN HaCaT cells (E) across the 
surface scaffold regions through under TEM analysis. The cell phenotypes observed 
appear to support data found from the previous H&E staining, in which the DN HaCaT 
cells displayed a thicker layer of cells across the scaffolds surface of space-restrictive 
scaffolds (Figure 3.28). (A) Highlights that the WT cells appear to flatten out and sink into 
the voids, with little to no cellular stacking occurring at the surface the scaffold. In contrast, 
(E) highlights DN HaCaT cells forming a 1-2 cell thick layer at the scaffold’s surface, 
displaying nuclear deformities. Images (B) and (F) further display cells in central scaffold 
regions, suggesting little to no difference observed between the WT and DN HaCaT cells. 
Both cell types display similar nuclear deformities when passing through non-restrictive 
areas of this region. However, differences can be observed between the WT and DN 
HaCaTs as they pass through the more restrictive interconnecting windows as displayed 
in (C), (D), (G) and (H). It can be seen that the DN HaCaT cells appear to display more 
irregular nuclear projections when faced with these restrictive interconnects, whereas the 
WT HaCaT cells appear to maintain an elongated, smooth nuclear projection. 
Classification for a restrictive interconnecting window was deemed any window with a 
diameter < 2 µm, through which nuclear deformation would be required to pass through.  
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Figure 3.34: TEM images of WT (A, B, C and D) and DN (E, F, G and H) HaCaT cells in 
various regions of the Strata
®
 Scaffolds. A and E depict the two cell types across surface 
regions, whereas B and F display both cells in central scaffold regions. C and G further 
highlight phenotypic differences observed between both cell types as they are preparing 
to migrate through restrictive interconnecting windows (Through gaps of 2 µm or smaller). 
D and H display cell phenotypes observed during migration through these restrictive 
windows. Arrows highlight hypothesised nuclear migration direction. Scale bar = 25 µm.  
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     On closer observation, it was further seen that WT HaCaT cells appear to re-localise a 
greater proportion of their cytoplasm through the voids prior to nuclear migration in 
comparison to the DN HaCaTs. Migration direction was assumed through observation of 
Golgi orientation alongside proposed suggestions that, under normal conditions, cells will 
accumulate their cytoplasm through the restrictive interconnects due to the nucleus 
requiring deformation to migrate [272, 267]. To further quantify this, the cytoplasmic 
positioning of 50 WT and DN HaCaT cells respectively were analysed during migration 
through restrictive interconnecting windows, with aims to assess whether the migration 
behaviour of LINC disrupted cells in space-restrictive 3D environments differs from WT 
cells. Representative images displaying analysis technique, alongside collated data can 
be seen in Figures 3.35 and 3.36 
 
Figure 3.35: TEM images depicting assessment criteria for cytoplasmic distribution analysis. (A) 
and (C) display WT HaCaT’s, Images (B) and (D) display DN HaCaT cells. Arrows display 
hypothesised migration direction, dashed lines highlight nuclear centre. Scale bar = 2 µm.    
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     The data presented in Figure 3.35 helps define how the cytoplasmic distribution was 
assessed during cell migration through interconnects. A central line was placed in the 
middle of the nucleus horizontal to the direction of migration; the cytoplasmic volume was 
then calculated on either side of the central line using the freehand tool in image J. If a 
higher percentage of the cytoplasm was situated behind the line, the cytoplasmic 
distribution was labelled as behind the nucleus and vice versa.  
     Using this measurement technique, the graphical data displayed within Figure 3.36 
was obtained. This data suggests that a difference between cytoplasmic distributions in 
WT and DN HaCaT cells during their migration through interconnects exists. It was seen 
that 80% of WT HaCaTs assessed displayed a cytoplasmic distribution in front of the 
nuclei, whereas only 55% of DN HaCaTs assessed displayed this phenotype. This data, 
therefore, suggests that the LINC complex disruptions present in DN HaCaT cells 
stimulates a reduction in cytoplasmic distribution ahead of nuclei during cell migration 
through restrictive interconnecting windows, compared to that of the WT controls.  
 
 
Figure 3.36: Percentage cytoplasmic distribution across WT and DN HaCaT cells during 
migration through restrictive interconnecting windows. The data summarises analysis of 50 
cells both WT and DN HaCaTs.  
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     Alongside cellular shape and cytoplasmic distribution variations between WT and DN 
HaCaT cells, further differences in nuclear shape were also observed (Figure 3.34 D and 
H). It appears that during migration through restrictive interconnects (< 2 µm) the WT 
HaCaTs maintain a similar nuclear width to that of the interconnecting window during early 
stages of post migration. In contrast to this, DN HaCaT cells appear to spread out their 
nuclear structure as soon as they pass through the interconnecting window, displaying a 
nuclear width and shape similar to that of the pre-migration nuclear segment. This 
difference between the two cell types was statistically analysed, based on the frequency 
of this hourglass phenotype occurring during migration through a restrictive 
interconnecting window (< 2 µm). The criteria to define the hourglass and constrictive 
phenotypic shapes are highlighted in Figure 3.37.  
 
 
 
   
 
  
    Hourglass phenotypes were defined by having a nuclear width of > 1.5x greater than 
that of the interconnecting window that the cell was migrating through 1.5 µm after the 
maximum constrictive point (points of maximum constriction can be seen highlighted with 
yellow stars in Figure 3.37). The collated data obtained using these analysis criteria on 50 
WT and DN HaCaT cells respectively can be seen presented in Figure 3.38.  
Figure 3.37: TEM images depicting the criteria for Hourglass (B) or Constricted (A) 
phenotypes. (A) Displays WT HaCaT cells, scale bar = 1.5 µm, (B) displays DN HaCaT cells, 
scale bar = 2 µm. Cells were only analysed if migrating through restrictive (< 2 µm) 
interconnecting windows. Arrows help identify width of nuclei during migration through 
restrictive interconnect (yellow stars) and post migration. Scaffold is outlined in red.  
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     The data presented in Figure 3.38 suggests that there is a difference in nuclear 
phenotype between WT and DN HaCaT evident during migration through restrictive 
interconnecting windows. It can be seen that around 75% of WT HaCaTs display a much 
more ‘constricted’ phenotype post-migration; displaying a nuclear width equal to or less 
than that of the size of the interconnect. In contrast, roughly 70% of DN HaCaTs appear to 
display a more ‘hourglass’ like phenotype, displaying nuclear widths greater than 1.5x the 
width of the interconnecting window 1.5 µm post-migration.  
     The data collected through this section, including H&E staining, immunofluorescence 
and EM data, suggests that the WT and DN HaCaT cells display distinctly unique 
characteristics when placed in restrictive 3D culture environments. This further suggests 
that disrupting the SUN-KASH interaction across the nuclear envelope stimulates changes 
in cell behaviour in both 2D and 3D growth conditions.  
 
Figure 3.38: Nuclear phenotypes observed in WT and DN HaCaT cells during migration 
through restrictive interconnecting windows. The data summarised analysis form 50 WT and 
DN HaCaTs respectively.  
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3.3.4 Both Alvetex® scaffold and Alvetex® Strata environments 
produce cellular stresses not experienced in 2D culture systems. 
3.3.4.1 Interconnecting windows provide stressful migration paths, resulting 
in cellular responses not observed within normal 2D cell culture. 
 
     Through further analysis of TEM micrographs of cells cultured in Alvetex Strata® and 
Alvetex® Scaffold, it was observed that the scaffold’s interconnecting windows possessed 
sharp edges, and indentations across the cell periphery were observed at these points. It 
was further observed that filamentous accumulations occurred at the sites of indentation 
in close proximity to the NE, highlighted in Figure 3.39.  
     As can be seen in Figure 3.39, the indentations are often deep. Image (A) displays an 
indentation that appears to be in the process of scraping a fragment of cytoplasm away 
from the cell during migration. The tip of the scaffold in this image was ~5 nm thick, which 
is sharp enough to perforate the plasma membrane. Further to this, some indentations 
were deeper than others, as highlighted in (B), (C), (D) and (E), in which scaffold 
indentations were observed in close proximity to the NE. These deeper indentations 
appear to alter nuclear shape, resulting in NE deformations. In addition, when sharp 
scaffold sections come into close association with NE regions, a large accumulation of 
filaments (hypothesised to be keratin based on filament thickness and morphology) is 
observed around the point of indentation, as seen most clearly in (D). It is therefore 
hypothesized that these sharp edges create a stressful environment for the cells, able to 
elicit a cellular response through potential keratin accumulation. However, to further 
validate these observations, further immuno-gold labelling would be needed to identify the 
filamentous accumulations.   
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   Figure 3.39: TEM images displaying cell indentations and keratin accumulation (highlighted 
with arrows). Images represent 14 day growth points of WT (A, B and C) and DN (D, E and F) 
HaCaTs in Alvetex
®
 Strata. Scaffold regions are outlined in red. Scale bars = 500 nm.  
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3.3.4.2 Restrictive interconnecting windows stimulate cytoskeletal 
accumulation during nuclear migration. 
 
     As both the WT and DN HaCaT cells migrate through the space-restrictive Strata® 
Scaffolds, observations suggest an accumulation of cytoskeletal components develop 
across the leading edge of the nucleus when faced with restrictive interconnects. 
Representative images highlighting this observation can be seen in Figure 3.40.  
 
   
 
 
 
     The data displayed in Figure 3.40 highlight the accumulation of cytoskeletal filaments 
across the NE upon migration through restrictive interconnects.  It can be seen that the 
cytoskeletal accumulation (suggested to be keratin) highlighted in B with yellow arrows is 
uniform across the NE in regions directly facing the interconnecting window, whereas 
further accumulation cannot be found across other nuclear regions. This suggests that 
cytoskeletal accumulation may be required to ‘pull’ the nucleus through the restrictive gap, 
providing further support for roles of cytoskeletal components in nuclear migration. Closer 
observations, displayed in (B), further suggest that this accumulation may not be directly 
attached to the NE surface, but remains at a distance of 50-100 nm from the nuclear 
surface; however this could also be due to the plane of sectioning. This could be a result 
Figure 3.40: TEM images showing cytoskeletal accumulation across the NE upon restrictive 
interconnect migration. Image display 14 day grown WT HaCaT cells in central Alvetex
®
 Strata 
scaffold regions. In (A) white arrows display nuclear migration direction, yellow arrows 
highlight observed filamentous accumulation across NE. Scaffold is outlined in red. In (B), 
yellow arrows highlight suspected keratin accumulation, red arrows highlight suggested MTs. 
Scale bars = 2 µm (A) and 100 nm (B).  
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of cytoskeletal proteins, such as nesprins, providing a link between cytoskeletal 
components and the NE, however, further investigations using immuno-TEM techniques 
would be required to validate this hypothesis.  
     These observations help to further support the hypothesis that the nature of the 
deformation exhibited by the NE and adjacent cytoskeleton are suggestive of a 
mechanism that pulls nuclei through the restrictive 3D environment, rather than through 
passive nuclear movement. This could therefore highlight potential pressures unique to 
such restrictive 3D culture environments, which are not present in conventional 2D culture 
systems.  
 
3.3.5 SUN-KASH bridge disruption in keratinocytes increases 3D 
migration potential by decreasing nuclear stiffness. 
3.3.5.1 DN HaCaTs display a decreased circularity index within central 
regions of the restrictive Strata Scaffolds compared to surface regions. 
 
     DN HaCaT cells are able to migrate deeper into the Strata® scaffold than their WT 
counterparts, it is believed that this is due to the DN mutation effectively disrupting the link 
between the INM and ONM, resulting in increased nuclear malleability.  This phenotype 
may allow DN HaCaT cell an increased capacity to squeeze through restrictive 
interconnecting windows, whilst using less energy to de-stabilise the proteins that govern 
NE architecture. To assess whether the nuclear malleability of DN HaCaT cells is indeed 
higher than that of the WT controls, nuclear circularity indexes in various regions of both 
the Alvetex® Scaffold and Alvetex Strata® scaffolds were assessed. This allows for 
accurate and direct comparisons to previous penetration investigations conducted in these 
materials. The 14 day growth time point at the air-liquid interface was identified as the 
most suitable for this investigation as cells can be found across both the surface and 
central regions of the scaffold in high numbers. The use of confocal microscopy to 
visualise sections of these scaffolds allowed for the analysis of specific Z axis regions, 
allowing for the majority of in-focus cells to be imaged. An example of the images 
obtained along with the measurement criteria used can be seen in Figure 3.41 and Figure 
3.42 respectively.  
124 | P a g e  
 
Figure 3.41: Images displaying 14 day grown WT and DN HaCaT cells in Alvetex
® 
Scaffold (A-D) and Alvetex
®
 Strata (E-H). Cells are stained for DAPI (Blue) and 
scaffolds for Nile red (Red). Scale bar = 25 µm. 
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Figure 3.42: Image series displaying assessment criteria. A) Highlights measurements for 
cells on the scaffolds surface were taken within the top 25 µm, whereas measurements for the 
scaffolds centre were taken from 75-150 µm into the scaffold. B) and C) display examples of 
how the measurements were taken. Within each region, in focus nuclei were highlighted using 
the free hand tool in ImageJ and then measured. D) displays an example output. Cells were 
stained for DAPI (blue). Scale bars = 25 µm. 
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     The data presented in Figure 3.41 highlights differences in cell packing density 
between the two cell lines across the two scaffolds, with the DN HaCaT cells showing a 
higher cell density per µm2 in comparison to their WT counterparts, as shown by H&E 
(Figure 3.19 and 3.21). The initial number of cells seeded to each scaffold for both cell 
lines was the same (250,000 cells), and so even though it is known that the WT HaCaTs 
replicate faster, it appears the DN HaCaT colonise both 3D scaffold systems more 
densely. In addition, DN HaCaT cells seeded onto space-restrictive Strata® scaffolds 
produce a layer of ~2-3 cell across surface scaffold regions, further supporting previous 
observations at the air-liquid interface for this cell line (Figure 3.28 and Figure 3.29).   
     Figure 3.42 (A) displays the defined regions from which the nuclear circularity index 
measurements were obtained. Measurements were taken across the scaffold’s surface 
and in its centre, to investigate whether nuclear circularity changes exist between the two 
environments. The ‘surface’ of the scaffold for the purposes of these measurements was 
considered as the first 25 µm from the top layer of cells. This, therefore, helps to provide 
an indication of nuclear circularity before the cells begin to adapt to the new environment 
within the scaffold, in which space is more limited and media flow is at a much lower rate. 
The central region measurements were taken from 75-150 µm into the scaffold. This 
region was selected due limitations in cell penetration depth, and so a maximum depth of 
150 µm allows for accurate comparisons to be made between both cell lines in each 
scaffold. Alongside this, the selected central region is far enough from the surface to 
ensure cell deformities have occurred, allowing for speculations on nuclear malleability to 
be made. (B) and (C) highlight two examples of how cells were analysed at the various 
scaffold regions. Nuclei were individually traced to ensure that only in focus nuclei were 
analysed and measured using ImageJ. An example of the output produced can be seen in 
(D), in which the circularity index of the traced nuclei can be seen in the highlighted area 
labelled Circ. This measurement technique provides an accurate estimation tool to 
decipher if differences exist between the DN and WT HaCaT nuclear circularity in different 
scaffold regions. The data collected via this method is shown in Figures 3.43 – 3.46 
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Figure 3.43: Differences observed between nuclear circularity index of WT and DN 
HaCaT cells across surface and central Alvetex
®
 Strata regions.  
Figure 3.44: Differences observed between nuclear circularity index of WT and 
DN HaCaT cells across surface and central Alvetex
®
 Scaffold regions.  
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Figure 3.45: Differences observed between nuclear circularity index of WT HaCaT 
cells across surface and central Alvetex
®
 Strata and Alvetex
®
 Scaffold regions.  
Figure 3.46: Differences observed between nuclear circularity index of DN HaCaT 
cells across surface and central Alvetex
®
 Strata and Alvetex
®
 Scaffold regions.  
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     The data presented in Figure 3.43 suggests that both the WT and DN HaCaT cells 
display a significant difference between their nuclear circularity at the surface and central 
scaffold regions in the Strata® scaffolds using an unpaired t-test at a p-value of ≤ 0.005. 
The Strata® Scaffold’s restrictive void sizes (~5-15 µm) and interconnecting windows (~4 
µm)  appear to stimulate nuclear deformities, suggesting that these deformities are 
required in order to pass from void to void. This requirement of nuclei to deform in order to 
migrate could be the reason why nuclear circularity is greatly reduced in central scaffold 
regions in comparison to surface regions. Further observations also suggest that the 
nuclei of the DN HaCaTs display a lower circularity index than their WT counterparts in 
both regions of the scaffold. This supports the observations in 2D culture systems 
previously discussed, in which the DN mutants also displayed nuclear abnormalities, such 
as increased nuclear heights to that of the WT HaCaTs (Figure 3.9).  
     The data presented in Figure 3.44 suggest there is no observable difference between 
the DN and WT HaCaT nuclear circularity across both the surface and central regions of 
the non-restrictive scaffolds. In the Alvetex® Scaffold, void diameters range from ~15-45 
µm, resulting in little to no restriction on movement between voids during migration, 
resulting in less nuclear deformation occurring during migration through interconnecting 
windows. However, the data does suggest that DN HaCaTs, again, display a significantly 
lower circularity index value to their WT counterparts in both surface and central scaffold 
regions.    
     Figures 3.45 and 3.46 look at comparisons between the central and surface scaffold 
region impact on cell circularity in both Alvetex® Scaffold and Alvetex® Strata for each cell 
line. The data suggests that for the WT HaCaT cells, circularity changes are observed in 
central scaffold regions of both materials, with Strata scaffolds stimulating the lowest 
nuclear circularity values. However, across the surface of both scaffold materials, no 
significant difference in WT HaCaT nuclear circularity was observed. For the DN HaCaTs, 
it can be seen that in both central and surface scaffold regions, the DN HaCaT cells 
display a much lower circularity index value when grown within the restrictive Strata 
scaffolds. This suggests that the DN HaCaT cells display an increased capacity to adapt 
to their environmental surroundings, displaying nuclear deformation as soon as scaffold 
penetration commences, whereas the WT HaCaT cells only appear to display changes in 
nuclear circularity after migration of ~75 µm into the scaffolds.   
     From these investigations, it can be seen that the DN HaCaTs appear to display an 
altered nuclear circularity index compared to that of the WT HaCaTs in all regions of both 
scaffold types. In addition, it has been shown that the nuclear circularity index significantly 
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reduces upon migration into the more restrictive Strata® scaffold for both cell lines, 
however, this difference appears to be greater for the DN HaCaT cells due to their lower 
initial circularity index. This indicates that decreased nuclear circularity and increased 
nuclear malleability could be providing the DN HaCaT cells with an advantage when 
migrating through restrictive environments; however, further investigations are required as 
the investigations thus far present only a suggestion of increased nuclear malleability in 
the DN HaCaT cells. To fully verify whether nuclear stiffness is indeed different between 
WT and DN HaCaT cells, mechanical testing of the NE is needed directly, through the 
application of atomic force microscopy (AFM) for example. 
 
3.3.5.2 DN HaCaT cells display an increased nuclear malleability upon 
external nuclear pressure from osmotic stress. 
 
     Previous investigations suggest that the DN HaCaTs display a reduced nuclear 
circularity index in comparison to their WT counterparts upon migration through restrictive 
3D culture environments. Coupled with further 3D migration analysis data displayed in 
section 3.3.3, it is suggested that an increased ability to deform the nuclear architecture 
(nuclear malleability) displayed within the DN HaCaT cells could be a crucial factor in 
increasing the migration potential through restrictive environments. However, the 
circularity index only suggest that the nuclei are more deformed and does not provide 
information as to their ability to deform their nuclei in direct response to an external factor 
over a set time.  
     To expand current knowledge of nuclear malleability between the WT and DN HaCaT 
cells, a follow up experiment using osmotic stress [273, 274] in the surrounding media as 
a controllable external factor to analyse nuclear deformation was conducted. It has been 
suggested that in a hypertonic solution, cells will lose most of their cytoplasmic volume 
due to osmosis of liquid into the surrounding solution. Due to this decreased volume within 
the cytoplasm, cytoplasmic area will shrink causing pressure from the organelles to be 
exerted on the nuclear envelope. This pressure, if great enough will stimulate nuclear 
deformation based on the stiffness/malleability of the nuclear envelope. If the nuclear 
envelope is more malleable in the DN HaCaT cells, a decreased nuclear circularity index 
compared to the WT HaCaT cells as the osmotic stress increases in the surrounding 
environment would be expected. The results of this study can be seen in Figure 3.47. 
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     To conduct this experiment, we incubated both WT and DN HaCaT cells at a 
confluence of 70% in a range of hypertonic sucrose concentrations (0 mM, 40 mM, 80 
mM, 160 mM, 320 mM, and 640 mM) added to normal growth media for a period of 30 
min under normal growth conditions. Cells were then fixed and immuno-fluorescently 
stained for lamin A/C (nuclear envelope marker) and with DAPI (nuclei). The literature 
suggests that a longer time point of over 30-40 minutes could provide cells time to adapt 
to the exerted stress and revert to a pre-stress phenotype. Images were obtained utilising 
the LEICA SP5 confocal microscope, with representative images for both cell types 
displayed in Figure 3.47.  
     The data displayed in Figure 3.47 shows fluorescence images from the control 
condition (0 mM sucrose) and the highest level of osmotic stress exerted (640 mM 
sucrose). Very few differences in nuclear circularity can be observed, with both cell lines 
displaying little variability in nuclear shape before and after osmotic stress. To quantify if 
any differences exists between the two cell lines over the course of osmotic stress, 
nuclear circularity of 200 cells at each sucrose concentration was carried out, the results 
of which are shown in Figure 3.48.  
     The data presented in Figure 3.48 displays the nuclear circularity deformation trends 
upon introducing the cells to varying hypertonic sucrose concentrations. The data 
presented in both (A) and (B) suggests that the increasing sucrose concentrations 
correspond to a decrease in calculated nuclear circularity for both cell types. Within R, a 
two way ANOVA was used to calculate whether a difference existed between the effects 
of sucrose on the WT and DN HaCaT nuclear circularity. The results obtained show 
evidence of a relationship between increasing levels of sucrose and observed nuclear 
malleability for both cell types (ANOVA, F5.2388 = 3.02, P = 0.010). However, the graphical 
data displayed in Figure 3.48 clearly shows that the DN HaCaT cells have a lower nuclear 
circularity index in the control condition without sucrose addition. Further statistical 
analysis supports this, showing strong evidence that the nuclear circularity differs between 
the control conditions for each cell type (ANOVA, F1.398 = 127.12, P < 0.001). To look for 
evidence that the relative effect of increasing sucrose concentrations on nuclear circularity 
differs between the two cell types, The data was normalize, making the control circularity 
index value obtained for both the WT and DN HaCaT cells the baseline to which other 
values were compared. This was performed through giving the control circularity a value 
of 1 (Representing a perfect circle), from which the effect of increasing sucrose 
concentration could be directly compared between the cell lines. The resulting normalised 
graphical data can be seen in Figure 3.49.  
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Figure 3.47: Image series displaying WT and DN HaCaTs incubated in both normal 
growth media (A, C, E and G) and growth media + 640 mM Sucrose (B, D, F and H). 
Cells are stained for lamin A/C (red). Scale bars = 5 µm. 
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Figure 3.48: Nuclear circularity across WT and DN HaCaT cells. A) Displays raw 
data alongside the mean and standard deviation plotted using ‘R’. B) Displays the 
refined data displaying the means for both the WT (Blue) and DN (Red) HaCaT 
cells. 
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Figure 3.49: Normalised nuclear circularity across each sucrose concentration 
plotted using ‘R’, displaying the means for both the WT (Blue) and DN (Red) 
HaCaT cells. Control conditions for each cell line were given a value of 1, 
allowing the effects of increasing sucrose concentrations to be directly 
compared. 
 
 
 
 
 
     The graphical data presented in Figure 3.49 suggests that as sucrose concentrations 
are increased, the nuclear circularity values for each cell type decrease. However, at a 
sucrose concentration of 640 mM, it is seen that the DN HaCaT cells exhibit a greater 
decrease in nuclear circularity than that of the WT HaCaT cells. To support this, F-tests 
were performed for each sucrose concentration (excluding the control) to test for 
differences between the nuclear circularity between the WT and DN HaCaT cells. Five F-
tests were performed in order to ensure the test is statistically significant when a P-value 
less than 0.05 / 1 = 0.01 is obtained. Of the 5 statistical tests performed, a significant 
change in the effect of sucrose between the WT and DN HaCaT cells was only detected 
when sucrose concentration was at 640 mM. This result is consistent with the trends 
observed from the plot of means and standard errors presented in Figure 3.48. This, 
therefore, suggests that the DN HaCaTs display a decreased nuclear circularity to that of 
WT HaCaTs at sucrose concentrations of 640 mM, suggesting that under high osmotic 
stress conditions, the DN HaCaT cells display an increased ability to deform their nuclei 
than that of the WT HaCaT cells. 
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3.3.5.3. DN HaCaT cells display softer nuclei and decreased nuclear stiffness 
under biological and non-biological conditions.  
 
     Results thus far indicate that DN HaCaT cells express an increased penetration 
potential into space-restrictive scaffolds, alongside an increase in nuclear malleability 
when compared to WT cells. However, during the osmotic stress experiment conducted 
previously, it was not taken into consideration, the possible alternate cellular features 
which could be affecting the deformation potential of the NE under these experimental 
conditions osmotic stresses. To validate this data, further investigation into the nuclear 
malleability differences between the WT and DN HaCaT cells was conducted using 
Atomic Force Microscopy (AFM). The Young’s modulus, and hence nuclear stiffness, can 
be directly measured via AFM [275].  
     Initially the two cell types were analysed under dry, non-biological conditions (not 
under normal growth conditions for specific cells as described in 2.14.1 of the methods 
section), in order to assess whether cellular AFM analysis was feasible using the 
instrument available. Cells were processed as described in the methods section and 
imaged using a Bruker MM8 AFM fitted with a 70 kHz scanasyst cantilever. Initial 
observations from this pilot experiment can be seen in Figure 3.50.  
     The initial data from the pilot investigation displayed in Figure 3.50 highlights cellular 
differences observed between the two cell types under these experimental conditions. It 
can be seen that initially, the 15 µm x 15 µm analysis grid allows single cells to be 
observed. As can be seen from the WT HaCaTs displayed within images (A) and (B), the 
drying process after fixation stimulates a collapse across an area corresponding to the 
nucleus, leaving behind a crater in the cell, lower than the surrounding cytoplasmic 
environment. In comparison to this, the DN HaCaT cells displayed in images (C) and (D) 
do not appear to undergo this nuclear collapse, displaying a nuclear protrusion higher to 
that of the surrounding cytoplasm, corresponding to the expected nuclear positioning.  
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Figure 3.50: AFM height maps for WT (A and B) and DN (C and D) HaCaT cells 
under non-biological conditions. Scale bars = cell height, with light shading 
representing the highest region of the cell.  
 
 
 
 
     The AFM used in this pilot study was not sensitive enough to give a Young’s modulus 
value for the cell nuclei; however, differences between the DN and WT HaCaT nuclei can 
be seen. These differences could arise from the WT cells exhibiting stiffer nuclear 
properties, and are therefore unable to withstand the compression pressures of drying, 
thus undergoing complete nuclear collapse. As a result, further analysis using a more 
sensitive AFM (NanoWizard 3 Bioscience AFM) that has been designed to analyse cells 
under biological conditions. Both DN and WT HaCaTs were grown on glass bottom petri 
dishes with a known modulus, so as not to affect the readings under experimental 
conditions. Analysis was performed on 15 WT and 15 DN HaCaT cells, consisting of both 
single and grouped cell morphologies. The AFM’s cantilever was aligned and run in a 
raster configuration across the cells surface, providing detailed information on the Young’s 
modulus and height, the results of which can be seen in Figure 3.51.  
137 | P a g e  
 
Figure 3.51: Phase contrast (A, D), height map (B, E) and Young’s Modulus (C, F) analysis for 
both WT and DN HaCaT’s under biological conditions. Cold shading (Blue) in B and E represent 
the highest cellular regions points, whereas the hot shading (Red) in C and F represents areas 
with the lowest Young’s Modulus values. Images represent 15 x 15 µm
2
 analysis areas.   
      
 
    
 
     The data presented in Figure 3.51 shows that differences can be observed between 
nuclear stiffness in both the WT and DN HaCaT cells. Initially, light microscopy images (A 
and D) support the previous findings that DN HaCaT cells cluster in tighter associations, 
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rather than form spaced colonies like their WT counterparts. Information provided in the 
height map (B and E) suggests that the DN HaCaTs display a more uniform colony 
morphology, appearing as a single dome with the highest point at the centre of the colony. 
In contrast, the WT HaCaT cells display a more dispersed colony morphology, with 
multiple peaks corresponding to nuclear localisation within each cell. The Young’s 
modulus measurements displayed in images C and F further show the variability of 
stiffness across the different cell regions, with the DN HaCaT cells displaying a decreased 
stiffness across cell regions correlating to nuclear localisation. Collated graphical data for 
these measurements can be seen in Figure 3.52.  
 
   
    
 
     The collated data displayed in Figure 3.52 initially suggests that the DN HaCaT cells 
are softer in each of the three cellular areas assessed. The data shows a central nuclear 
Young’s modulus of 4.97 kPa in the WT HaCaT cells compared to the 2.86 kPa value for 
Figure 3.52: Calculated young’s moduli across three selected cellular regions of WT and DN 
HaCaT cells. (A) Displays comparisons between both WT and DN HaCaT cells across each 
cellular region. (B) and (C) represent comparisons between cellular regions in the same cell line.  
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DN HaCaT cells. This suggests that the central regions of WT HaCaT cells are much 
stiffer than that of the DN HaCaTs. 
     Interestingly, it was observed that the calculated Young’s modulus values in both WT 
and DN HaCaTs were much higher at the nuclear periphery and cytoplasmic regions than 
that of the nuclear centre. This appears to contradict current knowledge and publications, 
which state that the nucleus is the stiffest organelle of the cell. At the peripheral nuclear 
regions, the WT HaCaT cells displayed an average Young’s modulus value of 6.61 kPa in 
comparison to the value of 5.05 kPa found for the DN HaCaTs. Similar readings were 
observed in cytoplasmic cell regions, with WT HaCaT cells displaying a modulus value of 
6.85 kPa compared to the DN HaCaTs 5.11 kPa. However, it is possible that due to the 
cellular region assessed being thinner further away from the nucleus that the stiffness of 
the coverslip may have an increased influence on the readings obtained. From this data it 
is possible to suggest that the loss of SUN-KASH interactions in the DN HaCaT cells 
stimulates nuclear architectural changes, leading to a decrease in nuclear stiffness.  
     One remaining flaw within this investigation is however, that to investigate the Young’s 
modulus of the nucleus within each cell line, we probed the cellular surface. Due to this, 
the AFM’s cantilever will have had to indent the plasma membranes surface far enough to 
indent the NE. In addition, there is currently little available data regarding the known 
distance between the plasma membrane and nuclear envelope within WT HaCaT cells. 
To validate the obtained results, further analysis is required.  
     Initially, the compression forces used by the cantilever and the maximum penetration 
observed during cellular analysis were assessed. An example of cantilever compression 
distances (cantilever indentation across the surface of the cell) observed for DN HaCaT 
cells can be seen in Figure 3.53, alongside collated data from across 30 WT and DN 
HaCaT cells respectively.  
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     The data presented within Figure 3.53 displays an example indentation map using a 
cantilever force of 150 pN. The image highlights that in the DN HaCaT cells the average 
maximum indentation observed was 2.5 µm at the central nuclear region. This region was 
previously seen to exhibit the lowest Young’s modulus for both cell lines assessed, 
Figure 3.53: Observed compression output data. (A) DN HaCaT cells displayed the 
highest indentation across both cell lines under a cantilever force of 150 pN. Scale bar 
displays areas of highest compression in white, and areas of low compression in dark. 
(B) Collated indentation data from across 30 WT and DN HaCaT cells respectively.  
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Figure 3.54: TEM images displaying measurement techniques used to assess nuclear 
envelope to plasma membrane distances. A) displays the cell overview with surface 
protrusions (highlighted with arrows) defining the cell surface. B), C) and D) further display how 
measurements were taken at 90° angles from the central dashed line. Scale bars = 500 nm. 
suggesting that the DN HaCaT cells display the largest indentation across nuclear regions 
using this applied force. The average maximum observed indentation for WT HaCaTs was 
calculated to be 2.2 µm supporting the previous observations that WT HaCaTs display a 
much less malleable central cellular area, corresponding to nuclear localisation.  
     It is now known that the cantilever was able to assess modulus values between 2 and 
2.5 µm below the plasma membranes surface; however it is still unclear whether the 
nuclear envelope resides at this depth below the plasma membrane. To assess whether 
the nuclear envelope was within this cantilever indentation zone, TEM on both WT and 
DN HaCaT cells was performed, with the aim to assess the distance between plasma and 
nuclear envelope membranes. The 2D TEM culture processing method described in the 
methods allows cells to retain their 2D phenotypic shapes, therefore, allowing cross 
sections to be taken through central cellular regions, allowing nuclear-plasma membrane 
distances to be assessed. A representation of how measurements were performed can be 
seen in Figure 3.54.  
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Figure 3.55: Calculated distance between nuclear envelope and plasma membrane 
in WT and DN HaCaT cells. The data represent averages of 600 measurements 
taken across 40 cells for each cell line.   
     Using the measurement technique described in Figure 3.54, a total of 40 individual 
cells for both the WT and DN HaCaTs were assessed. For each cell, high magnification 
images were taken across the length of nuclear envelope and plasma membrane regions 
along the cells surface, with 5 measurements being taken at 90° angles to the central 
plane of the cell, the results of which can be seen in Figure 3.55.  
 
 
 
 
 
     The data displayed within Figure 3.55 suggests that the average distance between 
nuclear envelope and plasma membrane in both cell lines is less than the measured 
cantilever indentation during AFM analysis. Interestingly, the data suggest the WT HaCaT 
cells display a significantly larger distance between nuclear and plasma membranes of 
572 nm in comparison to a distance of 510 nm calculated for the DN HaCaT cells using a 
student’s t-test where p ≤ 0.005. This observation could suggest that the associations 
between KASH proteins and cytoskeletal components may be perturbed in the DN HaCaT 
cells, resulting in a displacement of cytoskeletal components across the NE surface. It can 
be further suggested that LINC disruptions present in DN HaCaT cells may stimulate 
abnormal nuclear positioning. This again could arise through disruptions in NE-
cytoskeletal linkages mediated by the LINC complex, resulting in less ‘scaffolding’ by the 
cytoskeleton to hold the nucleus in place, therefore due to gravity or other cellular forces, 
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the nucleus may be forced closer the cells basal region. From this analysis, it can be 
concluded that in the AFM investigation, the cantilever indentation did indeed penetrate 
far enough into the cell to assess differences between nuclear malleability’s of both WT 
and DN HaCaT cells.  
     The data gathered in this investigation suggests that under both biological and non-
biological conditions, the WT and DN HaCaT cells display significant differences in their 
biomechanical properties. In addition, the data suggests that LINC complex disruptions 
reduce the observed nuclear stiffness alongside cytoplasmic stiffness, suggesting further 
roles for SUN-KASH connections in maintaining nuclear architecture and cellular stiffness.  
 
 
3.3.6    SUN-KASH disruptions have variable effects on LINC 
associated protein organisation and expression patterns.  
3.3.6.2    Loss of SUN-KASH interactions does not appear to alter F-actin 
organisation. 
 
     As previous data suggests loss of the SUN-KASH connection across the perinuclear 
space stimulates a decrease in nuclear stiffness, we further aimed to assess whether 
further disruptions could be identified in actin or lamin protein networks, which have both 
been implicated in the maintenance of nuclear stiffness. Actin networks have been 
suggested to play roles in maintaining nuclear structure, aiding nuclear migration and 
cellular migration, all of which are functions in which DN HaCaT cells have displayed 
abnormalities. To assess the phenotypic differences in actin organisation in the WT and 
DN HaCaT cell lines, super resolution microscopy was used. This high-powered imaging 
technique allows fine structural details to be assessed for each cell line. Cells stained with 
TRITC-conjugated phalloidin as described, and then imaged using the OMX super 
resolution microscope. Images for both WT and DN HaCaT cells lines can be seen in 
Figure 3.56.  
     The images presented in Figure 3.56 depict both WT and DN HaCaT cells at a 
confluence of 70%. The data suggests that the actin organisation displays minimal 
variation between the WT and DN HaCaT cells which varies to that presented in Figure 
3.14, suggesting that the formation of a clear actin cap is more prevalent in WT HaCaT 
cells. However, due to the experiment described in Figure 3.14 presenting actin formation 
144 | P a g e  
 
upon early stage cell-substratum attachment, it is possible that following 24 h substratum 
attachment, the DN HaCaTs are able to form similar actin arrangements spanning the 
nucleus. It can be seen through this super resolution analysis of 20 cells for both WT and 
DN HaCaT cells that stress fibre formation across the nuclear surface and actin 
organisation across the cellular periphery appear to be similar, suggesting that the loss of 
LINC connections spanning the NE does not affect cortical and cytoplasmic F-actin 
organisation.  
 
 
 
Figure 3.56: Images of TRITC-conjugated Phalloidin staining in WT (A and C) and 
DN (B and D) HaCaT cells. Scale bars = 10 µm.   
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3.3.6.3    Disruptions in SUN-KASH perinuclear interactions stimulate 
variable lamin B, but not lamin A/C organisational changes.  
 
     As suggested in Figure 3.56, F-actin cytoskeletal organisation does not appear to be 
altered between DN and WT HaCaT cell lines. To further investigate why the DN HaCaT 
cells display phenotypic differences in nuclear malleability, the lamin protein network was 
assessed using super resolution microscopy. Alongside actin, it is suggested that the 
lamin network is a further key component of nuclear stiffness; therefore we aimed to 
assess whether any structural or organisational changes to lamin A/C or lamin B networks 
could be observed between WT and DN HaCaT cells. Cells were processed and stained 
for lamin A/C and lamin B as described in the methods section. The obtained super 
resolution images of lamin A/C stained cells can be seen in Figure 3.57, with lamin B 
staining displayed in Figure 3.58. 
     The data displayed in Figure 3.57 suggests that in both the WT and DN HaCaT cells, 
lamin A/C distribution remains constant across the surface and central regions of the 
nuclei. It can be seen that the surface distribution of lamin A/C appears to form filament 
like structures in both cell lines. Central nuclear analysis further shows clear nuclear rim 
staining in both cell lines, suggesting that lamin A/C distribution and positioning in the 
nucleus has not been altered through the disruption of SUN-KASH interactions across the 
nuclear envelope.  
     Alongside lamin A/C, the distribution of lamin B within both cell lines was assessed. As 
lamin B is seen to remain constant through numerous disease phenotypes deriving from 
lamin alterations, it was hypothesised that no differences would be seen in lamin B 
organisation and distribution between the WT and DN HaCaT cells. However, the data 
presented in Figure 3.58 suggests that differences between lamin B distributions in the 
DN HaCaT cells exist. At the nuclear surface, spherical staining can be seen within the 
WT HaCaT cells, but not the DN HaCaT cells. Further to this, these circular structures 
appear to form channels protruding into the central regions of the nucleus, only visualised 
through lamin B staining for the WT HaCaT cells, but not the DN HaCaTs. This suggests 
that these structures observed express no lamin A/C, however further more in-depth 
investigation would be needed using TEM analysis to conclude this.   
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 Figure 3.57: Lamin A/C staining within WT (A, B, C and D) and DN (E, F, G and H) 
HaCaT cells. Images C and G display nuclear surface staining, whereas D and H 
display central nuclear staining. Scale bars = 5 µm.   
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Figure 3.58: Lamin B staining within WT (A, B, C and D) and DN (E, F, G and H) 
HaCaT cells. Images C and G display nuclear surface staining, whereas D and H 
display central nuclear staining. Scale bars = 5 µm.   
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3.3.6.4    Analysis of LINC complex proteome expression in WT and DN 
HaCaT cells grown in 2D and 3D environments.  
 
     Disrupting the link between inner and outer nuclear envelope through severing the 
SUN-KASH perinuclear interaction stimulates numerous phenotypic abnormalities. 
Significantly, this disruption appears to induce a migration advantage in space-restrictive 
3D environments and decreased nuclear stiffness in DN HaCaT cells, whilst displaying 
little to no abnormalities in lamin and actin organisation within the cell. To further 
investigate why these phenotypes are observed upon LINC complex disruptions, western 
blotting was employed to assess protein expression levels of various LINC complex 
proteins and binding partners. This investigation, therefore, aims to assess whether any 
expression variations in LINC complex proteins exist in these DN HaCaT cells that could 
be inductive factors to the phenotypes observed.  
     The presence of LINC complex variations was assessed in 6 samples; 2D cultured WT 
HaCaTs, 2D cultured DN HaCaTs, 3D cultured WT HaCaTs, 3D cultured DN HaCaTs and 
2x 2D DN revertant mutants (DN HaCaT cells maintained without G418 selection drug). 
The 3D cultured samples were grown in Alvetex® Strata scaffolds for 9 days due to both 
cell lines displaying similar migration distances into the scaffold at this stage. The DN 
revertant mutants represent the DN HaCaT cells with the selection drug (G418) removed 
from the growth media for 2 months to assess that the phenotypes observed in DN 
HaCaT cells are indeed the direct consequence of DN SUN1 expression. 
     Initial western blotting for three standard equal loading markers; β-actin, β-tubulin and 
GAPDH was performed. For each protein assessed, results represent data from 3x 
repeats with new lysates during each repeat. Western blot results, alongside densitometry 
analysis, can be seen in Figure 3.59.  
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     As can be seen from data displayed in Figure 3.59, equal loading has been achieved 
across all three markers, indicating that each lane contains equal concentrations of each 
protein. The data suggest no statistical difference between each of the equal loading 
markers using a two way ANOVA where p ≤ 0.05. This suggest that levels of β-tubulin, β-
actin and GAPDH remain constant between the WT and DN HaCaT cell lysates, in both 
2D and 3D culture environments.  
Figure 3.59: Equal loading marker expression across our samples. (A) Displays 
western blot data observed upon loading of equal protein concentrations (B), (C) and 
(D) represent densitometry analysis across three repeats for each protein. 3D lysates 
represent Strata
®
 scaffolds.      
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     Following this initial analysis, the variation in expression levels of inner nuclear 
envelope proteins of the LINC complex upon LINC complex disruptions was assessed. 
The proteins analysed included SUN1, SUN2, emerin, lamin A/C and lamin B, and the 
results can be seen in Figure 3.60.  
     The data presented in Figure 3.60 suggests that there are statistical differences using 
a two way ANOVA where p ≤ 0.05, between expression levels of some LINC complex 
proteins situated across the INM. To validate these observed differences, post hoc F-tests 
were applied between lanes in the data to investigate where these differences lie. It can 
be seen in (B) that SUN1 expression levels appear to remain consistent across each 
sample, with a significant increase in expression levels observed in 3D WT HaCaT cells (p 
≤ 0.001). In comparison, (C) suggests that levels of SUN2 within 3D restrictive cultures 
appears to significantly reduce in comparison to that of 2D culture conditions (p ≤ 0.001), 
whereas little to no variation can be seen between the WT and DN HaCaT cells in both 
environments. Alongside this, cellular levels of emerin and lamin A/C appear to be 
different. For emerin, the data presented in (F) suggests that there is a significant increase 
in expression levels across 3D restrictive culture environments compared to that of the 2D 
(p ≤ 0.001), again with little variation observed between the WT and DN HaCaTs in both 
environments. Lamin A/C however displays large differences in expression levels. It can 
be seen from (D) that in 2D culture environments, lamin A/C expression appears to 
remain constant between the two cell lines, however, within 3D culture systems, it can be 
seen that the WT HaCaTs express a significant increase in lamin A/C protein levels (p ≤ 
0.001). Data for lamin B levels can be seen displayed within (E), suggesting that no 
significant difference is observed between the WT and DN HaCaT cells in both 2D and 3D 
environments.  
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Figure 3.60: Western blot data for each analysed protein across our samples. (A) 
Displays western blot data observed upon loading of equal protein concentrations. (B), 
(C), (D), (E), and (F) represent densitometry analysis across three repeats for each 
protein. 3D lysates represent Strata
®
 scaffolds.      
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     Following assessment of key LINC complex proteins across the INM, two KASH 
containing outer nuclear envelope proteins, both crucial for the maintenance of LINC 
connections across the perinuclear space, were investigated. These proteins were 
nesprin-1 and nesprin-2. Antibodies targeted to the N-terminal actin binding domain (ABD) 
of each protein were used in order to assess the range of nesprin isoforms containing this 
region. Representative data displaying nesprin-1 and nesprin-2 isoform levels across both 
WT and DN HaCaT cells in 2D and 3D environments can be seen in Figure 3.61.  
     The data presented in Figure 3.61 suggests that significant differences are present 
across the full range of nesprin-1 and nesprin-2 isoforms which retain the N-terminal ABD. 
As shown in (B) and (C), significant differences using a two way ANOVA at a p-value of 
0.05, are seen between nesprin-2 isoforms across the entire range of molecular weights 
assessed. Using post hoc F-tests, the protein expression levels of nesprin-2 isoforms 
above 250 kDa can be seen to significantly decrease in DN HaCaT cells (p ≤ 0.001) when 
placed into restrictive 3D environments, where as in 2D culture systems, WT and DN 
HaCaT cells appear to express similar levels. Further significant differences are observed 
in nesprin-2 isoforms below 250 kDa (p ≤ 0.001), in which isoform levels appear to 
increase in 2D DN HaCaT cells compared to other conditions.  
     Alongside this observed data for nesprin-2 isoforms, nesprin-1 proteins also present 
significant isoform variability between different conditions. It can be seen that for isoforms 
above 250 kDa (F), nesprin-1 expression levels remain constant across all samples other 
than the DN HaCaT cells grown in restrictive 3D culture environments, in which 
significantly reduced expression levels are observed (p ≤ 0.001) using post hoc f-tests. 
For isoforms between 75 – 250 kDa, wider variability can be seen, in which WT HaCaT 
cells express significantly increased levels of nesprin-1 isoforms in both 2D and 3D culture 
systems in comparison to that of DN HaCaT cells (p ≤0.001). For isoforms less than 75 
kDa (D), it can be seen that WT HaCaTs significantly express increased nesprin-1 levels 
under conventional 2D growth conditions compared to that of DN HaCaT cells (p ≤ 0.001). 
The DN and WT HaCaT cells also appear to express significantly reduced levels of these 
nesprin-1 isoforms in restrictive 3D culture systems compared to that of 2D systems (p ≤ 
0.001).  
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Figure 3.61: Western blot data for each analysed protein across our samples. (A) Displays 
western blot data observed upon loading of equal protein concentrations. (B), (C), (D), (E), and 
(F) represent densitometry analysis across three repeats for each protein. 3D lysates represent 
Strata
®
 scaffolds. Arrows highlight variability between WT and DN HaCaT expression patterns.     
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Figure 3.62: Western blot data for each analysed protein across our samples. (A) 
Displays western blot data observed upon loading of equal protein concentrations. (B), 
(C) and (D) represent densitometry analysis across three repeats for each protein. 3D 
lysates represent Strata
®
 scaffolds.       
     To further assess roles of LINC complex disruptions on normal cellular function, we 
next examined expression profiles of cytokeratin’s, lap2α and E-cadherin. These proteins 
were selected due to their noted roles in cell architecture, cell cycle regulation and cell-cell 
adhesion, respectively, aside further roles in maintaining cell/nuclear structure, all of which 
have been shown thus far to be altered in the DN HaCaT cell line. Representative western 
blotting data is presented in Figure 3.62. 
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Figure 3.63: Western blot data for each analysed protein across our samples. (A) 
Displays western blot data observed upon loading of equal protein concentrations. (B) 
and (C) represent densitometry analysis across three repeats for each protein. 3D 
lysates represent Strata
®
 scaffolds.      
     The data presented in Figure 3.62 suggests that there are significant differences 
between LINC associated proteins in the WT and DN HaCaT cell lines. Using further post 
hoc F-tests, it can be seen that in (B) the DN HaCaT cells appear to express significantly 
higher E-cadherin levels in 2D culture systems compared to that of the WT HaCaT cells (p 
≤ 0.001). Interestingly though, it appears that both cell lines express similar levels in 
restrictive 3D culture systems, with no significant difference observed between them. The 
data presented in (C) displays significant changes in expression levels of lap2α (p ≤ 
0.001) in which DN HaCaTs display a significant increase in expression levels across 2D 
culture systems compared to that of WT cells. Finally, the data presented in (D) 
represents the sum total of all bands detected suggesting that no significant difference 
can be observed between the levels of cytokeratin in the 2D and 3D culture systems 
between the WT and DN HaCaT cell lines.  
     As previous data has suggested that LINC complex disruptions stimulate a loss of cell 
polarity and directed nuclear migration, we aimed to assess whether the levels of tubulin 
were changed between the WT and DN HaCaT cell lines when grown in 2D and 3D 
culture systems. As microtubule networks are one controlling factor of cell polarity, 
acetylated tubulin levels in comparison to dynamic tubulin present in each sample were 
assessed, as can be seen in Figure 3.63. Tubulin acetylation is a modification acting to 
regulate both MT structural and functional properties in the cell.  
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     The data displayed in Figure 3.63 suggests that through the use of a two way ANOVA 
where p ≤ 0.05, significant differences can be seen between levels of acetylated tubulin in 
2D and 3D culture environments (B). Through the application of post hoc f-tests, it was 
shown that DN HaCaT cells express significantly lower levels of acetylated tubulin than 
WT HaCaTs in conventional 2D culture (p ≤ 0.001). However, the levels of acetylated 
tubulin are seen to reduce significantly when placed into 3D growth systems for both cell 
lines (p ≤ 0.001). Alongside this, dynamic tubulin detected with antibodies against YL ½ 
(tyrosinated) tubulin (C) levels appear to be significantly lower in the restrictive 3D 
environments for both cell lines compared to conventional 2D growth environments (p ≤ 
0.001).  
     Throughout this chapter, presented information suggests that the 3D scaffold 
environments used could be inducing cell stress. Indications for this can be seen within 
section 3.3.3 in which cells colonise surface regions of the scaffolds, and section 3.3.4.1 
in which sharp scaffold sections from the central region can be seen indenting the plasma 
membrane, inducing keratin accumulation when in close proximity to NE. To test whether 
cells are indeed stressed within this environment, two known stress markers [276], JNK 
and p38, were assessed. Phosphorylation of these two proteins indicates cellular stress, 
suggesting the cell is acting to reduce the damaging effects of surrounding stressful 
factors. These western blots can be seen in Figure 3.64. 
     The data presented in Figure 3.64 suggests that the levels of total p38 (D) and JNK (B) 
remain consistent in each cell line in both 2D and 3D growth systems. However, 
significant differences between each sample can be seen for the phosphorylated form of 
both proteins using a two way ANOVA with a p-value of 0.05. It can be seen that both 
phosphorylated JNK and phosphorylated p38 levels significantly increase in WT HaCaT 
cells grown in restrictive 3D growth environments upon the application of post hoc f-tests 
(p ≤ 0.001). This may therefore suggest that these cells are under increased stress in 
comparison to other samples assessed.  
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Figure 3.64: Western blot data for each analysed protein across our samples. (A) 
Displays western blot data observed. (B), (C), (D) and (E) represent densitometry 
analysis across three repeats for each protein. 3D lysates represent Strata
®
 scaffolds.    
 
 
 
 
     The data gathered through western blot analysis of both WT and DN HaCaT cells 
grown in conventional 2D and restrictive 3D culture environments suggests that a wide 
variety of LINC components are altered between each cell line and each growth condition. 
It appears that even though statistically significant, some LINC components display minor 
expression level changes, such as SUN1, SUN2 and emerin. Whereas the nesprins and 
lamin A/C networks alongside cytoskeletal components and associated proteins display 
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larger variations in expression levels between WT and DN HaCaT cells. Of these 
alterations in expression levels, lower nesprin-1 isoforms express the most striking 
expression variations, in which the isoform produced at ~90 kDa appears to be completely 
absent in DN HaCaT cells across both 2D and 3D environments. When collated with AFM 
data, showing the DN HaCaT cells express a softer NE, it can be suggested that this 
isoform may play a role in the maintenance of nuclear integrity and stiffness. However, 
further assessment and identification of this isoform would be required to verify this. A 
collated view of all western blot analysis conducted thus far can be seen summarised in 
Table 3.1. 
 
 
Table 3.1: Summarised data of western blot analysis across WT and DN HaCaTs in both 2D 
and 3D culture environments. Increasing arrow numbers = increased expression.   
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3.3.7    DN and WT HaCaTs display variable phenotypes when 
applied to alternate biomaterial models. 
3.3.7.1     Both DN and WT HaCaT cells retain phenotypes expressed under 
2D growth condition when applied to commercially available polycarbonate 
scaffolds.  
 
     Through the use of a variety of techniques, it has been established that the DN HaCaT 
cells display a decreased nuclear stiffness. To further assess the nuclear malleability 
potential between both the WT and DN HaCaT cells, cells were cultured on another 
commercially available scaffold in order to evaluate their migration potential through a 
highly restrictive pore size of 3 µm. The material chosen for this investigation is the 
Transwell® polycarbonate scaffold, which presents a single layered, porous material for 
the cells to migrate through. This material does not show the same pore diameter 
variability as observed in the Alvetex® Strata material, however, due to its monolayer 
structure; it does not represent a true 3D cell growth environment.  
     500,000 WT and DN HaCaT cells respectively, were seeded onto individual 
polycarbonate scaffolds and cultured for 3 days and then processed and H&E stained. 
The resulting images are displayed in Figure 3.65.  
 
      
Figure 3.65: H&E images of polycarbonate scaffolds 3 days post-seeding with WT and 
DN HaCaT cells. Scale bars = 50 µm.   
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     The low magnification images displayed in Figure 3.65 suggest that both cell lines are 
unable to fully penetrate into the restrictive void diameters during the 3 day growth period. 
However, it can be seen that the DN HaCaT cells display a thicker layer of cells across 
the surface of the scaffolds. Further high-magnification images displayed in Figure 3.66, 
helps to support this.  
 
 
 
     From the data presented in Figure 3.66, it can be seen that the thick cell layer 
produced by DN HaCaT cells appears similar to the layer observed when cultured in the 
Alvetex® Strata scaffolds. This cellular accumulation is not observed for the WT HaCaT 
cells. Under high magnification, it can also be seen that bot cell lines are in fact displaying 
migration potential through the scaffold. It can also be seen that a larger number of the 
DN HaCaT cells migrate through the restrictive pores within the scaffold compared to WT 
cells, as highlighted with arrows in A and B.  
     To further quantify these observations for cellular accumulation across the scaffold 
surface and number of cellular protrusions into the restrictive pores observed for each cell 
line, 5 sections of 5 scaffolds from 3 repeats were assessed, as seen in Figure 3.67.  
 
 
 
 
 
 
Figure 3.66: High magnification images of 3 day H&E stained polycarbonate scaffolds 
seeded with WT (B) and DN (A) HaCaT cells. Arrows highlight areas of observed cell 
penetration. Scale bars = 10 µm.   
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Figure 3.67: Collated data displaying height differences between WT and DN HaCaT 
cells across the surface of polycarbonate scaffolds (A) alongside observed cellular 
protrusions per 100 µm across the length of scaffold (B).   
 
 
 
 
     As can be seen from Figure 3.67, the data presented in (A) suggests there is a 
significant difference between the DN and WT HaCaT cell height across the surface of 
polycarbonate scaffolds, using a student’s t-test where p ≤ 0.005. The DN HaCaT cells 
express a calculated height of 5.7 µm across the scaffold, whereas the WT HaCaT cells 
express a much smaller height of 2.1 µm. Further statistical significance can also be seen 
in the number of cellular protrusions into the polycarbonate scaffolds, in which DN HaCaT 
cells appear to produce more than that of the WT HaCaT cells.  
     The data collected within this investigation therefore suggests that when placed into 
alternative scaffold environments to that of those previously used, the majority of cellular 
phenotypes are retained for both the WT and DN HaCaT cells lines. The DN HaCaT cells 
maintain their denser cell packing and increased surface height compared to WT 
counterparts. Both DN and WT HaCaTs display signs of cell penetration through the 
materials, however more cellular protrusions into the polycarbonate scaffold can be 
observed for DN HaCaT cells compared to that of WT HaCaTs.  
 
3.3.7.2    No phenotypic differences in nuclear morphology can be observed 
using the 2D micro-pillared material. 
 
     To further assess the nuclear malleability between the DN and WT HaCaT cells lines in 
a 2D environment, a novel micro-pillared surface was used (material details described in 
the methods [229]. The aim of this investigation was to assess whether both cell lines 
were able to attach between the micro-pillars protruding from the materials surface, and in 
A B Observed cell protrusions per 100 µm length of 
scaffold 
Cell surface thickness (µm) 
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Figure 3.68: Immunofluorescence images of both WT (A) and DN (B) HaCaT cells adhered to 
micro-pillared materials. Actin cytoskeleton is stained in Red and nuclei in Blue Scale bars = 
10 µm.    
turn assess whether the nuclear deformities induced by this attachment were variable 
between the two cell lines. Cells were seeded onto the materials and processed as 
described previously upon growth over a 5 day period. Following this, fluorescence 
staining was performed for TRITC-conjugated phalloidin and DAPI. Representative 
images can be seen displayed in Figure 3.68.  
 
 
 
     As can be seen from images presented in Figure 3.68, little difference can be observed 
between the WT and DN HaCaT cells when placed onto this material. It can be seen that 
both cell lines display actin accumulation and cellular packing as previously identified in 
conventional 2D culture systems. This data, therefore, suggests that both the cell lines 
appear grow across the surface of the pillars, rather than settle between the 7 x 7 µm 
spaces between each pillar. However, the imaging technique used is unable to display the 
pillars across the materials surface, meaning that our current assumptions would need 
further validation through the incorporation of a surface imaging technique such as AFM 
or SEM. This would allow the identification of not only the cells situated across the 
surface, but also the pillars, displaying whether the cells do indeed grow across the 
surface of these micro-pillars. To validate this; nuclear circularity was assessed between 
both WT and DN HaCaT cells, as displayed in Figure 3.69.  
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Figure 3.69: Collated data displaying calculated nuclear circularity index values in 
conventional 2D culture and micro pillared materials for WT and DN HaCaT cells.    
 
 
 
     The data presented in Figure 3.69 suggests that there is no difference between the 
calculated nuclear circularity index values obtained for both cell lines between 
conventional 2D and micro pillared surfaces. The graph further supports the previous data 
suggesting that the nuclear circularity index is different between the WT and DN HaCaT 
cells lines in in both culturing environments.  
     The data presented in this investigation therefore suggests that the WT and DN HaCaT 
cells were unable to penetrate into the spaces between the micro-pillars, resulting in the 
cells forming colonies across the pillar surface. In addition, the circularity index remained 
consistent with conventional 2D culture systems, suggesting that the material was not 
able to stimulate nuclear deformities within either cell line during our investigation period.  
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3.4    Summary of Experimental Findings. 
 
     Work in this chapter has sought to investigate the effects of severing SUN-KASH 
protein interactions within the PNS on cellular functionality and behaviour. This protein 
impairment through the incorporation of DN SUN1 acts to disrupt the LINC complex, 
which has been shown to play roles in multiple cellular functions [102, 241, 99, 41].  
 
3.4.1    DN SUN1 overexpression results in phenotypic 
abnormalities, including increased nuclear height, decreased cell-
substratum attachment and reduced 2D migration in scratch-
wound assays. 
 
     Initial investigations showed that the LINC complex disruptions present in DN HaCaT 
cells stimulated increased cellular cohesion within the colonies. It was found that the DN 
HaCaT cells exhibited a smaller cellular area to that of WT HaCaT cells, allowing more 
cells to fill the same 100 x 100 µm2 area (Figure 3.5 and 3.6). Possible explanations for 
this observation arise from further investigations showing that the DN HaCaT cells present 
a larger nuclear height and a slightly reduced nuclear volume. This phenotype suggests 
the DN HaCaT cells are able to occupy a smaller area to that of the WT HaCaT cells, 
allowing for the closer association between cells. Further evidence has also been 
provided by western blot analysis between 2D cultured WT and DN HaCaT cells (Figure 
3.62). It appears that the DN HaCaT cell lines display an increase in E-cadherin levels, 
which in turn, may increase the DN HaCaT binding affinity to surrounding cells due to E-
cadherin’s roles in maintaining cell-cell attachments [277]. This combination of increased 
E-cadherin alongside increased cell-cell proximity (cell crowding) may also suggest the 
DN HaCaT cells are presenting a columnar epithelium morphology, similar to that of 
keratinocytes situated across the basal layer in normal skin epithelium [278].  
     Thus far it has been found that disrupting this SUN-KASH perinuclear bridge (and 
therefore LINC complex connections) stimulates 2D phenotypic abnormalities in 
cellular/nuclear shape and cell-cell attachment. It has been shown that siRNA 
knockdowns of nesprin-1 are able to stimulate an increase in nuclear height [140] due to a 
decrease in actin attachment points across the NE, therefore reducing the forces applied 
by the actin cytoskeletal network across the nuclear surface. Data presented in Figure 3.9 
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supports this, suggesting the displacement if KASH protein across the NE in DN mutant 
cells, stimulates an increase in nuclear height. However, super-resolution microscopy data 
for actin organisation across the NE did not reveal any discernible differences in actin 
topology between WT and DN HaCaT cells (Figure 3.56). This suggests that either, the 
DN insertion impairs the ability of NE actin arrangements to withstand extracellular 
mechanical forces, but does not alter its cellular localisation, or that the nuclear height 
increase may result from disruptions to alternate protein networks such as the MT or lamin 
network systems, which are also implicated in maintaining nuclear height [279].  
     To validate this, further investigation would therefore be required to directly assess 
whether the actin cytoskeleton does indeed possess altered mechanical properties. To 
test this, AFM analysis could be used to test the mechanical properties of isolated NEs 
both with and without nuclear actin associations between each cell line. This would allow 
the direct assessment as to whether mechanical properties inferred by NE-associated 
actin differs between WT and DN HaCaT cells, and therefore whether the observed 
nuclear height increase can be attributed to this. 
     Subsequent investigations assessed functional differences expressed between the WT 
and DN HaCaT cells lines regarding cell-substratum attachment and migration potential. It 
has been shown through time course analysis and live cell imaging that the DN HaCaT 
cells appeared to flatten much slower post trypsinisation than the WT HaCaT cells (Figure 
3.11). Further investigations lead to suggestions that this could be a result of variations in 
vinculin and cytoplasmic actin organisation between the two cell lines. It was shown that 
the vinculin organisation remained similar for both cell lines up to 12 h post trypsinisation, 
however, at the 24 h time point, it can be clearly seen that the WT HaCaT cells display an 
accumulation of vinculin across the cellular periphery in focal adhesions. In contrast, DN 
HaCaT cells retain similar cytoplasmic localisation to the pre 12 h time points (Figure 3.12 
and 3.13). Aside from this, actin organisation was further shown to accumulate at 
peripheral cell areas in the DN HaCaT cells lines, whereas the WT cells displayed a more 
even actin distribution between the cell’s nucleus, cytoplasm and periphery. This 
contradicts the super resolution data of actin presented in Figure 3.56 in which no 
difference in actin organisation was observed. Potential reasoning behind this however 
comes from DN HaCaT cells presenting a decreased attachment rate to the cellular 
substratum as described in this investigation. As the actin assessments conducted in this 
investigation were taken 24 h post seeding, the super resolution images display the same 
cells 72 h post seeding. This suggests that the DN HaCaT cells may accumulate the same 
actin arrangement, however due to their reduced cell-substratum flattening rate; this 
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process may take significantly longer as a result of LINC complex disruptions across the 
NE.   
     Following this, investigations aimed to assess whether the LINC disruptions present in 
DN HaCaT cells stimulated any further phenotypic differences in 2D migration potential 
through the use of a conventional scratch wound assays. Resulting data presented in 
Figure 3.17 shows that the DN HaCaT cells migrate significantly slower than their WT 
counterparts. In contrast to WT, DN cells are unable to completely close the wound 48 h 
post wounding. It has been previously suggested that the loss of SUN-KASH interactions 
across the NE leads to a loss of cell polarity [59], which subsequently leads to the loss of 
directed cell migration. Based on this evidence, findings within this investigation may 
suggest that the reduced wound closure displayed by DN HaCaT cells may be a 
cumulative outcome of cell-substratum and -polarisation defects.  
      
3.4.2    LINC complex disruption in HaCaT cells increases 
penetration into space-restrictive 3D culture environments.  
 
     The use of two commercially available 3D culture scaffolds; Alvetex® Scaffold and 
Alvetex® Strata, allowed us to investigate the ability of WT and DN HaCaT cell lines to 
migrate through space-restrictive and non-restrictive 3D environments. For the non-
restrictive Alvetex® Scaffold environment, it was shown that the phenotypic observations 
were similar to that of the 2D wound healing assay. Specifically, WT HaCaTs were shown 
to migrate faster through the scaffolds, alongside DN HaCaTs displaying a more compact 
grouping of cells across the full depth of the scaffold (Figure 3.21). Further to this, WT 
HaCaT cells displayed a preferred growth across the two extreme surface regions of the 
scaffold, whereas the DN HaCaT cells maintained their tightly packed cell morphology 
throughout the material (Figure 3.19).  
     It was speculated that the WT but not the DN HaCaT cells did not colonise the central 
scaffold regions due to this region presenting a stressful environment for the cells. One 
potential explanation for this observation comes from the DN HaCaT cells potentially 
displaying a loss of contact inhibition due to the severance of LINC connections across 
the NE. This could result in their increased clustering observed. However, further 
assessment of this hypothesis would be required to validate this. It can be further 
suggested that due to the high porosity of the material, media flow would be limited within 
the central region of the scaffold, meaning that cell accumulation in this region could result 
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in hypoxic and acidic conditions developing over longer culture periods. Testing the 
conditions in the central region of the scaffold would, however, be difficult due to the 
fragility of the material and its limited thickness of 200 µm.  
     Interestingly however, further data supported suggestions that central regions of the 
scaffold may provide stressful environments for the cells (Figure 3.39). Through the use 
TEM imaging, it was shown that interconnects between the voids present sharp edges of 
~1 nm. Cells were seen to be heavily indented by these edges, but crucially, when 
indentations were in close proximity to nuclear regions, potential keratin accumulation was 
observed around the point of indentation, in which the cells appeared to protect their 
nuclei. To verify whether cells were under stress within these space-restrictive scaffolds, 
western blot analysis for known stress markers JNK and p38 was further conducted. It 
was observed that phosphorylation levels for both proteins were seen to be significantly 
upregulated for WT HaCaT cells within the space-restrictive 3D scaffolds in comparison to 
DN HaCaT cells (Figure 3.64), suggesting that these cells are indeed responding to 
stresses from their environment.  
     All of the potential stresses described above could be reasons why WT HaCaT cells 
are unable to colonise central regions of the scaffold. However, the DN HaCaT cells retain 
their 2D phenotypic growth patterns (i.e. cell crowding) and appear to colonise these 
regions. This observation could be a result of either the DN HaCaT cells expressing an 
increased resistance to environmental stress, or an inability to detect and respond to 
surrounding stresses due to a loss of mechano-transduction across the NE.    
     Both cell lines were also cultured in the space-restrictive Alvetex® Strata scaffolds 
(Figure 3.24). Interestingly, it was found that over the first 7 days of growth, WT HaCaT 
cells displayed faster migration potential; however, they then appeared to remain in the 
central regions of the scaffold with little to no further migration post 9 days. In contrast, the 
DN HaCaT cells continually migrated through the scaffold at a much slower rate than the 
WT HaCaTs, passing them at the 9-day time point (Figure 3.25). It can be suggested that 
this increased migration potential may arise from the stresses described in non-restrictive 
scaffolds, in which reduced media flow and sharp interconnecting windows may damage 
cells during migration. In these more space-restrictive Strata® Scaffolds, these stresses 
would be amplified as a result of decreased void diameters, subsequently leading to 
reduced media flow and more restrictive interconnecting windows. As it was suggested 
that DN HaCaT cells appear to resist these stresses (through colonising central scaffold 
regions in non-restrictive scaffolds) due to a potential loss of mechanotransduction, these 
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cells may display a migration advantage, in which cells may continue to migrate even 
though cell damage is obtained.  
     One further suggestion as to why WT migration appears to halt in central scaffold 
regions could arise from the increased cell density observed as cells migrate through the 
restrictive scaffolds (shown in Figure 3.24 where WT HaCaT cells appear to display a 
more compact morphology due to the scaffolds decreased void diameters). This could 
lead to increased media consumption within central scaffold regions, alongside increased 
cellular damage due to migration through restrictive interconnecting windows, leading to 
subsequent cell damage and migration arrest.  
     In addition, it was shown that the LINC disruptions present in the DN HaCaT cells 
stimulated alterations in cell behaviours across the seeding surface of the restrictive 
Strata® scaffolds, and the leading migratory edge of cells in the centre. The DN HaCaT 
cells appeared to display an increased cell density and stratification across the seeding 
surface of the scaffold compared to WT counterparts; which presented a single cellular 
layer upon air/liquid interface induction (Figure 3.28). These observed shape changes in 
DN HaCaT cells appear to reflect the organisation of keratinocytes in vivo, in which serial 
differentiation across the epidermal layer of skin leads to significant morphological 
changes in cell shape [271] (Figure 3.28, 3.29 and 3.30).  
     It was further shown in Figures 3.26 and 3.27 that the DN HaCaT cells migrated 
through the scaffold as a cohesive unit across the leading edge, whereas the WT HaCaT 
cells display much more variability in penetration rates across this edge. Coupled with the 
2D phenotypic observations and non-restrictive 3D migration data, this observation could 
suggest that the WT HaCaTs express increased proliferation rates to that of the DN 
HaCaT cells in these space-restrictive scaffolds. However, with data suggesting LINC 
complex disruptions stimulate loss of cell polarity and therefore directed movement in 2D 
environments, the increased cohesion of cell migration across the leading migratory edge 
may arise from DN HaCaT cells being unable to select for ‘the easiest route’ through the 
scaffold. The restrictive scaffold material used presents variable void diameters and 
interconnect sizes, leading to assumptions that when presented with a large and small 
interconnect size, the WT HaCaTs could be able to selectively migrate through the less 
restrictive interconnect which will not require nuclear deformities to pass through. The DN 
HaCaT cells on the other hand would be unable to select for the easiest route, therefore 
leading to a more uniform migration pattern. One alternate explanation is that the 
increased expression levels of E-cadherin in DN HaCaT cells influences their migratory 
behaviour. However, increased E-cadherin levels were not observed for the DN HaCaTs 
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when cultured in the restrictive Strata® Scaffold (Figure 3.62). This therefore supports our 
initial suggestions that the inability of DN HaCaT cells to direct migration may be the main 
contributing factor to their observed migratory behaviour. 
     This migratory edge analysis lead to further investigations using high-powered TEM to 
investigate whether any behavioural differences existed between the two cell types in 
central regions of the space-restrictive Strata® scaffold. Two main phenotypic differences 
were observed, the WT HaCaTs displayed significantly increased cytoplasmic 
redistribution ahead of nuclei during migration through restrictive (<4 µm) interconnect 
sizes (Figure 3.34) compared to DN HaCaT cells. Alongside HaCaT cells exhibited a more 
‘hourglass’ nuclear shape when compared to WT nuclei upon migration through these 
restrictive interconnecting windows (Figure 3.38).  
 
3.4.3    LINC complex disruption in HaCaT keratinocytes 
significantly decreases nuclear stiffness. 
 
     From the data gathered thus far, it has been shown that the DN HaCaT cells exhibit 
numerous phenotypic changes, the most distinct of these being the increased penetration 
potential into space-restrictive 3D culture scaffolds. This phenotype closely resembles 
those exhibited by highly metastatic cancer cells upon migration from their source to other 
areas of the body. These cells often exhibit increased nuclear malleability, in turn, 
increasing the ability of cells to squeeze between gaps smaller than that of the nuclei 
[283].  
     It was therefore investigated whether the disruption in SUN-KASH interactions present 
in DN HaCaT cells resulted in a decrease in nuclear stiffness, stimulating the observed 
migration advantage in space-restrictive 3D environments. It was initially observed that 
both WT and DN HaCaT cells display a decreased nuclear circularity index in central 
regions of the scaffold compared to surface regions (Figure 3.43 – 3.46). This suggests 
that nuclear shape changes are required to penetrate into these restrictive scaffolds. To 
gain an increased understanding of the effects of LINC disruptions on the mechanical 
properties of nuclei, we applied the use of AFM (Atomic Force Microscopy), Transwell 
assays and osmotic stress analysis techniques to assess; 1) whether LINC disruptions 
stimulated a significant decrease in nuclear stiffness, and 2) whether this increased 
nuclear malleability inferred a migration advantage when nuclear deformation is required 
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for migration (Figure 3.49, 3.52 and 3.67). It was found that the DN HaCaT cells did 
indeed exhibit a decreased nuclear stiffness. It has been shown that down regulation of 
nesprins across the NE leads to an increase in nuclear size, which in turn can be reversed 
through the incorporation of nesprin mini (rod-less) engineered isoforms [101]. This 
suggests that nesprins may form a cage like network across the ONM anchored by SUN-
KASH protein interactions, able to provide structural rigidity to the nucleus. When this 
cage is disrupted, as in the DN HaCaT cells, this structural rigidity/nuclear cage may be 
lost, leading to a reduction in nuclear stiffness. 
 
3.4.4    DN SUN1 induced LINC complex disruption induces 
altered expression patterns for multiple LINC proteins, notably 
nesprin-1/-2 across both 2D and restrictive 3D culture conditions. 
 
     The final investigations in this section aimed to validate that the previous observations 
were due to a severed link between SUN-KASH proteins across the perinuclear space. 
Current views on nuclear stiffness suggest lamins and actin play the crucial roles in 
maintaining nuclear stiffness [114, ,267]. It was therefore aimed to assess protein 
expression levels of lamin A/C, lamin B and actin alongside cellular organisation, in order 
to assess if any differences exist DN and WT HaCaT cells lines. Using super-resolution 
microscopy, little variation between the actin and lamin A/C protein networks in the cells 
(Figure 3.56 and 3.57) was observed. However, lamin B distribution did appear to be 
altered (Figure 3.58), with DN HaCaT cells displaying a loss of what appears to be lamin 
B invaginations into the nucleus. When coupled with protein expression data for each 
protein, it can be seen that lamin A/C levels appear to be increased in 3D WT cells in 
comparison to their 2D counterparts, whereas lamin B and actin levels remain consistent.  
     This observed difference in lamin A/C expression across DN and WT HaCaT cells in 
restrictive 3D culture environments could be due to the direct interactions present 
between lamin A and SUN proteins [29, 66]. As endogenous SUN proteins are 
outcompeted for interactions with KASH proteins in DN HaCaT cells, it is possible that this 
loss of SUN-KASH interaction may elicit alterations in lamin A/C expression as a 
redundancy mechanism to retain nuclear integrity. It is already known that upon lamin A/C 
dysregulation in HGPS, SUN1 accumulation across the NE is increased, so a potential 
mechanism may also exist for lamin A/C expression to safeguard the nuclear integrity 
upon the detection of a severed link between INM and ONM.    
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     Through the application of western blot analysis of further LINC associated proteins, it 
was shown that disrupting the SUN-KASH bridge across the perinuclear space alters 
emerin and SUN2 expression patterns, but does not appear to affect expression of SUN1. 
For both WT and DN HaCaT cells, SUN1 expression remained consistent across the 2D 
and 3D culture environments, whereas emerin expression appeared to increase when 
both DN and WT HaCaTs were subjected to the space-restrictive 3D environments. A 
further decrease in SUN2 protein expression was observed across WT and DN HaCaT 
cells compared to their 2D counterparts (Figure 3.60). These observations in emerin 
expression could be a result of the cells natural response to stresses in their environment. 
It was shown by Hadden et al. that when HeLa S3 cells were subject to both mild and 
severe hyperthermia stress, a spiked increase in emerin levels was observed, followed by 
a subsequent decrease [290]. The functional attributes of these observed variations in 
emerin expression have not yet been ascertained, however, it does help to underline the 
complexity of cellular responses to cellular stress, suggesting further research to increase 
our understanding of this process is required. The observed differences in SUN protein 
expression could arise in differential levels of pre-lamin A within 2D and 3D cultured cells. 
It is known that pre-lamin A is closely associated to emerin and Lap2α across the nuclear 
envelope [291] and is able to stimulate the up regulation of SUN1 [292]. As a result of the 
above data also displaying a reduction in Lap2α expression levels within restrictive 3D 
environments, it is possible that levels of pre-lamin A may be reduced in the 3D cultured 
systems, leading to the observed alterations in emerin and SUN expression levels. To 
validate this, future work should be conducted into assessing levels of pre-lamin A present 
within cells grown in 2D and restrictive 3D growth environments.  
     Further western blot analysis revealed that the levels of nesprin-1 and nesprin-2 
isoforms appeared to vary greatly between the WT and DN HaCaT cell lines. Their 
isoform expression levels appeared to remain consistent in both the 2D and 3D culture 
environments, however, isoform expression differences could be observed between the 
two cell lines across both environments (Figure 3.61). The most striking observation is the 
differences observed in the nesprin-1 western blot across the 90 kDa range. It can be 
seen that the WT HaCaT cells express a clear band in this region that is not present in the 
DN HaCaT cells. The precise identity and roles of this nesprin isoform are currently 
unknown; however it can be speculated that this isoform could regulate nuclear structure 
and mechanical properties. In order to validate this hypothesis however, future work could 
aim to isolate this isoform and attempt to rescue nuclear stiffness through its re-
incorporation back into the DN HaCaT cells, to see if nuclear stiffness is increased.  
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     Finally, the levels of acetylated tubulin in both the WT and DN HaCaT cells grown 
within both environmental conditions were assessed due to increasing evidence 
suggesting that tubulin acetylation is a potential factor in cellular invasion and metastasis 
[293]. The obtained data suggests that the DN HaCaT cells exhibit a reduction in 
acetylated tubulin levels alongside a large reduction in acetylation levels in restrictive 3D 
environments (Figure 3.63). This data does not correlate with current opinions in cancer 
biology, suggesting that increased tubulin acetylation levels in metastatic and basal like 
breast cancer cells is able to promote microtenticle formation, adhesion and invasive 
migration into surrounding tissue [293]. However, it is often an accumulation of multiple 
phenotypes that leads to cancer development and metastasis, suggesting that the DN 
mutant may not represent the whole picture behind increasing metastatic potential within 
cells.  
     Through the data presented in this chapter, it has been shown that severing the link 
between SUN-KASH interactions across the perinuclear space stimulates cell 
abnormalities in both 2D, space-restrictive and non-restrictive 3D culture environments. It 
has also been highlighted that nuclear malleability is a potential avenue to investigate 3D 
cellular migration potential through restrictive environments. Due to this, following work 
will aim to increase the understanding of the roles of LINC complex proteins in cancer 
metastasis, in particular whether similar phenotypes in protein expression or cell 
behaviour can be observed in various cancer cell lines in addition to the DN HaCaT cells 
used in this work.    
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4. Assessing the roles of LINC complex 
disrupted keratinocytes using 3D fibroblast 
co-culture models  
4.1    Introduction. 
 
     The development of in vitro 3D cultures which closely mimic the in vivo environment of 
tissues is a current venture to produce more accurate biological models [370]. Results 
thus far have been obtained using non-physiological polystyrene models, which replicate 
conditions far from that of the in vivo situation, as in the body, keratinocytes do not exist in 
single culture environments, or display close contact with plastic.  To tackle this limitation 
of experiments conducted thus far, we aimed to replicate a more in vivo like 3D culture 
environment in which to test our keratinocyte cell lines.  
     HaCaT cells are derived from the epidermal layer of human skin, situated above the 
dermis. This dermal region consists mainly of connective tissue, comprising of three main 
cellular subtypes; fibroblasts, macrophages and adipocytes, working in close association 
to maintain tissue integrity and resistance to stress and strain [371]. These close 
associations between dermal fibroblast and keratinocytes are of great importance in tissue 
development due to the complex interplay of cellular signalling and associated protein 
interactions occurring between the two layers [372]. With this in mind, to increase the 
biological relevance of our models, we aimed to co-culture HaCaT cells used thus far with 
dermal fibroblast cells, to more closely replicate the in vivo situation. Using these models, 
we aim to tackle two questions; 1) whether fibroblast incorporation into the 3D scaffolds 
stimulates alterations in WT and DN HaCaT cells penetration potential, and 2) whether 
any differences can be observed previously in cell stacking observed during DN culture in 
space-restrictive scaffolds.   
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4.1.1    Keratinocytes and fibroblasts mediate numerous tissue 
functions in human skin through complex cross talk between 
dermal and epidermal regions.  
 
4.1.1.1    Human keratinocytes change keratin expression profiles during 
differentiation in epidermal skin layers, stimulating changes in cell function 
and tissue properties. 
   
     The epidermis, a keratinized stratified squamous epithelium can be found across the 
bodily surface of terrestrial vertebrates, functioning to protect against pathogen, allergen 
or toxic substance entry. The epidermis comprises mostly of keratinocytes, which are 
organized into five main cellular layers; the Stratum Basale (SB), the Stratum Spinosum 
(SS), the Stratum Granulosum (SG), the Stratum Lucidum (SL) and the Stratum Corneum 
(SC) (Figure 4.1).  
 
 
Figure 4.1: Schematic of the stages of epidermal differentiation in human skin, 
highlighting relative size and regions of each associated region. The SL is situated 
between SG and SC layers, [507]. 
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     The dermal region of skin is a connective tissue containing collagen and elastic fibres, 
working in close association with fibroblasts to provide a structural framework. Situated 
directly above this cellular layer is the SB, the deepest epidermal region comprising of a 
single keratinocyte layer. From this region, terminal proliferation and differentiation of 
keratinocytes occurs, leading to the development of the subsequent cellular layers [271, 
278].   
     Keratinocytes situated across each epidermal layer express unique sets of keratin 
intermediate filaments. In the SB layer, keratinocytes express keratin 5 (A basic, Type II 
intermediate filament protein) and keratin 14 (An acidic, Type I intermediate filament 
protein) [373]. This keratin pair is strongly associated with regions of stem cell localisation, 
often found down regulated in further differentiated layers [374]. The K5/K14 keratin 
filaments are found bundled as tonofilaments associated with desmosomes and 
hemidesmosomes. The functional importance of this keratin pair across the basal layer of 
the epidermis has been well documented through the use of genetic studies [375], in 
which the dominant negative loss of K5/K14 function across  basal skin keratinocytes is 
often associated with the development of hereditary skin blistering diseases, such as 
epidermolysis bullosa simplex (EBS). The loss of K5/K14 function leads to the subsequent 
development of fragility within the basal layers of the epidermis, meaning that through the 
application of mechanical force, intraepidermal blistering can develop [376].  
     This keratin pair has displayed further importance in the assessment of cancer 
progression, with the expression pattern of both K5 and K14 suggested to remain 
constant during cancer development across many tissues. Keratin 5 for example is 
present in the basal layer of both keratinized and non-keratinized epithelium, due to this, 
Vasca et al. suggested K5 as a potential diagnostic marker for the detection of 
differentiated and undifferentiated regions of tumours from the oral cavity, oropharynx, 
hypopharynx and larynx [377]. Further evidence also highlights roles for K5  in assessing 
breast pathology, including the identification of myoepithelial cells, the classification of 
proliferative lesions and the recognition of specific subtypes of invasive ductal breast 
carcinomas [378].  
     The transition of keratinocytes from the proliferative basal cell layer to the post mitotic 
spinous layer is characterised by a change in keratin expression, such as the exchange of 
K5 and K14 for suprabasal epidermal keratins like the Type II keratin K1 and the Type I 
keratin K10 [379, 380]. The pairing of K10 and K1 elicits an increase in mechanical 
integrity to the surrounding tissue due to the formation of dense intermediate filament 
bundles. Further to these structural roles, it has been identified that this keratin switch, 
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most notably the expression of K10 is able to inhibit cell proliferation and cell cycle 
progression [381], with further loss of K10 expression associated with increased 
keratinocyte turnover [382], suggesting functional roles played by this keratin switch 
during terminal keratinocyte differentiation. Serial differentiation then continues from the 
SS to the SG, in which cells begin to develop a more flattened morphology. Following this 
layer is the SC, consisting of a mixture of lipids and dead keratinocytes, forming a 
flattened, water resistant barrier across the surface of the epidermis. During the final 
stages of keratinocyte differentiation into this layer, keratin proteins align into highly 
ordered arrays through interactions with the matrix protein filaggrin. This protein is able to 
aggregate with keratin filaments, forming tight bundles, which subsequently stimulates 
cellular collapse into this observed flattened cell shape [383].  
     It is suggested that this process of serial differentiation in human keratinocytes aids in 
the development of a wide range of cellular functions throughout the epidermis, due to the 
associated cellular changes with each differentiation step. Aside these alterations in 
keratin expression patterns, cell-cell interactions between keratinocytes and other cellular 
populations also vary during terminal differentiation [384]. For example, in healthy human 
skin, the cross talk between keratinocytes and melanocytes situated across the basil 
epidermal layer is important for tissue maintenance. Keratinocyte cells are able to regulate 
the proliferation and cellular behaviours exhibited by melanocytes via interconnections 
through E-cadherin. The extracellular domains of these E-cadherin proteins form stabile 
connections between actin cytoskeletal networks within each cell through associated α- 
and β-catenins [385]. This cellular linking between cytoskeletal elements across cells was 
then further suggested to infer the ability of multiple cells to act as one across the tissue, 
able to resist mechanical forces which would tear single cells apart [386].  
     It is therefore evident that the complex differentiation and cellular interaction patterns 
expressed by keratinocytes within the epidermis allow the formation of a complex network 
of cellular functions. In comparison to this however, it has been continually documented 
that keratinocytes grown in synthetic 2D and 3D culture systems do not express this 
complexity in cell-cell interactions or differentiation potential without the implication of 
external factors [387, 388, 389]. This helps to highlight the need for a more in vivo like 
model to assess whether differences in WT and DN HaCaT cells displayed thus far reflect 
how they would behave in vivo.     
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4.1.1.2    Human dermal fibroblasts display a wide range of functions, 
including maintaining tissue integrity, re-modelling the ECM and organising 
epidermal function. 
 
     Dermal regions of the skin are located below the basement membrane of the 
epidermis, consisting of multiple cell types working in conjunction to maintain organ 
homeostasis. One major component of this dermal layer are the fibroblast cells. These 
resident mesenchymal cells produce collagen and other ECM proteins including laminin-1, 
laminin-5 and fibronectin [390, 391, ,392], shown to function in maintaining skin structure 
and integrity. Alongside its roles in creating and re-engineering the surrounding 
extracellular matrix, dermal fibroblasts have also been implicated in further tissue 
functions. In recent in vitro investigations, it was shown that complex cross talk between 
dermal fibroblasts and monocyte-derived dendritic cells (MoDC) was required for the 
efficient migration through the surrounding ECM [393]. In this study, it was shown that 
innate-immune activation stimulated the activation of MoDC’s. This in turn stimulates the 
release of TNFα (tumour necrosis factor alpha) and IL-1β (interleukin-1β), which 
subsequently stimulated the release of MMP1 (human collagenase) and PGE2 from 
neighbouring dermal fibroblasts, resulting in a re-modelling of the ECM. This ECM 
remodelling was further shown to increase the migratory potential of MoDCs through the 
tissue environment, helping to highlight further roles of dermal fibroblasts in remodelling 
the ECM as a method of controlling the cutaneous immune response.  
     Dermal fibroblast cross talk has also been implicated in the remodelling phase of 
wound healing. This phase of wound healing is considered the longest process, 
continuing from a period of weeks to months. One of the main characterising features of 
this stage is the active re-organisation of the ECM by the dermal fibroblast population. 
Through the accumulation of collagenase and MMPs, Type III collagen secreted by the 
myofibroblast population is gradually replaced by the Type I collagen [394]. During this 
process, dermal fibroblasts help to facilitate an increase in crosslinking between collagen, 
reduction in fibronectin and an increase in localised proteoglycans, helping to increase 
overall the strength of the resulting scar. This therefore, highlights that dermal fibroblasts 
help to re-organise the EMC of the scar, developing a composition more similar to that 
observed in non-wounded tissue [395].  
     It has been shown thus far that dermal fibroblasts exhibit a wide range of functionality 
through the re-organisation of ECM components in response to various environmental 
cues. Aside these roles, current investigations suggest further roles for fibroblasts in 
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organising epidermal function through cellular cross talk between epidermal and dermal 
tissue regions. This link between keratinocyte and fibroblast regions is controlled by both 
paracrine and autocrine linkage. Initial in vitro investigations suggest fibroblast cells 
secrete soluble factors that diffuse to the overlaying epidermis, influencing keratinocytes 
in a paracrine manner [396, 397]. This was shown through investigating keratinocyte 
growth behaviours under fibroblast co-culture conditions in vitro. Using this system, it was 
shown that under single culture conditions, keratinocyte cells appear to produce a thin 
epidermal layer and become apoptotic ~2 weeks post seeding in collagen gels [396]. 
However, the introduction of a fibroblast cell layer before keratinocyte seeding, followed 
by growth at the air-liquid interface (similar to conditions found under in vivo conditions) 
resulted in a much more defined epidermal layer, displaying clear SB, SS, SG and SC 
layers. This highlighted the potential for cross-talk existing between the keratinocyte and 
fibroblast cells within the system, allowing the formation of a more defined keratinocyte 
organisation and differentiation pattern to that observed in single cultures.  
     Furthering these findings, follow on investigations highlighted the importance of 
fibroblast secreted cytokines and growth factors, revealed both autocrine and paracrine 
effects of these secreted factors on epidermal keratinocytes. Autocrine activity is 
displayed by the TGF-β induced secretion of connective tissue growth factor (CTGF), 
which helps promote the synthesis of collagen into the ECM, alongside increase 
neighbouring fibroblast proliferation [398]. Paracrine activity displayed by dermal fibroblast 
cells affects keratinocyte growth and proliferation directly, through the secretion of 
keratinocyte growth factor (KGF), IL-6 and fibroblast growth factor (FGF) [399, 400, 397]. 
In response to these external signals, keratinocytes increase expression levels of IL-1 
compared to that of monoculture cells [401], which in turn, stimulates increased KGF 
expression by the fibroblast cells, suggesting the existence of a double paracrine loop 
[402, 403, 404].  
     Further work now suggests roles for this keratinocyte-fibroblast paracrine linkage within 
mechanisms of UVB-induced wrinkling in skin, suggesting a complex interplay exists 
between keratinocyte cytokine release and subsequent increased elastase expression by 
dermal fibroblasts [405]. More interestingly however, there is current speculation that the 
production of keratinocyte microvesicles, stimulated under wound healing conditions 
regulates the expression of multiple genes in dermal fibroblasts [406]. It was found that 
when keratinocyte microvesicles derived from wounding skin were added to dermal 
fibroblast cultures, expression of 21 genes was significantly regulated, including those 
associated with the production of MMP1, MMP3, IL-6, IL-8 and genes associated with 
TFG-β signalling.  
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     Current data therefore suggests that not only do both keratinocyte and fibroblast cells 
play important individual roles in the maintenance of skin functions, but that they also 
possess complex interactions across dermal and epidermal regions, allowing a diverse 
range of functional responses to environmental cues to be implemented. These findings 
help to provide further support for the inclusion of fibroblast cells into our simplified model, 
as the complex interactions between keratinocytes and fibroblasts may induce altered 
phenotypic behaviours by the WT and DN HaCaT cells in comparison to their single 
culture conditions.    
 
4.1.1.3    ECM composition can alter cell behaviours, including cell-
substratum adhesion, cell migration and cell spreading both in vivo and in 
vitro.  
 
    The incorporation of keratinocytes and dermal fibroblasts into simplified 3D models 
should help to more accurately emulate cellular environments which closer resemble the 
normal in vivo system. Fibroblast introduction will stimulate complex interplay between 
keratinocyte and fibroblast cells through the secreted ECM. Current literature suggests 
that in both in vivo and in vitro culturing systems, the secretion of ECM and its 
composition is heavily influenced by its surrounding environment  [407]. This produced 
ECM infers a wide variety of biochemical and mechanical stimuli to surrounding cells, with 
perturbation stimulating drastic phenotypic and behavioural abnormalities. 
     As current understanding suggests that the mechanical stiffness of the growth 
environment influences cellular growth properties, current investigations apply the use 
polyacrylamide (PA) gels with increasing and decreasing Bis-acrylamide content, to 
assess the effects of environmental stiffness on cellular morphology [408]. In this study, It 
was shown that through the incorporation of both NRK-52E and 3T3 fibroblast into the 
‘hard’ polyacrylamide substrate, cell spreading was increased, whereas cells applied to 
the ‘softer’ material displayed an increased variability in lamellipodia in the NRK cells, 
alongside an increased motility in the 3T3’s. This investigation therefore provides insight 
into the cells ability to adapt to environmental composition. 
     The modulation of ECM environmental stiffness has been shown to be a key 
component in aiding cellular migration through localised tissue environments. In vivo 
mouse models have demonstrated that the tissue stiffness in mammary gland regions of 
the breast increases upon type-1 interferon receptor loss [409]. This increased stiffness 
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was attributed to an increase in collagen expression, alongside an increase in 
liberalisation and cross-linking between these collagen fibres. The identification of 
increased crosslinking between collagen fibres was further correlated to an increase in 
lysyl oxidase expression, an amine oxidase which acts as a collagen cross-link initiator. 
To further this work, MCF 10A cells were grown in in vitro collagen gels displaying varying 
cross-linking densities [410]. It was found that as the collagen matrix stiffness was 
increased through increased cross-linking, structural organisation of acini formation was 
disturbed, alongside an increase in colony size. This suggests that an increase in 
environmental stiffness is sufficient to elicit structural abnormalities and altered cell 
behaviours in model 3D systems.  
     In papers described thus far, variability between cellular responses to these varying 
matrix conditions is observed based on the cell line applied. For example, it has been 
demonstrated that varying grades of cancer cells display adaptable cell behaviours in 
response to substrate rigidity  [411]. In this study, a variety of cancer cell lines (including 
MDA-MB-231, MCF7, HPSC and VMM18 cells) were assessed for their ability to grow 
within collagen coated PA gels displaying elastic moduli ranging from 150 – 9600 Pa. 
Variability in cellular mobility was observed across the range of cell lines tested, however, 
it was found that in cells displaying increased mobility on rigid surfaces (such as the A549 
and MDA-MB-231 cells), the same cells displayed a cell-cycle blockade or increased 
apoptotic events when grown on softer surfaces. Interestingly however, it was further 
demonstrated that some cells (Such as the mPanc-96 cells) displayed no preference of 
increased growth or motility to any Pa range tested, suggesting that the environmental 
stiffness may affect cells in different ways. This investigation however, clearly suggests 
that for some cell types, the mechanical properties of the ECM can play a large role in the 
attachment and migration potential through environmental substrates. 
     The presence of specific ECM components within the cellular growth environments has 
also been implicated in enhancing cellular behaviours when grown on model 3D matrices. 
The presence of fibronectin in 3D collagen I gels in vitro has been implicated in increasing 
the cellular migration potential of Chinese hamster ovary (CHO) cells [412]. It was shown 
that in control collagen I substrates, CHO cells displayed delayed substrate attachment 
whilst retaining a spherical morphology up to 2 h post seeding. In contrast, those cells 
seeded onto matrices coated with fibronectin adopted a more characteristic flattened 
cellular morphology in this time frame. This observed difference in attachment potential 
was lost by the 24 h time point, by which time both cellular conditions displayed no 
significant difference in cell flattening. Interestingly, further observations in this study 
suggested fibronectin introduction did not display any significant effects on cellular 
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proliferation potential; however, it did appear to drastically enhance cellular penetration 
into the collagen I gel. After the initial 3 days of culturing, 12.4% of the CHO cells cultured 
with fibronectin were found integrated into the collagen matrix, whereas without the 
fibronectin presence, only 6.1% of the cells were found to have integrated into the gels.  
     Together, these investigations help to demonstrate that the composition of ECM 
microenvironments is able to help drive cellular behaviours. The introduction of fibroblast 
cells, known to secrete ECM components into surrounding microenvironments to 3D 
migration experiments conducted in this thesis may therefore help to infer similar protein 
environments closer to those found under normal biological conditions.  
 
4.1.2    Current In vitro models are able to accurately replicate the 
in vivo tissue conditions, allowing the assessment of cell 
migration and metastasis. 
 
     In the development of 3D in vitro models, a growing field is emerging to develop model 
systems that more closely reflect the cellular environment in primary tissue systems. The 
majority of this research focuses on the development of 3D models, which more 
accurately reflect tumour environments found within a variety of cancers [413, 414, 415], 
with aims to increase our understanding of the complex cellular defects leading to cancer 
development, as well as for use as drug screening models.  
     However, for the purpose of our investigations, we aim to look more closely at the 
migratory potential of keratinocyte cells across in vitro systems, which closely resemble 
normal human skin. Collagen gel systems appear to make up the vast majority of models 
in this area due to their close associations to the normal ECM found within human skin 
[416, 417]. The fibroblast mediated synthesis of protocollagen molecules into surrounding 
tissue environments in vivo, helps to provide physical and mechanical stability to the 
connective tissue within skin, acting like a scaffold to which other ECM components such 
as fibronectin and glycosaminoglycans can connect.  Current college matrices are aiming 
to replicate this scaffold environment to interstitially study cellular migration and invasion 
under controlled in vitro conditions [418, 419]. In each of these systems, re-organisation of 
the ECM equivalent collagen matrix was adapted to investigate the migratory potential of 
various cell types, in order to increase our understanding of the complex interplay of the 
role of cell-environment interactions on migratory behaviour.  
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Interestingly, current investigations are now expanding these models, with intentions to 
develop model matrix systems derived solely from cellular components. One such system 
has been able to produce a synthetic skin model via self-assembly of autologous cultured 
cells without the addition of exogenous antigenic growth factors or scaffold matrices, able 
to produce its own vascularisation [420]. This micro vascularised reconstructed skin model 
(MRS) was formed through the in vitro culture of neonatal HDF cells for 4 weeks, followed 
by the subsequent addition of HUVEC and keratinocyte cell sheets. The system was then 
moved to the air interface to allow keratinocyte differentiation. Using this developed 
system, the group was further able to investigate the migratory behaviour of melanoma 
cells within their vascularised environment [421]. They were able to show that not only did 
the melanoma display similar migratory characteristics as to those found in vivo, 
displaying migratory behaviour through the epidermal-dermal barrier, but was also able to 
re-organise the vasculature of the model system.  
     It can therefore be suggested that even though a vast array of in vitro models to 
assess cellular migration and metastatic potential exist, the production and re-organisation 
of ECM components through fibroblast function may provide more accurate 
representations of the in vivo system. With this in mind, we aim to co-culture human 
keratinocytes on a sub-population of human dermal fibroblasts, to assess cell penetration 
potential through a simplified dermal equivalent alongside the effects of fibroblast 
inclusion on both WT and DN HaCaT cell morphology and differentiation potential.   
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4.2    Chapter Aims.  
 
     This chapter aims to expand current understanding of both WT and DN HaCaT 
migration properties through the 3D culture environments assed thus far, by introducing a 
co-culture system of fibroblast cells. The introduction of HDF (Human Dermal Fibroblast) 
cells into both space-restrictive and non-restrictive scaffold systems allows the 
assessment of LINC disruptions on cellular penetration in a more ECM-rich in vivo like 
environment. Further to this, due to LINC roles in many aspects of cell biology including 
cell polarity, migration, cell-cell and cell-substratum attachment, we further aimed to 
assess its roles in epidermal tissue formation in vitro. To achieve this, histological 
techniques alongside immunofluorescence analysis will be applied to assess whether 
differences in penetration, alongside expression of known epidermal differentiation 
markers like K10 exist between WT and DN HaCaT cells in these systems.  
 
4.2.1    Objectives. 
 
 To assess the roles of LINC disruptions on cellular penetration potential through 
space-restrictive and non-restrictive 3D fibroblast-HaCaT co-culture scaffold 
systems. 
 
 To assess whether LINC disruptions affect stratification potential of HaCaT cells in 
co-culture in vitro systems.  
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4.3    Results. 
4.3.1    Fibroblast introduction into space-restrictive and non-
restrictive scaffolds reduces penetration potential of WT but not 
DN HaCaT cells. 
4.3.1.1    Human dermal fibroblasts colonise both scaffold environments 
within 14 days of growth. 
 
     Previous investigations in Chapter 3 were able to highlight that LINC disruption inferred 
a migration advantage in restrictive 3D growth systems. It was further shown that this 
migration advantage could be potentially attributed to a decreased nuclear stiffness. 
Current investigations therefore aimed to further assess the migration ability of LINC 
disrupted HaCaT cell in a further, more in vivo like migration model.  
     As keratinocytes and fibroblast cells display a complex array of intercellular 
interactions in human epidermis, alongside basement membranes forming a physical 
barrier to cell migration, current investigations aim to assess whether producing a 
simplified co-culture model of HDFs cultured alongside WT and DN HaCaT cells would 
stimulate altered phenotypes to those observed in Chapter 3.  
     Initially, a devised experimental plan incorporating the use of HDF cells alongside the 
WT and DN HaCaT cells into both scaffold environments was employed, displayed in 
Figure 4.2.  
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Figure 4.2: Experimental design for the fibroblast + HaCaT co-culture 
penetration assessment in both restrictive and non-restrictive scaffolds.  
 
 
 
     As described in Figure 4.2, both Alvetex® Scaffold and Alvetex® Strata  were seeded 
with 250,000 HDF cells, then left to grow under submerged conditions in standard growth 
media. Samples were then extracted and fixed at the 14 d time point and processed 
through H&E (Figure 4.3).  
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Figure 4.3: Non-restrictive Alvetex
®
 scaffold (A), and restrictive Alvetex
®
 
Strata (B) environments seeded with 250,000 HDF cells and grown for 14 
days under submerged culture conditions.  
 
 
 
 
     Figure 4.3 suggests fibroblast cells colonise the whole 200 µm area of both 3D 
scaffolds. The uniformity of fibroblast coverage appears to resemble that of WT HaCaT 
cells, displaying a reduction in cell density across central scaffolds regions. Interestingly, 
further observations highlight weak eosin staining of potential extracellular matrix 
components lining the surface of voids throughout the material, suggesting that fibroblasts 
appear to maintain normal cellular functionality, able to secrete large amounts of 
extracellular matrix components into their environment.  
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Figure 4.4: H&E staining of both WT (A) and DN (B) HaCaT cells in Alvetex
®
 co-cultures at 
2, 4, 6, 8, 10 and 14 day time points post HaCaT seeding. Scale bars = 100 µm. 
4.3.1.2    WT and DN HaCaT cells display reduced migration speeds in both 
restrictive and non-restrictive scaffold environments pre-seeded with 
fibroblasts. 
 
     Following successful fibroblast culture over the first 14 days, 250,000 WT and DN 
HaCaTs, respectively, were seeded to the fibroblast coated Alvetex® Scaffold and 
Alvetex® Strata environments. HaCaT cells were then left to grow in the co-culture for a 
further 14 day period under submerged growth conditions as described in both the 
methods and Chapter 3, with time points taken at 2, 4, 6, 8, 10 and 14 days of growth, 
allowing direct comparisons to previous observations in non-co-culture conditions to be 
made. H&E stained images for each time point of both WT and DN HaCaT cells in can be 
seen displayed in Figures 4.4 and 4.5.  
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Figure 4.5: H&E staining of both WT (A) and DN (B) HaCaT cells within Strata
®
 co-cultures 
at 2, 4, 6, 8, 10 and 14 day time points post HaCaT seeding. Scale bars = 100 µm. 
 
  
 
     Figure 4.4 displays both WT and DN HaCaT cells grown submerged in co-culture 
conditions across non-restrictive Alvetex® scaffold environments. It can be seen that both 
cell types are able to penetrate into the co-culture environment. WT HaCaT cells appear 
to display a 1-2 cell thick layer across the scaffolds surface from 6 d growth onwards. As 
no such layer was observed in the Alvetex only condition presented in Chapter 3, it can be 
suggested that fibroblast insertion may be creating a more restrictive environment. 
However, the most obvious difference observed in cell penetration between WT and DN 
HaCaT cells in this co-culture system comes between 10 and 14 d time points. It appears 
that to the 10 d time point, both cells express similar penetration potentials, however, 
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upon experiment completion after 14 days, DN HaCaT cells appear to have migrated 
through the full scaffold region, whereas WT HaCaT cells appear to migrate only half way 
through the full length of the scaffold.   
     Data presented in Figure 4.5 displays similar cell migration phenotypes as to that 
observed in non-restrictive co-culture conditions for both cell lines assessed. Initial cellular 
penetration for both WT and DN HaCaT cells appears to be reduced in comparison to the 
non-restrictive system, however, it again appears that the DN HaCaT cells were able to 
penetrate deeper into the scaffold at the 14 day time point in comparison to their WT 
HaCaT counterparts.  
     From this acquired data set alone, it is difficult to accurately assess WT and DN 
HaCaT penetration potential in both adapted co-culture systems due to the incorporation 
of a further fibroblast cell line. This makes it difficult to accurately select for keratinocytes 
or fibroblasts across the heterogeneous cell population using H&E staining alone. Due to 
this limitation, the use of immuno-fluorescence techniques was applied, in which staining 
for specific fibroblast markers and keratinocyte markers will allow the accurate 
quantification of HaCaT penetration into these 3D systems to be assessed. Sections from 
each time point were processed through immunofluorescence staining against keratin 14 
(K14; keratinocyte marker) and vimentin (fibroblast marker). Images for the 14 day time 
points can be seen displayed in Figure 4.6, displaying a representation of how we 
differentiated between the fibroblast and HaCaT cells across the same culture 
environment.  
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     Figure 4.6 highlights how K14 and vimentin staining allowed the specific localisation of 
HaCaT and fibroblast cells across the co-cultures. Interestingly, it is shown that when 
stained against vimentin, staining appeared to localise in front of the leading edge of 
HaCaT cells, across the opposite surface to that of seeding. When co-staining with K14, 
both WT and DN HaCaT cells are easily detected across the system. Regions of K14 
positive staining appears to be distinct from that of vimentin staining, leading to potential 
Figure 4.6: Immunofluorescence staining of DAPI (blue) and vimentin (yellow) in Alvetex
®
 
(A, B) and Strata
®
 (C, D) scaffolds for both WT and DN HaCaT cells at the 14 d time point. 
(E) and (F) display K14 (red)/vimentin (green) and DAPI co-staining in Strata
®
 Scaffolds. 
Scale bar = 20 µm.  
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Figure 4.7: Alvetex
®
 Scaffold co-culture penetration between WT and DN HaCaT’s over a 14 
days period post-seeding. This data is collated from across three independent repeats.  
suggestions that as the HaCaT cells migrate through the co-culture environment, they 
may be pushing the fibroblast cells through the scaffold. This would account for the 
distinct vimentin staining observed across the leading edge of migrating HaCaT cells.  
     As shown in Figure 4.6, the use of vimentin and K14 counter staining in the co-culture 
models allowed both WT and DN HaCaT cells to be distinguished from the heterogeneous 
population of cells. Using this staining, cell penetration was assessed across each time 
point, with collated data displayed in Figures 4.7 and 4.8.  
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Figure 4.8 Alvetex Strata
®
 co-culture penetration between WT and DN HaCaT’s over a 14 
days period post-seeding. This data is collated from across three independent repeats. 
 
 
     Data presented in Figure 4.7 suggests that over the first 8 days of growth, differences 
in cell penetration appear to be minimal between WT and DN HaCaTs, displaying 
migration of up to ~100 µm into the scaffold. Upon reaching 10 and 14 day time points, it 
appears that the DN HaCaT cells display an increased penetration potential compared to 
that of the WT HaCaT cells, able to migrate the full length of the scaffold in the 14 day 
experimental set up. This migration potential is not emulated by the WT HaCaT 
counterparts, which appear to display a reduced migration speed through this co-culture 
environment. Upon statistical analysis using a student’s t-test, significant differences were 
only observed between the WT and DN HaCaT penetration at 10 and 14 d time points 
when p ≤ 0.005. This data therefore suggests that the insertion of fibroblast cells into the 
non-restrictive Alvetex® Scaffold reduces the penetration potential of WT HaCaT cells 
compared to their LINC disrupted counterparts. 
     Alongside this, data presented in Figure 4.8 suggests that again, there is little 
difference between the WT and DN HaCaT cells penetration up to the 8 day time point, 
after which, the DN HaCaT cells appear to display an increased penetration potential to 
that of the WT HaCaT cells. Interestingly however, neither cell line was able to migrate 
through the complete 200 µm length of the co-culture scaffolds, suggesting that even in 
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Figure 4.9: Differences between WT and DN HaCaT penetration through Alvetex
® 
Scaffold 
and Alvetex
®
 Strata scaffolds, under single and co-culture conditions over a 14 days period 
post-seeding. 
this more restrictive scaffold environment, the fibroblast inclusion appears to reduce 
penetration potential of both cell lines compared to that of the non-restrictive scaffold 
environment. Further statistical analysis using a student’s t-test helps to show that the 
differences observed in scaffold migration across the 10 and 14 day time points were 
statistically significant where p ≤ 0.005.  
     As the collated data presented thus far suggests that the incorporation of fibroblasts 
into Alvetex® Scaffold and Alvetex® Strata environments appears to display clear 
differences between DN and WT HaCaT cell penetrations potential, we further compared 
migration potential across each scaffold between co-culture and single culture conditions 
conducted in chapter 3. The aim of this direct comparison is to more accurately assess 
the effects of fibroblast co-cultures on the migration potential of each cell line in each 
scaffold system, as displayed in Figure 4.9.  
 
 
     Data presented in Figure 4.9 suggest the introduction of fibroblast co-culture systems 
appears to have more drastic effects on WT HaCaT penetration in both restrictive and 
non-restrictive scaffold systems. The data presented in (A) highlights WT HaCaT 
penetration in non-restrictive scaffolds under single and co-culture conditions. These 
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experimental conditions present the most drastic differences observed, suggesting that 
the fibroblast introduction reduces migration speeds through the scaffold across each time 
point assessed. (B) Displays the same experimental set up with the DN HaCaT cells, 
showing again that the fibroblast introduction to non-restrictive scaffolds appears to 
reduce penetration speed. However, the DN HaCaT cells are able to penetrate the 
through the full length of the scaffold, suggesting that these cells may present a migration 
advantage over their WT counterparts. Data presented in (A) and (B) helps to suggest that 
the introduction of fibroblast cells to the non-restrictive scaffolds increases its 
restrictiveness to cellular migration. This could arise due to either the fibroblast cells or 
their ECM secretions adding a further layer of migration inhibition, forming a ‘barrier’ 
through which the HaCaT cells will have to migrate in order to penetrate further into the 
material.  
     Data presented in (C) and (D) highlights once again, that fibroblast introduction into 
restrictive scaffold environments appears to reduce migration potential for both WT and 
DN HaCaT cells compared to their single culture counterparts. Interestingly however, it 
can be seen that for DN HaCaT cells, the 2 day and 14 day time points appear to be 
similar between single and co-culture conditions. This suggests that even though 
significant differences between single and co-culture conditions are observed across the 
intermediate time points, DN HaCaT migration behaviour remains the same at the 
experimental beginning and end time points. This could suggest that these DN HaCaT 
cells may present adaptive behaviours, in which over time and exposure to the restrictive 
and potentially damaging environment, cells may adapt to their surroundings, and be able 
to migrate at a faster rate. However, to fully conclude this, further investigation would be 
required.  
     All of the differences observed were statistically quantified using a student’s t-test 
where p ≤ 0.005, suggesting statistical differences exist in migration potential between WT 
and DN HaCaT cells across both scaffold environments for single and co-culture systems.  
 
4.3.2    DN HaCaT cells display increased cellular stacking across 
the surface of co-culture Strata Scaffold systems. 
 
     Alongside differences in cell migration through the restrictive and non-restrictive 
scaffold systems upon co-culture formation, further investigations aimed to assess 
whether the introduction of fibroblast cells to the co-culture environments would affect the 
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morphology of cells stacking across surface scaffold regions for WT and DN HaCaT cells. 
Previous investigations suggested that the DN HaCaT cells displayed cellular stacking 
above the restrictive strata scaffold during air-liquid interface induction, with suggestions 
that the restrictive nature of the scaffold, coupled with cell polarity defects lead DN HaCaT 
cells to develop this phenotype. This experimental set up was therefore repeated with co-
culture systems in both restrictive and non-restrictive scaffolds.  
     HDF cells were cultured in both scaffold environments for 14 days as described 
previously, followed by seeding of WT and DN HaCaT cells, respectively. These HaCaT 
cells were grown submerged in culture for 4 days, followed by a further 8 days grown at 
the air-liquid interface. Images for both WT and DN HaCaT cells grown under these 
conditions can be seen displayed within Figure 4.10.  
     As suggested in Figure 4.10, DN HaCaT cells grown in non-restrictive co-culture 
conditions do not appear to undergo any cell stacking across surface regions (B), whereas 
WT HaCaT cells appear to produce a 1-2 cell thick layer (A). In contrast to this, restrictive 
Strata Scaffolds appear to induce no cellular stacking for the WT HaCaT cells (D), but a 
drastic cellular accumulation across the surface for DN HaCaTs (C), displaying cellular 
shape changes alongside cell flattening across the cell layer. Under closer observation, 
DN HaCaTs appear to display a layer of ~3-4 cells presenting a more cuboidal like cellular 
shape, with a flattened layer of 2-3 cells situated on top of these cells in the restrictive 
Strata co-culture conditions (E).   
     To further quantify these observed differences, the size of this cellular accumulation 
was analysed above the scaffold, with measurement techniques alongside collated data 
displayed in Figure 4.11.  
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Figure 4.10: H&E stained Alvetex
®
 and Strata
®
 co-culture scaffolds after 8 days at the air-
liquid interface. Images (A) and (B) display WT and DN HaCaT cells, respectively in Alvetex
®
 
Scaffolds. Images (C) and (D) represent DN and WT HaCaT cells in Strata
®
 Scaffolds 
respectively. (E) Displays increased magnification of DN HaCaT cells in Strata
®
 scaffolds. 
Scale bars = 50 µm. 
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Figure 4.11: (A) displays measurement technique used for the assessment of 
cellular stacking above the scaffolds seeding surface. Measurements were taken 
using the Image J software as described in chapter 3. (B) Represents graphical data 
of 375 measurements across 3 repeats, comparing cell surface thickness between 
WT and DN HaCaT cells in Strata
®
 scaffolds under single and co-culture conditions.  
 
 
 
 
           
Data presented in Figure 4.11 suggests that the calculated thickness for DN HaCaT cells 
in single culture Strata® Scaffolds were 14 µm, whereas the calculated thickness in the co-
culture system was shown to be ~59 µm. This suggests that the introduction of fibroblasts 
into restrictive scaffold systems stimulated an increased surface thickness of nearly five 
times. Further statistical quantification using a student’s t-test suggests this observed 
difference is statistically significant where p ≤ 0.005, showing that fibroblast introduction 
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stimulates an increase in cellular stacking across the scaffold surface. In contrast, it can 
be seen that no significant difference between the cellular stacking above Strata® 
Scaffolds can be seen for the WT HaCaT cells, between both single and co-culture 
conditions. A further statistically significant difference is further observed between WT and 
DN HaCaT cells grown on single culture systems using a student’s t-test where p ≤ 0.005, 
suggesting the DN HaCaT cells display an increased thickness of cell stacking.   
     The data presented in this section reveals that the introduction of fibroblasts to the 3D 
scaffold systems appears to affect the cellular stacking potential of DN HaCaT cells more 
than that of the WT HaCaT cells. The observed results could represent the effects of LINC 
disruptions stimulating a loss of cellular polarity in the DN HaCaT cells. This loss of 
directed cell migration, may allow the cells to migrate more freely in all directions without 
the effects of contact inhibition reducing cell stacking potential. Further to this, an 
increased cell crowding effect could also be an important factor in the observed 
phenotype. As both keratinocytes and fibroblasts colonise the surface voids in the 
material, the limited space available may for cell to migrate and proliferate in the only 
direction available, up. However, due to data from WT HaCaT observations in non-
restrictive co-cultures displaying no cell stacking, suggestions as to alternate signalling 
cues or environmental factors can be implicated due to the cellular stacking observed 
under co-culture conditions in the same scaffold, similar to that observed in keratinocyte 
differentiation and stratification.  
 
4.3.3    WT and DN HaCaT cells display varied expression patterns 
of differentiation markers across single and co-culture systems. 
4.3.3.1    Both WT and DN HaCaT cells express similar basal layer markers 
across both single and co-cultures scaffold systems. 
 
     To further investigate the observed stacking phenotypes displayed thus far, 
subsequent experimentation aimed to assess whether differences in known skin 
differentiation marker expression were present between the single and co-culture 
conditions. These investigations will therefore discern whether this observed cell stacking 
is indeed a result of differentiation as suggested in Chapter 3.  
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     Staining for the basal skin marker (K14) was initially used to assess whether any 
differences in expression could be seen across restrictive and non-restrictive, single and 
co-cultured conditions. This staining can be seen displayed in Figures 4.12 and 4.13.  
 
 
 Figure 4.12: Immunofluorescence staining of WT HaCaT cells for K14 (red) and 
DAPI (blue) across single (A, B) and co-culture (C, D), Alvetex Scaffold (A, C) and 
Alvetex Strata (B, D) systems. Scale bars = 25 µm.  
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      As displayed in Figure 4.12, WT HaCaT cells appear to show positive staining for K14, 
helping to distinguish these keratinocytes from the fibroblast cells in the co-culture. 
Alongside this, K14 expression appears to be reduced in Strata single culture conditions. 
However, accurate indications as to protein levels across individual cells cannot be 
ascertained through immunofluorescence alone, meaning further protein analysis through 
techniques such as western blotting would be required to verify this.  
     The data presented in Figure 4.13 suggests the DN HaCaT cells also stain positively 
for the K14 basal marker. Within the Alvetex scaffolds, expression appears uniform across 
all scaffold regions, in contrast however, cells across surface regions of restrictive Strata 
scaffolds appear to present an increased expression of K14 in both single and co-culture 
conditions.  
Figure 4.13: Immunofluorescence staining of DN HaCaT cells for K14 (Red) and 
DAPI (Blue) across single (A, B) and co-culture (C, D), Alvetex Scaffold (A, C) and 
Alvetex Strata (B, D) systems. Scale bars = 25 µm.  
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     Through this investigation it has been shown that limited variation in expression of K14 
is observed between WT and DN HaCaT cells under single and co-culture. This suggests 
that disruptions to the LINC complex expressed by the DN HaCaT cells do not appear to 
limit the expression profile of K14 markers. 
 
4.3.3.2    LINC disruptions stimulate increased cell differentiation across 
restrictive scaffold surface regions. 
 
     To expand on previous findings through K14 staining, following investigations aimed to 
assess whether cellular differentiation is occurring across the layer of observed cell 
stacking found in the restrictive strata scaffolds. To do this, the differentiation marker 
chosen was K10, allowing the detection of early keratinocyte differentiation from a basal 
like phenotype, to that closely resembling regions of the stratum spinosum. This resulting 
staining can be seen displayed in Figure 4.14 and 4.15.  
 
 
Figure 4.14: Immunofluorescence staining of WT HaCaT cells for K10 (red) and 
DAPI (blue) across single (A, B) and co-culture (C, D), Alvetex Scaffold (A, C) and 
Alvetex Strata (B, D) systems. Scale bars = 25 µm.  
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Figure 4.15: Immunofluorescence staining of DN HaCaT cells for K10 (red) and 
DAPI (blue) across single (A, B) and co-culture (C, D), Alvetex Scaffold (A, C) and 
Alvetex Strata (B, D) systems. Scale bars = 25 µm.  
 
 
 
     The data presented in Figure 4.14 suggests a low level of K10 expression can be seen 
across both single culture systems and the Strata co-culture system, suggesting the WT 
HaCaTs across these conditions are not undergoing early stages of cellular differentiation, 
often associated with skin stratification. Interestingly however, positive K10 staining is 
presented across the surface cell layer in the Alvetex scaffold co-culture system (C), 
suggesting that these cells are undergoing differentiation. This therefore helps to suggest 
that in the non-restrictive scaffold environment, fibroblast presence appears to stimulate 
cellular differentiation under an air-liquid interface.  
     Alongside these observations, Figure 4.15 displays further variations in K10 expression 
between experimental conditions. Initial observations suggest DN HaCaT cells display 
K10 positivity at varying degrees throughout the non-restrictive Alvetex scaffold under 
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both single and co-culture conditions. It can be further seen that in the more restrictive 
Strata Scaffold systems, K10 expression appears to be localised across the surface layer 
of cells where cellular stacking was previously observed. This observed signal appears to 
be further increased across the fibroblast co-culture condition in restrictive scaffolds, 
suggesting that the increased thickness of cell stacking could be a result of increased 
early stage cellular differentiation as a result of fibroblast influence. 
     Thus far investigations have shown that under varying experimental conditions, both 
the DN and WT HaCaT cells express early stage differentiation markers. For the WT 
HaCaT cells, this could derive from the associations established between keratinocytes 
and fibroblasts in the non-restrictive scaffold environments. Whereas for the DN HaCaT 
cells, the region of highest K10 expression are observed across surface regions of 
restrictive scaffolds, displaying high levels of cellular stacking. The introduction of 
fibroblast cells to these restrictive scaffolds appeared to stimulate an increase in K10 
expression in comparison to single culture counterparts. However, whether the expression 
of early differentiation markers by DN HaCaT cells in regions of increased cellular 
stacking is a causative or resulting factor of the cell stacking phenotype still remains 
unknown.  
 
4.3.3.3    Expression levels of YAP and E-cadherin correlate within regions of 
early differentiation for both WT and DN HaCaT cells. 
 
     One final avenue of investigation across these co-culture systems was to assess 
whether levels of E-cadherin and YAP expression are altered between WT and DN 
HaCaTs in restrictive and non-restrictive systems. YAP is a crucial component of the 
Hippo pathway, responsible for cellular proliferation and contact inhibition, suggesting that 
increased YAP signalling could indicate regions of altered contact inhibition. E-cadherin 
on the other hand was previously shown in Chapter 3 to display higher expression in 2D 
DN HaCaT cells, but equal levels between DN and WT HaCaT’s in 3D systems. 
Experimentation therefore aims to assess whether further expression variation is 
observed upon fibroblast introduction to both restrictive and non-restrictive 3D culture 
systems.  
     Under the same experimental conditions, double staining against YAP and E-cadherin 
was conducted as described in the methods. Resulting images from both WT and DN 
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Figure 4.16: Immunofluorescence staining of both WT (A, C and E) and DN (B, D and 
F) HaCaT cells for E-cadherin (Yellow), YAP (Red) and DAPI (Blue) across co-culture 
Alvetex
®
 Scaffold systems. Scale bars = 25 µm.  
HaCaT cells across each experimental condition can be seen displayed in Figures 4.16 
and 4.17.  
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Figure 4.17: Immunofluorescence staining of WT (A, C and E) and DN (B, D and F) 
HaCaT cells for E-cadherin (Yellow), YAP (Red) and DAPI (blue) across co-culture 
Strata
®
 scaffold systems. Scale bars = 25 µm.  
 
 
 
 
     The data provided in Figure 4.16 suggests that the WT HaCaT cells express reduced 
levels of E-cadherin expression compared to their DN counterparts. Alongside this, YAP 
expression appears to remain consisted across the full length of scaffold for both WT and 
DN HaCaT cells; however the DN HaCaT cells appear to display an increased nuclear 
accumulation in comparison to WT cells, however, due to these images representing Z 
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slices through the scaffolds, this cannot be fully concluded from these images due to it 
being unknown whether we are viewing peripheral or central cell areas. In contrast 
however, data presented in Figure 4.17 suggests that in restrictive Strata® Scaffold co-
cultures, E-cadherin expression appears to be much weaker for WT HaCaT cells in 
comparison to the DN HaCaT’s. Both cell lines express an accumulation of E-cadherin 
staining across the seeding surface of the scaffolds, with DN cells expressing higher 
levels. Of further interest is the co-staining with YAP in both WT and DN HaCaT cells. In 
regions of high E-cadherin expression, YAP expression appears to be reduced, seen most 
clearly in the DN HaCaT cells. In these cells, regions of intense E-cadherin staining further 
correlated with regions of increased cell stacking and differentiation. To fully assess this 
observed relationship between YAP and E-cadherin expression however, further protein 
quantification would need to be conducted through the use of western blot analysis.  
     This investigation has aimed to assess whether WT and DN HaCaT cells display any 
variations in YAP or E-Cadherin expression across the co-culture restrictive and non-
restrictive models. Through the use of immunofluorescence analysis, it is shown that WT 
HaCaT cells appear to express reduced levels of E-cadherin across both restrictive and 
non-restrictive co-culture systems compared to that of DN HaCaT cells. With further 
analysis suggesting that the observed accumulation of E-cadherin across the restrictive 
scaffold surface, correlated not only with regions of high cell stacking behaviour, but also 
with reductions in YAP expression. This observation suggests that the observed cell 
differentiation displayed by the DN HaCaTs in Figure 4.17 may be a result of complex 
interplay between cellular adhesion, cell proliferation and contact inhibition. However, to 
fully validate these observations, total protein expression would need to be assessed 
through western blotting techniques, as immunofluorescence analysis only provides an 
indication as to expression levels.   
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4.4    Summary of Experimental Findings. 
 
     This chapter has sought to investigate the effects of LINC complex disruptions on 
cellular migration in more in vivo like 3D culture environments. To implement this, a sub-
culture of HDF cells were inserted into both Alvetex® Scaffold and Alvetex® Strata. The 
insertion of dermal fibroblasts into these scaffold environments could potentially alter the 
chemical composition of the materials surface due to the production of ECM components 
by the fibroblast cells based on environmental stimuli [396]. This new chemical 
environments could potentially stimulate variations in cellular migration potential due to 
further suggestions as to chemical cross talk between endogenous keratinocytes and 
fibroblasts in in vivo skin environments [399]. Further aims in this chapter were to assess 
the effects implementing this co-culture system into both scaffold environments on 
keratinocyte behaviour across surface scaffold regions, more specifically, whether 
fibroblast incorporation was able to alter cell packing and keratinocyte differentiation 
potential. It has been well documented in the literature that fibroblast inclusion into 
keratinocyte cultures increases differentiation potential due to the cross talk between each 
cell line [422], with current evidence further suggesting that mesenchymal-derived signals 
are essential for correct epidermal morphogenesis, homeostasis and differentiation [423]. 
We therefore hypothesise that inclusion of these HDF cells will stimulate altered cell 
stacking phenotypes to those observed in Chapter 3.  
 
4.4.1    Fibroblast inclusion into both Alvetex® Scaffold and 
Alvetex® Strata environments reduces migration potential of WT, 
but not DN HaCaT cells. 
 
     Initial investigations were able to show that the human dermal fibroblast cells are able 
to colonise all regions of both the space-restrictive and non-restrictive scaffolds 
environments within a 14 d period. The ability of these fibroblast cells to migrate through 
the entire length of both the restrictive and non-restrictive environments comes as no 
surprise due to their mesenchymal cell origin. Mesenchymal cells often adopt spindle 
shaped morphologies, dependant on integrin mediated adhesion dynamics and high 
cytoskeletal traction forces, resulting in an increased plasticity to migration in more 
challenging environments [424, 425]. This is further exemplified through the classic 
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epithelial to mesenchymal transition (EMT) mechanism employed by many high-grade 
cancers to migrate from the tumour source, and through surrounding tissue to other bodily 
areas [426]. The exchange of E- for N- cadherin subtypes alongside protein expression 
variations of keratin proteins (often associated with epithelial cells) for vimentin allows 
cancer cells to alter their epithelial cell-cell adhesion junction composition to a more 
mesenchymal form, aiding the migration through surrounding tissues [427, 428].     
     Analysis of the scaffolds using standard histology stains highlighted the presence of 
weak eosin staining across the scaffold surface regions, potentially denoting ECM protein 
deposition in Figure 4.3. This staining could suggest the deposition of ECM components 
such as collagen, which could in turn, stimulate alterations to behaviour of HaCaT cells 
within these 3D scaffold environments as it is well noted in the literature that in vivo like 
microenvironments and ECM composition are key to in vivo like development and 
differentiation of keratinocytes in in vitro skin equivalent models [429]. However, the eosin 
component of this staining technique only provides a general stain for certain ECM 
components. To further validate whether fibroblast cells are indeed secreting ECM into 
their surrounding environments, further more specific staining techniques can be used 
including Masson’s trichome and Herovici staining techniques, allowing the differentiation 
between cells and ECM, alongside both young and mature collagen, respectively [430] 
[431]. Investigations could further employ the use of immunofluorescence analysis for 
targeted ECM components to increase our understanding of the ECM composition.   
     Following the establishment of a fibroblast sub-culture, both WT and DH HaCaT cells 
were seeded onto both space-restrictive and non-restrictive scaffold environments for 14 
days in submerged growth. Initial observations of the vimentin staining (used to display 
fibroblast cells in the environment) displayed in Figure 4.6, suggested that that the 
fibroblast cells were collecting across the bottom of both scaffold environments. When co-
stained with K14, it was further shown that this accumulation of vimentin staining can be 
seen to localise in front of the leading edge of HaCaT cells, providing potential 
suggestions that both HaCaT cells lines may be physically pushing the fibroblast cells 
deeper into the scaffold during their migration.  
     As the use of both K14 and vimentin staining in co-culture system allowed the accurate 
identification of HaCaT cells localisation in the scaffold environments, migration analysis 
was conducted to assess penetration potential between WT and DN HaCaT cells. The 
collated data presented in Figures 4.7 and 4.8 helps to show that in both scaffold systems, 
DN HaCaT cells display an increased penetration potential over the 14 day investigation. 
It was further shown that the only significant differences in penetration potential between 
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WT and DN cells were found at the 10 d and 14 d time points across both co-culture 
scaffold systems.  
     Interestingly however, when compared with single culture migration assessed in 
Chapter 3, it can be seen that the incorporation of fibroblast cells to both scaffold 
environments stimulates a significant impact on 3D cellular migration potential (Figure 
4.9). It can be seen that for the WT HaCaT cells, total migration potential in both restrictive 
and non-restrictive scaffold environments has been reduced through fibroblast 
incorporation, with cells being unable to migrate completely through the non-restrictive 
environments. This implies that the introduction of fibroblast cells to the system increases 
the restrictiveness of the Alvetex® Scaffold environment, more closely resembling those 
displayed by the space-restrictive Alvetex® Strata single cultures. The DN HaCaT cells 
also display a reduced migration potential during early time points in both scaffold 
environments. However, no significant differences between the final penetration distance 
displayed for both DN single and co-culture systems could be seen. This suggests that 
even though the ECM deposited by fibroblast cells potentially poses an increased 
restriction to cellular migration into the scaffolds, the DN cells are still able to migrate 
through these restrictive environments, potentially due to the increased nuclear 
malleability described in Chapter 3.  
 
4.4.2    Inclusion of fibroblast cells into both scaffold systems 
stimulates increased cell stacking across surface regions for WT 
and DN HaCaT cells under air-liquid interface conditions. 
 
     Although it was difficult to distinguish between HaCaT and fibroblast cells through H&E 
staining alone, closer observations of surface scaffold regions of these co-cultures under 
air-liquid interface conditions (Figures 4.10 and 4.11) display obvious phenotypic 
differences between WT and DN HaCaTs. It can be seen that the WT HaCaT cells grown 
in Alvetex® Scaffold co-cultures display a small layer of flattened cells above the scaffolds 
surface, alongside a much more compact cellular morphology. In contrast, when placed 
into the space-restrictive Strata® Scaffold, a similar cellular flattening phenotype can be 
observed alongside an obvious reduction in cellular penetration. These observations 
suggest that the introduction of fibroblast cells into these systems may infer an increase in 
restrictiveness, alongside potential fibroblast-keratinocyte communication, resulting in 
stratification events similar to that found in the epidermis [437].   
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     In comparison, the DN HaCaT cells displayed significant phenotypic differences under 
higher magnifications, including increased cell stacking alongside potential cell shape 
change associated with keratinocyte differentiation. It can be seen that in the Alvetex® 
Scaffold co-cultures, DN mutants colonise all regions of the scaffold, alongside producing 
a single cellular layer across the surface similar to that observed in WT cells in the same 
system. The DN HaCaT cells however, displayed an increased cellular accumulation 
across the surface, ~5-6 cells thick when grown in the more restrictive Strata® co-culture 
environments. Initial observations of this cellular stacking identifies cell shape changes to 
more cuboidal like phenotypes in regions closest to the scaffolds surface, slowly changing 
to a more flattened phenotype across cell surface regions. This observation could 
potentially arise from the fibroblast incorporation producing a more restrictive 
environment. Upon closer analysis, this increase in cellular stacking was increased 
fivefold compared to that found within the single culture systems.  
      
4.4.3    DN HaCaT cells display increased expression of keratin 
10, often associated with keratinocyte differentiation upon 
introduction to fibroblast co-culture systems. 
 
     Due to data thus far suggesting cell stacking is increased for DN HaCaT cells in space-
restrictive co-culture conditions in comparison to single culture conditions, further 
investigation aimed to assess whether differences in keratin differentiation markers could 
be observed across each culture systems between WT and DN HaCaT cells under air-
liquid interface conditions. Initial staining against the basal keratinocyte marker K14, 
displayed little variability between the WT and DN HaCaT cells grown in both the single 
and co-culture conditions (Figures 4.12 and 4.13). Due to these observations, it is 
suggested that the incorporation of fibroblast cells into each culture condition does not 
display any significant differences in K14 expression, suggesting that both HaCaT cell 
lines appear to maintain a basal like keratin expression profile [441]. However, as 
immunofluorescence analysis only provides an indication as to protein expression profiles, 
further western blotting would be needed to verify that no significant changes in K14 
expression is observed between each cell line in each experimental condition.  
     In contrast however, when stained for K10, a known early keratinocyte differentiation 
marker, differential expression patterns can be observed between both WT and DN 
HaCaT cells across single and co-culture systems. It can be seen that for WT cells, K10 
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expression appears to be very low across each scaffold condition other than the non-
restrictive co-culture system, in which specific K10 staining can be seen localised across 
the single layer of flattened cells situated across the scaffolds surface. This suggests that 
cells in these regions are undergoing early stages of the keratin differentiation as a result 
of fibroblast introduction. Interestingly, it is further suggested that the increased 
restrictiveness of the scaffold is a further contributing factor to this observed differentiation 
phenotype due to no presence of K10 staining observed in the non-restrictive scaffold co-
culture.  
     In comparison, DN HaCaT cells displayed an overall increase in K10 staining across 
each experimental condition. It was shown that in both the single and co-culture non-
restrictive Alvetex® Scaffold environments, K10 positive staining could be seen across all 
regions of the scaffold, however, its expression was not detected in every cell. Within the 
more restrictive Strata® Scaffold single and co-culture conditions, localised expression of 
K10 could be identified across the region of cellular stacking situated across the scaffolds 
surface. It is however difficult to discern whether this K10 accumulation across the 
scaffolds surface is in fact a causative or resulting factor of the cellular stacking, meaning 
that further experimental investigations would be required in order to validate potential 
mechanisms behind this observation. The results do however display some similarities to 
observations found in mice lacking the ABD domain of nesprin-2. In these mice, it was 
shown that significant epidermal thickening resulting from increased nuclear size in 
keratinocytes occurred, however no further alterations in differentiation or proliferation 
were shown [171]. These results suggest that the increased cell stacking and subsequent 
differentiation of DN HaCaT cells in co-cultured space-restrictive scaffolds may result from 
the LINC disruption altering nuclear shape. It was reported in Chapter 3 that the DN 
mutants display an increased nuclear height and that in restrictive Strata® Scaffolds, 
displayed cellular stacking. However, why the DN HaCaT cells display increased cellular 
stacking and differentiation potential in co-culture conditions is unknown thus far. It may 
result from further implications of LINC complex disruption to than that of maintaining NE 
integrity, which will require future investigation.   
     Final investigations aimed to assess the potential differences in E-Cadherin and YAP 
(Yes Associated Protein) expression across co-culture systems for both WT and DN 
HaCaT cells. E-Cadherin is a transmembrane protein involved in cell-cell adhesion 
whereas YAP is a crucial component of the Hippo signalling pathway, known control 
organ size through regulating cellular proliferation and apoptosis. YAP represents one of 
the mammalian orthologues of Yki (Yorki), which works in conjunction with TAZ (PDZ-
binding motif) to bind several transcription factors upon activation [443]. YAP has also 
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been shown to regulate the expression of both Hoxa1 and Hoxc13 genes [444], known to 
regulate gene expression, morphogenesis and cellular differentiation.  
     From our staining’s, it can be seen that in non-restrictive co-culture systems, WT 
HaCaT cells appeared to display low levels of E-cadherin staining across all scaffold 
regions, correlated with uniform YAP staining. In contrast however, the DN HaCaT cells 
appeared to display an increased E-cadherin expression, alongside a further increase in 
YAP expression (Figure 4.16). This increased E-cadherin expression for DN HaCaT cells 
could potentially infer the observed increased migration potential displayed in Figures 4.7 
and 4.8.  
     The data within this chapter suggests that introduction of fibroblast cells to the space-
restrictive and non-restrictive scaffolds are able to stimulate a reduction in cellular 
migration potential for WT HaCaT cells. Alongside this, the incorporation of HDF cells 
appears to stimulate the formation of drastic phenotypic differences in DN HaCaT cells as 
to those observed in single culture conditions as a potential result of alterations in YAP 
and E-Cadherin expression profiles. This therefore helps to suggest that the formation of a 
simplified skin model through fibroblast incorporation has shown that DN HaCaT cells 
retain their increased migration potential, whilst WT HaCaT cells display a reduction in 
penetration potential. This presents further support to the hypothesis that increased 
nuclear malleability in DN HaCaT cells may be the contributing factor to their increased 
penetration potential through restrictive 3D environments.  
     It was difficult however to assess whether the loss of LINC connections affected the 
cellular responses to potential ECM components secreted by the fibroblast during co-
culture conditions. To further investigate whether LINC disruptions present in DN HaCaT 
cells could alter cellular responses to these cues through loss of mechanotransduction 
mechanisms, application of fractionated western blot techniques allowing the separate 
assessment of both nuclear and cytoplasmic protein composition could be used. This 
would allow the assessment and quantification of transcription factor localisation in the cell 
such as YAP, helping to indicate whether cells are indeed sensing, and responding to 
external stimuli.  
213 | P a g e  
 
5. Assessing LINC protein roles in cancer 
progression and metastatic potential 
5.1    Introduction. 
      
     From roles in maintaining cell signalling pathways (e.g. mechano-transduction, MAPK, 
Wnt) [294, 295, 252, 9], chromatin organisation [296], chromosome movement [85] and 
DNA damage repair [161], LINC components display fundamental roles in maintaining the 
normal function of healthy tissues. Due to this wide ranging functionality within the cell, it 
is no wonder that the LINC complex plays suggested roles in multiple human diseases, 
including Emery-Dreifuss muscular dystrophy (EDMD) [176], hearing loss [184] and 
progeria [297]. Current understanding of roles for LINC components in cancer 
development however, is still not well understood. Present views suggest roles for nuclear 
deformability as a rate limiting step in cellular migration [266], to which SUN-KASH 
perinuclear interactions alongside the INM lamin network plays key roles in maintaining 
nuclear architecture. Further to this, a recent study has highlighted significant down 
regulation of SUN, nesprin and lamin proteins within high grade breast cancer tissues 
[203]. These findings suggest LINC components could potentially play fundamental 
pathological roles in breast cancer development. 
 
5.1.1    LINC roles in cancer development. 
 
     As the LINC complex displays connections to multiple disease phenotypes often 
characterised by nuclear abnormalities, it is not surprising that further roles in cancer 
development are also suggested due to many early diagnostic methods using nuclear 
structure as a prognostic tool [298]. One protein network key to maintaining LINC 
connections across the NE is the lamin network. This type V intermediate filament network 
situates across the INM in the form of highly ordered filamentous structures. B-type 
lamins, including lamin B1 and lamin B2, are encoded by the LMNB1 and LMNB2 genes 
respectively [299, 300]. It is interesting to note that limited mutations in B-type lamins are 
observed across a range of diseases, potentially due to these mutations leading to early 
lethality, shown through mouse knock-downs of lamin B1 and knock-outs of lamin B2 
[301, 20]. This suggests B-type lamins are essential to cellular function. Current work, 
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however, suggests potential roles for B-type lamins in the development of chromatin 
instability, often associated as a hallmark of cancer development [302]. Through shRNA-
mediated silencing of lamin B1 in cancer cell lines, it was shown that cells exhibited a 
delay within the S phase of the cell cycle. This delay was attributed to the stalling and 
collapse of replication forks, which in turn resulted in inefficient repair of double stranded 
DNA breaks. This inefficient repair resulted in persistent DNA damage signalling and 
assembly of extensive repair foci on the chromatin. This data, coupled with further 
investigation displaying lamin B1 interactions with promoters of DNA damage repair like 
BRCA1 and RAD51, suggests that the maintenance of lamin B1 is required for efficient 
DNA replication and repair.  
     In contrast, A-type lamins are encoded by a single gene, LMNA, which undergoes 
alternative splicing to generate the major A- and C- type lamins. The expression pattern of 
lamins is ubiquitous and developmentally regulated, with expression only detected within 
differentiated cells [26]. Due to their known roles in maintaining nuclear architecture and 
chromatin organisation, mutations in the LMNA gene stimulates a broad range of human 
diseases, collectively known as ‘laminopathies’ [28]. This group of mutations comprises of 
multiple clinical disorders, including several forms of muscular dystrophies, such as 
autosomal dominant (AD)-EDMD [303] and LMNA-related congenital muscular dystrophy 
(L-CMD) [304]. De-regulation of lamin expression levels have also been observed in 
various cancers. It has been reported that loss of lamin A/C expression can be seen within 
colon cancer [305], small cell lung cancer [306], leukaemias [307], ovarian cancer [308] 
and breast cancers [309, 24]. Interestingly however, overexpression of lamin A/C has 
been further reported in ovarian cancers [310], colorectal cancers [311], prostate cancers 
[312] and skin cancers [313]. This therefore suggests associations between lamin A/C 
expression and cancer severity involves a complex interplay of up and down regulations, 
which are not yet fully understood.  
     Alongside lamins, SUN proteins also display connections to the development of 
numerous disease phenotypes. SUN proteins localise to the INM through interactions with 
lamins and emerin [33, 66], enabling the formation of trimetric SUN structures [67]. These 
SUN trimers form probable hexametric complexes with three nesprin KASH domains 
across the perinuclear space, which is shown to recruit nesprins across the nuclear 
envelope [59]. This physical interaction provides a platform to transmit mechanical forces 
between the cytoskeleton and nucleoskeleton [57]. The implications of the localisation of 
SUN1 and SUN2 across the inner nuclear envelope, alongside its wide range of binding 
partners makes it a likely candidate for potential roles in diseases such as 
cardiomyopathies and X-linked EDMD [180, 250]. In both investigations, the phenotypes 
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produced upon dysregulation of lamin A/C or emerin respectively, affected SUN 
expression profiles. The cardiomyopathy phenotype was partially rescuable through the 
down regulation of SUN1, whereas in EDMD, SUN1/SUN2-emerin binding affinity was 
observed to be weakened. Further observations link SUN1 to the maintenance of genome 
integrity, through roles in regulating telomere tethering to the nuclear envelope during post 
mitotic nuclear assembly [314]. However, the neoplastic regulation and expression of 
LINC components, including SUN proteins, alongside their clinical significance within 
difference cancers is not yet fully understood.  
     To date, nuclear structural defects have been attributed to loss of lamin A/C expression 
within cells [309, 24]. However, Matsumoto et al. [203] was able to show that previously 
observed lamin A/C loss within various breast cancers, was accompanied by loss of 
further crucial LINC components, including nesprin-2. Nesprins are vertebrate spectrin-
repeat (SR) containing proteins, expressing an evolutionary conserved C-terminal KASH 
domain, able to maintain nuclear architecture through SUN-KASH perinuclear 
interactions. One hallmark of this protein family is its drastic variability in cellular function. 
Specifically, the SYNE-1 and SYNE-2 genes each have enormous complexity due to their 
multiple exon splice sites. The SYNE-1 gene for example displays a predicted 16 KASH 
containing and 14 ABD containing isoform variants within mammalian systems alone 
[177]. This large isoform variability leads to potential implications in the development of 
multiple disease phenotypes. Nesprin-1 and nesprin-2 have been implicated in a range of 
disease phenotypes including musculoskeletal diseases like EDMD and arthrogryposis 
multiplex congenita (AMC), alongside premature aging diseases [303, 178, 315].  
     Recent investigations are now implicating suggestive roles for nesprins in cancer 
development. High-throughput genome sequencing studies have identified nesprins as 
potential candidate genes [200, 316]. Alongside this, the SYNE-1 region has been 
identified as a susceptibility locus for breast and lung cancers [197], with SYNE-1 
promoter hypermethylation being shown to impair nesprin-1 expression in various lung 
cancer cell lines [199]. Further nesprin-1 polymorphism have also been associated with an 
increased risk of invasive ovarian cancer development [317]. Specific links to cancer 
metastasis have also been described, in which SYNE-1 genetic abnormalities are absent 
from pancreatic tumour sources, but present upon subclone metastasis to the liver and 
lungs [195]. This suggests mutations in the nesprin-1 gene may occur during metastasis. 
Further to this, mutations in the SYNE-2 gene have also been detected in breast cancers 
[200]; leading to suggestions that nesprins may play further roles in cancer development.  
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     The exact mechanisms by which nesprins and alternate LINC complex components 
contribute to the development of cancer phenotypes are thus far, unknown; however, 
suggestions are emerging that nuclear stiffness could be a rate limiting factor in cellular 
migration. Coupled with knowledge that the nucleus is the stiffest organelle, alongside 
nesprin roles within maintaining nuclear architecture and integrity, it has been suggested 
that these nesprin mutations allow an increase in nuclear malleability. These mutations in 
turn, may allow cells to penetrate through the restrictive tissue environments, enabling 
intravasation and extravasation [318].  
 
5.1.2    Current understanding of breast cancer development and 
metastatic mechanisms. 
 
     Worldwide, breast cancer is the most common cancer form within women, displaying a 
reported 1.68 million new cases diagnosed in 2012 alone. Mortality attributed to breast 
cancer is currently the second leading cause of death for women in developed regions 
[319]. Of tissue systems in both males and females, the breast region is one of the most 
susceptible to genetic instability, arising through permanent mutations in tumour 
suppressor genes and proto-oncogenes. This increased susceptibility arises due to 
delayed tissue maturation until the completion of the first full term of pregnancy. Within 
this un-differentiated breast tissue, it has been shown that binding affinity to carcinogens 
is increased, leading to increased potential of mutations arising from DNA damage.  
     In normal breast pathology, tissue consists of epithelial and stromal components, with 
the milk producing ductolobular system forming from a dual layered epithelium, resting on 
a basement membrane (basal lamina) enveloped by stroma. Both normal and cancerous 
pathology of breast tissue can be seen in Figure 5.1, highlighting the observed differences 
in cellular organisation upon cancer development. 
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Figure 5.1: Pathological examples of normal breast tissue (A) and high grade triple 
negative breast tissue (B). Images highlight loss of normal tissue structure as a result of 
uncontrolled proliferation. Scale bars = 100 µm 
 
 
 
 
     As shown in Figure 5.1, one hallmark of breast cancer development is the uncontrolled 
cell proliferation, leading to a loss of structural organisation arising from mutations in 
oncogenes or tumour suppressor genes.  
     Oncogenes refer to genes through which inappropriate activations can lead to cancer 
development, one of which includes HER-2, often displaying gene amplification upon 
cancer development. This amplification leads to increased levels of signalling cascades 
though a variety of cellular signalling pathways, including the mitogen activated protein 
(MAP) kinase and Phosphodyl Inositol 3-kinase (PI3K)/Akt pathways, leading to increase 
cell motility, apoptosis resistance and metastasis [320]. Alongside oncogenes, mutations 
in tumour suppressor genes can also stimulate uncontrolled cell growth and increased 
cancer malignancies, such as that found upon abnormal p53 expression.  p53 is 
considered a guardian of the genome, responsible for maintaining DNA integrity via 
regulating DNA damage repair, able to halt cellular proliferation until the acquired DNA 
damage is repaired, or apoptosis is activated. Mutations in p53 make up the most 
common genetic abnormality within breast cancer, with links to poor prognosis [321] and 
estrogen receptor (ER) negativity [322].  
     A further hallmark within high grade breast cancer development is the development of 
uncontrolled cell cycle progression, induced by dysregulation of cyclin-dependant kinases 
(CDKs). When activated, CDKs promote phosphorylation of target proteins such as 
retinoblastoma proteins (pRb), a primary gatekeeper controlling cell cycle passage from 
resting G0 to active cycling states and mitosis. These CDKs are regulated positively by 
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cyclins and negatively by cyclin dependent kinase inhibitors (CKIs). Of specific importance 
within breast tissue is the function of cyclin D1. Cyclin D1 is known to oscillate in 
expression levels according to the stage of the cell cycle, playing key roles in cell cycle 
progression from the G1 to S phase [323]. This protein is found to be overexpressed in 40-
50% of invasive breast cancers [324], with further evidence suggesting that high cyclin D1 
expression levels can be positively correlated to ER positivity and increased proliferation 
rates [325, 326], similar to those phenotypes expressed within many high grade breast 
cancers.    
     As highlighted so far, a multitude of hallmarks are present within breast cancers, 
resulting from alterations in cell cycle progression as a result of oncogene mutations. The 
development of breast cancers can be grouped into different stages, depending on tumour 
size, tissue occupation and metastatic properties. The specific staging category assigned 
to individual tumours depends on the combination of these factors. A simplified example 
of breast cancer tumour staging can be seen displayed within Figure 5.2 and Table 5.1.  
 
 
 
Figure 5.2: Pathological examples of each stage in breast cancer development, 
alongside associated severity of each stage.  
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     As can be seen, a multitude of categories exist based on tumour phenotypes, 
migration patterns and metastatic potential. Cancer severity can also be influenced by 
regions of cancer development within the breast and alternate bodily regions post 
metastasis. This complexity in phenotypic expression patterns is leading current research 
to investigate potential markers specifically altered within breast cancer, to not only devise 
targeted therapies, but also monitor and track the invasive nature of cancers post 
metastasis, with aims to increase patient prognosis.  
 
5.1.3    Current understanding of breast cancer migration and 
applications of 3D scaffold environments. 
 
     The high mortality rates associated with many cancer forms derives not only from the 
source and site of primary tumour formation, but also from the ability of the tumour cells to 
invade surrounding tissue environments and metastasise to distant bodily areas [327]. 
One major model by which cancer cells are proposed to acquire their invasive motility is 
through the epithelial-mesenchymal transition (EMT), characterised by the exchange of 
epithelial markers such as E-cadherin for mesenchymal markers like N-Cadherin and 
vimentin [328]. In breast cancers, the core EMT gene signature is associated with the 
claudin-low molecular subtype, displaying reduced expression levels of tight and adherens 
junction proteins [329]. This subtype is most prevalent in highly aggressive triple negative 
breast cancers (ER-, PR-, HER2-), which often display poor prognosis for the patient. 
Table 5.1: Defined breast cancer staging categories through tumour development.  
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However, these claudin low subtypes of breast cancer are also the least common 
subtype, accounting for ~12% of tumours [330]. This suggests that even though the core 
EMT phenotype is present in some aggressive breast cancer forms, the majority of human 
breast cancers do not express this core EMT signature. The correlated assumption that E-
cadherin levels are uniformly lost within cancerous tissues due to this EMT transition 
means that cell cohesion within many breast cancer tumours is often overlooked.  
     Current investigations now suggest E-cadherin expression levels vary significantly 
between histological subtypes. With ~75% of all breast cancer cases deriving from 
invasive ductal carcinomas [331], it is interesting to note that membrane E-cadherin 
expression levels are absent in <10% of these tumours [332]. Further evidence also 
suggests membrane E-cadherin levels within metastatic breast cancers is equal to, or in 
some cases higher than that found within the primary tumour source [333]. Taken 
together, these investigations suggest breast tumours are typically cohesive; expressing 
membrane bound E-cadherin in both primary and metastatic tumour sources. This 
potentially implicates strong cell-cell interactions, leading to breast cancer cells migrating 
as a collective unit.  
     Over the past few years, multiple theories of how breast cancer cells are able to 
cohesively migrate from the tumour source to distant bodily areas have been proposed,  
including the fibroblast leader’s model and cancer cell leader’s model. Employing novel 
3D scaffold environments, these suggested theories display the attachment of breast 
cancer cells to either stromal fibroblasts (which are intrinsically mesenchymal and excel in 
extracellular matrix remodelling) [334], or cancer cells expressing high levels of metastatic 
markers [335, 336] as a means of metastasising from the primary tumour site. Further 
suggestive roles for macrophage-tumour cell interactions are also proposed, due to 
macrophage accumulation at the site of tumour inflammation being closely linked to a 
decrease in patient prognosis [337]. Using 3D Matrigel models, two potential mechanisms 
by which tumour cells can use macrophages to exit the tissue source are suggested. For 
one mechanism, macrophages remodelling of the extracellular matrix is suggested to form 
channels in the tissue, through which tumour cells can migrate and leave the source 
tissue [338]. Alongside this, a second mechanism using an in vitro intravasation model, 
displayed that direct interactions between macrophages and tumour cells triggered RhoA 
dependent invadopodia formation in the tumour cells, leading to migration through the 
endothelium [339].  
     This collated data therefore helps to highlight the variable complexity displayed by 
breast cancers upon metastasis, alongside current attempts to gain insights into these 
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mechanisms using novel 3D environments. It is however suggested that due to limitations 
in current 3D technologies available thus far, these technologies are unable to provide 
clinical grade observations, comparable to those found within mouse models used to 
study the invasive nature of cancerous tumours.  
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5.2    Chapter Aims. 
 
     This chapter aims to characterise both expression levels and architectural positioning 
of selected LINC complex proteins across a range of breast cancer cell lines. To achieve 
this, multiple analysis techniques including western blotting, immunofluorescence, primary 
tissue staining and plasmid transfections will be used. From this it is aimed to provide 
insights into potential roles of LINC complex proteins in the development of metastatic 
phenotypes.  
 
5.2.1    Objectives. 
 To assess expression levels and arrangement of various LINC components across 
a range of breast cancer cell lines.  
 
 To assess differences in migration potential across a range of breast cancer cell 
lines through restrictive 3D growth environments. 
 
 To establish whether migration behaviour of low and high grade breast cancer 
lines can be altered through alterations in SUN-KASH interactions and nuclear 
architecture. 
 
 To assess whether nesprins could provide a novel target for highly metastatic 
breast cancer grading. 
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5.3    Results. 
5.3.1   LINC complex components vary drastically across low-, 
medium- and high-grade breast cancer cell lines. 
5.3.1.1    LINC expression levels vary drastically between different cancer 
cell lines. 
 
     LINC components are suggested to play multiple cellular roles, affecting cell migration 
in both 2D and 3D culture systems, alongside nuclear and cellular stiffness. In multiple 
cancers, metastasis is the leading cause of mortality, in which cells migrate from the 
source tissue to alternate areas of the body. Although multiple mechanistic phenotypes 
have been suggested to contribute to this process, we suggest that nuclear malleability is 
a crucial factor in allowing the cell to ‘squeeze’ through surrounding tissue environments. 
With links between LINC components and nuclear stiffness, initial pilot investigations were 
conducted to assess LINC proteins expression across various cancer cell lines.  
     Lysates were produced as described in the methods section, from; MCF7 and MDA-
MB-231 cell lines (low- and high-grade breast cancer cells, respectively), SW480 and 
SW620 cell lines (low- and high-grade colorectal cancer cells, respectively), and HeLa 
cells (representing high grade cervical cancer cells). The human keratinocyte HaCaT cell 
line was further included as well as the monkey kidney fibroblast COS7 cell line as non-
cancerous controls. Initial data for LINC protein expression levels can be seen in Figure 
5.3.   
     Figure 5.3 suggests variations exist between LINC complex components assessed 
across varying cell lines. Interestingly, expression levels of β-actin, lamin A/C and SUN1 
appear to remain constant across each cell line. In contrast, variable expression is 
displayed for nesprin-2 and Nup88 levels, in which for both proteins, expression levels 
appear to reduce in the high-grade cancers. This data, coupled with centrin, emerin and 
lamin B staining showing further sample variability, suggests that LINC components do 
appear to vary drastically between cancer cell lines. However, due to the complexity of 
differences observed, it is difficult to discern whether any functional relationships can be 
seen whilst using limited numbers of samples from numerous cancer sources.  
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Figure 5.3: Western blot data for LINC complex proteins across a 
range of both cancerous and non-cancerous cell lines.  
 
 
 
5.3.1.2    Standard equal loading markers display variable expression 
patterns across breast cancer cell lines. 
 
     As suggested in section 5.3.1.1, the selected LINC components analysed appear to 
vary drastically across the cell lines assessed, however, it is difficult to discern whether 
these differences exist due to the variability in cancer grades, or due to the natural 
expression variability between tissue sources (i.e. colorectal expression of LINC 
components may vary to that of breast epithelium). To further characterise LINC 
component roles in the development of high-grade cancers, further investigations were 
conducted, with aims to characterise LINC complex protein expression patterns and 
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cellular positioning in breast cancer. To do this, we employed six cell lines representing 
various breast cancer grades. As controls, we used MCF 10A and MCF 12A cell lines, 
alongside MCF7, HCC-38 and T47D lines to represent low to medium grades. The MDA-
MB-231 cell line was used as a triple negative (PR, ER and HER2 negative) breast cancer 
representative, displaying highly metastatic properties in both in-vitro and in-vivo 
environments.  
     Lysates were produced and run through SDS-PAGE to separate proteins based on 
weight. Equal loading was assessed through Coomassie Blue staining to visualise total 
protein levels in each sample, as shown in Figure 5.4.  
 
 
 
     As shown in Figure 5.4, the protein loading is constant between each lane, with slight 
variability arising from natural protein expression differences across each cell line. To 
validate equal loading, further western blot analysis was conducted for three standard 
equal loading markers, β-tubulin, β-actin and GAPDH, with resulting staining displayed in 
Figure 5.5.  
Figure 5.4: Coomassie Blue staining of breast cancer cell lines 
following SDS-PAGE.  
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Figure 5.5: Western blot data for equal loading markers (A) Displays western blot 
staining observed. (B), (C) and (D) represent collated densitometry analysis across 
three repeats for each protein.    
 
 
  
     The data presented in Figure 5.5 suggests equal protein loading is present across the 
majority of samples. Interestingly for both β-tubulin and GAPDH, the T47D cell line 
displays a reduction in protein expression, which initially suggests that less protein is 
present within this sample. Subsequent β-actin analysis however, displays that lower 
protein levels can be found within the HCC-38 cell line, whereas as the T47D cells now 
present equal protein levels. These observations suggest variability exists between 
standard equal loading markers across the cancer cell lines. However, when combined 
with Coomassie Blue staining, the three standards do suggest equal loading has been 
achieved. 
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5.3.1.3    Cytoskeletal protein positioning and expression levels vary 
between low-, medium- and high-grade breast cancer cell lines.  
 
     Once equal loading was established, cytoskeletal component expression levels were 
assessed due to their known roles regulating cell/nuclear migration and nuclear stiffness. 
These cytoskeletal proteins analysed include intermediate filament, microtubule and actin 
components. To assess whether cellular localisation defects arise within these 
cytoskeletal components from increasing cancer severity, immunofluorescence analysis 
was performed on 70% confluent MCF 10A, MCF7 and MDA-MB-231 cell lines. Initial 
actin staining across these cell lines can be seen in Figure 5.6. 
     The data displayed in Figure 5.6 suggests that variations exist in actin organisation 
across these cancer cell lines. It is shown that control MCF 10A cells display actin 
localisation evenly throughout the cytoplasm and across the nuclear and cellular 
periphery. These observations can also be seen in the MCF7 cells, however, there does 
appear to be a more prominent nuclear absence of actin. In contrast to both the MCF 10A 
and MCF7 cell lines, the high-grade MDA-MB-231 cells appear to express the majority of 
their actin components across the cellular periphery in filapodia. Closer inspection of this 
observation is shown in more detail in Figure 5.7. 
     As shown in Figure 5.7, MDA-MB-231 cells appear display the majority of their actin 
across peripheral cell projections, potentially aiding their well characterised increase 
migratory potential. It is further shown that MCF7 cells appear to accumulate actin across 
cytoplasmic regions, producing a defined ring of actin around the NE. The MCF 10A cells 
appear to display an even distribution of actin between regions of the cytoplasm and cell 
periphery. When coupled with β-actin expression levels presented in Figure 5.5, our data 
suggests that variation in organisation, but not protein expression is observed between 
the low-, medium- and high-grade breast cancer cell lines. 
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Figure 5.6: TRITC-conjugated phalloidin (Red) stained MCF 10A (A, A’, A’’), MCF7 (B, B’, B’’) 
and MDA-MB-231 (C, C’, C’’) cells displaying F-actin organisation. Nuclei were further stained 
with DAPI (Blue). Scale bars = 10 µm.   
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Figure 5.7: TRITC-conjugated phalloidin (Red) stained MCF 10A (A, A’), MCF7 
(B, B’) and MDA-MB-231 (C, C’) cells displaying F-actin organisation. Nuclei were 
further stained with DAPI (Blue). Scale bars = 10 µm.   
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     As previous data suggests the actin cytoskeletal organisation appears different 
between control, low- and high-grade breast cancer cells, further investigations aimed to 
assess whether differences were present between MT and IF networks, with resulting 
images displayed in Figures 5.8 and 5.9.  
 
 
  
 
Figure 5.8: β-tubulin (Red) stained MCF 10A (A, A’, A’’), MCF7 (B, B’, B’’) and MDA-MB-
231 (C, C’, C’’) cells displaying microtubule organisation. Nuclei were further stained with 
DAPI (Blue). Scale bars = 10 µm.   
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     Figure 5.8 displays microtubule network organisation across the three breast cancer 
cells analysed. It appears that under closer observation, no difference is observed in 
organisation across the cells, suggesting that the microtubule network organisation 
remains unaltered across the range of cell lines investigated. In contrast, Figure 5.9 
suggests variation exists in cytokeratin organisation across these cells. It appears that the 
MCF7 cells display a more defined organisation of cytokeratin distributed throughout the 
cytoplasm compared to the MCF 10A cells. The MDA-MB-231 cells however, appear to 
display a more nuclear envelope specific accumulation of cytokeratin, with further 
observation suggesting these cells express lower levels in comparison to MCF7 and MCF 
10A cells.  
     To further investigate the observed differences in IF and microtubule organisation, 
western blotting technique was applied to assess whether these fluorescence 
Figure 5.9: Cytokeratin (Red) stained MCF 10A (A, A’, A’’), MCF7 (B, B’, B’’) and MDA-
MB-231 (C, C’, C’’) cells displaying cytokeratin organisation. Nuclei were further stained 
with DAPI (Blue). Scale bars = 10 µm.   
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observations correlated to variations in protein expression levels across a range of breast 
cancer cell lines. Collated western blot staining is displayed in Figure 5.10.  
 
 
 
 
     Data presented in Figure 5.10 suggests that IF and gamma-tubulin expression varies 
across the range of cell lines analysed (ANOVA, F8.2536 = 4.64, P = 0.010 and F7.1138 = 3.98, P = 
Figure 5.10: Western blot staining for cytoskeletal proteins across breast cancer cells. 
(A) Displays western blot staining observed. (B), (C) and (D) display collated 
densitometry analysis across three repeats for each protein.    
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0.010 respectively). Using post hoc F-tests, it was shown that vimentin expression appears 
to be significantly increased in MDA-MB-231 cells, whereas cytokeratin expression 
appears to significantly reduce in the high-grade MDA-MB-231 when compared to their 
low-grade MCF7 counterparts (where p ≤ 0.001). This correlates with observations in 
immunofluorescence staining, in which MCF7 cells displayed a greater level of 
cytoplasmic organisation to that of both the MCF 10A and MDA-MB-231 cells. Further 
variability is also observed in gamma tubulin levels, suggesting a significant reduction in 
the low-grade MCF7 and HCC-38 cell lines (ANOVA, F7.3125 = 4.01, P = 0.010, followed by F-
test post hoc analysis where p ≤ 0.001), suggesting contrasting results to that observed 
for β-tubulin expression levels in Figure 5.5.   
     The use of both fluorescence and western blotting analysis techniques suggests that 
although differences can be observed between cytoskeletal networks across low- and 
high-grade breast cancer cells, the variability observed makes it difficult to approach any 
solid conclusions. However, observations were able to suggest that a correlation may 
exist between decreased expression levels of IF proteins such as cytokeratin, alongside 
an increase in vimentin levels, and increased metastatic phenotypes. This appears to 
support current views in the literature which suggest that increased vimentin expression is 
associated with characteristic EMT transition [340] and subsequent metastatic potential. 
Further evidence however suggests that further investigation will be needed to verify this 
finding, as it has been documented that 2D growth environments may stimulate cancer 
cell lines to alter their protein expression patterns [341]. It was shown that MCF7 cells 
were shown to decrease vimentin expression levels when placed into novel 3D culture 
systems. This suggests further factors may also be influencing protein expression profiles 
across each cell line, other than just the cancer grade.     
 
5.3.1.4    LINC associated proteins situated across the INM display variability 
in expression patterns across breast cancer cell lines. 
 
     To further examine LINC complex connections to breast cancer development, further 
investigations aimed to assess localisation and expression levels of select INM proteins, 
known to display LINC complex associations. Initial experimentation aimed to investigate 
whether SUN protein positioning was displaced across breast cancer cells of varying 
pathological grades. To assess this, immunofluorescence analysis using a LEICA SP5 
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confocal microscope was conducted for both SUN1 and SUN2 in MCF 10A, MCF7 and 
MDA-MB-231 cell lines, the result of which can be seen in Figures 5.11 and 5.12.  
     Data presented in Figures 5.11 and 5.12 suggest that both SUN1 and SUN2 
expression remains localised across the NE. SUN1 localisation appears to remain 
consistent between the control and low-grade cells across NE regions, with an apparent 
increase in intra-nuclear staining observed for the MCF 10A cells. However for the high-
grade MDA-MB-231 cells, it appears that expression of SUN1 increases in cytoplasmic 
regions of the cell. SUN2 however, displays no variation in cell positioning across each 
cell line assessed. Staining for SUN proteins also reveals one further cancer hallmark, an 
increase in nuclear deformities upon cancer progression, as the high-grade MDA-MB-231 
representative cell line displays significant abnormalities in nuclear shape to that of control 
and low-grade counterparts.   
 
 
Figure 5.11: SUN1 (Red) stained MCF 10A (A, A’, A’’), MCF7 (B, B’, B’’) and MDA-MB-
231 (C, C’, C’’) cell lines displaying inner nuclear envelope organisation. Nuclei were 
further stained with DAPI (Blue). Scale bars = 10 µm.   
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Figure 5.12: SUN2 (Red) stained MCF 10A (A, A’, A’’), MCF7 (B, B’, B’’) and MDA-MB-
231 (C, C’, C’’) cell lines displaying inner nuclear envelope organisation. Nuclei were 
further stained with DAPI (Blue). Scale bars = 10 µm.   
 
 
 
 
     Alongside SUN protein localisation, further analysis of lamin A/C and lamin B 
positioning across the INM was assessed. Much of the literature suggests that lamin A/C 
expression levels vary between low- and high-grade cancers, whereas lamin B levels 
remain constant. Aims were therefore to assess whether their topographical positioning in 
control, low- and high-grade cell lines  through immunofluorescence staining, results of 
which can be seen displayed in Figures 5.13 and 5.14.  
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Figure 5.13: Lamin A/C (Red) stained MCF 10A (A, A’, A’’), MCF7 (B, B’, B’’) and MDA-
MB-231 (C, C’, C’’) cell lines displaying inner nuclear envelope organisation. Nuclei were 
further stained with DAPI (Blue). Scale bars = 10 µm.   
     The data presented in Figures 5.13 and 5.14, suggest that the localisation of both 
lamin A/C and lamin B appear to remain constant across the NE between control, low- 
and high-grade breast cancer cells. However, it can once again be seen that lamin A/C 
and lamin B staining highlights the drastic nuclear deformities present in the high-grade 
MDA-MB-231 cell lines in comparison to the low-grade and control cells.  
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     Following staining against SUN and lamin proteins across the INM, we further aimed to 
assess whether further variability existed in emerin protein localisation across control-, 
low- grade and high-grade breast cancer cell lines. Images of this staining can be seen in 
Figure 5.15. 
     The data presented in Figure 5.15 suggests that emerin organisation, like that of the 
lamin A/C and lamin B, appears to remain consistent across the NE of breast cancer cells 
assessed, displaying specific localisation to the NE. It can be seen however, that some 
intra-nuclear staining is observed in control MCF 10A cells but not in MCF7 or MDA-MB-
231 cells, potentially suggesting miss-localisation of emerin upon cancer development.  
Figure 5.14: Lamin B (Red) stained MCF 10A (A, A’, A’’), MCF7 (B, B’, B’’) and MDA-MB-
231 (C, C’, C’’) cell lines displaying inner nuclear envelope organisation. Nuclei were 
further stained with DAPI (Blue). Scale bars = 10 µm.   
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Figure 5.15: Emerin (Red) stained MCF 10A (A, A’, A’’), MCF7 (B, B’, B’’) and MDA-MB-
231 (C, C’, C’’) cell lines displaying inner nuclear envelope emerin organisational 
differences. Nuclei were further stained with DAPI (Blue). Scale bars represent 10 µm.   
 
 
 
 
     Next we used western blotting to quantitatively compare expression levels of lamins, 
SUNs and emerin across the varying grades of breast cancer cell lines (Figure 5.16).  
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 Figure 5.16: Western blot analysis of INM proteins across breast cancer cell lines. (A) 
Displays western blot staining observed. (B), (C), (D), (E), (F) and (G) displays collated 
densitometry analysis across three repeats for each protein.    
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     Figure 5.16 suggests that variability can be seen between INM protein expression 
across the breast cancer cells assessed. It is shown that expression of SUN1 and Lamin 
B1 remain consistent across the various cancer grades, with little variability observed 
between samples. However, variability between SUN2 levels can be seen across the 
ranging breast cancer cells, in which significant up regulation in T47D cell lines are 
observed, alongside a significant reduction in expression across MCF 10A and MCF7 cell 
lines (ANOVA, F5.3752 = 3.56, P = 0.010 followed by subsequent F-test post hoc analysis where 
p ≤ 0.001). Although variability is observed, it is difficult to discern if correlations exist 
between SUN2 expression levels and cancer progression due to the differential 
expression patterns displayed between control cell lines. This variation in protein 
expression across control cells could arise due to the unique history of the cells. Although 
from the same tissue region, these cells were isolated from different patients of differing 
ages (60 year old and 35 year old), suggesting that patient variability, alongside genetic 
changes resulting from cell line establishment, may stimulate protein expression profiles 
which vary between cells from the same tissue region.   
     Further observations suggest lamin B1 expression levels also appear to display 
significant variability across the samples (ANOVA, F6.5488 = 2.92, P = 0.010). Further post hoc 
F-test analysis where p ≤ 0.001 suggests lamin B2 expression appears to be significantly 
upregulated in MCF 12A and MDA-MB-231 cell lines compared to MCF 10A and MCF7 
cell lines, suggesting that lamin B1 expression could be associated with late stage 
development of cancerous phenotypes. It is further shown that variability in lamin A/C and 
emerin expression patterns also exists, in which lamin A/C is significantly upregulated in 
MCF 12A cells (ANOVA, F3.6388 = 4.95, P = 0.010, followed by subsequent F-test post hoc 
analysis where p ≤ 0.001), whereas emerin is significantly upregulated within the MCF7 
cells (ANOVA, F4.2379 = 3.62, P = 0.010, followed by F-test post hoc analysis where p ≤ 0.001). 
     Thus far, collated data suggests that LINC components associated to the INM display 
differential variability across the breast cancer cells analysed. However, this variability 
appears to display little correlation to the specific cancer grade, suggesting these 
observed differences may be a result of downstream effects from further cellular 
alterations, which remain thus far undetected.  
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5.3.1.5    Nesprin proteins display drastic variability between control and 
cancerous breast cell lines.  
 
     Following observations in Chapter 3, in which LINC complex disruptions stimulated a 
reduction in nuclear stiffness alongside increased migration potential through restrictive 
scaffolds, current investigations aim to characterise nesprin protein organisation alongside 
expression levels across a range of breast cancer cell lines. At first, immunofluorescence 
analysis for nesprin-1’s ABD domain (staining all nesprin-1 isoforms retaining the N-
terminal ABD region) was conducted, to assess whether correlations exist between 
cellular localisation and cancer progression. Data from this staining is displayed in Figure 
5.17.  
 
  
Figure 5.17: Nesprin-1 (ABD) (Red) stained MCF 10A (A, A’, A’’), MCF7 (B, B’, B’’) and 
MDA-MB-231 (C, C’, C’’) cell lines displaying Nesprin-1 isoforms containing the N-
terminal ABD domain. Nuclei were further stained with DAPI (Blue). Scale bars = 10 µm.   
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     Data shown in Figure 5.17 suggests nesprin-1 ABD staining appears to be in closer 
associations across defined cellular regions which could correlate to the ER in MCF 10A 
cells, compared to low and high grade breast cancer representative cells. In MCF 10A and 
MCF7 cells, nesprin-1 ABD staining appears specifically localised to the NE with diffuse 
cytoplasmic staining. In the MDA-MB-231 cells however, staining reveals a potential loss 
in direct NE staining, with resulting images displaying a punctate staining pattern across 
cellular regions potentially correlating to ER. These observations could potentially suggest 
that expression levels of nesprin-1 ABD domain containing isoforms could be lost under 
cancer progression, resulting in the more diffuse staining observed in the MCF7 and 
MDA-MB-231 cells lines, however, quantitative protein analysis techniques would be 
required to verify this, such as PCR and western blotting approaches.   
     As the nesprin-1 ABD fluorescence staining suggests a potential variability in 
organisation across breast cancer samples, further protein analysis was performed to 
investigate whether correlations could be seen with protein expression levels. This will 
allow the assessment of whether observed alterations in nesprin-1 ABD localisation is a 
direct result of miss-localisation across the NE, or a result of variability in ABD containing 
isoform expression differences across the breast cancer lines. Resulting western blot 
analysis alongside staining for both nesprin-1 N- and C-terminal region is displayed in 
Figure 5.18. 
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Figure 5.18: Western blot data for Nesprin-1 C-terminal KASH and N-terminal ABD 
domains across breast cancer cell lines. (A) Displays western blot staining observed. (B), 
(C), (D) and (E) represent collated densitometry analysis from across three repeats.    
 
 
 
 
     The data presented within Figure 5.18 suggests significant variability in nesprin-1 
isoform expression levels does exist across the range of breast cancer cell lines (ANOVA, 
F5.1165 = 3.91, P = 0.010). It can be seen that across the 1000 kDa giant nesprin-1 isoform, no 
observable relationships can be discerned. However, when observing the lower isoforms 
of nesprin-1 N- and C-terminal regions (<250 kDa), it appears that the lower nesprin-1 
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Figure 5.19: Nesprin-2 C-terminal (Red) stained MCF 10A (A, A’, A’’), MCF7 (B, B’, B’’) 
and MDA-MB-231 (C, C’, C’’) cell lines displaying isoforms containing the C-terminal 
KASH domain. Nuclei were further stained with DAPI (Blue). Scale bars = 10 µm.   
isoforms are expressed to a significantly higher level within the two non-cancerous control 
cell lines for isoforms exhibiting both C-terminal and N-terminal regions using post hoc F-
tests where p ≤ 0.001. Alongside this, levels appear to significantly reduce upon cancer 
development, suggesting that the lower isoforms for nesprin-1 could be a potential factor 
within the development of cancerous phenotypes, rather than the more commonly 
analysed GIANT isoform.  
     Following these observations, further investigations aimed to assess whether similar 
organisation and expression trends existed for alternate KASH proteins across breast 
cancer cell lines. To do this, immunofluorescence studies were performed using 
antibodies against N and C-terminal nesprin-2 epitopes, from which data can be seen 
presented in Figures 5.19 and 5.20.   
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     The data presented in Figures 5.19 and 5.20 suggest that some organisational 
differences exist between the cancer cells assessed for nesprin isoforms containing the C-
terminal KASH domain but not the N-terminal ABD domain. It is shown that the C-terminal 
staining appears to become more cytoplasmic as the cancer grade increases, with the 
control MCF 10A cells displaying specific nuclear envelope staining and MCF7 and MDA-
MB-231 lines expressing increasing cytoplasmic distribution. In contrast, nesprin-2 N-
terminal ABD localisation retains mainly specific NE localisation across each cell line.  
 
Figure 5.20: Nesprin-2 N-terminal (Red) stained MCF 10A (A, A’, A’’), MCF7 (B, B’, B’’) 
and MDA-MB-231 (C, C’, C’’) cell lines displaying isoforms containing the N-terminal ABD 
domain. Nuclei were further stained with DAPI (Blue). Scale bars = 10 µm.   
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Figure 5.21: Nesprin 2 C-terminal (Red) stained MCF 10A (A, A’, A’’), MCF7 (B, B’, B’’) and 
MDA-MB-231 (C, C’, C’’) cell lines. Displaying increased cytoplasmic staining as cancer 
grade increases. Nuclei were further stained with DAPI (Blue). Scale bars = 10 µm.   
     To validate observations suggesting nesprin-2 C-terminal regions appears to become 
more cytoplasmic as the breast cancer grade increases, quantitative analysis of pixel 
intensities across the whole length of MCF 10A, MCF7 and MDA-MB-231 cell lines was 
performed, to assess cell regions in which staining could be observed. Images alongside 
graphical data collated from across triplicate measurements of 50 cells are displayed in 
Figures 5.21 and 5.22.  
 
 
 
  
 
247 | P a g e  
 
 
 
 
  
     From the data presented within Figures 5.21, it is suggested that nesprin-2 C-terminal 
staining (antibody binding to the last two SRs that precede KASH domains) appears to 
disperse from the nuclear envelope within high grade breast cancer cell lines, stimulating 
an increase in cytoplasmic staining. Further pixel mapping data displayed in Figure 5.22, 
highlights that in both control and low grade breast cell lines (A and B), pixel intensity 
appears to peak at the NE, followed by a reduced signal correlating to central nuclear and 
cytoplasmic regions. In contrast, MDA-MB-231 cell lines display an increase in 
cytoplasmic signal retention, whilst retaining low expression levels within central nuclear 
regions. (D) Further supports this observation, suggesting a significant increase in 
cytoplasmic accumulation of nesprin-2 C-terminal staining in the MDA-MB-231 cells 
(ANOVA, F4.2253 = 5.09, P = 0.010). It can therefore be suggested that the localisation of 
nesprin-2 C-terminal KASH domain isoforms may be disrupted within high-grade breast 
cancers, leading to a potential dissociation from the nuclear envelope into the surrounding 
cytoplasm.   
Figure 5.22: Pixel intensity map of Nesprin-2 C-terminal stained MCF10A (A), MCF7 (B) 
and MDA-MB-231 (C) cell lines. Images display pixel intensity across the whole cell. Arrows 
display nuclear envelope staining regions. (D) Displays percentage NE/cytoplasmic nesprin-
2 C-terminal staining, collated from across 50 cells of each cell line, repeated three times.  
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Figure 5.23: Western blot data for Nesprin-2 C-terminal KASH and N-terminal ABD domains 
across breast cancer cell lines. (A) Displays western blot staining observed. (B) and (C) 
represent collated densitometry analysis across three repeats for each protein.    
     To further assess whether observed organisational differences between control, low 
and high grade breast cancer cells were due to disruptions in protein interactions, or 
alterations in protein expression levels, further western blot analysis was conducted. 
Staining against nesprin-2 N- and C-terminal regions alongside quantification analysis can 
be seen in Figure 5.23.  
 
 
 
 
     Figure 5.23 suggests that similar trends to that observed within nesprin-1 isoform 
analysis can be seen in which the lower nesprin-2 isoforms are down-regulated in the 
cancerous cell lines in comparison to control cell lines. It is shown that the GIANT 
isoforms of nesprin-2 situated at 800 kDa display limited variability across the breast 
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cancer cell lines for N-terminal ABD domain. However, significant variability is observed 
across the C-terminal KASH domain isoform expression levels, in both high and low 
isoform variants (ANOVA, F4.5387 = 4.12, P = 0.010). Further post hoc analysis through the 
application of F-tests where p ≤ 0.001 suggests the most obvious of these differences is in 
the reduction of lower nesprin-2 isoforms in cancerous cell lines, in which little to no 
expression of lower C-terminal containing isoforms are detected across the cancerous cell 
lines. This data, coupled with fluorescence analysis could suggest that lower C-terminal 
KASH containing isoforms of nesprin-2 could provide a potential anchor for the larger 
nesprin-2G isoform across the NE. This is suggested due to breast cancer cell lines 
displaying a reduced expression of these lower isoforms, alongside an increased 
cytoplasmic accumulation of nesprin-2 C-terminal staining. This nesprin diffusion from the 
NE to cytoplasm could result in a loss of nuclear stiffness due to a disruption in LINC 
connections across the NE (Chapter 3). This resulting loss of nuclear stiffness may in turn 
aid in the development of metastatic behaviours, due to suggestive evidence linking 
nuclear stiffness to cancer metastasis [272].  
     Following observations for nesprin-1 and nesprin-2 isoforms, further assessment of the 
KASH containing protein nesprin-3 cell positioning across different breast cancer grades 
was conducted. Cells were stained for nesprin-3 as described in the methods section, 
from which data can be seen, displayed in Figure 5.24.  
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Figure 5.24: Nesprin-3 stained MCF 10A (A, A’, A’’), MCF7 (B, B’, B’’) and MDA-MB-231 
(C, C’, C’’) cell lines. Nuclei were further stained with DAPI (Blue). Scale bars = 10 µm.   
 
 
 
     Data displayed in Figure 5.24 suggests no obvious localisation differences are 
observed for nesprin-3 across the control, low grade and high grade breast cancer cell 
lines. The staining suggests specific nesprin3 localisation across the NE and potential ER, 
with no intra-nuclear staining.  
     Further analysis of nesprin-3 and nesprin-4 expression levels across a range of breast 
cancer cell lines was then conducted, with aims to investigate whether correlations exist 
between nesprin-3/-4 expression levels and cancer progression. Experimental data 
alongside densitometry analysis is displayed in Figure 5.25.  
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Figure 5.25: Western blot data for nesprin-3 and nesprin-4 expressions across breast cancer 
cell lines. (A) Displays western blot staining observed. (B) and (C) displays collated 
densitometry analysis across three repeats for each protein. Arrows highlight predicted 
bands correlating to nesprin-3 and nesprin-4 respectively.    
 
 
 
 
     The data presented in Figure 5.25 suggests that significant variability is observed 
across the range of breast cancer cell lines for both nesprin-3 (ANOVA, F6.2188 = 3.62, P = 
0.010, followed by subsequent F-test post hoc analysis where p ≤ 0.001) and nesprin-4 
(ANOVA, F4.5365 = 4.32, P = 0.010, followed by subsequent F-test post hoc analysis where p ≤ 
0.001) isoform expression levels. For nesprin-3, it can be seen that both the full length 
isoform can be seen (~120 kDa) alongside a lower isoform variant. To assess nesprin-3 
expression across each cell line, densitometry analysis was performed across the whole 
252 | P a g e  
 
lane for each cell line. Aside this, nesprin-4 staining displayed the expected band at ~42 
kDa, however, further non-specific staining was also observed. These further detected 
isoforms may be a result of non-specific antibody binding, or not yet characterised 
nesprin-4 isoforms. To maintain objectivity, the total signal from within each lane was 
assessed, as in the nesprin-3 analysis. Although significant differences are observed 
however, the variations do not appear to correlate with increased cancer severity. This 
therefore suggests the observed variability in nesprin-3 and nesprin-4 expression patterns 
may arise from cell specific variation, rather than the cancer severity.  
 
5.3.1.6    Further proteins involved in maintaining cell polarity, nuclear 
architecture and cell-cell interactions display variability across breast 
cancer cell lines. 
 
     Due to levels of nesprin-1 and -2 isoforms decreasing upon increasing cancer cell line 
severity, further investigations aimed to assess the expression patterns of known 
associated proteins to nesprin-1 and -2, alongside known cancer markers across a range 
of breast cancer cell lines. Western blot staining was performed against centrin and 
pericentrin (known centrosome markers), E-cadherin and lap2α (proteins involved in 
maintaining cell-cell adhesion and cell-cycle regulation/chromatin organisation 
respectively) and p53 (a protein known to play roles in cancer progression). Data from this 
investigation is shown in Figure 5.26.  
     Figure 5.26 suggests further significant differences can be observed for pericentrin 
expression across the range of breast cancer cells; however, this variability in expression 
does not appear to correlate with an increase in cancer severity (ANOVA, F3.2669 = 3.01, P = 
0.010, followed by subsequent F-test post hoc analysis where p ≤ 0.001). However, for 
centrin, it appears that protein expression increases from control, to low then high grade 
cell lines (ANOVA, F3.0021 = 2.92, P = 0.010, followed by subsequent F-test post hoc analysis 
where p ≤ 0.001). This observed correlation however is not true for all cell lines assessed, 
as the T47D and HCC-38 cell lines (representing medium grade cancers) display reduced 
centrin levels, further suggesting that these observations may be cell specific rather than 
cancer grade specific.  
     Alongside these observations, it is further shown that levels of both p53 and lap2α 
proteins increase as the cancer severity increases. Highest p53 expression is observed in 
medium and high grade breast cancer cells, whereas lap2α expression peaks in all 
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Figure 5.26: Western blot data for LINC associated proteins and known cancer marker 
expression across breast cancer cell lines. (A) Displays western blot staining observed. (B), 
(C), (D), (E) and (F) displays collated densitometry analysis across three repeats for each 
protein.    
cancerous cells. Protein expression levels for E-cadherin also vary drastically across the 
range of cell lines assessed, with lowest expression observed in MCF 12A and MDA-MB-
231, representing control and high grade breast cancers respectively suggesting 
variability in E-cadherin expression may be cell line specific.  
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     These observations therefore suggest that correlations can be seen between lap2α 
and p53 expression levels and cancer severity. However for the further LINC associated 
proteins analysed it is difficult to discern whether expression levels correlate to the breast 
cancer severity, potentially due to further variables in alternate gene/protein expression 
patterns specifically present within each cell line.  
 
5.3.1.7    Nuclear pore complex proteins display differential expression 
patterns across a range of breast cancer cell lines. 
 
     As previous data presented in Chapter 3 suggests loss of SUN-KASH connections 
across the perinuclear space stimulates alterations in nuclear architecture, further 
investigations aimed to assess positioning and expression levels of known nuclear pore 
complex proteins. The nuclear pore complex, alongside the LINC complex plays an 
important role in maintaining nuclear architecture, helping to form anchor points 
connecting inner and outer nuclear membranes. As data thus far suggests LINC complex 
disruptions lead to a decrease in nuclear stiffness, and that specific LINC components 
such as lower nesprin isoforms appear to be down regulated in high grade cancers, 
further work aims to investigate whether NPC variations also exist in high grade breast 
cancers, and whether NPC defects could be crucial components for the development of 
highly metastatic phenotypes.  
     Initial investigations aimed to assess the organisation of select NPC proteins across 
control, low grade and high grade breast cancer cell lines using immunofluorescence 
techniques. Cells were stained for Mab414 (NPC marker) and Nup88 (NPC protein) as 
described within the methods, with resulting staining displayed in Figures 5.27 and 5.28.  
255 | P a g e  
 
Figure 5.27: Mab414 (Red) stained MCF 10A (A, A’, A’’), MCF7 (B, B’, B’’) and MDA-MB-
231 (C, C’, C’’) cell lines. Images display NPC organisation across the NE. Nuclei was 
further stained with DAPI (Blue). Scale bars = 10 µm.   
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Figure 5.28: Nup88 (Red) stained MCF 10A (A, A’, A’’), MCF7 (B, B’, B’’) and MDA-MB-231 
(C, C’, C’’) cell lines. Nuclei were further stained with DAPI (Blue). Scale bars = 10 µm.   
 
 
 
     Data presented in Figures 5.27 and 5.28 suggest that the organisation of Mab414 and 
Nup88 across the range of breast cancer cells appears to remain consistent. It is shown 
that Mab414 displays specific NE staining across control, low and high grade cell lines. In 
contrast, Nup88 staining displays both NE and cytoplasmic staining (potentially correlating 
with ER) across all cell lines analysed. One observed difference however, is a possible 
increase in cytoplasmic staining of Nup88 in high grade MDA-MB-231 cells, however, 
further protein analysis would need to be conducted to verify this.   
     As it is difficult to assess whether protein expression levels are indeed altered within 
the cell lines based on immunofluorescence staining alone, further western blot analysis 
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for Mab414 (antibody targeted against FG nucleoporins) and Nup88 protein expression 
levels was conducted. This will allow the verification as to whether the observed 
differences from Figure 5.28 are indeed due to an increase in Nup88 expression, or due to 
abnormalities in protein organisation. This western blot analysis can be seen displayed in 
Figure 5.29.  
 
 
 
     The data presented in Figure 5.29 suggests significant variability exist between 
expression profiles of both Mab414 (ANOVA, F4.1152 = 4.13, P = 0.010, followed by subsequent 
F-test post hoc analysis where p ≤ 0.001) and Nup88 (ANOVA, F3.6498 = 3.23, P = 0.010, 
Figure 5.29: Western blot data for NPC protein expressions across breast cancer cell 
lines. (A) Displays western blot staining observed. (B) and (C) represent collated 
densitometry analysis across three repeats for each protein.    
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followed by subsequent F-test post hoc analysis where p ≤ 0.001) across the range of 
breast cancer cell lines. However, it is difficult to discern whether correlations exist 
between the variability in expression levels and grade of cancer, suggesting that the 
observed protein expression differences may be a result of cell specific variability. 
Mab414 expression appears to remain constant across the ~70 kDa band, which can be 
potentially identified as Nup62 in each sample. Further to this, the band displayed in MCF 
10A and MCF 12A at ~50 kDa could represent Nup50, showing reduced expression upon 
cancer progression. Of further interest is the band expressed at ~35 kDa, in which 
expression is only present in low and medium grade breast cancer cell lines, suggesting 
that expression profiles of this protein may correlate to early stages of cancer progression, 
before high grade metastasis develops.  In contrast, Nup88 levels appear to display 
reduced expression in MCF7 cells. This data further supports observations from Figure 
5.28, in which Nup88 cytoplasmic accumulation appeared to be constricted in MDA-MB-
231 cells, suggesting this observation is due to increased Nup88 expression observed in 
MDA-MB-231 cells compared with MCF 10A and MCF7 cell lines.   
 
5.3.1.8    Heat shock protein expression displays variability across breast 
cancer cell lines.   
 
     To further investigate potential links between observations highlighted thus far, and 
stress signalling pathways linked closely to cancer development, following investigations 
aimed to analyse expression levels of known chaperones, including HSP27, CRYAB and 
GFAP. These investigations therefore aim to increase understanding of links between 
cancer severity, nesprin expression and chaperone expression patterns within breast 
cancer. Western blotting across the range of breast cancer cell lines was conducted with 
multiple antibodies against CRYAB and HSP27, alongside a single antibody for GFAP. 
Results obtained from this western blot data can be seen displayed in Figures 5.30 and 
5.31.  
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Figure 5.30: Western blot data for heat shock protein expressions across breast cancer 
cell lines. (A) Displays western blot staining observed. (B), (C) and (D) displays collated 
densitometry analysis across three repeats for each protein.    
Figure 5.31: Western blot data for heat shock protein expressions across breast cancer 
cell lines. (A) Displays western blot staining observed. (B), (C) and (D) displays collated 
densitometry analysis across three repeats for each protein.    
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     From data presented in Figures 5.30 and 5.31, variations in chaperone expression can 
be seen (ANOVA, F4.3789 = 5.62, P = 0.010). For both CRYAB antibodies used the predicted 
band correlating to ~16 kDa was the assessed using densitometry, suggesting that 
expression appears to significantly decrease upon cancer development when post hoc F-
tests were applied where p ≤ 0.001. However, further bands were also observed at higher 
kDa (Detected by the 3148-CRYAB), but due to the potential of these bands being 
unspecific binding, they were not assessed. However, these bands could also represent 
differences in protein variants arising from gene mutations expressed within each cell line, 
leading to alterations in post-translational modifications of the proteins.  
     Further to this, HSP27 protein expression is also shown to vary across the breast 
cancer cells (ANOVA, F5.2679 = 4.82, P = 0.010). The predicted band at ~20 kDa was assessed 
for densitometry. The data suggests expression appears to remain consistent in MCF7 
and T47D cells in comparison to control cells. Alongside this, expression patterns using 
the ACD5-HSP27 antibody appear to significantly decrease in the MDA-MB-231 and 
HCC-38 cell lines in comparison to the control cell lines when subjected to post hoc F-test 
analysis where p ≤ 0.001.  
     Alongside these two chaperones, GFAP expression also displayed variation across the 
breast cancer cell lines assessed. For the purpose of densitometry, total protein in each 
lane was compared due to known differences in isoform expression between cell lines. It 
is shown that expression patterns presented in both control cell lines differ to that 
expressed within cancerous lines. MDA-MB-231 cells appear to display a loss of detected 
GFAP, with remaining cell lines displaying expression of alternate molecular weight 
bands. These observations could arise due to the varying cancer grades expressing 
different GFAP isoforms [342]; however, this would need further investigation through 
PCR and western blot analysis against known GFAP isoforms to confirm.  
     These investigations have aimed to characterise LINC protein expression levels and 
organisation across a variety of breast cancer cell lines. Through the use of 
immunofluorescence and western blotting techniques, it is suggested that between the 
ranges of control, low- and high-grade breast cancer cell lines analysed, variations are 
observed across multiple LINC components. However, many of these observed 
differences do not directly correlate to and increase or decrease in the cancer grade, and 
therefore may be a result of cell specific expression patterns.  
     One interesting observation however, was found in nesprin-1 and -2 protein expression 
patterns. It was shown that lower nesprin-1 and -2 isoforms decrease in low/high cancer 
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cell lines in comparison to the two control lines. This is also correlated to an increase in 
cytoplasmic staining for the nesprin-2 C-terminal KASH domain as the grade of cancer 
increases. This observation, coupled with data presented in Chapter 3 suggests nesprin 
proteins may hold functional roles within the development of cancerous phenotypes such 
as metastatic properties. This data therefore suggests further investigation is needed into 
the potential roles of nesprin-1 and nesprin-2 (specifically the lower isoforms) in the 
development of cancerous phenotypes.  
 
5.3.2    Control, low- and high-grade breast cancer cell lines 
express differential migration potential through restrictive 3D 
environments. 
 
5.3.2.1    High-grade MDA-MB-231 breast cancer cell lines display enhanced 
migration through restrictive 3D scaffolds compared to control MCF10A and 
low-grade MCF7 cells.   
 
     When collated data thus far is linked to data presented in Chapter 3; suggesting LINC 
disruptions decrease nuclear stiffness and increase migration potential through restrictive 
3D scaffold, it can be hypothesised that the loss of these lower nesprin-1/-2 isoforms 
could be a potential causative factor to the observed migration potential of multiple 
cancers due to suggestions that nuclear stiffness is a rate limiting step in migration 
through 3D environments [272]. To investigate this, current investigations aim to assess 
control, low and high grade cancer migration potential through restrictive 3D Strata 
scaffolds, to observe if differences exist. MCF 10A, MCF7 and MDA-MB-231 cells were 
grown within individual Strata® scaffolds and maintained submerged in normal growth 
media for 14 days as described in the methods section. Scaffolds were fixed at the 2, 4, 6, 
8, 10 and 14 d time points to assess penetration rate, with the resulting data displayed in 
Figure 5.32.  
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    The data presented in Figure 5.32 suggests MDA-MB-231 cells display a significantly 
increased migration potential through restrictive Strata® Scaffold environments compared 
to control and low grade counterparts. It is shown that MDA-MB-231 cells were able to 
migrate through the full scaffold length between the 2 and 4 d time points, whereas the 
MCF7 and MCF 10A cells penetrated a maximum of 50 µm into the scaffold by the 14 d 
time point. Further observations also suggest MCF7 cells displayed a faster migration 
potential over the first 6 days of growth in comparison to MCF 10A cells, with both cell 
lines then displaying a reduction in scaffold penetration when ~50 µm penetration was 
achieved. Through the use of a student’s t-test, we were able to show that the observed 
differences in migration potential between MCF 10A and MCF7, alongside MCF 10A and 
MDA-MB-231 were statistically significant when p ≤ 0.005 across all-time points except 14 
d. At this time point, no significant difference between scaffold penetrations could be seen 
between the MCF 10A and MCF7 cell lines.   
     The data presented in this investigation therefore suggests that the high grade MDA-
MB-231 cell lines display an increased migration potential through the restrictive 3D 
Strata® scaffolds compared to the low grade MCF7 and control MCF 10A cell lines. One 
potential contribution to this could be an increased nuclear malleability within the high 
grade MDA-MB-231 cells due to their altered nesprin distribution and expression levels 
highlighted in Figures 5.17 – 5.23. 
Figure 5.32: Cell penetration of MCF 10A (Control), MCF7 (Low grade) and MDA-MB-231 
(High grade) cancer cell lines through restrictive Strata
®
 scaffold environments. Data 
represents collation of measurements from across three independent repeats.    
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5.3.2.2    MCF7 and MDA-MB-231 breast cancer cell lines display similar cell 
phenotypes in restrictive 3D scaffolds.  
 
     Thus far, data suggests as the cancer grade increases, the cellular migration speed 
through restrictive Strata scaffolds also increases, however it is unclear as to whether any 
further differences between low and high grade breast cancer cell lines exist. Protein 
expression analysis suggests lower nesprin-1/-2 isoforms expression decreases in high 
cancerous cell lines compared to controls (Figure 5.18 and 5.23), however little variation 
is observed between the cancerous cell lines. Therefore to further investigate why such a 
drastic difference between low and high grade breast cancer penetration exists, high 
powered TEM and SEM analysis on both 2D and 3D grown MCF7 and MDA-MB-231 cell 
lines was conducted, with aims to decipher whether any differences in migration 
behaviour and cellular/nuclear shape could be observed.  
     Initial investigations aimed to assess whether cell surface properties varied between 
the two cell lines, in both 2D and multiple regions of the 3D scaffolds through SEM 
analysis. Cells were grown for 6 days, fixed and imaged as described in the methods 
section on both 2D silicon chips and in 3D space-restrictive Strata® scaffolds. Images can 
be seen displayed in Figure 5.33.  
     Data provided in Figure 5.33 shows that both the MDA-MB-231 and MCF7 cells display 
differences in cell surface phenotypes between 3D scaffold environments and 
conventional 2D culture systems. It is shown that for both cell lines, when grown on 2D 
silicone chips, the leading edge of the cell displays filapodia formation. Across this 
migratory edge cell projections can be seen. However these projections are not observed 
across any other cell regions than the leading migratory edge. In contrast, for both cell 
lines, the plasma membrane appears to display an increase in cellular projections across 
the whole cell, alongside displaying a much more spherical cell shape within 3D culture 
systems. These cellular projections, best highlighted within images E and F, suggest that 
these increased numbers of projections could be a result of increased cell surface area in 
contact with the surrounding material, helping the cell migrate through the scaffold 
environment. No differences in surface properties can be observed between MCF7 and 
MDA-MB-231 cells within each growth environment, suggesting that the observations are 
a result of environmental influence, and not cell line variation.   
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Figure 5.33: Scanning electron microscopy images of MDA-MB-231 (A, C and E) and MCF7 
(B, D and F) breast cancer cell lines. Images A and B display cells grown on 2D silicon chips. 
C and D represent cells situated across the restrictive scaffolds surface. E and F display 
cellular morphologies in central scaffolds regions. Arrows highlight the observed cellular 
projections. Scale bars = 2.5 µm      
 
 
 
 
 
     Alongside SEM analysis, TEM analysis was also conducted to investigate how the low 
and high grade breast cancer cell lines respond to the restrictive scaffold environment on 
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a sub-cellular level. Cells were grown in the restrictive scaffolds for 6 days and processed 
as described in the methods section. Initial observations suggest that both low and high 
grade breast cancer cell lines displayed similar migration phenotypes through the scaffold. 
It was shown that each cell line was able to migrate through restrictive interconnects 
(interconnecting windows smaller than nuclear diameters), with mitochondrial 
accumulation occurring at the perceived front of the nucleus. Representative images 
alongside quantification of this phenotype are displayed in Figure 5.34. 
 
 
Figure 5.34: TEM images of MDA-MB-231 (A) and MCF7 (B) breast cancer cell lines 
displaying mitochondrial positioning during restrictive interconnect migration. (E) 
Displays quantification of mitochondrial positioning across 50 cells for each cell line 
assessed. Scale bars = 2 µm.  
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     Figure 5.34 suggests both MCF7 and MDA-MB-231 cell lines display mitochondrial re-
positioning in front of the nucleus during migration through the restrictive interconnecting 
windows. Quantification displayed in (E) further suggests ~80% of both MCF7 and MDA-
MB-231 cell lines displayed this mitochondrial re-positioning in front of the nucleus during 
migration through restrictive interconnecting windows. These observations suggest that as 
the nucleus is the largest organelle, it may act as the restrictive component during 
migration through tight spaces, delaying migration due to nuclear deformities being 
required to pass through the windows.  
     Further investigations were then conducted to see if further nuclear and NE 
phenotypes abnormalities were present in MCF7 and MDA-MB-231 cell lines during 
migration through restrictive interconnects. Interestingly, it was found that within both cell 
lines, drastic nuclear deformities could be seen upon migration through restrictive 
interconnecting windows, alongside differences between INM and ONM distance on either 
side of the restriction (i.e. pre and post migration). Images of these observed nuclear 
deformities alongside quantification of NE dilations pre and post migration can be seen 
displayed in Figures 5.35 and 5.36.  
 
 
Figure 5.35: TEM images of MDA-MB-231 (A) and MCF7 (B) breast cancer cell lines 
displaying nuclear deformities during restrictive interconnect migration. (C) Displays 
quantification of nuclear phenotypes during restrictive interconnect migration. Scale 
bars = 500 nm.  
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     The data presented in Figure 5.35 suggests both MCF7 and MDA-MB-231 cells display 
similar nuclear deformities upon migration through restrictive interconnects. Initially, it is 
shown that both cell lines infrequently display drastic nuclear shape abnormalities upon 
migration through restrictive spaces, suggesting support for the need of nuclear 
deformities during cell migration through these materials. Further analysis displayed in 
Figure 5.36 suggests that differences are also seen between INM and ONM before and 
after migration through restrictive spaces for both cell lines. This investigation aimed to 
assess whether variation in PNS spacing could be observed before and after restricting 
interconnect migration, to gain insight into whether SUN-KASH interactions may be 
altered. The data suggests NE dilation significantly decreases post interconnect migration 
using a student’s t-test where p ≤ 0.005 for both cell lines assessed. These result further 
supports suggestions that both MCF7 and MDA-MB-231 cells display defects in NE 
spacing during restrictive interconnect migration.  
     One final observation of interest found during TEM analysis of both MCF7 and MDA-
MB-231 cell lines in restrictive Strata® scaffolds was that the cancer cells appear to 
express differences in phenotypic responses to proposed stressful regions of the scaffold 
displayed in Chapter 3. In this chapter, edges of interconnecting windows were shown to 
Figure 5.36: Quantification of MDA-MB-231 and MCF7 NE dilations pre and post 
restrictive interconnect migration.  
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Figure 5.37: TEM images of MDA-MB-231 (A, C and E) and MCF7 (B, D and F) 
breast cancer cell lines displaying cellular indentations during restrictive interconnect 
migration. Green outlines highlight NE. Scale bars = 500 nm.  
penetrate HaCaT cells during migration, leading to suspected intermediate filament 
accumulation across the region of penetration when in close nuclear proximity. 
Representative images of these same penetration events in cancer cell lines can be seen 
displayed in Figure 5.37.  
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     Figure 5.37 suggests both MCF7 and MDA-MB-231 cells do not appear to respond to 
the cellular indentations in the same way as HaCaT cells. It is shown that in both nuclear 
proximity and cellular extremities, breast cancer cells display limited cytoskeletal 
accumulation across the indentation. One potential suggestion for this lack of filamentous 
accumulation may be due to these cells may being unable to detect or respond to these 
surrounding environmental stresses in the correct manner, however, further analysis into 
stress response pathways and cell behaviour would be required to verify this hypothesis.  
     Data presented in this investigation helps suggest that MCF7 and MDA-MB-231 cell 
lines display similar cellular phenotypes in both 2D and 3D culture environments. 
However, these observations vary drastically from those of alternate cell lines placed in 
these environments such as the HaCaT cell lines. Observed differences between these 
cell lines could be a result of LINC disruptions across the nuclear envelope, leading to 
loss of mechano-transduction, and therefore the cells ability to respond to environmental 
stimuli. However, this is thus far speculation and further investigation would be required to 
verify this potential theory as current data provides only potential support for this due to 
the drastic nuclear deformities displayed upon migration through the restrictive 3D 
environments, suggesting that the nuclear envelopes structural integrity may be 
compromised as a result of this restrictive environment.  
 
5.3.3    Manipulating LINC complex connections stimulates 
altered cellular phenotypes in breast cancer cell lines. 
 
5.3.3.1    The incorporation of DN Sun1, but not nesprin-2 mini stimulates 
phenotypic difference in low-grade breast cancer cell lines. 
 
     To further investigate potential roles of nesprin-2 within the metastatic phenotypes 
observed by the MDA-MB-231 cells and DN HaCaT cells in Chapter 3, further 
investigations aim to test whether disruption or re-insertion of LINC components into low- 
and high-grade breast cancer cell lines is able to alter their phenotypes within 3D 
environments. This will therefore shed light on whether disruptions in SUN-KASH 
interaction across the nuclear envelope are a functional requirement for the increased 
migration potential displayed in high grade breast cancer cell lines.   
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     To test this, a range of transfections in both MCF7 and MDA-MB-231 cell lines was 
conducted. MDA-MB-231 cells were transfected with nesprin-2 mini constructs, with the 
intention of re-localising nesprin-2 proteins across the NE, therefore increasing NE 
integrity. This mini construct [101] contains the ABD and KASH domain of nesprin-2G, but 
lacks the large rod domain, making the protein much smaller. We further transfected 
MCF7 cells with dominant negative (DN) SUN1 and DN KASH constructs (ONM bound 
fragment of nesprin-2 retaining the transmembrane and KASH domain). The DN SUN1 
construct severs the link between SUN-KASH interactions spanning the perinuclear space 
by out-competing endogenous SUN proteins for KASH interactions. The DN KASH 
construct however, displaces KASH proteins situated across the NE, maintaining the 
SUN-KASH interactions within the PNS, but displacing endogenous KASH proteins across 
the NE. A further pEGFP control was also used to test that the resulting phenotypes were 
not a direct result of transfection, but rather the constructs inserted. Images displaying 
transfection efficiency alongside observed phenotypes are displayed in Figure 5.38.  
     The data presented in Figure 5.38 helps suggest the transfection efficiency for each 
construct was above 50%, suggesting that any results obtained from experimentation 
using this material will be a result of the alterations in LINC components.  
     Following transfections, cells were placed into two experimental set ups, a hanging 
drop experiment (in which 200 cells were suspended upside down in a 100 µl drop of 
media) to assess whether cell-cell interaction potential was altered upon LINC disruptions 
(similar to that displayed by the DN HaCaT cells), alongside a 3 day migration experiment 
through the restrictive 3D Strata® scaffolds. It has been shown that MDA-MB-231 cells are 
able to migrate completely through Strata® scaffolds between 2 and 4 day time points. As 
transient transfections last up to 2-3 days, experiments aimed to test whether the 
disruption or re-insertion of LINC components affects the migration potential of cells 
through restrictive environments. Experimental data for both hanging drop and restrictive 
scaffold penetration investigations can be seen displayed in Figures 5.39 and 5.40.  
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Figure 5.38: Fluorescence images displaying transfection efficiency across MCF7 and 
MDA-MB-231 cell lines. (A) and (B) display MDA-MB-231 cells transfected with pEGFP 
and nesprin-2 mini respectively. (C), (D) and (E) display MCF7 cells transfected with 
pEGFP, DN SUN1 and DN KASH respectively. Scale bars = 10 µm.      
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Figure 5.39: Images displaying hanging drop experimental analysis following LINC 
complex manipulation. (A) Displays cellular packing of MCF7 cells between DN KASH, DN 
SUN1 and non-transfected cells. (B) Shows packing phenotypes of MDA-MB-231 and cells 
transfected with nesprin-2 mini. Further quantification from across 20 experimental 
replicates can be seen displayed in (C). Scale bars = 200 µm         
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     Figure 5.39 suggests that the disruption of LINC connections across the NE in MCF7 
cells stimulates altered colony phenotypes. It is shown that upon transfection of MCF7 
cells with DN SUN1, the total single cell population within the hanging drop significantly 
decreases using a student’s t-test where p ≤ 0.005. Alongside this, further differences 
were observed between single cell numbers of MCF7 and MDA-MB-231 cell lines, in 
which MDA-MB-231 presented a more cohesive cell population, with less single cells 
observed. The incorporation of nesprin-2 mini constructs into both MCF7 and MDA-MB-
231 cells simulated no change in the number of single cells observed. These observations 
therefore suggest the disruption of SUN-KASH interactions across the NE through DN 
SUN1 insertion, could potentially stimulate a more cohesive colony phenotype, similar to 
those observed within the DN HaCaT cells in Chapter 3.   
     The data presented within Figure 5.40 suggests that the disruption of SUN-KASH 
connections across the NE in low grade MCF7 cells stimulates increased cell migration 
potential through restrictive 3D scaffolds. It is shown that DN SUN1 incorporation, the 
penetration depth significantly increases to ~100 µm,  in comparison to ~55 µm displayed 
by control MCF7 cells using a student’s t-test where p ≤ 0.005. It was further shown that 
** 
Figure 5.40: Quantification of restrictive scaffold penetration between MCF7, MCF7 + 
pEGFP, MCF7 + DN KASH, MCF7 + DN SUN1, MDA-MB-231, Mda-MB-231 + pEGFP and 
MDA-MB-231 + nesprin-2 mini, 3 days post seeding.  
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insertion of control GFP signal peptides alongside DN KASH displayed no significant 
effect on cellular migration through the scaffold environment. This suggests the 
destabilisation of SUN-KASH interactions across the perinuclear space, leading to a loss 
of NE structural integrity, may be critical for increasing cell penetration potential through 
restrictive environments. Further to this, the experimental data also suggests the insertion 
of nesprin-2 mini and GFP signal peptide into the high grade MDA-MB-231 cells was 
unable to stimulate any alterations in migration potential through the restrictive strata 
scaffolds.  
     Through data presented in this investigation, it can be suggested that the SUN-KASH 
interaction may potentially provide a limiting factor in the migration potential of cells 
through restrictive 3D scaffolds. With further evidence suggesting that the re-organisation 
of nesprin-2 across the NE being unable to reduce the penetration speed of high grade 
cancer cells. This helps highlight that nuclear architecture defects are not the only factor 
stimulating the increased cellular penetration potential present within the high grade 
breast cancer cell lines.   
     Due to the use of transient transfections within this investigation, the data obtained 
may not represent the true nature of this SUN-KASH disruption in real scenarios. This is 
due to a number of limiting factors such as the increase in cell death post transfection, 
plasmid maintenance deteriorating within 3-4 days post transfection and the fact that the 
transfected population of cells is not homogeneous. This therefore means that further 
investigations into this SUN-KASH interaction in cancer migration potential should be 
conducted through the production of stable transfected cell lines.  
 
5.3.3.2    Stabile transfection of DN SUN1 into MCF7 cells stimulates 
increased nuclear abnormalities and subsequent cell death.  
 
     Due to the limitations of assessing cell penetration potential within the first few days 
post transfection as described in 5.3.3.1, further experiments aimed to produce a stably 
transfected MCF7 cell line expression DN SUN1, as this was the only construct to display 
migration differences within 3D restrictive Strata scaffolds. Before cell line production, the 
concentration of Geneticin®/G418 (The drug to which the DN SUN1 plasmid encodes 
resistance against) required to kill all MCF7 cells within 7 days was investigated. This 
concentration ensures that sufficient selection pressure is maintained within the 
transfected culture, positively selecting for cells expressing the desired construct post 7 
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days of transfection, allowing subsequent cloning to be performed. Data from kill curve 
investigations can be seen in Figure 5.41 displaying cells stained using the LIVE/DEAD® 
fixable red dead stain kit.   
 
 
 
 
 
 
 
     The data presented in Figure 5.41 suggests that 100% cell death was achieved at the 
7 day time point using a G418 concentration of 1200 µg/ml. The staining kit used acts 
through binding with free amines, upon cell death, cell membranes are compromised, 
losing the ability to regulate transport of compounds across the plasma membrane, 
resulting in free diffusion of the dye into cytoplasmic regions of the cell. This dye then 
B 
Figure 5.41: LIVE/DEAD
®
 Red Dead staining within MCF7 cells under varying cell G418 
concentrations, to assess drug concentration required to kill 100% of cell in 7 days. In (A) 
Panel (A-F) represents incrementing G418 concentrations of 100, 200, 400, 800, 1000, 
1200 and 1500 µg/ml respectively. Red staining display the resulting Red Dead staining 
and blue staining represents nuclear DAPI staining. (B) Displays collated kill curve data.             
A 
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Figure 5.42: Nuclear analysis across MCF7cells transfected with GFP signal peptide, DN 
Sun1 and nesprin-2 mini. Data presented represents analysis of 150 cells within each 
transfection.  
displays an increased fluorescence signal in dead cells due to the dyes ability to react with 
both cell surface and cytoplasmic amines. The data presented in (B) highlights that MCF7 
cells displayed limited death up to a concentration of 400 µg/ml, following which further 
increase in concentration displayed a significant increase in cell death percentage.  
     It was established that for plasmid selection in MCF7 cells, a concentration of 1200 
µg/ml of G418 was sufficient. Using this information, MCF7 transfections were performed 
through electroporation as described in the methods, with aims to investigate whether the 
destabilisation of SUN-KASH interactions across the NE was able to increase the 
migration potential of MCF7 cells.  
     Following transfection, cells were maintained in conventional culture conditions 
alongside 1200 µg/ml of G418 in order to actively select for the cells expressing the 
desired plasmid. Interestingly however, 5 days post transfection, 70% of cells died within 
the culture flask, with the remaining cells displaying reduced replication rates. Upon closer 
analysis of the remaining cells, it was seen that cells displayed abnormal nuclear 
architecture alongside multi-nucleated cells. Quantification of these observations from 
across three independent repeats can be seen in Figure 5.42.  
 
 
 
     Data presented in Figure 5.42 suggests transfection with DN SUN1 stimulates drastic 
nuclear abnormalities alongside increase frequency of multi-nucleated cell formation. It 
can be seen that significant differences between nuclear numbers present post 
transfection can only be seen within MCF7 cells transfected with DN SUN1 using a 
** 
** 
** 
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student’s t-test where p ≤ 0.005. Continual observation of the transfected cells suggested 
that this multi-nucleated phenotype stimulated cell death before cloning could be 
conducted. Interestingly however, this data does suggest that the DN introduction 
stimulates cellular phenotypes different to that observed in HaCaT cells, as the formation 
of multi-nucleated cells is not observed within the DN HaCaT cells described in Chapter 3.  
 
5.3.4    Nesprin-2 C-terminal polyclonal antibody staining displays 
differential expression patterns between primary control, ER+ and 
triple negative breast cancers.  
 
5.3.4.1    Nesprin-2 C-terminal KASH domain isoforms display localised 
expression within luminal epithelial cells in healthy breast ducts. 
 
     Thus far, investigations have shown that high grade breast cancer cell lines are able to 
penetrate into restrictive 3D scaffolds much faster than their low grade and control 
counterparts. With further suggestions that this increased migration potential could be 
attributed to altered expression patterns and cellular organisation of nesprin proteins, with 
disruptions of SUN-KASH interactions potentially increasing migration potential. This 
collated data does suggest that the KASH containing nesprin proteins may play key roles 
in the development of metastatic phenotypes observed across many aggressive breast 
cancers. However, thus far, cell line data has been used to establish whether links exist 
between nesprin organisation and cancer metastasis. To further validate this hypothesis 
that nesprins do indeed play roles within cancer metastasis development, further 
investigations aimed to characterise the expression patterns of nesprin-2 across various 
grades of primary breast tissues.  
     Initially, control breast tissue obtained through breast reduction mammoplasty was 
sourced from Breast Cancer Now in the form of pre-embedded and pre-sectioned material 
from a range of 6 patients. Staining for nesprin-2 C-terminal domains was conducted, as 
previous work within section 5.3.1.5, suggests significant loss of nesprin-2 C-terminal 
organisation and protein expression within cancerous breast cancer cell lines. Sections 
were processed and stained as described in the methods section, with images of nesprin 
C-terminal and actin staining displayed in Figure 5.43.  
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Figure 5.43: Control pre-menopausal breast tissue. (A) displays H&E staining across the 
analysed section of tissue. (B, C and D) display DAPI staining across varying 
magnifications of the same structure. (B’, C’ and D’) shows nesprin-2 C-terminal KASH 
domain staining. And images highlighted in (B’’, C’’ and D’’) show actin staining. Scale bars 
= 30 µm (B), 20 µm (C) and 10 µm (D). 
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     The data presented within Figure 5.43 suggests that the expression pattern of nesprin-
2 C-terminal KASH domains remains localised to the luminal epithelial cells of the ducts. It 
can be seen that specific nuclear envelope staining is seen within the cells in closest 
proximity to the central duct, with reductions in nesprin-2 expression in more peripheral 
myoepithelial cells. The staining also helps to show that the ductal regions appear to be 
the only nesprin positive areas of the sample, suggesting nesprin presence within these 
structures may be crucial to maintaining their complex structural arrangements.  
     So far, fluorescence data has suggested that the ductal regions of the control breast 
tissue present nesprin-2 C-terminal KASH domain positive staining. Further speculation 
can be made as to the localisation of positive cells within this region correlating to the 
luminal epithelial cells. However, due to the complexity of tissue organisation, it is difficult 
to conclusively state whether these cells are indeed luminal cells. To validate this, further 
staining was performed within control breast tissue using the myoepithelial marker p63 
[343] in order to increase our understanding of cellular arrangements within the structures 
present. Cells were processed and stained for nesprin-2 C-terminal and p63 as described 
within the methods section, with images displayed in Figure 5.44.  
     Figure 5.44 helps to highlight the cellular organisation present in the observed ductal 
regions of control breast tissue, through p63 labelling of myoepithelial cells found across 
peripheral basal layer of the duct. The data suggests that nesprin-2 C-terminal 
counterstaining is localised to the luminal epithelial cells, with much weaker staining 
observed in the peripheral myoepithelial cells. This collated data therefore suggests that 
within non-cancerous breast tissue, nesprin-2 C-terminal staining appears to localise 
across luminal epithelial cells of the duct, with much weaker staining present in the 
myofibroblast, myoepithelial and basal cells present in the tissue.  
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Figure 5.44: Control pre-menopausal breast tissue. (A) Displays H&E staining across the 
analysed section of tissue. (B, C and D) display DAPI staining across varying 
magnifications of the same structure. (B’, C’ and D’) shows nesprin-2 C-terminal KASH 
domain staining. Images highlighted in (B’’, C’’ and D’’) show p63 staining and images (B’’’, 
C’’’ and D’’’) display merged p63 and nesprin-2 staining. Scale bars = 30 µm (B), 20 µm (C) 
and 10 µm (D). 
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5.3.4.2    Nesprin-2 C-terminal KASH domain isoforms display an altered 
cytoplasmic cellular localisation and decreased expression within ER+ and 
triple negative breast cancers. 
 
     Following initial investigations into nesprin expression patterns across non-cancerous 
breast tissue, further investigations aimed to test whether any alterations in nesprin-2 
expression levels were present across varying grades of breast cancer. To assess this, 
tissue sections from ER+ and triple negative breast cancer patients were obtained from 
Breast Cancer Now and stained for nesprin-2 C-terminal domains as described before, 
with resulting images for each condition displayed in Figures 5.45 and 5.46 respectively.  
     Figures 5.45 and 5.46 helps highlight the drastic morphological differences in tissue 
architecture found upon cancer development within the breast. H&E staining in Figure 
5.45 displays how uncontrolled cell proliferation rates stimulate an increase in cellular 
packing density across the tissue, drastically deforming the observed ductal structures 
found in healthy tissue. Immunofluorescence staining further supports these observations, 
through increased cell proximity and packing density observed through DAPI and actin 
staining. Interestingly however, it can be seen under high magnifications nesprin-C-
terminal expression levels appear to be less nuclear envelope specific and correlate 
heavily with the cytoplasmic actin staining. This suggests that the nesprin staining may be 
displaced from the nuclear envelope upon cancer development. To further assess nesprin 
staining within both non-cancerous and ER+ breast cancer tissues, we used the pixel 
distribution analysis tool within the LEICA LAS AF imaging software to quantify nesprin 
distribution across the cell (Figure 5.47).  
     Alongside ER+ tissues samples, the data presented within Figure 5.46 further displays 
nesprin staining within triple negative tissue. Interestingly however, it can be seen that 
nesprin 2-C-terminal expression levels appear to be reduced in the cancerous regions of 
the tissue. This evidence suggests that nesprin-2 C-terminal KASH domain loss may be a 
crucial factor within the progression of cancer phenotypes, however, with our current 
evidence, we are unable to state whether this observation is a cause or result of the 
cancer progression. To further assess this, future investigations should aim to analyse 
protein and gene expression levels through western blotting and PCR techniques, to gain 
a greater understanding as to whether nesprin-2 C-terminal KASH domains are indeed 
down-regulated in highly metastatic cancers.  
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Figure 5.45: ER+ pre-menopausal breast cancer tissue. (A) Displays H&E staining across the 
analysed section of tissue. (B, C and D) display DAPI staining across varying magnifications of 
the same structure. (B’, C’ and D’) shows nesprin-2 C-terminal KASH domain staining. Images 
highlighted in (B’’, C’’ and D’’) further display actin staining. Scale bars = 40 µm (B), 30 µm (C) 
and 20 µm (D). 
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Figure 5.46: Triple negative pre-menopausal breast cancer tissue. (A) Displays H&E staining 
across the analysed section of tissue. (B, and C) display DAPI staining across varying 
magnifications of the same structure. (B’ and C’) shows nesprin-2 C-terminal KASH domain 
staining. Images highlighted in (B’’ and C’’) further display actin staining. Scale bars = 30 µm 
(B), 20 µm (C). 
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     Figure 5.47 displays collated data from 50 individual cells within each tissue type, 
helping to support suggestions that nesprin 2-C-terminal staining within the ER+ breast 
cancer tissue expresses variable cellular topology. It can be seen from (A) that the peaks 
of highest nesprin-2 pixel intensity can be seen at nuclear envelope regions, whereas the 
actin peaks are found within more distant cellular regions at the plasma membrane. In 
contrast to this, the peaks for both actin and nesprin 2 staining in ER+ cells appear to 
localise to peripheral cellular regions. This result therefore suggests that nesprin-2 
localisation is drastically altered, leading to a more cytoplasmic distribution, which further 
correlates with previous nesprin-2 C-terminal staining observations across control, low 
Figure 5.47: Pixel topology analysis of nesprin-2 C-terminal domain staining 
(Green) and actin staining (Blue) within non-cancerous breast tissue (A) and ER+ 
cancerous breast tissue. Nuclear envelope positioning is displayed with arrows. 
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and high grade breast cancer cell lines in section 5.3.1.5. However, to further asses this 
data, more detailed observations would need to be conducted, as the ER+ cancer cells 
appear to cluster in much closer associated cellular colonies. This could result in a 
reduced distance between nuclear envelope and plasma membranes, leading to more 
observations of nesprin-2 staining across the cellular periphery. Therefore to validate 
these findings, further TEM analysis can be performed to assess nesprin-2 C-terminal 
localisation in relation to NE and plasma membranes.  
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5.4    Summary of Experimental Findings. 
 
     Throughout this chapter, investigations have aimed to characterise the cellular 
organisation and expression levels of various LINC complex proteins across a wide range 
of breast cancer cell lines.  
 
5.4.1    LINC complex proteins display variable expression 
patterns across breast, cervical and colorectal cancer cell lines. 
 
     Initial pilot data, investigating select LINC complex protein expression levels across a 
range of cancer types (Figure 5.3), displayed complex protein variability across the 
varying cancers assessed. More specifically, variability in emerin, nesprin-2G isoforms, 
lamin B1/B2 and Nup88 expression was observed. However, within each representative 
cancer form, it is difficult to establish whether any functional relationships exist between 
the low and high grade cancer samples. Nesprin-2G expression for example appears to 
be reduced in MDA-MB-231 cells compared to their low grade counterparts MCF7’s, 
whereas little variation can be seen between the low- and high-grade colorectal cancer 
cell lines SW480 and SW620. These observations highlight potential cell line specific 
variability in LINC complex protein expression. Whereas current understanding of the 
tissue specificity for many LINC components is limited, current literature suggests nesprin 
proteins present tissue specific isoform expression, with smaller isoforms able to induce 
potential tissue specific functions not present in other bodily regions [80]. This potential for 
different bodily tissues to express various nesprin isoform levels suggests that to 
effectively assess the role of LINC components in cancer progression through the 
assessment of cell lines, multiple cell lines must be assessed from within the same cancer 
type, originating from similar regions of the tissue source.  
     Due to these observations, following experimentation was conducted in breast cancer 
cell lines, due to its high importance within current clinical investigation, alongside its ease 
of investigations due to the availability of a wide range of model cell lines for the disease.   
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5.4.2    Variation in LINC protein expression is observed across 
breast cancer cell lines, alongside localisation defects in both cell 
lines and primary breast tissue samples; most significantly in low 
molecular weight nesprin-1/-2 isoforms.  
 
     Initial investigations into the expression of LINC proteins between these breast cancer 
cell lines lead to an interesting observation. It was observed that through Coomassie Blue 
staining, sample loading within the blot appeared equal (Figure 5.4), however, variations 
between HCC-38 and T47D cell lines across each standard loading marker were found 
(Figure 5.5). It was shown that the HCC-38 cells expressed a reduction in β-actin, 
whereas the T47D cell line displayed reductions in both GAPDH and β-tubulin expression. 
Potential explanations for these observations come from our increasing understanding of 
cell specific protein expression levels, in which drastic variability in supposed equal 
loading markers can vary between cell lines [344]. With this knowledge, collated data from 
the equal loading markers employed, alongside initial Coomassie Blue staining lead to the 
assumption that loading was equal across each breast cancer protein sample.  
     Following investigations aimed to investigate cytoskeletal organisation between MCF 
10A, MCF7 and MDA-MB-231 cell lines (representing control, low- and high-grade breast 
cancers).  It was shown in Figures 5.6 - 5.9 that microtubule organisation was retained 
across each cell line assessed. In contrast however, the actin and cytokeratin networks 
expressed drastic organisational differences, with actin displaying an observed peripheral 
localisation at cellular projections. In MCF7 and MCF 10A cells, actin appeared more 
evenly distributed across the nuclear, cytoplasmic and cell periphery regions.  
     It was further shown that cytokeratin appeared to be much less abundant within control 
and high-grade breast cancers compared to the low-grade MCF7 cells, which displayed a 
highly ordered structural arrangement of cytokeratin through its cytoplasm. This is further 
supported through protein expression analysis (Figure 5.10), through which specific 
keratin proteins like vimentin were shown to display reduced expression profiles in high-
grade MDA-MB-231 cells in comparison to low-grade MCF7 cells.  
     Further investigations into expression patterns and organisation of core LINC complex 
components including SUN, KASH and lamin protein family members were then 
conducted. Interestingly, the gathered data appears to support current suggestions that a 
loss of core NE proteins which are crucial for maintaining nuclear architecture is more 
prevalent in highly metastatic cancers. Evidence in the literature suggests in high-grade 
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breast cancers (similar to those represented by MDA-MB-231 cell lines) a down regulation 
in lamin A/C, lamin B2 and SUN2 is observed, which supports findings within our 
investigations suggesting loss of expression for each protein in the high-grade cell lines 
[203]. It is suggested that loss of NE protein functionality could stimulate chromatin 
instability and increased oncogene expression [302], metastatic phenotype development 
[353] and malignancy in various cancer types [354].  
     Aside functional defects arising from loss of key LINC components, it is also suggest 
that the loss of these LINC connections across the nuclear envelope impairs nuclear 
integrity, and therefore increases nuclear malleability. It is known that loss of LINC 
components such as nesprins and lamins compromises nuclear architecture [14]. Coupled 
with data from Chapter 3 and protein expression patterns displayed in Figures 5.18 and 
5.23 suggesting loss of low molecular weight nesprin-1/-2 C-terminal isoform expression 
in high-grade cell lines, it can be suggested that this observed loss of lower nesprin 
isoforms stimulates an increase in nuclear malleability, allowing ‘softer’ nuclei to migrate 
through more restrictive environments.  
     It is further suggested that displacement of nesprin-2 C-terminal KASH domains from 
the NE is also present within high-grade breast cancer cell lines (Figures 5.21 and 5.22). 
When further applied to primary pathological breast tissue samples, implications for the 
use of nesprin-2 -C-terminal antibody staining as potential markers for cancer grading is 
apparent. It can be seen that nesprin-2 C-terminal KASH domains appear to dissociate 
from the NE upon cancer development in ductal epithelial cells specifically (Figures 5.43 – 
5.46). As the cancer progresses to a triple negative phenotype, nesprin-2 C-terminal 
staining further reduces, suggesting potential use for this protein region as an early 
staging marker for breast cancer biopsies.   
     Current understanding of the functionality of lower nesprin-1 and nesprin-2 isoforms is 
limited due to the difficulty in isolating and distinguishing between the potential protein 
variants. This means that conclusive effects of nesprin roles in cancer development 
remain unknown thus far; however, the data presented here does suggest that the lower 
nesprin isoforms may be a crucial future target to investigate the relationships between 
nuclear stiffness and cancer metastasis in breast cancer.   
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5.4.3    LINC associated proteins including lap2α, E-cadherin and 
Nup88, alongside the protein chaperones HSP27, GFAP and 
CRYAB display variability in protein expression profiles across 
breast cancer cell lines.  
 
     Further observations in protein variations came through analysing LINC associated 
proteins, including NPC proteins, and centrosome markers, relative to p53, E-cadherin 
and lap2α. Interestingly, although significant differences were observed in centrosome 
marker expression levels, no obvious correlations were displayed between expression 
levels and breast cancer severity (Figure 5.26). For example, we saw a significant 
increase in pericentrin levels in MDA-MB-231 cells in comparison to the low-grade MCF7 
cells, which correlated directly with the literature. It is suggested that increased pericentrin 
levels would stimulate an increase in centrosome number, which in turn would result in 
altered mitotic spindle formation and function, leading to genome instability [355, 356, 
357]. This would then lead the development of aneuploidy (a known cancer hallmark).  
However, alongside our high-grade cancer cells expressing increased pericentrin levels, 
the control MCF 10A cells also present similar expression levels, leading to a conflict to 
this suggestion.  
     Aside this, further variations in expression levels were observed in Mab414, a nuclear 
pore complex marker, in which the high-grade MDA-MB-231 displayed a reduced total 
protein expression of lower nuclear pore proteins (Figure 5.29). Alongside its roles in 
regulating nuclear transport and chromatin organisation, knowledge on potential roles of 
nuclear pore proteins within cancer development is limited to only a few components such 
as Nup88 [358]. However, current evidence presented by Martignetti et al. highlight the 
nuclear pore complex as a future target in cancer research using algorithmic analysis of 
key miRNAs contributing to the development of triple negative breast cancers [359]. 
Within these investigations, key miRNA and gene expression levels were identified across 
a range of triple negative breast cancer tissues, suggesting correlations in miRNA 
expression profiles which regulate NPC function. Collectively, these data suggest that the 
NPC function could be compromised in high-grade breast cancer patients.   
     Further investigations were conducted into expression levels of oncogenic markers like 
p53, cell proliferation markers and cell-cell adhesion proteins. Observations suggest p53 
and lap2α levels appear to increase during increased cancer cell lines severity, whereas 
E-cadherin levels appear varied across cell lines (Figure 5.26).  
290 | P a g e  
 
     As already stated, genomic mutations leading to disruptions in known oncogenes pose 
a sever risk within the human population. Due to this fact, multiple avenues are being 
perused in order to increase our understanding of the development of cancer in order to 
design more specific treatment methods. One such area is the investigation as to cellular 
disruptions in chaperone proteins, responsible for regulating protein folding ensuring 
protein functionality is retained. To validate whether a correlative variation in heat shock 
expression levels exist across varying breast cancer cell lines, the assessment of HSP27, 
CRYAB and GFAP was conducted (Figures 5.30 and 5.31). Our data suggested that the 
levels of CRYAB appear to be down-regulated across many breast cancer cell lines. 
Interestingly however, the 3148-CRYAB (Polyclonal) antibody further displayed bands at 
alternate molecular weights, which could correlate to unspecific binding, or alternatively 
may display alternate protein variants which vary across the breast cancer cell lines. 
.Aside this, further variations in HSP27 and GFAP were also identified, in which high 
grade breast cancer cell lines were shown to express reduced expression levels of 
HSP27, alongside increased expression of GFAP in all lines except the triple negative 
MDA-MB-231 cell lines.   
 
5.4.4    High-grade MDA-MB-231 cells display significantly 
increased migration potential through space-restrictive 3D 
environments which is not reversible through nesprin-2 mini 
insertion. 
 
     As much of the literature thus far suggests that an increase in breast cancer severity 
correlates with an increase in migratory potential, further investigations aimed to assess 
the migration potential of control (MCF 10A), low-grade (MCF7) and high-grade (MDA-
MB-231) breast cancer cell lines in the restrictive Strata® scaffolds. This investigation 
therefore aims to assess whether any associations between LINC proteins expression 
assessed thus far and migration behaviour in space-restrictive environments can be 
observed. It was shown that MDA-MB-231 cells displayed the greatest migration potential 
through the space-restrictive scaffold environments, with further EM analysis displaying 
little variation in cellular morphologies across the different scaffold regions between cell 
lines. When collated with protein analysis data, it can be suggested that this observed 
migration advantage could be attributed to a decrease in nuclear stiffness, similar to that 
observed within LINC disrupted DN HaCaT cells in Chapter 3.  
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     It has been shown that the high-grade MDA-MB-231 cells express reduced levels of 
LINC components responsible for maintaining NE integrity (Figures 5.9 – 5.26) including 
lamin A/C, lamin B and lower nesprin-1 and -2 isoforms. These observations suggest a 
disruption to the LINC complex, and subsequent loss of NE integrity present in MDA-MB-
231 cells, which in turn may provide them with their increased migration potential through 
space-restrictive environments. This is supported by suggestions in the literature that 
nuclear size and deformability may be a rate limiting step in cellular migration through 
restrictive environments [272].  
     In an attempt to validate whether nuclear malleability is indeed a contributing factor in 
the migration potential of high-grade breast cancer cell lines through restrictive 
environments, further experimentation aimed to disrupt and re-introduce LINC 
components across low- and high-grade breast cancer cell lines respectively. 
Interestingly, we found that the incorporation of DN SUN1 constructs into low-grade breast 
cancer cell lines stimulated a significant increase in cellular clustering alongside an 
increased penetration potential through restrictive Strata® scaffolds. However, it was 
further shown that the incorporation of a nesprin-2 mini construct into the high-grade 
MDA-MB-231 cell lines was unable to revert the increased cell clustering or migration 
potential phenotypes expressed (Figures 5.39 and 5.40).  
     These observations suggest that the disruption of SUN-KASH interactions across the 
perinuclear space is able to incite a migration advantage in the low-grade breast cancer 
cell lines. However, this increased migration potential still remains lower than that of the 
high-grade breast cancer cell lines, suggesting that further gene and protein expression 
differences exist between the low- and high-grade cell lines, inferring the difference in 
migration potential. On the other hand however, the DN SUN1 population was 
heterogeneous in its expression of the DN SUN1 construct, meaning that further repeats 
of this experiment with a homogeneous population would be required to increase the 
validity of these findings.     
     Of further interest were observations suggesting that the incorporation of DN KASH 
constructs into the low-grade breast cancer cell lines inferred no migration changes. This 
construct is considered a milder LINC disruption to that displayed by the DN SUN1 
construct. DN KASH maintains the SUN-KASH perinuclear linkage whilst displacing KASH 
proteins from the ONM, therefore severing cytoskeletal interactions to the NE surface. 
This data therefore hints to the potential that this inferred migration advantage displayed 
by the DN SUN1 construct insertion, could result from the loss of SUN-KASH interactions 
across the NE, rather that the loss of ONM protein associations. Potential reasoning for 
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this observation may come from evidence presented by Wang et al. [59]. They were able 
to show that the upregulation of SUN2 in Ovcar-3 cell was able to increase migration 
potential, with final remarks suggesting a potential regulatory role played by SUN2 coiled-
coil motifs in cell migration. It is therefore possible that as our system targets SUN-KASH 
binding, the regulatory roles played by SUN2 coiled-coil domains may be perturbed, 
leading to an altered cell response in pathways involved in cell migration.  
     It was further shown that the incorporation of nesprin-2 mini into the high-grade breast 
cancer cell lines was unable to produce a slower migration phenotype. One potential 
explanation for this however, is the use of nesprin-2 mini as a means of re-establishing 
NE integrity. This mini construct is much smaller than the endogenous nesprin-2G protein 
due to the removal of the vast majority of spectrin repeat proteins situated between N- and 
C-terminal regions. The decrease in nuclear size attributed to mini insertion may 
counteract the potential increased nuclear stiffness, meaning that the nuclei are now small 
enough to migrate through the restrictive interconnects without the need of nuclear 
deformities. However, to fully validate this, further investigations will be needed to assess 
the effects of incorporating numerous LINC complex components within these high-grade 
cancer cells, to see if re-establishment of nuclear stiffness without altering nuclear size 
does indeed affect migration potential.  
     One further potential flaw within this investigation was the use of transient transfections 
to assess the effects of LINC disruptions on migratory behaviours across various cell 
lines. The process of transient transfection using electroporation does not elicit 100% 
transfection efficiency, alongside inducing cellular stresses. These combined factors could 
contribute to alterations in cellular migration potential irrespective of the components 
inserted into the genome. To combat this experimental weakness, we attempted to 
produce a new cell line of stably transfected MCF7 + DN SUN1, in order to produce a 
cloned population of cells expressing the desired plasmid. However, we found that the 
expression of DN SUN1 in these cells stimulated an increase in multi-nucleated cells, 
suggesting that within these cells, the mechanisms behind maintaining efficient DNA 
replication or separation during mitosis was disrupted, leading to eventual cell death. 
However, this observation does provide further indications as to potential roles of nesprins 
within cancer development, as multi-nucleation alongside abnormalities in DNA 
replication, centrosome amplification and chromatin splitting are considered hallmarks of 
cancer development [369].  
     Through the assessment of a range of LINC complex proteins and associated proteins, 
correlations have been observed between expression levels in specific components 
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responsible for maintaining nuclear architecture, such as the lamin and nesprin proteins 
and breast cancer cell lines severity. With further primary tissue analysis suggesting 
further protein organisational defects arising during breast cancer development, we 
suggest that key components of the LINC complex, including nesprins, SUN proteins and 
lamins are vitally important within breast cancer progression. Specifically, nesprin-2 C-
terminal containing isoforms display the greatest potential for use as an early prognosis 
marker for high-grade breast cancer development. To further validate this however, future 
investigations should assess gene and protein expression levels within primary tissues 
correlating to the staining work conducted here using PCR and western blotting 
techniques. This will help to further validate whether the expression of C-terminal regions 
of nesprin-2 are indeed reduced within high-grade breast cancers, alongside providing 
insights to the levels of lower nesprin-1 and nesprin-2 isoforms within the tissue.  
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6. Investigating binding potential between C-
terminal regions of nesprin-2 and Nup88 
6.1    Introduction. 
 
     As described previously, five proteins containing KASH-domains have been identified 
to date, termed nesprin-1, -2, -3, -4 and KASH5 [78, 452, 234]. Each nesprin is encoded 
by a separate gene, giving rise to a multitude of structurally and functionally diverse 
isoforms [452]. Of these nesprin isoforms, the largest are termed nesprin-1 and nesprin-
2G, and comprise an N-terminal actin binding domain and a C-terminal transmembrane 
domain, separated by a large spectrin repeat (SR) rod segment [234, 232]. One hallmark 
of these nesprin proteins is the retention of the evolutionary conserved C-terminal KASH 
domains across the majority of isoforms. This domain encompasses a single 
transmembrane segment, followed by a conserved PNS localised peptide which 
associates directly with SUN protein luminal domains [32, 33]. This interaction helps to 
link the ONM to the INM through further interactions between SUN and lamin proteins 
[29]. Unlike the high conservation of C-terminal regions, nesprin N-terminal regions 
display complex diversity due to the differing spectrin repeat compositions. They also 
contain distinct protein binding regions, imparting further roles for nesprins in maintaining 
ONM connections with cytoskeletal components such as actin through Nesprin-1 and -2G 
[14, 76, 77], microtubule motor proteins (i.e. kinesin 1) through nesprin-4 [78], and 
intermediate filaments through nesprin-3 [86, 182] (Figure 6.1). 
     The specific maintenance of NE connections between INM and ONM regions through 
nesprin-2G interactions have been shown to play further functional roles in maintaining 
nuclear architecture [101]. It was shown that specific interference of nesprin-2G N-
terminal interactions with nesprin-3, alongside C-terminal interactions across the NE 
resulted in an increase in nuclear size. More importantly, this nuclear defect was able to 
be rescued and reversed through the re-incorporation of nesprin-2 mini (nesprin-2 -C and 
-N-terminal regions connected by a smaller interconnecting rod domain), producing a 
smaller nuclear size. This data, therefore, suggests that the interacting potential of both N 
and C-terminal domains of nesprin-2 plays crucial roles in maintaining normal cellular 
architecture.  
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Figure 6.1: A) Domain architecture of the largest nesprin family members in humans. B) 
Direct and indirect protein interactions displayed by nesprin-1, -2, -3 and -4 across the NE. 
Nesprin-1 and -2 giant interact directly with F-actin, and indirectly to microtubules via kinesin 
and dynein across the ONM. Nesprin-3α indirectly binds IFs through plectin, which is further 
able to crosslink multiple cytoskeletal networks. Nesprin-4 associates indirectly to MTs 
through kinesin 1. [508] 
 
 
 
 
 
 
     Interestingly, further research suggests that, not only are -N and -C-terminal 
interactions with NE components crucial for maintaining nuclear architecture through LINC 
connections, but are also crucial for the recruitment of functional proteins to the NE 
surface. Recruitment of the diaphanous related formin (DRF) FHOD1 to the nuclear 
envelope and its roles in actin binding and the formation of TAN lines across the NE have 
been well characterised [453]. Recent investigations have shown that the recruitment of 
FHOD1, and subsequent TAN line formation across the NE, is mediated by interactions 
with nesprin 2G across the N-terminal residuals 1340-1678 corresponding to spectrin 
repeats 10-12 [94]. In this paper, Kutscheidt et al. identified the binding interaction 
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between Nesprin-2 and FHOD1 through yeast two hybrid screening accompanied by GST 
pulldowns. Subsequent assessment of these interactions displayed that the nesprin-
2G/FHOD1 interaction provides a second connection between the NE and actin cables. 
This second connection is essential for the formation of TAN lines and thus nuclear 
movement in the cells.  
    In addition, further interacting potential has been suggested between nesprin-2 and α-
catenin across the nuclear envelope [9]. This, in turn, suggests roles for nesprin 2 in the 
regulation of Wnt signalling across the NE. Through the use of yeast two-hybrid 
screening, alongside immunoprecipitation, it has been shown that the -C-terminal region 
of nesprin-2 displays interacting potential with α-N-catenin. It was further shown that this 
nesprin-2/α-catenin interaction is able to regulate β-catenin dependent transcription. 
Through the use of SP-GFP-SUN-1-C (construct able to sever KASH-SUN protein 
interactions in the NE lumen) incorporation into HaCaT cells, resulting in the disruption of 
nesprin-2 across the NE, nuclear accumulation of β-catenin was seen to reduce. From this 
work it is suggested that nesprin-2 complexes with emerin, α- and β- catenin upon Wnt 
signal activation, forming a quaternary protein complex, from which β-catenin can 
sequester into the nucleus and undergo its normal transcriptional functions.  
 
6.1.2    Nup88, a potential nesprin-2 binding partner. 
 
     As described thus far, the N- and C-terminal regions of nesprin-2 display functional 
roles in both maintaining nuclear architecture and in the recruitment of proteins across the 
NE. Of further importance are interactions between nesprin-2 C-terminal domains and 
KLC1. This KLC1 interacting potential was identified through isolation of the last 4 C-
terminal spectrin repeats (termed N2-SR) [77], followed by subsequent yeast two hybrid 
and GST-pulldowns. An illustration of nesprin-2G, alongside the N2-SR construct and 
spectrin repeat structural representations can be seen in Figure 6.2. Interestingly 
however, the unpublished data from this yeast two-hybrid screen suggests further 
interacting potential with multiple proteins, one of which is the NPC protein Nup88.  
     The NPC mediates molecular exchange across the NE with the aid of ~30 different 
nucleoporins. These nucleoporins are organised into distinct sub complexes able to form 
the major building blocks of the NPC, displaying an octagonal core formed from a central 
framework connecting INM and ONM rings [454, 455]. The nucleoporin Nup88 resides 
across the cytoplasmic face of the NPC, found in a complex with the nucleoporins Nup214 
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Figure 6.2: A) Nesprin-2G and N2-SR structural features, alongside NT and CT antibody 
binding regions. B) Myc-tagged N2-SR transfected into COS7 cells, displaying both NE and 
ER staining, with cells stained for Myc (green) and DAPI (blue). Scale bar = 10 µm. C) 
Hypothesised crystal structure of the left handed antiparallel triple-helical-coiled coil spectrin 
repeats [77, 509].  
and Nup358, as well as the nuclear export factor CRM1 [456, 457]. Nup88 has been 
found to localise to intranuclear regions displaying chromatin associations, suggesting 
potential roles of Nup88 in gene regulation [458].  
 
 
      
 
 
     Nup88 is composed of two structural domains: an N-terminal β-propeller making up 
two thirds of the proteins (residuals 1-584 in humans); and a C-terminal alpha helical 
coiled coil (residuals 585-741) [459]. This observed coiled-coil domain mediates the 
interactions with Nup214 [460], whereas the N-terminal β-propeller domain interacts with 
the NPC-targeting domain of the nucleoporin Nup98, thought to localise across both the 
cytoplasmic and nucleoplasmic face of the NPC [461]. This wide range of interacting 
partners, alongside both its cytoplasmic and nucleoplasmic localisation suggests complex 
functionality for Nup88. It has been shown that the formation of Nup88-Nup214 complexes 
are not directly required for the import of proteins through the NPC, but is, however, 
crucial for CRM1-mediated nuclear export [462]. This suggests that Nup88 function across 
the NPC is required in the maintenance of nuclear transport. Further roles have been 
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identified for Nup88 in the maintenance of NFκB activation across the NE [463]. In this 
investigation, it was shown that overexpression of the Nup214-Nup88 complex 
sequestered CRM1 to the cytoplasmic foci of the NPC, resulting in the inhibition of protein 
export. This investigation therefore suggests regulating Nup88-Nup214 interactions, could 
act to regulate the duration and strength of NFκB signal responses. However, further 
investigations have now verified Nup88 as a regulating component of nucleoplasmic NFκB 
transport [464]. Through the application of a small interfering RNA (siRNA) against Nup88 
NFκB dependent reporter gene activation was inhibited, and nuclear accumulation of 
NFκB was observed. In contrast, nuclear import of alternate factors, including 
glucocorticoid, was not affected. This suggests that specific regulatory interactions exist 
between NFκB and Nup88 across the NE. Interestingly, in many highly metastatic 
cancers, NFκB displays constitutive activation in both nuclear and cytoplasmic regions of 
the cell [465], however, depletion of Nup88 in these cells was shown to reduce TNF-
induced nuclear accumulation of these NFκB subunits.  
     Investigations into the roles of nucleoporins in cancer development have shown that a 
small number of nucleoporins display tumorigenic properties, including Nup62, Nup214, 
Nup358, and Nup88 [466]. Although the exact roles of Nup88 in cancer development are 
not well understood, the expression levels of both Nup88 protein and mRNA are seen to 
be increased in highly metastatic cancers [467, 468, 469]. For example, increases in 
serum levels of Nup88 correlate to the development of highly aggressive colorectal cancer 
phenotypes [470]. Quantitative sandwich enzyme-like immunosorbent assay (ELISA) 
analysis on blood serum of pre- and post-operative colorectal cancer patients, show that 
levels of Nup88 were higher in pre-operative patients in comparison to post-operative 
patients. Further positive correlations between Nup88 serum levels and depth of tumour 
penetration were also observed, suggesting that not only are Nup88 correlated with 
increased cancer metastasis, but they may also provide novel biomarkers for use in the 
early grading of tumours.  
     These hypothesised interactions between Nup88 and nesprin-2 through yeast two-
hybrid investigations could provide implications for functional relationships existing 
between these two proteins in the development of cancer phenotypes.  
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6.2    Chapter Aims. 
 
     In this chapter the roles of LINC complex proteins in the development of highly 
metastatic cancer phenotypes will be investigated. It has been shown previously that 
nesprins play key functional roles in the maintenance of LINC connections across the NE. 
Disruptions in the SUN-KASH bridge lead to increased migration potential due to an 
increase in nuclear malleability. It is aimed to assess whether relationships exist between 
nesprins and binding partners (e.g. Nup88) in relation to the development of cancerous 
phenotypes. To achieve this, a range of cell biology and biochemistry techniques, 
including cellular transfections and GST-pulldowns, and advanced microscopy 
techniques, will be used in order to validate whether physical interactions exist between 
these two proteins.  
 
6.2.1    Objectives. 
 To assess whether nesprin-2 and Nup88 co-localise in vitro.  
 
 To validate whether a physical interaction exists between the SR region of nesprin-
2 and Nup88.  
 
 To establish whether functional relationships exist between Nup88 and nesprin-2 
in simplified cellular models. 
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6.3    Results. 
6.3.1    Nesprin 2 CT domain displays strong co-localisation with 
the nuclear pore protein Nup88.  
6.3.1.1    The C-terminal domain of nesprin-2 and Nup88 display strong co-
staining across the NEs of multiple cell types. 
 
     Maintaining LINC connections across the NE is an important factor in retaining nuclear 
stability through SUN-KASH interactions across the peri-nuclear space. Alongside SUN-
KASH interactions, nesprins display further interacting potential with the NPC protein 
Nup88. It was shown through yeast-two hybrid screening, that nesprin C-terminal SR 
regions displayed binding affinity with kinesin light chain 1 (KLC1) [77], alongside further 
unpublished interacting potential with Nup88. As both of these proteins have been shown 
to display abnormal expression patterns in high grade cancers, investigations aimed to 
validate these potential Nup88 and nesprin-2 C-terminal interactions through in vitro cell 
systems.  
     Initial investigations assessed whether nesprin-2 C-terminal regions and Nup88 
displayed co-localisation across HaCaT, SW480 and SW620 cell lines. HaCaT cells were 
chosen due to their known high expression profiles of LINC proteins, whereas SW480 and 
SW620 lines were selected due to their representation of both low and high grade 
colorectal cancers [471]. Cells were cultured, processed and stained through 
immunofluorescence as described within the methods section, with images displayed in 
Figure 6.3.  
     Data presented in Figure 6.3 suggests expression levels of nesprin-2 C-terminal 
regions appears to be uniform across the NE for each cell line, with SW620 cells 
displaying more punctate NE staining to that observed in SW480. Interestingly, Nup88 
staining appears to display strong co-localised NE staining with nesprin-2 C-terminal 
regions across each cell line assessed, alongside more dispersed Nup88 cytoplasmic 
staining, suggesting Nup88 function may not solely reside across the NE. From these 
observations, it is evident that each of these cell lines analysed could act as a good model 
system to investigate Nup88 and nesprin-2 C-terminal domain interacting potential. 
However, HaCaT cells were chosen to maintain consistency with previous work through 
this thesis.  
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Figure 6.3: Immunofluorescence staining against nesprin-2 C-terminal domain (A, B and 
C), Nup88 (A’, B’ and C’) and DAPI (Blue). Images represent HaCaT (A), SW480 (B) and 
SW620 (C). Scale bars = 10 µm. 
 
 
 
 
6.3.2    Nup88 and the C-terminal region of nesprin-2 display co-
localisation within HaCaT cells across the NE. 
6.3.2.1    Indirect immunofluorescence suggests Nup88 and nesprin 2 C-
terminal display close associations across the NE. 
 
     As displayed thus far, HaCaT cells display strong expression of both Nup88 and 
nesprin 2 under normal biological conditions, making them highly suited for the 
assessment of co-localisation potential between these two proteins. Initial investigations 
then aimed to optimise staining conditions for each protein to provide high specificity of 
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Figure 6.4: Immunofluorescence staining against nesprin-2 C-terminal domain (green) 
and Nup88 (red) within HaCaT cells across the NE surface. Scale bars = 1.25 µm.  
staining. The results of this optimisation lead to the clear identification of both Nup88 and 
nesprin-2 C-terminal (using the pAbk1 antibody and the Nup88 antibody defined in the 
methods section) attached fluorophores across the NE, as displayed in Figure 6.4.   
 
 
 
     As seen in Figure 6.4, the attached fluorophores between Nup88 and nesprin-2 can be 
clearly distinguished across the NE’s surface. Using this optimised staining, following 
investigations aimed to quantify cellular co-localisation between the two proteins. To do 
this, images were taken across the NE’s surface for counterstaining between Nup88, 
Nesprin-2’s C-terminal region, NPC markers and Nup214 (a known Nup88 binding partner 
as a positive control) respectively. The fluorophore intensity was then assessed using the 
LEICA LAS AF image analysis software to establish whether the peaks of fluorophore 
intensity co-localised between each protein, with resulting images alongside example 
analysis techniques seen displayed in Figure 6.5.  
303 | P a g e  
 
Figure 6.5: Immunofluorescence and peak intensity analysis between Nesprin-2 CT (Green) 
and Nup88 (Red) (A), nesprin-2 NT (Red) and Nup214 (Green) (B), Nesprin-2 NT (Red) and 
Nup88 (Green) (C), nesprin-2 CT (Green) and Mab414 (Red) (D), and Nup214 (Green) and 
Nup88 (Red) (E) in HaCaT cells. Corresponding peak intensity between co-stains can be 
seen within A’’, B’’, C’’, D’’ and E’’ respectively. Blue lines in the graphs display the 
background DAPI staining, not seen in the images. Yellow lines on the images represent 
regions of analysis, across which fluorophore intensity was assessed. Scale bars = 2.5 µm 
for A, B, C, D and E, and 1 µm in A’, B’, C’, D’, E’.  
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Figure 6.6: Percentage co-localisation data for each co-stain conducted. Data 
collected from across 50 cells in each staining condition.  
     Figure 6.5 suggests that Nup88 and Nesprin-2 C-terminal regions do indeed appear to 
co-localise across the NE surface. However, to increase objectivity in each set of peak 
analysis measurements, each fluorophore was analysed individually through switching off 
the counterstained channel during image analysis. Lines were then drawn across 
individual fluorophore dots to avoid selecting for dots which appear to display a high 
degree of co-localisation. Using this objective method of analysis, it is suggested that 
intensity peaks for Nup88 and Nesprin-2 C-terminal stained cells, alongside Nup88 and 
Nup214 stained cells display a high degree of signal overlap between the two 
fluorophores (Figure 6.5 A and E).  
     In contrast, intensity peaks for nesprin 2 N-terminal regions and Nup88/Nup214 
respectively displays no-co-localisation (Figure 6.5 B and C), suggesting that the 
fluorophores are not in close proximity across the NE. Interestingly, the data also 
suggests a relationship between NPC’s and Nesprin-2 C-terminal regions (D), in which C-
terminal nesprin-2 peaks appear to situate in close proximity to Mab414 peaks of high 
intensity. Further quantification of this co-localisation analysis can be seen displayed 
within Figure 6.6, displaying collated co-localisation for each co-stain across the NE of 
HaCaT cells.  
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     The data presented in Figure 6.6 suggests that significant differences are observed 
between the co-localisation of analysed proteins across the NE of HaCaT cells (ANOVA, 
F5.3525 = 3.51, P = 0.010). Highest degrees of co-localisation are observed between the 
Nup88 + Nup214 co-staining and Nup88 + nesprin-2 CT co-staining. This finding suggests 
that the C-terminal region of nesprin-2 displays a high degree of close association with 
Nup88, as the comparative Nup214 + Nup88 co-stain represents co-localisation between 
known binding partners. High co-staining is also observed between the nesprin-2 CT and 
Mab414, suggesting that nesprin-2 CT regions are in close association with NPCs across 
the NE. Assessment of nesprin-2 NT regions displayed low levels of co-localisation with 
Nup88 or Nup214 across the NE, suggesting that if close associations do exist between 
these two proteins, it occurs at low frequency or is regulated by an intermediate protein. 
     To further validate our observations suggesting that in HaCaT cells, Nup88 and 
nesprin-2 C-terminal regions display co-localisation across the NE, FRET FLIM analysis 
alongside transfection techniques were employed.   
     The application of FRET FLIM analysis initially involved the assessment of 
fluorescence lifetimes for Nup88 tagged fluorophores both with and without the presence 
of nesprin-2 C-terminal staining in HaCaT cells. Nup88 was tagged with an Alexa Fluor 
488 secondary antibody (acting as the donor), and nesprin-2 C-terminal regions with 
Alexa Fluor 568 (acting as the acceptor). As these two fluorophores expressing 
overlapping emission and excitation spectrums, this technique will allow us to assess 
whether a decrease in donor fluorescence lifetime occurs when co-localised with the 
acceptor fluorophore. If this decrease is observed, then close proximity between donor 
and acceptor fluorophores is suggested. Cells were fixed, stained and imaged as 
described in the methods section. Initial image analysis was conducted using the 
symPhoTime software on Nup88 only stained HaCaT cells to obtain a baseline 
fluorescence lifetime. An example output from this image analysis technique, alongside 
collated experimental data is displayed in Figure 6.7.  
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Figure 6.7: (A) Screenshot displaying analysis output of HaCaT nuclei stained for 
Nup88 and nesprin-2 C-terminal regions. (B) Displays collated life time data from 
across 50 cells within each condition.  
 
 
 
     Data presented in Figure 6.7 suggests a significant difference exists in fluorescence 
lifetimes between Nup88 tagged fluorophores across single and co-staining conditions 
using a student’s t-test where p ≤ 0.005. Data presented in (B) suggests a fluorescence 
lifetime difference of 0.6 nS between single Nup88 staining and co-staining between 
Nup88 and nesprin-2 CT regions. This suggests the Nup88 tagged donor fluorophore can 
307 | P a g e  
 
Figure 6.8: Immunofluorescence staining against Nup88 (A), myc-SR (B) and merge 
(C). (D) Presents higher mag of the observed co-localisation in HaCaT cells. Scale 
bars = 10 µm in (A-C) and 4 µm in (D). 
be found in close proximity to the nesprin-2 CT bound acceptor fluorophore, leading to a 
transfer of energy between the two. This helps to provide further suggestions as to 
potential co-localisation of Nup88 and nesprin-2 C-terminal regions across the NE.  
     To increase understanding of associations between Nup88 and nesprin-2 C-terminal 
regions, transfections using myc-N2-SR (a construct containing the last 4 C-terminal 
spectrin repeats of nesprin-2 (Figure 6.2) were conducted in HaCaT cells. This SR 
construct was that used in the initial yeast two-hybrid screen suggesting a Nup88 
interaction. Overexpression of this construct in HaCaT cells would therefore lead to an 
increased level of observed co-localisation between Nup88 and the myc-tagged SR. 
Transfected cells were fixed and stained against Nup88 and the myc-tag to assess co-
localisation between inserted SR fragments and Nup88. Resulting images can be seen 
displayed within Figure 6.8.  
 
 
 
     Data presented in Figure 6.8 suggests further co-localisation exists between the myc-
tagged SR and Nup88. The incorporated SR appears to localise to the NE and ER regions 
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Figure 6.9: (A+B) Immunofluorescence staining of Nesprin-2 C-terminus (Green) and Nesprin-
2 N-terminus (Red) in HaCaT cells. (C) Displays merged images. Scale bars = 5 µm.  
of the cell, in which the highest degree of co-localisation can be observed with Nup88. 
This therefore presents further supporting evidence that Nup88 and nesprin 2 C-terminal 
regions do appear to display close association in vitro.  
 
6.3.2.2    Nesprin-2 N- and C-terminal regions display distinct staining across 
the nuclear envelope.  
 
     Observations thus far, suggest evidence for co-localisation between Nup88 and the 
nesprin-2 C-terminus, but not N-terminal regions across the NE. This suggests that both 
the N and C-terminal regions of nesprin-2 could potentially occupy distinct regions across 
the NE. To investigate this further, the use of super resolution microscopy was applied to 
discern whether distinct staining between both N- and C-terminal regions of nesprin-2 
could be observed. HaCaT cells were fixed, stained and imaged as described within the 
methods section, with images displayed in Figure 6.9.  
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     Data presented in Figure 6.9 suggest a nesprin-2-N- and C-terminal regions occupy 
distinct regions across the NE, due to clear distinctions able to be made between red and 
green fluorophores. It can be seen that infrequent co-localisation is observed, more 
frequently seen across peripheral nuclear regions. This data therefore provides further 
support to Figures 6.5 and 6.7, suggesting that the N- and C-terminal domains of nesprin-
2 occupy distinct NE regions.  
     Due to these observations using indirect immunofluorescence techniques, the validity 
as to protein localisation cannot be 100% conclusive. This is due to the fact that the 
binding distance between fluorophore and targeted protein is separated by a further 
primary antibody, which results in an indirect protein label at both low and high 
magnifications. To overcome this, further investigations using biochemical techniques 
such as GST-pulldowns and immuno-precipitations may be performed to assess protein 
interacting potential.  
 
6.3.3    The N2-SR fragment displays binding to Nup88 in GST-
pulldown assays. 
 
     Following investigations aimed to assess whether Nup88 and nesprin-2 C-terminal 
observed co-localisation correlated with physical binding potential. To assess this, GST-
pulldown techniques were used. Constructs containing the last four C-terminal spectrin 
repeats of nesprin-2 C-terminal (termed N2-SR) were attached to GST beads, then 
incubated with COS7 cell lysates ectopically overexpressing pEGFP-Nup88 as described 
within the methods section. The resulting western blot staining against Nup88, GFP and 
GST can be seen displayed within Figure 6.10.  
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Figure 6.10: Western blot staining against Nup88 (A), GFP (B) and GST (C) for the GST 
Pulldown. Arrows represent the expected ~135 kDa GST-SR bound Nup88 band in (A-B). In 
(C) arrows represent both GST-SR bound Nup88 and the GST bead. In this image, 
degradation can also be seen of the GST-SR fusion. 
 
 
 
 
     Data presented in Figure 6.10 helps suggest that a physical connection may exist 
between the N2-SR fragments and pEGFP-Nup88. The pre-pulldown pellet and 
supernatant lanes were extracted upon cell lysate production to ensure that the cells were 
expressing the transfected pEGFP-Nup88, whereas the following control and GST-SR 
post-pulldown lanes represent the cellular supernatant after incubation with GST and 
GST-SR beads, respectively. The final two lanes represent the isolated control GST 
beads and GST tagged SR beads post incubation with the COS7 + pEGFP lysate. Nup88 
western blot stain suggests a pEGFP-Nup88 band can be detected at ~ 130 kDa, which 
correlates to the size of the Nup88 protein with pEGFP attached. Due to the absence of 
pEGFP-Nup88 in the control GST lane, it is suggested that the GST pulldown has 
specifically pulled down pEGFP-Nup88. Of further interest is the lack of endogenous 
Nup88 expression detected in COS7 cells. This could potentially arise from COS7 cells 
expressing low levels of the protein, alongside further potential of the Nup88 antibody 
applied not detecting non-human Nup88. To validate this, further staining against GFP 
and GST were conducted. Further staining can be seen for both GFP and GST correlating 
to the observed band displayed through Nup88 staining. Interestingly however, the GST 
stain displays fragmented staining within the GST-SR lane, suggesting that the construct 
may have begun to degrade.  
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     This data, therefore suggests that the N2-SR fragment used in initial yeast two-hybrid 
screening displays potential binding potential with Nup88. However, the results from this 
experiment will require further validation, as these data do not control for potential 
intermediary proteins situated between the Nup88 and GST-SR or whether binding is 
mediated by the attached pEGFP, although the yeast two-hybrids suggests a direct 
binding. Further to this, follow on investigation will be needed to validate whether the 
fragments displayed upon GST staining are indeed degradation products or further 
binding interactions between the N2-SR fragment and alternate cellular components. A 
further follow on experiment could be to further narrow down the binding regions, 
therefore gaining further insight into which of the final 4 C-terminal SRs are responsible for 
this interacting potential, alongside repeating the pulldowns with fragmented Nup88 
regions.  
 
6.3.4    A potential functional relationship exists between Nup88 
and nesprin-2 in vitro.  
6.3.4.1    Incorporation of pEGFP-Nup88 into HaCaT cells stimulates nuclear 
abnormalities.   
 
     Investigations thus far have suggested Nup88 and nesprin-2 display co-localisation 
across the NE and potential physical interactions. However, further investigations aim to 
assess whether functional relationships existed between these two proteins. It is 
suggested that Nup88 levels are found up-regulated across a variety of metastatic 
cancers, alongside a high frequency of mutations in nesprins. To replicate these 
conditions, a series of transient transfections were performed in HaCaT cells, to establish 
whether increased/decreased levels of either Nup88 or nesprin-2 stimulated alterations in 
protein organisation or expression levels of the other. Transfections in HaCaT cells were 
performed as described in the methods for control pEGFP, pEGFP-Nup88, Nup88 siRNA, 
nesprin-2 RNAi and myc-tagged nesprin-2 SR, with resulting images of each transfection 
displayed in Figure 6.11.  
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Figure 6.11: Immunofluorescence staining displaying for control pEGFP (A), pEGFP 
Nup88 (B), myc-SR (C), nesprin-2 RNAi (D) and Nup88 siRNA (E). For each 
transfection, green staining (other than in panels A and B where green displays GFP) 
represents Nup88 and red staining represents nesprin 2. Scale bars = 10 µm.  
 
 
 
 
     Data in Figure 6.11 suggests the transfections performed were successful for each 
plasmid assessed. Incorporation of each plasmid appeared to stimulate no abnormal cell 
phenotypes other than within the overexpression of pEGFP-Nup88. It was found that the 
insertion of this plasmid into HaCaT cells stimulated the development of nuclear defects, 
including nuclear blebbing, enlarged nuclei and the formation of multi-nucleated cells. To 
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Figure 6.12: (A) and (B) highlight example nuclear deformities observed upon pEGFP 
Nup88 insertion, including nuclear blebbing and multi-nucleation. (C) Displays collated data 
of phenotypes observed in HaCaT cells 3 days post transfection with pEGFP Nup88.  
quantify these observations, 400 cells were closely observed for these abnormalities, with 
collated data displayed in Figure 6.12.   
 
 
 
 
     The data presented in Figure 6.12 suggests the introduction of pEGFP-Nup88 
stimulates an increase in nuclear abnormalities detected. It is shown that observed levels 
of nuclear blebbing and multi-nucleated cells is significantly increased upon pEGFP-
Nup88 transfection calculated using a student’s t-test where p ≤ 0.005. These 
observations therefore suggest that the introduction of pEGFP-Nup88 may disturb normal 
cellular architecture.  
     Following successful transfections of each construct into HaCaT cells, protein analysis 
was conducted through the application of western blotting techniques to assess whether 
the introduction of each construct stimulates a change in expression levels for Nup88 or 
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Nesprin-2 respectively. Lysate production and subsequent western blot analysis was 
conducted as described in the methods. Each sample was then stained against proteins 
of interest as displayed in Figure 6.13.  
     Data presented in Figure 6.13 displays the effects of altering expression levels of either 
Nup88 or nesprin-2 on expression levels of specified proteins of interest. Initially, it is 
shown that insertion of control pEGFP displays no significant alterations in Nup88 or 
nesprin-2 expression. Interestingly however, it is further shown that incorporation of 
pEGFP-Nup88 appears to stimulate a decrease in nesprin-2G isoform expression levels. 
To verify this observation was a result of pEGFP-Nup88 insertion, we further stained the 
blot for Nup88, highlighting two distinct bands. The lower band correlates to endogenous 
Nup88, whereas the higher band found at ~130 kDa correlates to the expected size of 
pEGFP tagged Nup88, therefore suggesting the observed decrease in nesprin-2G 
expression may be a result of the over expressed Nup88 levels.   
     Alongside this, closer analysis of both Nup88 and nesprin-2 knockdown lysates 
suggests that no significant differences can be observed across the range of proteins 
analysed, other that in Nup88 and nesprin-2 respectively. However, it is seen that upon 
nesprin-2 RNAi introduction, lower nesprin isoforms are retained. In contrast the GIANT 
isoform of nesprin 2 (~800) can be seen to display reduced expression levels, suggesting 
that the knockdown produced was only for the GIANT isoform.  
     The introduction of myc-SR into the HaCaT cells appears to again stimulate no 
significant changes in Nup88 or nesprin-2 expression patterns across the cells. However, 
the success of transfection can be validated through the analysis of lower CT nesprin 
isoforms, in which the SR fragment can be clearly identified through the pAbK1 antibody 
which targets the last two SRs across the C-terminal of nesprin-2, preceding the KASH 
domain.  
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Figure 6.13: Western blot analysis of HaCaT transfections. (A) Displays western 
blot staining observed. (B), (C), (D), (E), (F) an (G) display collated densitometry 
analysis across three repeats for each protein. Arrows represent pEGFP-Nup88 
(Nup88 stain) and myc-SR (in pAbK1 stain).     
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     The data generated through this investigation suggests that of all transfections 
performed, the introduction of pEGFP Nup88 was the only condition to produce both 
nuclear architecture and protein expression defects in the HaCaT cells. However, due to 
the over expressed Nup88 construct containing a pEGFP tag, we cannot fully rule out the 
possibility that the attached GFP tag is stimulating these observations. This is especially 
crucial for Nup88 which displays both nuclear and cytoplasmic localisation, suggesting 
that an increase in size could restrict inserted Nup88 function in the cell, or in turn, disrupt 
the normal functioning of endogenous Nup88. Therefore to further validate these findings, 
we would aim to employ the use of smaller tags to Nup88 like myc or HA. With these 
smaller tags, we would be able to assess whether the resulting phenotypes observed 
were indeed a result of plasmid expression, or of disruptions arising from the size of the 
pEGFP tag.  
 
6.3.5    Nup88 displays unique characteristics for nuclear pore 
proteins. 
6.3.5.1    Nup88 displays co-localising potential with KLC1 in the cytoplasm. 
 
     Thus far it has been shown that Nup88 and nesprin-2 display co-localisation across the 
NE, alongside potential functional relationship in which nup88 levels may determine 
expression levels of nesprin-2G. However, through these investigations, it was also 
observed that Nup88 displays a high degree of cytoplasmic staining across all cell lines 
assessed. As Nup88 is classified as a NPC protein, its localisation is often associated 
across the NE, however, further experiments aimed to investigate whether Nup88 
specifically co-localises with select cytoplasmic proteins, in order to gain a greater 
understanding of its potential roles within the cell.  
     Immunofluorescence techniques were used to assess whether Nup88 displayed 
cytoplasmic co-localisation with components of the ER, KLC1, actin or tubulin protein 
networks. Cells were grown, fixed and stained as described in the methods for each 
component, as displayed in Figure 6.14.  
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Figure 6.14: Immunofluorescence staining of Nup88 (A, B, C’ and D’), β-tubulin (A’), β-actin 
(B’), ER (C) and KLC1 (D) in HaCaT cells. Scale bars = 10 µm.  
 
 
 
 
     As shown in Figure 6.14, Nup88 displays co-localisation with KLC1 in cytoplasmic 
regions of the HaCaT cells, whereas no further co-staining could be seen for other co-
staining conditions. Cytoskeletal staining presented in (A) and (B) displays Nup88 
cytoplasmic accumulation is situated within central and nuclear regions. The actin stain 
displays regions of the cell periphery, helping to show that Nup88 in these regions are 
expressed at low levels. It is further shown that no co-localisation is observed between 
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Nup88 and the ER other than directly across the NE (C). The use of immunofluorescence 
staining alone however, only provides an indication as to potential co-localisation; further 
investigations would be required to validate this finding, using biochemical analysis such 
as immuno-precipitation and more advance fluorescence analysis such as FRET-FLIM.  
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6.4    Summary of Experimental Findings. 
 
     Work in this chapter has sought to investigate whether co-localisation and physical 
interactions exist between nesprin-2 and Nup88 as suggested through unpublished yeast 
two-hybrid data presented by Schneider et al. [77]. Further aims include establishing 
whether in vitro manipulation of both Nup88 and nesprin-2 invokes a functional alteration 
in either protein, to investigate potential implications in the development of cancerous 
phenotypes.  
 
6.4.1    C-terminal regions of nesprin-2 display close association 
to Nup88 in HaCaT cells through indirect immunofluorescence.  
 
     Initial investigations helped to characterise both Nup88 and nesprin-2 C-terminal 
distributions across a range of cell lines. It was shown that in the SW480 and SW620 
colorectal cancer cell lines (low- and high-grade adenocarcinomas, respectively), no 
variation was observed through immunofluorescence staining for Nup88. In contrast, 
nesprin-2 C-terminal staining displayed specific localisation across the NE in both cell 
lines assessed, with the high-grade SW620 cells displaying more punctate staining, 
showing regions of no staining across the NE. These results appear to both support and 
contradict current literature views. Contradiction comes from evidence suggesting Nup88 
levels are observed to increase during the progression of many cancer forms [200]. Our 
data does not support this view due to SW620 cells displaying similar localisation and 
expression for Nup88 to the low-grade SW480 cells. This finding could suggest that 
continuous culture in 2D environments may have altered levels of Nup88 expression in 
comparison to their original tissue source (As much literature data comes from primary 
biopsy analysis). Support for nesprin-2 staining, however, comes from evidence in the 
literature suggesting that nesprin-2 genes (alongside further nesprin genes) display 
mutations which correlate to cancer severity [316, 472].  
     Further characterisation of both Nup88 and nesprin-2 levels were performed in HaCaT 
cells, displaying that both Nup88 localised to both NE and cytoplasmic cell regions 
alongside nesprin-2 C-terminal staining localising specifically to the NE. From these 
observations, the HaCaT cell line was selected as a model for our further work to test the 
co-localisation potential between Nup88 and nesprin-2 in vitro as these cells appear to be 
used as a model in numerous LINC associated research areas [233, 473, 41].  
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     The LEICA LAS AF image analysis software was employed to observe fluorophore 
intensity peaks, with aims to investigate whether these peaks correlated between nesprin 
C-terminal regions and Nup88 (Figure 6.5 and 6.6). It was observed that direct overlap of 
emission peaks could be seen between nesprin-2 C-terminal vs Nup88 and Nup88 vs 
Nup214 co-staining conditions, whereas no direct co-localisation could be observed 
between N-terminal nesprin-2 regions and Nup88. Further quantification displayed that 
across 50 cells analysed in each co-stain, the highest percentage of co-localisation 
occurred between nesprin-2 C-terminal regions and Nup88, Nesprin-2 C-terminal regions 
and NPCs, as well as Nup88 and Nup214. This suggests that nesprin-2 C-terminal 
regions appear to co-localise with Nup88, validated through the Nup88 vs Nup214 positive 
control also displaying a high degree of co-localisation. Nup88 and Nup214 are well 
characterised binding partners in mammalian cells [462, 474], suggesting the analysis 
method used is able to detect these close associations effectively.  
     To further strengthen observations suggesting C-terminal regions of nesprin 2 display 
close in vitro associations with Nup88, two further techniques were used, FRET FLIM 
analysis and overexpression of the suspected binding region N2-SR (Figures 6.7 and 6.8). 
Through FRET FLIM assessment, it was shown that when co-stained against Nup88 and 
nesprin-2, with Nup88 containing the donor fluorophore, a significant fluorescence life time 
reduction of this donor fluorophore was observed, suggesting that these two proteins are 
found in close association within the HaCaT cells. Alongside this, transfection of myc-
tagged N2-SR into the HaCaTs displayed further co-localisation between Nup88 and the 
proposed binding region. These follow on investigations provide further supporting 
evidence that both Nup88 and nesprin-2 display potential interactions under in vitro 
conditions due to their close cellular associations, similar to that suggested in the initial 
yeast two-hybrid screen [77].  
     As nesprin-2 C-terminal but not N-terminal regions displayed co-localised staining 
across the NE with Nup88, further super resolution microscopy techniques were employed 
to support this (Figure 6.9). It is shown that staining for N- and C-terminal regions of 
nesprin-2 is distinct across the NE surface, with limited co-localisation observed across 
peripheral nuclear regions. This suggests both N- and C-terminal nesprin-2 regions may 
occupy distinct regions of the NE, forming a cage like meshwork surrounding the NE, 
similar to that suggested by Lu et al. [101], through which nesprin-1G and nesprin-2G 
were suggested to associate across the ONM through mediated interactions with nesprin-
3.  
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6.4.2    Interacting potential is displayed between Nup88 and the 
last 4 SRs preceding nesprin-2s C-terminal KASH domain. 
 
     One drawback with the experimental approaches conducted thus far is the use of 
indirect immuno-fluorescence. The attachment of primary followed by secondary 
antibodies in our experimental systems leads to fluorophore emission observed away from 
the initial protein source. To overcome these limitations, observations of fluorescent 
tagged Nup88 and C-terminal nesprin-2 regions transfected into HaCaT cells could be 
conducted, as to remove the need of antibody analysis. Further to this, live cell imaging 
techniques could be used to gain further understanding of whether these co-localisations 
are consistent throughout all stages of the cell cycle. However, the use of biochemical 
techniques was selected to establish whether a protein-protein binding potential existed 
between the C-terminal region of nesprin-2 and Nup88 in the form of a GST-Pulldown 
(Figure 6.10).  
     Using the N2-SR construct described by Schneider et al. [77], N2-SR was attached to 
GST beads, followed by incubation in COS7 + pEGFP Nup88 lysates. Resulting western 
blot analysis displayed that these GST-SR beads displayed potential Nup88 binding 
through both Nup88 and GFP staining, displaying a ~130 kDa band correlating to pEGFP 
Nup88. A further GST stain displayed the same band, alongside potential degradation of 
the SR fragment presented as smears in the lane. These observed high molecular weight 
bands were not observed with GST alone, suggesting that these observations were a 
result of SR attachment. Although the detection of Nup88 in the GST-SR fragment 
suggests that a physical interaction may exist between Nup88 and nesprin-2 C-terminal, 
one further control would be needed to conclusively show this. The incorporation of 
pEGFP bound GST beads would help to validate whether the observed pulldown of 
pEGFP Nup88 is a result of SR binding to Nup88, rather than the possible binding of SR 
to the pEGFP tag attached to the Nup88 protein. 
 
6.4.3    Overexpression of pEGFP-Nup88 stimulates a reduction in 
nesprin-2 expression. 
 
     Following establishment of potential interactions between Nup88 and the C-terminal 
region of nesprin-2 through GST-pulldown analysis, further investigations aimed to 
decipher whether functional relationships existed between the two proteins in model 
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HaCaT systems. Transfections producing overexpression and knockdowns of Nup88 and 
nesprin-2 components were performed and subsequently assessed through 
immunofluorescence and western blotting techniques. Post-transfection observations 
displayed limited cell and nuclear abnormalities across all transfections conducted, apart 
from the insertion of pEGFP-Nup88, in which increased levels of nuclear blebbing and 
multinucleated cells were observed (Figure 6.12).  
     Protein expression analysis through western blotting techniques displayed in Figure 
6.13 suggests functional variation in nesprin-2 levels upon pEGFP-Nup88 overexpression. 
Upon pEGFP-Nup88 overexpression, nesprin-2G expression appears to reduce, to similar 
levels observed within nesprin-2 siRNA lysates. No further significant variation could be 
identified across the range of transfections conducted, other than within emerin 
expression levels, displaying a reduction in protein expression upon both pEGFP-Nup88 
and Nup88 siRNA insertion. Interestingly, little evidence is found in the literature 
highlighting potential implications as to these emerin decreases in cells overexpressing 
Nup88. However, as it has been suggested that Nup88 is able to bind directly to lamin A/C 
across the INM [478], it can be suggested that Nup88 may bind to the same site of lamin 
A/C as emerin [479], and therefore outcompete endogenous emerin for its lamin binding, 
resulting in a subsequent loss of emerin expression.  
     When correlated with work presented in Chapter 3, suggesting that loss of LINC 
connections across the NE mediated by nesprin, decreases nuclear stiffness. Work 
identified in this investigation suggests that this LINC disruption could stem from a loss of 
nesprin-2G isoforms expressing C-terminal regions as a result of Nup88 overexpression 
(as further supported in primary tissue work in chapter 4). Further evidence as to potential 
regulatory roles of Nup88 on the expression of nesprin-2 comes from data suggesting 
Nup88-Nup214 mediated CRM1 regulation controls nuclear export [462]. It was shown 
that overexpression of Nup88-Nup214 complexes were able to trap CRM1 and Rel to the 
cytoplasmic face of the NPC, resulting in immune response activation and the inhibition of 
protein export from the nucleus. As Nup88 overexpression is prevalent in many high 
grade cancer forms, it is possible that export of nesprin components under these 
conditions is unable to occur due to the loss of nuclear export, resulting in incorrect 
protein expression patterns. However, substantial investigation would be required to 
validate this due to the complexity of proteins and gene regulation abnormalities present 
in cancer cell development.  
     A further limitation to this experimental approach is the GFP tag attached to the 
overexpressed Nup88. This tag could potentially reduce the normal functioning of Nup88 
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through impairing protein migration through the NPC due to its increased size. As stated 
previously, high powered electron microscopy techniques could be used validate whether 
pEGFP-Nup88 displays abnormalities in cellular location in comparison to endogenously 
expressed Nup88 through immuno-gold double labelling.  
      Through these investigations, it has been observed that Nup88 displays both NE and 
cytoplasmic distributions. To further investigate this, immunofluorescence analysis was 
conducted to assess whether this observed cytoplasmic localisation was seen to correlate 
to selected cytoskeletal components (Figure 6.14). The data suggests that of the stains 
conducted; only KLC1 displayed potential co-localisation. This finding appears to support 
evidence in the literature, suggesting that an interacting potential exists between KLC1 
and Nup214 (a Nup88 binding partner) [203], suggesting that these observed co-
localisations may arise through Nup214 mediated binding. Further investigations however, 
would need to be conducted to validate this potential co-localisation through biochemical 
analysis methods including GST-pulldowns using KLC1 fragments published previously 
[77] alongside immunoprecipitation assays. This would therefore provide a clear indication 
as to whether a physical binding potential existed between Nup88 and KLC1.  
     Through the data presented in this chapter, it has been shown that cellular co-
localisation alongside a potential binding interaction exists between Nup88 and nesprin-2, 
more specifically across the final 4 spectrin repeats of the C-terminal region (N2-SR). 
Further evidence also suggests functional relationships may exist between Nup88 and 
nesprin-2 in vitro; in which increased Nup88 levels stimulate a down regulation of nesprin-
2 isoforms, similar to that found in many cases of highly metastatic cancers.  
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7. Summary and General Discussion 
7.1    Thesis Background. 
 
     The nucleus and its contents (e.g. chromosomes and proteins) are continuously 
subject to mechanical forces from extracellular cues, often resulting in dynamic nuclear 
deformation and structural rearrangements. For example, during muscle contraction and 
relaxation in Drosophila, nuclei are often subject to variable cytoplasmic strain, but are 
able to maintain a stable nuclear morphology. It was proposed by Wang et al. that this 
nuclear stability was maintained through the elastic properties of MSP3000 (nesprin 
homolog) across the ONM [480]. Through interactions with MTs, MSP3000 is able to form 
a flexible perinuclear shield across the ONM, stabilised by Shot (spectraplakin) and EB1. 
This protective cage therefore enables the nuclei to withstand the continual mechanical 
forces subjected on the nucleus.  
     Alongside extracellular stimuli acting on the nucleus, further mechanical forces act 
from intracellular sources of both nucleoplasmic and cytoplasmic origins, arising from 
transcriptional events and DNA synthesis, alongside the dynamics of the cytoskeleton 
respectively. This knowledge spurred research to investigate the mechanical properties of 
the NE itself, aiming to understand how this double membrane system and its associated 
protein networks could not only resist mechanical forces, but also transmit these physical 
forces to the nuclear interior, eliciting a cellular response.  
     It was shown using a variety of experimental techniques; including micropipette 
aspiration, atomic force microscopy (AFM) and cellular strain assays, that the interphase 
nucleus is 2 ~ 10 times stiffer than the surrounding cytoplasm for endothelial cells and 
articular chondrocytes  [286, 287, 481, ,482]. Further research aiming to understand which 
cellular features may be contributing to this observed nuclear stiffness, lead to 
implications of LINC complex regulation. In recent work, it has been documented that 
numerous LINC complex components including lamins [114, 483] and the SUN-KASH 
interactions [484, 59] are responsible for the maintenance of nuclear architecture and 
resulting nuclear stiffness. Compelling evidence was further highlighted by Lu et al., in 
which saturation of the KASH binding domains by a DN SUN1 construct (leading to a 
displacement of endogenous KASH-proteins (including nesprin-1/-2) from the NE and 
subsequent LINC complex disruption) lead to an enlargement of nuclear areas in HaCaT 
cells [101]. Through this, it was demonstrated that maintaining LINC connexions across 
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the PNS were required to preserve nuclear architecture. The further function of LINC 
components in regulating nuclear-cytoskeletal interactions has also been suggested to 
play significant roles in nuclear stiffness and mechanotransduction across many cellular 
systems [153, 485]. It is suggested that the complex interplay of KASH protein expression 
(nesprin-1/-2/-3 and -4) aside associated connections with MTs, IFs and actin cytoskeletal 
components, contribute to cellular resistance against mechanical stress induced by the 
environment.  
     Due to this evidence suggesting complex roles played by the LINC complex in 
regulating nuclear stiffness, further research began investigating the roles of nuclear 
stiffness in cellular migration in 3D environments. It is suggested that an increase in 
nuclear malleability may increase cell migration potential across 3D systems, for example, 
it is believed that neutrophil functionality is maintained through its ability to squeeze 
through space-restrictive gaps between tissue systems. On close inspection, Rowat et al. 
[202] were able to highlight that this highly mobile cells was influenced heavily by its high 
nuclear malleability. It was shown that in genetically modified HL-60 cells, a defined 
increase in lamin A composition resulted in an incremented increase in nuclear stiffness, 
correlating to a decrease in the cells ability to migrate through micron-scale restrictions. 
With research now suggesting that HL-60 cells express low levels of further LINC complex 
components including nesprin-2G, nesprin-1G, SUN1, plectin and vimentin [486], aside 
similar  phenotypes highlighted across cell lines displaying increased migration potential 
through restrictive environments [272, 267], it is now suggested that nuclear deformability 
may constitute as a rate limiting step during cell migration in 3D environments.  
     Due to observations thus far suggesting strong evidence for roles of the LINC complex 
in maintaining nuclear stiffness, alongside further evidence suggesting nuclear malleability 
as a rate limiting step in 3D migration, current investigations are beginning to link these 
two research areas in an effort to increase our understanding of cancer metastasis. Of 
high significance in this field is current evidence presented by Matsumoto et al. [203], 
suggesting that breast cancer tissues express a significant reduction in expression levels 
of LINC complex proteins, including SUN1/2, lamin A/C and nesprin-2. This evidence, 
coupled with that’s described thus far provides strong support for the potential roles that 
LINC complex components could play in the development of metastatic behaviours across 
a range of cancers.  
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7.2    Summary of Experimental Findings. 
7.2.1    LINC complex disruptions elicit phenotypic changes in 
cell/nuclear shape alongside 2D and 3D migration potential. 
7.2.1.1    Severing the SUN-KASH perinuclear interaction elicits increased 
nuclear height, decreased cell-substratum attachment and decreased 2D 
migration potential. 
 
     In Chapter 3, the effects of LINC complex disruptions through DN SUN1 interference in 
HaCaT cells were characterised in both 2D and 3D culture systems, leading to numerous 
significant findings. Firstly, the incorporation of DN SUN1 and subsequent LINC 
disruptions elicited an increase in cell-packing density (Figure 3.5) alongside an increase 
in nuclear height (Figure 3.9). From this data, it was shown that the DN HaCaT cells 
displayed a two-fold increase in both cell numbers per 100 µm2 and observed nuclear 
height. These findings, though novel due to the DN system applied, appear to support 
findings by Anno et al. [139], suggesting that upon nesprin-1 silencing in HUVEC cells, 
nuclear heights were shown to increase. When linked more closely with further 
investigations displaying roles of nesprin-2 localised TAN lines across nuclear surface in 
maintaining mechanotransduction across the NE [93], our findings suggest that loss of 
LINC connections across this nuclear surface may result in dysfunctional cytoskeletal 
interactions arising from nesprin-mediated binding.  This disruption to the normal LINC 
connections may therefore result in a reduction in mechanical force exerted across the 
nuclear surface by cytoskeletal components, leading to intranuclear forces increasing 
nuclear height as a result of this decreased resistance.  
     Further alterations in cell – substratum attachment speeds and actin organisation were 
also observed within early time points post trypsinisation (Figures 3.12, 3.13), however, 
the actin organisation between DN and WT HaCaT cells was found to display no 
discernible difference post after 48 hours post trypsinisation. Observations from this 
investigation could therefore have arisen due to DN HaCaT cells requiring more time to 
re-organise cellular networks due to a potential loss of  mechano-transduction across the 
NE, as vinculin function is known to correlate with actin organisation [280]. Further support 
for our findings also comes from evidence suggesting  mutations in C-terminal KASH 
domains of both nesprin-1 and nesprin-2, present in Emery-Dreifuss muscular dystrophy 
(EDMD), have been shown to lead to reduced cell-substratum attachment rates [176]. 
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This therefore suggests potential roles for this maintained SUN-KASH interaction in cell-
substratum attachment, meaning that our DN mutant cells display some similarities to 
phenotypes presented in EDMD.  
     It was also shown that in conventional 2D scratch wound assays, the WT HaCaT cells 
were able to close the wound significantly faster than that’s of the DN HaCaT cells (Figure 
3.16 and 3.17)  Data obtained from this investigation supports views in the current 
literature, suggesting mutations or knockdowns in nesprin proteins displays a reduced 2D 
migration speed to close a defined wound [140, 176]. Therefore, to further interpret our 
results, the application of live cell imaging and single cell tracking techniques could be 
incorporated. This will help to validate whether the DN HaCaT cells indeed migrate at a 
slower rate to the WT HaCaT cells, or whether their LINC disruptions impair their ability to 
migrate into the wound, leading to migration along the length or away from the site of 
wounding. 
7.2.1.2    DN HaCaT cells display increased nuclear malleability which may 
infer a migration advantage in space restrictive Strata® Scaffolds.  
 
     Through the incorporation of DN HaCaT cells into two 3D scaffold systems displaying 
space-restrictive and non-restrictive environments, it was further observed that the DN 
HaCaT cells displayed a migration advantage over WT cells in the space-restrictive 
scaffolds (Figure 3.24 and 3.25). In contrast to this, DN HaCaT cells displayed a reduced 
migration potential compared to WT cells in the non-restrictive scaffolds (Figure 3.21 and 
3.22). When coupled with evidence in the literature suggesting that nuclear deformability 
constitutes a rate limiting step in migration through 3D environments [272], it can be 
suggested that the LINC disruptions present in DN HaCaT cells may further decrease the 
integrity of the NE. This suggestion is further supported by current hypothesis that LINC 
components may form an ‘outer nuclear cage’ through close associations between 
nesprin-1G, nesprin-2G and nesprin-3, similar to that of the nuclear lamina [101]. It is 
therefore possible that severing the SUN-KASH link may perturb this ONM structure, 
resulting in a decrease in nuclear ‘stiffness’. This would therefore provide an increased 
ability of DN HaCaT cells to squeeze through environments in which nuclear deformability 
would be required.  
     To increase our understanding as to why DN HaCaT cells displayed a migration 
advantage through space-restrictive 3D environments, AFM analysis was applied to 
assess the nuclear stiffness of WT and DN HaCaT cells. It was shown that DN HaCaT 
cells were significantly softer in comparison the WT cells, displaying nuclear young’s 
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moduli of 2.86 kPa and 4.97 kPa respectively (Figure 3.52). As there is no direct evidence 
suggesting SUN-KASH interactions infer NE stiffness, our data can be supported through 
evidence suggesting that LINC components are regulators of nuclear architecture [101, 
111]. We theorise that this loss of correct LINC function across the NE may lead to an 
increased malleability of the nucleus. Support for these propositions comes from 
investigations into cancer development, suggesting that in many high grade cancers, 
nuclear deformities including blebs and enlarged nuclei are prevalent. These 
abnormalities in nuclear structure suggest the LINC complex may be compromised. 
Further support for this theory comes from the assessment of cancerous breast tissue, 
suggested a significant down regulation of SUN1, SUN2, lamin A/C and nesprin-2 
expressions [203]. This hints at the possibility that one potential mechanism through which 
cancer cells may develop metastatic tendencies, could be through the loss of LINC 
components, subsequently increasing nuclear deformability. In addition to this, it was also 
found that the nuclei within both WT and DN HaCaT cells displayed a lower Young’s 
modulus value than the surrounding cytoplasm. This appears to contradict current views 
suggesting that the nucleus is the stiffest organelle [284, 285, 286, 287, 288]. However, 
the discrepancy observed could be due to the model cell line used in this investigation. 
The human keratinocyte HaCaT cell line has a large amount of keratin in its cytoplasm 
[289], which in turn could be a contributing factor to the increase cytoplasmic stiffness 
observed. This observation could further arise from the outer cytoplasmic regions 
assessed being much thinner than that of the central nuclear region. This could mean that 
the coverslip beneath the cell may have had more of an impact on the force 
measurements across these thinner cell regions due to there being less distance between 
the surface and basal regions of the cell.  
 
7.2.1.3    DN HaCaT cells display decreased stress signalling during growth 
in space restrictive growth environments aside increased cell stacking 
potential across the scaffolds surface.  
 
     Further investigations into known stress signalling marker expression levels were also 
conducted, in which increased phosphorylation levels of both P38 and JNK were found 
within the WT HaCaT cells grown within space-restrictive 3D scaffolds, but not found 
within the non-restrictive scaffolds or DN HaCaT cells (Figure 3.64). Limited literature is 
available to suggest that the LINC complex disruptions present within DN HaCaT cells 
could induce stress resistance properties, however, there is supporting evidence that 
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SUN-KASH disruption could result in a loss of mechano-transduction, and therefore, 
appropriate cellular responses to environmental cues [10, 281]. This therefore leads to 
suggestions that the LINC disruptions present in DN HaCaT cells may be the contributing 
factor for this observed colonisation of central scaffold regions, due to a loss of 
mechanotransduction, which in turn, impairs detection of the surrounding stress.    
     It was also evident that upon incorporation into the space-restrictive scaffolds, the DN 
HaCaT cells displayed an increased occurrence of cell stacking events across the surface 
of the scaffolds (Figure 3.28, 3.29 and 3.30). The role of nesprins in skin development and 
keratinocyte differentiation is not well understood, however, in muscle development, it has 
been shown that nesprins switch isoforms, replacing the larger nesprin isoforms with 
shorter isoforms across the nuclear envelope at specific stages [282]. The DN HaCaT 
cells display a disruption in endogenous SUN-KASH interactions. However, due to nesprin 
proteins displaying numerous isoforms, some of which do not express the KASH domain, 
this dominant negative interference approach may not disrupt the normal functioning of 
these isoforms, and may, in fact, increase their activity through redundancy mechanisms. 
As the functional roles of many KASH-less isoforms is not currently known, this theorised 
increase in activity may contribute the stimulation of early keratinocyte differentiation 
within the DN HaCaT cell lines.  
     Alternatively, this observed increase in cell stacking across the surface of the scaffold 
may also result from the increased levels of E-cadherin and increased cell density 
characterised in 2D. When coupled with potential mechanotransduction loss (suggested 
upon LINC complex disruptions [102]) and increased cell-cell adhesion, the DN HaCaT 
cells may display an impaired contact inhibition, leading to the proliferation of daughter 
cells into the only cell-free space available, yielding to an upwards trajectory. This 
however would need further validation through the assessment of contact inhibition 
signalling events, to investigate whether DN HaCaT cells do indeed display abnormal cell 
signalling when in close proximity to other cells.    
     Final findings indicated that significant protein expression differences could be seen 
between WT and DN HaCaT cells in lower N-terminal retaining isoforms of nesprin-1 
(specifically across the 90 kDa band) (Figure 3.61). This loss of the 90 kDa N-terminal 
isoform expression in DN HaCaT cells remained consistent across both 2D and space-
restrictive 3D environments. As it is well documented that multiple KASH and ABD 
retaining nesprin isoforms exist, able to infer tissue specific expression patterns and 
potential unique roles to cells [487, 80, 488], it could be suggested that the loss of lower 
N-terminal containing nesprin-2 isoforms may disrupt the organisation of the larger 
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nesprin-2G isoform across the ONM. This may result from a role of these lower isoforms 
functioning to retain the structural integrity of the LINC complex across the NE through 
aiding nesprin to nesprin interactions as suggested for an alternate role of nesprin-3 in the 
formation of an ONM nesprin cage [101].   
 
7.2.2    The incorporation of LINC disruptions into human 
keratinocyte cell lines increased penetration and differentiation 
potential when co-cultured in fibroblast-seeded scaffolds.  
7.2.2.1    DN HaCaT cells retain their increased penetration rates through 
space restrictive scaffold environments upon the introduction of co-cultured 
HDF cells. 
 
     In Chapter 4, the biological relevance of the migration models used thus far in chapters 
3 and 4 was increased by the inclusion of a pre-seeded fibroblast layer before 
keratinocyte seeding; with aims to greater reflect the in vivo skin environment. The data 
presented suggests that 1) the DN HaCaT cells retained their increased penetration 
potential over WT cells in both space-restrictive and non-restrictive co-cultures (Figures 
4.4, 4.5, 4.7 and 4.8), and 2) fibroblast incorporation into the scaffolds leads to an 
increase in cell stacking and differentiation across the surface of space-restrictive co-
culture systems (Figure 4.12 – 4.17). Aside this, it is also observed that the DN HaCaT 
cells retain their uniform penetration phenotypes through both space – restrictive and non 
– restrictive scaffolds as previously observed in Chapter 3. Through both Vimentin and 
K14 staining across the co-culture conditions, it can be seen that the fibroblast cells 
appear to collect across the leading edge of keratinocytes within the scaffolds (Figure 
4.6). These observations suggest that the keratinocytes may be pushing the fibroblast 
cells through the scaffold due to the limited space available to migrate within the system.    
     These observations do not directly correlate to current in vitro skin equivalent models 
as many of these systems apply fibroblasts, followed by a surface keratinocyte layer, 
displaying little to no migration through the basal fibroblast layer. However, this 
observation is supported within the cancer literature, through investigations aiming to 
increase understanding of the collective migration, by which cancer cells migrate as a 
collective sheet of cells. This collection of cells is able to develop uniform polarity, and 
defined front to rear asymmetry [432]. Evidence has suggested that during migration, this 
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mass of cells is able to stimulate an extracellular ‘pushing’ force on surrounding cells, 
forging a path for the trailing cancerous mass of cells to follow [433, 434]. Further to this, 
more recent investigations have highlighted that these pushing forces enabling ECM and 
cell remodelling comes from the formation of tube like structures in their surrounding by 
plastically deforming their surroundings through the use of both pushing and pulling forces 
[435]. This evidence could suggest that both WT and DN HaCaT cells exhibit potential 
phenotypes associated with cancer invasion, however, to fully verify this, live cell imaging 
techniques incorporating the use of light sheet technology could be employed, allowing 
the visualisation of both HaCaT and fibroblast cells in these 3D systems in real time. This 
technique would therefore provide more accurate information as to the interactions 
between both cell lines in this 3D co-culture environment.  
     The observed difference in penetration potential between WT and DN HaCaT cells 
upon incorporation into more in vivo like environments provides further support for current 
suggestions that nuclear stiffness may present a rate limiting step to cell migration through 
3D environments [272]. As previous data in Chapter 3 suggests DN HaCaT cells exhibit 
increased nuclear malleability, alongside current views in the literature suggesting LINC 
components are key to the maintenance of nuclear integrity [436], it is proposed that the 
decreased nuclear stiffness presented by LINC disrupted DN mutants enables increased 
cell penetration through this more in vivo like environment.  
     Aside this, it can also be suggested that the reduced migration potential displayed by 
the WT HaCaT cells may be a result of intercellular communication between the pre-
seeded fibroblast cells and the HaCaT cells. It is suggested that both paracrine and 
autocrine cross talk exists between keratinocytes and fibroblasts in epidermal regions of 
the skin [388], which in turn is able to influence keratinocyte behaviours, such as 
differentiation patterns and expression of interleukins [398]. This could further suggest that 
cross talk between the fibroblasts and keratinocytes may affect cell behaviour in these co-
culture environments, leading to reduced migration potential when compared to their 
single culture conditions. The DN HaCaT cells may further be unable to respond to these 
environmental cues due to a suggested loss of mechanotransduction upon LINC 
severance [15]. This theory supports our findings as little difference in final penetration 
potential after the full 14 days in culture is observed between DN HaCaT cells in single 
and co-culture conditions.     
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7.2.2.2    Under Co-culture conditions, the DN HaCaT cells display increased 
differentiation potential compared to that of the WT HaCaT cells and single 
culture conditions within space restrictive Scaffolds.  
 
     Interestingly however, the increased cell stacking and differentiation observed displays 
similarities to further findings in the literature, suggesting that specific loss of nesprin-2 in 
mouse epithelium resulted in decreased proliferation and differentiation events including 
Ca2+ induced protein kinase C (PKC) activation and MAPK signalling during wound 
closure [251, 278]. This evidence suggests that the loss of nesprin-2 mediated LINC 
connections may negatively affect mechanotransduction events, leading to an inability of 
cells to respond to extracellular cues dictating cellular behaviour. The resulting loss of 
LINC connections in DN mutants may therefore stimulate a loss mechanotransduction 
between nuclear and peripheral cell regions through cytoskeletal linkage to the NE 
mediated by nesprins. When coupled to data presented in Chapter 3, suggesting 
increased colony cohesion for DN HaCaT cells, this could suggest that LINC disrupted 
cells no longer express contact inhibition phenotypes. In support of this theory, mounting 
evidence is demonstrating that in skin, the development of malignant transformations in 
fibroblast and keratinocyte cells is characterised by a loss of contact inhibition function 
[489, 490]. This therefore provides mounting speculation that LINC complex 
destabilisation is a key process in the development of highly metastatic cancers.   
Upon further analysis, it can also be seen that both cell lines applied to the space – 
restrictive and non – restrictive scaffolds appear to display increased differentiation 
potential upon the incorporation of fibroblast cells to the system (Figures 4.12. and 4.13). 
It is suggested in the literature that no correlations have yet been made between the 
restrictive nature of 3D culturing models and differentiation potential of keratinocyte cells. 
However, it has been suggested that the stiffness of culturing environment is able to 
influence the cell-cell interactions and colony behaviour of keratinocytes [442]. It was 
shown that human neonatal epidermal keratinocytes (HEKn) grown on softer matrices, 
presented an increase in cell-cell adherence junction formation, alongside increased 
levels of β4 integrin expression when compared to cells grown on stiffer matrix 
environments. When applied to our observations, it is possible that fibroblast introduction 
to the restrictive scaffold may decrease the stiffness of surrounding matrix environments 
(as upon fibroblast inclusion, HaCaT cells are in direct contact with fibroblast cells and the 
ECM rather than the plastic scaffold). This decreased matrix stiffness could induce 
alterations in expression profiles for differentiation markers like K10 within the WT HaCaT 
cells. However, to fully verify this, further assessments as to protein expression would be 
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required using western blotting to assess whether there is indeed a change in K10 
expression, similar to that observed in alternate 3D skin equivalent models [403].  
 
7.2.2.3    Increased E-cadherin expression is observed across surface 
scaffold regions in DN HaCaT co-culture conditions, in comparison to the 
WT and non-restrictive culture conditions.  
 
     Final investigations in this chapter aimed to assess whether differences in E-Cadherin 
and YAP (Yes Associated Protein) expression exists across co-culture systems for both 
WT and DN HaCaT cells. It was observed that WT HaCaT cells appeared to display low 
levels of E-cadherin staining across all scaffold regions, correlated with uniform YAP 
staining. In contrast however, the DN HaCaT cells appeared to display an increased E-
cadherin expression, alongside a further increase in YAP expression (Figure 4.16). This 
increased E-cadherin expression for DN HaCaT cells could potentially infer the observed 
increased migration potential displayed in Figures 4.7 and 4.8. These increased E-
cadherin levels alongside increased migration penetration appears to correlate with 
phenotypes of cancer cells during metastatic invasion of surrounding tissues. Aside EMT, 
some cancer cells migrate as a collective body of cells, with increased E-cadherin levels 
observed [445]. When further combined with literature suggesting that increases in YAP 
expression can be associated with cancer progression [446, 447], aside a loss of contact 
inhibition [448], it can be suggested that the combination of both E-cadherin and YAP 
expression differences between WT and DN HaCaT, alongside increased nuclear 
malleability in DN mutant cells, may be a contributing factor allowing DN HaCaT cells to 
migrate through these co-culture environments.   
     Interestingly it is further shown that when both WT and DN HaCaT cells are placed into 
the more restrictive scaffold environments, E-cadherin expression appears to be localised 
across surface scaffold regions correlating to regions of cell stacking, with WT cells 
expressing a weaker signal than that of the DN HaCaT cells (Figure 4.17). It is further 
shown that YAP staining appears to remain consistent with observations in non-restrictive 
co-culture conditions, with DN HaCaT cells displaying increased levels to that of WT 
HaCaT cells. These observations appear to support current views within the literature, 
suggesting that increased expression of E-cadherin levels at the cell periphery is a 
determining factor in keratinocyte differentiation across in vitro systems [449]. One 
potential explanation for the increased peripheral E-cadherin expression in DN HaCaT 
cells could be due to the LINC roles in connecting the NE to cell periphery through 
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associated cytoskeletal interactions [450, 451]. LINC disrupted mutants may sever the 
direct signal transduction link between cell-cell adhesion junctions and the NE, resulting in 
altered regulation of adherens junction proteins like E-cadherin. However, to validate this 
further, complex protein analysis would be required through the application of western 
blotting techniques in order to assess the extent of these observed protein variations.    
 
7.2.3    The loss of lower C-terminal retaining nesprin-1 and -2 
isoforms is shown to correlate with breast cancer development.  
7.2.3.1    Variations between LINC and cytoskeletal proteins are observed 
across the range of cancer lines, with correlations between increased cancer 
grade and nesprin loss evident. 
 
     In Chapter 5, the protein expression profiles and cellular localisation of LINC complex 
components was assessed across a range of breast cancer cell lines and primary tissues, 
highlighting two major findings. Firstly, through cell line analysis, it was observed that 
protein localisation of many LINC components was retained including lamin A/C, SUN2 
and lamin B (Figure 5.11 - 5.15), however significant miss-localisation of C-terminal 
nesprin-2 staining was highlighted (Figure 5.21 and 5.22). As no direct evidence has yet 
been reported for the exact localisation of LINC components upon cancer progression, it 
can be suggested that due to known roles of nesprin-2 in the regulation of nuclear 
architecture through maintaining SUN-KASH interactions [171, 41], a disruption to 
expression profiles of alternate LINC components (such as nesprin-1/-3 or -4) may 
dislodge or outcompete nesprin-2 C-terminal KASH domains for SUN interactions (Similar 
to that displayed in our DN HaCaT mutant). This may then stimulate a displacement of C-
terminal isoforms of nesprin-2 from the NE to the ER, or alternatively, a complete 
severance of these proteins from the NE into the cytoplasm.  
     Further to this it was shown that cytoskeletal organisation, specifically the actin protein 
network, but not protein expression levels appear to vary between the cancer grades 
(Figure 5.6 and 5.7). These observations support current views that reorganisation of the 
actin cytoskeleton is critical for invasive cancer behaviour [345, 346]. With more current 
literature suggesting the importance of ARF6 mediated Rac1 accumulation at the cell 
periphery, stimulating actin cytoskeletal re-organisation in the development high-grade 
metastatic phenotypes [347]. It can be suggested that the observed accumulation of actin 
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at peripheral areas of MDA-MB-231 cells could be a result of increased Rac1 activity, as 
Rac1 promotes actin polymerisation during lamellipodia extension, through activating the 
Arp2/3 activator WAVE, alongside increasing actin monomer availability through 
regulating cofilin (an F-actin modulator) [348]. This provides more F-actin available to aid 
in cell mobility. 
     Aside the actin cytoskeletal network, further observations suggested variability also 
exists in both protein expression and cellular organisation (Figures 5.9 and 5.10). 
Interestingly, observations in vimentin specifically appear to contradict views of the current 
literature. It is suggested that vimentin is a key marker for EMT transition, in which 
epithelial cells reduce expression levels of keratin IFs and increase expression levels of 
vimentin IFs [349]. With further evidence suggesting vimentin expression is associated 
with the development of mesenchymal shape development and increased motility [350], it 
is suggested that MDA-MB-231 cells should be high expressers of this protein. It is 
possible however, that due to their time in a non-restrictive 2D culture environment, and 
the MDA-MB-231 cells may be in a process of reverting their EMT switch in IF expression, 
slowly increasing expression of keratins whilst decreasing vimentin expression.    
     These observed organisational defects in cytokeratin components do however link 
closely with current literature views, suggesting that within multiple disease models, 
cytoskeletal organisation is reorganised, allowing alterations in cellular migration potential 
and function, such as within the EMT, proposed to be one hallmark displayed during 
metastatic cancer development [351]. Further evidence suggests that the intermediate 
filament and actin networks play crucial roles in maintaining cellular architecture, in which 
loss of functionality can stimulate cellular deformities and loss of cellular stiffness [352], a 
further potential hallmark of metastatic cancers.  
 
7.2.3.2    Expression of the oncogenic marker p53 appears to increase upon 
cancer progression aside variable expression patterns of E-cadherin, a 
protein often associated with the progression of EMT. 
 
     Aside protein networks associated with the cytoskeleton, further analysis was 
conducted to investigate expression levels of known oncogenic markers often associated 
with EMT and poor patient prognosis. It was found that an increased expression of p53 
was observed upon cancer progression, whereas E-cadherin displayed variable 
expression patterns across the cell lines assessed (Figure 5.26). This increased 
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accumulation of p53 across the increasing grades of breast cancer cell lines correlates 
with known literature, suggesting that the increased accumulation of p53 is linked to the 
loss of BRAC1 and 2 protein expression [360], which is a known marker for high 
metastatic breast cancers. Alongside this, lap2α upregulation has been further linked to 
the development of high-grade breast cancer formation [361], which again, is supported 
by our findings.  
     E-cadherin on the other hand was shown to displays a more complex picture. Loss of 
E-cadherin is a known marker of EMT, which is speculated as a hallmark of highly 
metastatic cancers, allowing penetration through surrounding tissues and to distant bodily 
regions. However, further evidence now suggests that loss of E-cadherin is mostly 
associated with the development of high-grade triple negative breast cancers [332], with 
further cancer phenotypes expressing equal or even more E-cadherin levels within 
metastatic tumour sites. Our data correlates closely with this, highlighting reduced E-
cadherin expression within the triple negative breast cancer cell line, and variable 
expression patterns through other samples suggesting that between across low- and 
medium grade breast cancer lines (MCF7, T47D, HCC-38) E-cadherin expression is 
retained, suggesting the maintenance of normal epithelial cell-cell adherence junctions. 
 
7.2.3.3    Known heat shock proteins displays variable expression levels 
across a range of cancer cell lines. 
 
     Within this chapter, we further aimed to assess whether correlations in expression 
patterns across known heat shock proteins and chaperones could be identified as cancer 
grade increases. Initially it was found that levels of CRYAB displayed increased 
expression levels within the two control cell lines. These obtained results appear to 
contradict current literature views which suggest an increased expression level of CRYAB 
upon metastatic cancer development [362]. However, recent evidence is beginning to 
suggest that even though levels of CYRAB are found within highly aggressive breast 
cancer forms, no direct prognosis correlation can be found between these and the 
metastatic potential of the cancer [363, ,364]. Alongside this, further evidence links the 
expression of CRYAB and VEGF regulation, in which the disruption of interactions 
between CRYAB and VEGF signalling through the insertion of NCL-41356 stimulated 
reduced tumour vascularisation [365]. This could therefore suggest that CRYAB regulation 
may not be a causative factor in the development of cancerous phenotypes, but rather a 
resulting factor, deriving from alternate changes in gene/protein expression events.   
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     Interestingly we also found further variations in HSP27 expression levels; in which 
high-grade breast cancer cell lines expressed reduced expression levels, whereas low-
grade breast cancers display an upregulation in comparison to their control counterparts 
using the monoclonal ACD5-HSP27 antibody. This again appears to contradict current 
views within the literature, suggesting that the up regulation of HSP27 may stimulate an 
increase in resistance against apoptosis [366], which is a major target for many anti-
cancer drugs. This therefore suggests that observed increases in HSP27 levels upon 
cancer development has also been further attributed to tumour vascularisation [367].  
     Finally, the expression levels of GFAP across breast cancer cell lines was also 
assessed, displaying increased expression profiles across each cancer cell line apart from 
MDA-MB-231 line, which expressed a significant decreased in protein expression. 
Interestingly it has been demonstrated that GFAP expression may be cell specific, through 
which immuno-histochemical analysis has identified localised expression to a small 
subpopulation of myoepithelial cells in normal and cancerous breast tissue  [368]. It was 
suggested that these GFAP levels increase within this subpopulation upon an increase in 
cancer severity, suggesting its potential roles as a prognostic marker of cancer 
aggressiveness, however, due to its localised expression, biopsies from varying tissue 
regions in the breast may yield conflicting results, similar to that potentially experienced in 
our results across the range of breast cancer cell lines.   
     Most strikingly however, our follow on research into further LINC associated protein 
organisation directly correlated to evidence in the literature, in which we demonstrated 
that C-terminal isoform expression of nesprin-2 appears to decrease in high-grade breast 
cancer tissue in comparison to low-grade and control tissues (Figure 5.43 – 5.47). This 
same result was observed by Matsumoto et al. [203], in which decrease levels of nesprin-
2 was observed across high-grade breast cancer tissues. It is therefore potential that the 
loss of these LINC components may be required for cancer development. However, 
whether nesprin is a causative or resulting factor in this process is yet to be seen. It is our 
current belief that the loss of the LINC connections results in disruptions to the nesprin 
cage situated across the ONM (proposed by Lu et al. [101]), which in turn decreases 
nuclear stiffness. It is suggested that this increased nuclear malleability enhances a cells 
ability to migrate through tumour environments and surrounding tissue (which present 
space-restrictive environments), allowing cancer cells to migrate to other bodily areas. 
Due to this, we propose that these LINC disruptions aid in the development of metastatic 
behaviours in the cancer cells, however, they may not be the causative factor of cancer 
development itself.  
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     Further western blotting analysis supported immunofluorescence observations in which 
variability between LINC complex protein expression patterns and cancer stage was 
observed (Figure 5.16 – 5.25). However, for the majority of proteins such as SUN1, lamin 
A/C and nesprin-3, no discernible correlation could be seen between the expression 
profile and breast cancer severity, similar to that observed through the literature [203]. For 
nesprin-2 C-terminal staining however, a clear decrease in expression was identified for 
lower isoforms upon cancer development (Figure 5.19). This, coupled with western blot 
analysis displayed in Figures 5.18 and 5.23 suggests an important role played by the 
lower C- and N-terminal retaining nesprin-1/-2 isoforms in cancer development, and more 
specifically in the potential regulation of larger nesprin-1/-2 isoforms. Loss of these protein 
regions may de-stabilise the NE through disrupting the distribution and level of nesprin-1/-
2G across the ONM, resulting in an imbalance of force-transduction between intra and 
extra-nuclear regions. It is further possible that as nesprin-1 has been implicated in 
regulating DNA damage repair, the loss of lower isoform expression upon cancer 
development may impair DNA damage repair through loss of associated interactions with 
proteins involved in the DNA damage response pathway, including MSH2 and MSH6 
[162]. 
  
7.2.4    Nup88 is an upstream regulator and binding partner of 
nesprin-2.   
7.2.4.1    Nup88 displays close cellular associations to nesprin-2 C-terminal 
regions, supporting suggestions from previous yeast-two hybrid data that 
these two proteins physically interact.  
 
     The results presented in Chapter 6 help combine the findings from across Chapters 3,4 
and 5 through investigating whether nesprin-2 C-terminal regions display interacting 
potential with Nup88, as dysregulation of both proteins has been suggested in the 
development of high grade cancer progression. A combination of immuno-fluorescence 
and biochemical analysis techniques showed that nesprin-2 C-terminal regions presented 
close cellular localisation and binding potential with Nup88 (across the last 4 SRs of 
nesprin-2 C-terminal) (Figures 6.5 – 6.10). This verifies suggestions presented by 
Schneider et al. [77], in which yeast two-hybrid screening suggested the existence of this 
interacting potential between nesprin-2 C-terminal regions and Nup88. Although the yeast 
two-hybrid data suggests that the observed interaction is direct, and that the Nup88 
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interactome displays common binding partners to that of nesprin-2 (e.g. lamin A/C and 
KLC1) [230, 491], it remains unclear whether the interaction observed is direct between 
the two proteins, or mediated through an intermediary protein.   
     Alongside this, it was further shown that close associations also exist between the C-
terminal region of nesprin-2 and the NPC marker Mab414. This potential localisation is not 
well characterised in the literature, however associations between the nesprin binding 
partner SUN1 and NPCs have been suggested [475], in which SUN1 RNAi knockdowns 
were shown to stimulate NPC clustering. Due to nesprin to SUN binding being mediated 
through SUN-KASH domain interactions, this high degree of co-localisation could be 
expected due to the C-terminal nesprin-2 antibody (pAbk1) targeting regions in close 
proximity to the KASH binding site. Further support for this observation is also suggested 
due to associations between the NPC protein Nup88 and lamin across the INM [230]. This 
association could mean that further NPC components stained in the Mab414 display close 
associations to nesprin C-terminal domains found bound indirectly to the lamin network 
through SUN associations. However, to further validate this observation, electron 
microscopy techniques could be used alongside immuno-gold labelling in order to 
visualise the NPC in more detail, therefore providing a more accurate representation of 
this close association. 
 
7.2.4.2    Nup88 may act as an upstream regulator of lower nesprin isoforms, 
as increased expression of Nup88 is associated with decreased nesprin-2 
expression.  
 
     It was further shown that through in vitro up-regulation of pEGFP-Nup88 fusions, that 
nesprin-2G was down regulated (Figure 6.13). These findings appear to strongly 
correlates with evidence presented by Hashizume et al. suggesting that the in vitro 
overexpression of full length Nup88 expressing a GFP tag into HeLa cells stimulated a 
significant increase in multinucleated cell development [476]. This finding is similar to the 
in vivo situations observed in high-grade breast cancer development, in which increased 
Nup88 levels are shown to closely correlate to increased cancer aggression and 
metastatic potential [467, 468, 470,  477, 492]. When collated with known whole genome 
and exome analysis suggesting SYNE genes are highly mutated in multiple cancers [195, 
198, 197, 196], and breast tissue assessment displaying reduced nesprin-2 expressions 
[203], it is suggested that Nup88 may play regulatory roles on the expression of nesprin-2. 
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It can be suggested that Nup88 upregulation may down regulate nesprin-2 through two 
potential regulatory mechanisms. Firstly, direct Nup88 interactions with nesprin-2 may 
potentially lead to its degradation, however, to this date; no links between Nup88 and 
SUMO signalling have been established, however, the Nup88 binding partner Nup358 has 
been shown to act as a SUMO (small ubiquitin-related modifier) [493]. This suggests 
potential roles of the Nup88/Nup358 complex in targeting nesprin-2 for degradation. 
However, no direct evidence for this action has yet been shown. Alternatively, Nup88 
attachment to nesprin-2 could further alter its conformation across the NE, leading to 
alterations in nesprin topology across the ONM. The second mechanism by which Nup88 
may regulate nesprin-2 is through the direct regulation of nesprin-2 gene transcription. 
Support for this comes from suggestive roles of Nup88 in the regulation of gene 
expression across multiple higher eukaryotes [458], suggesting that increased levels of 
Nup88 may directly reduce nesprin-2 transcription levels, and subsequently nesprin-2 
protein levels in the cell.  
     One final observation from this experimental section further displays potential co-
localisation between the microtubule associated motor protein KLC1 and Nup88 across 
the cytoplasm of the cells. This finding appears to support evidence in the literature, 
suggesting that an interacting potential exists between KLC1 and Nup214 (a Nup88 
binding partner) [203], suggesting that these observed co-localisations may arise through 
Nup214 mediated binding. Further investigations however, would need to be conducted to 
validate this potential co-localisation through biochemical analysis methods including 
GST-pulldowns using KLC1 fragments published previously [77] alongside 
immunoprecipitation assays. This would therefore provide a clear indication as to whether 
a physical binding potential existed between Nup88 and KLC1. 
     For further detailed discussion of the experimental findings generated in this thesis, 
please refer to each of the primary results chapters.  
 
7.3    Theorised model - loss of correct nesprin 
localisation across the ONM leads to decreased nuclear 
stiffness and subsequent increased metastatic potential 
during cancer development.  
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     The data presented in this thesis suggests that the maintenance of LINC complex 
connections across the NE is a crucial factor in maintaining normal cellular function. It was 
shown that disruption to this complex protein network leads to the development of a 
decrease in nuclear stiffness, abnormal cell-cell/cell-substratum attachments, increased 
migration potentials and increased cell-stacking and differentiation under air-liquid 
interface conditions. Due to the known complexity of LINC complex function in the cell, it 
is difficult to discern direct mechanisms as to how this network of proteins can affect the 
development of cancer.  
     However, through further investigations suggesting Nup88 may be an upstream 
regulator of nesprin-2, alongside smaller isoforms displaying the largest decrease in 
expression profiles upon cancer progression, we propose the following model.  
     As previously suggested by Lu et al. [101], nesprin-1G, -2G and nesprin-3 form a 
potential ONM cage across the NE, able to regulate nuclear size and shape. We 
suggested that the smaller KASH containing nesprin-1/-2 isoforms function to anchor the 
giant isoforms across the NE, through interactions with SR regions. Upon Nup88 
upregulation (often a characteristic of high grade cancers), a down-regulation of nesprin-
2G is induced. Nesprin-2 down-regulation may come from Nup88 directly affecting the 
transcriptional regulation of lower nesprin-1/-2 isoforms, which in turn leads to a 
displacement of giant nesprin isoforms across the NE due to a loss of NE anchors. 
Alternatively, Nup88 may affect the regulation of giant nesprin isoforms through Nup358 
mediated SUMO degradation, leading to nesprin loss. Both models consistently suggest a 
disruption to the proposed ONM nesprin cage, which in turn reduces the NE integrity. This 
reduced integrity may allow intranuclear forces pushing against the INM to increase 
nuclear size and further disrupt nuclear architecture (characteristics of cancerous nuclei). 
These sequences of events may in turn decreases nuclear stiffness, and subsequently 
increase migration potential through space-restrictive environments (Figure 7.1).  
     Further to this, these LINC disruptions may present a more complicated picture, as it 
was further suggested that these disruptions to the LINC complex impaired the cells ability 
to interpret environmental cues and constraints. It was suggested that the DN mutants 
were unable to detect the potential damaging effects of migrating through restrictive 
scaffold environments, evident through stress signalling alterations. It can therefore be 
proposed that as a cancer cell initially loses nuclear stiffness and begins to migrate 
through surrounding tissue environments, it may be unable to detect further damage to 
the cell, which in turn could perpetuate further DNA damage, leading to the increased 
development of cancerous phenotypes.   
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Figure 7.1: Theorised model for the roles of lower KASH containing nesprin-1/-2 isoforms 
situated across the ONM in the maintenance of nuclear architecture. It is suggested that in normal 
nuclei, nesprin-1/-2/-3 interactions across the ONM form a cage like lattice similar to that of the 
INM localised lamina. The giant isoforms of both nesprin-1 and -2 are anchored across their 
length to the NE through SR interactions with lower KASH-retaining nesprin-1/-2 isoforms (A). 
Upon Nup88 upregulation or genetic abnormalities associated with cancer development, these 
lower nesprin-1/-2 KASH-retaining isoforms are down-regulated and displaced from the NE into 
the surrounding cytoplasm, resulting in a loss of anchoring for the giant nesprin isoforms. This 
stimulates either a loss of LINC complex order across the NE, resulting in miss-localised 
positioning of SUN-KASH complexes (B). It is also possible that loss of these lower isoforms may 
result in loss of ONM integrity. As the nucleus is under constant force, it is possible intranuclear 
forces may increase nuclear size in regions where no connections between INM and ONM exist 
(areas without NPC’s or SUN-SKASH interactions) (C) due to the nesprin cage no longer being 
able to counteract this force. This could therefore result in nuclear enlargement in specific nuclear 
regions, stimulating the formation of nuclear blebbing. Both instances in (B) and (C) would disrupt 
LINC complex function in maintaining nuclear architecture, alongside reducing nuclear stiffness. 
343 | P a g e  
 
7.4    Conclusions. 
 
     In conclusion, the work presented in this thesis has demonstrated that the 
maintenance of LINC complex connections across the NE is critical in maintaining normal 
cellular architecture in 2D culture environments. The further application of synthetic 3D 
culture technologies demonstrated that these LINC complex disruptions present in DN 
mutants may also be a determining factor in cellular migration potential through potentially 
damaging space-restrictive environments, due to an increased nuclear malleability.  
     This increased nuclear malleability, and resulting increase in migration potential links 
closely to migration properties of high-grade, metastatic cancers, through which 
penetration into surrounding tissue is enhanced. Investigating both immunofluorescence 
localisation and expression levels of LINC complex proteins (notably nesprin-1/-2), 
suggests that upon cancer development, the expression patterns of lower C-terminal 
retaining nesprin-1/-2 isoforms is decreased. It can therefore be concluded that the 
retention of lower C-terminal nesprin-1/-2 isoforms may be required for the correct 
assembly of LINC complex interactions surrounding the ONM. Loss of these lower 
isoforms may therefore provide a hallmark of metastasis development across a range of 
high-grade breast cancers, leading to a decrease in nuclear stiffness due to the loss of 
correct LINC complex assemblies.   
 
7.5    Future Work. 
 
     The results presented in this thesis highlight several key areas of further work which 
would help expanding our knowledge of LINC complex roles in nuclear stiffness, 
keratinocyte differentiation potential and breast cancer metastasis. 
 
7.5.1    Further experiments arising from Chapter 3. 
 
     As it was identified that DN HaCaT cells presented increased migration potentials in 
the more space-restrictive scaffolds, it was suggested that their increased nuclear 
malleability lead to these observed advantages. However, current data has only 
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highlighted this in snapshots through time point analysis. Therefore to expand on this 
work, further investigations should aim to investigate the mechanisms as to how cells 
migrate through 3D culture environments, as the exact mechanisms to how nuclei deform 
during restrictive-pore migration are not well understood.  
     As the scaffold materials employed in our investigations display opaque properties, it is 
difficult to assess live cell motility through both phase contrast and fluorescence 
techniques during cell migration. It is therefore suggested that the use of light sheet 
technology is applied. This microscopy technique is designed to investigate fluorescent 
signals within thick tissue samples [494, 495], and is therefore well suited to our culture 
systems. Live cell imaging of NE markers, MT, IF and actin networks could be applied to 
both WT and DN HaCaT cells in order to visualise nuclear behaviour during migration 
through space-restrictive interconnects. This would therefore provide further insight into 
how cells manipulate their nuclei in 3D migratory environments, alongside alluding to roles 
of the LINC complex in this process, which could prove invaluable for designing future 
therapeutic targets able to inhibit metastatic behaviours displayed by many cancer cells 
[496, 283].   
     From this Chapter, it was also suggested that upon culture in space-restrictive scaffold 
environments, WT HaCaT cells, but not DN HaCaT cells displayed increased expression 
levels of stress associated signalling proteins (p38 and JNK). This suggested that 1) these 
environments pose a potential damaging environment, and 2) the DN HaCaT cells may 
have been unable to sense the damaging effects of the surrounding environment, and 
therefore were unable to respond accordingly. From this evidence, it is suggested that 
further experimentation is needed in order to detect whether further DNA damage can be 
detected in cells migrating through these scaffolds. We propose that if migration through 
space-restrictive environments could induce DNA damage, then this could lead to 
increased levels of DNA damage in cancer cells during early stages of metastasis, which 
in turn may increase the cancerous phenotype through perpetual DNA damage. To verify 
this, DN and WT HaCaT cells should be stained for three well characterised DNA damage 
markers; a biotinylated oligonucleotide hairpin probe (HPP), an antibody against single 
stranded DNA (ssDNA) and detection of double stranded DNA (dsDNA) breaks through 
terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) staining [497]. 
This would therefore verify whether DNA damage is also occurring during migration 
through these environments, leading to further increases in migration potential.  
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7.5.2    Further experiments arising from Chapter 4.  
 
     One key finding within this investigation was that the production of a simplified co-
culture model pre-seeded with human dermal fibroblasts lead to limited changes in the 
penetration potential displayed by the DN HaCaT cells in comparison to bare scaffolds 
tested in Chapter 3. However, this model presented limited similarities to the in vivo 
situation found in normal epidermis, so to increase the biological relevance of our findings, 
the use of more advanced 3D skin models could be applied to further investigations, 
similar to that developed by Carlson et al. [498]. This model builds the skin equivalent 
across a surface of collagen, which more accurately represents the basement membrane 
of the epidermis. Following this, fibroblast and keratinocyte cells are seeded and 
maintained in culture at the air-liquid interface. The use of this system would allow us to 
investigate whether the DN HaCaT cells express similar behavioural phenotypes when not 
faced with synthetic polystyrene environments. Further to this, it is also possible to 
investigate the differences in cell behaviour between WT and DN HaCaT cells in the same 
model. For example, following fibroblast seeding, a heterogeneous population of DN and 
WT HaCaT cells could be seeded onto the fibroblast layer and lifted to the air-liquid 
interface. Due to the DN HaCaT cells expressing GFP-SUN1, it would be easy to identify 
these cells within the heterogeneous culture, meaning that through the use of live cell 
imaging techniques such as light sheet microscopy, direct comparisons could be made 
between WT and DN HaCaT cells within the system. This would therefore allow cell-cell 
interactions, migration behaviour and differentiation potential to be directly compared 
between the two cells. In addition, it may also provide further use as a disease model, 
allowing the investigation as to whether these LINC disrupted DN HaCaT cells express 
similar migration behaviours to that of squamous-cell carcinomas, therefore leading to 
further suggestions as to roles for LINC components in the development of cancerous 
phenotypes.     
     It was further shown in this chapter that the DN HaCaT cells appeared to display and 
increased cell-stacking and differentiation potential to their WT counterparts, when grown 
at the air-liquid interface in space-restrictive scaffolds. We suggest that this increased cell 
stacking phenotype in DN HaCaT cells is a result of increased E-cadherin with potential 
loss of contact inhibition, leading to daughter cells proliferating into the only available 
space, up. However, previous data has shown that both WT and DN HaCaT cells display 
equal levels of E-cadherin when maintained in 3D culture environments, at the point of 
initial seeding, DN HaCaT cells will express higher levels of E-cadherin due to our data 
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suggesting that in 2D culture, DN HaCaT express increased E-cadherin levels. To validate 
that contact inhibition is perturbed in these DN HaCaT cells however, protein expression 
levels of both WT and DN HaCaT cells would need to be assessed, through specifically 
investigating whether p27Kip1 expression changes.  
     The growth arrest in contact inhibition is stimulated by p27Kip1 cyclin dependant 
cyclase, which binds cyclin CDK complexes, inferring G1 arrest in the cell cycle [499, 500, 
501]. Therefore, we would expect a decrease expression of p27Kip1 in DN HaCaT cells if 
contact inhibition is disrupted, similar to that expressed by multiple cancer cells [502]. This 
investigation would therefore help decipher whether the observed cell stacking and 
subsequent differentiation events displayed by the LINC disrupted DN HaCaT cells are 
indeed a result in perturbations in contact inhibition signalling pathways.  
     Further findings in this chapter demonstrated that YAP (a key component of the hippo 
signalling pathway) expression also appeared to differ between the two cell lines, 
however, it was unclear whether this expression change correlated to a switch in 
localisation from cytoplasmic to nuclear. To verify whether YAP signalling is indeed 
perturbed in the DN HaCaT cells, fractionated western blotting to select nuclear and 
cytoplasmic proteins could be assessed between the two cell lines grown in space-
restrictive scaffolds [503]. This would allow the identification as to whether 1) the 
expression profiles of YAP do indeed change between the WT and DN HaCaT cells, and 
2) whether YAP localisation is altered between the two cell lines. This would help increase 
our understanding as to roles of the LINC complex in maintaining Hippo signalling, a 
pathway known to regulate cell proliferation in response to extracellular cues [504].  
 
7.5.3    Further experiments arising from Chapter 5. 
 
     In Chapter 5, one of the key findings was the reduction in nesprin-2 C-terminal 
isoforms expression profiles across high grade breast cancer tissues using 
immunofluorescence analysis; however immunofluorescence analysis only provides an 
indication as the expression levels of proteins, and due to this, further analysis is needed. 
To verify that the loss in immunofluorescence stains in triple negative tissues correlates to 
a reduction in protein expression levels, and not for example alterations in protein 
confirmation or aa sequence, resulting in impaired antibody binding, further western blot 
analysis should be conducted. Western blot assessment for C-terminal nesprin-2 isoform 
expression patterns across primary breast tissue lysates will help to increase our 
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understanding of changes in isoform expression patterns during cancer development, and 
assess whether there is a sequential loss of total C-terminal retaining nesprin-2 isoforms, 
or only select isoforms. Further to this, it is also suggested to conduct RT-PCR across 
these tissue samples, in order to gain an understanding as to whether the observed loss 
of nesprin-2 expression via immunofluorescence analysis is a result of reduced mRNA 
expression within cells.  
     A further key observation within this chapter was the identification of a loss of lower 
nesprin-1/-2 isoform expression profiles in cancerous cell lines. Very little is currently 
known about the functional roles played by the lower nesprin-1/-2 isoforms, and therefore 
their identification and subsequent sequence characterisation would be a key aspect in 
future work. To gain an indication as to their potential roles in the cell, and whether they 
do indeed play a role in maintaining nuclear stiffness, their domain compositions and 
cellular localisation would need to be assessed. This would require the production of 
antibodies specific to unique regions of these isoforms and subsequent imaging through 
super resolution microscopy to identify whether they are situated across the INM or ONM. 
Following their identified localisation in the cell, further experimental analysis would need 
to be conducted to gain an insight into their potential binding partners, therefore gaining 
an insight into their potential functions in the cell. This could be conducted through the use 
of GST-Pull down and immunoprecipitation assays, allowing the identification of possible 
interacting partners and cell/tissue localisation of these interactions.  
     Aside this, further rescue experiments would need to be conducted to assess whether 
the expression of these shorter nesprin-1/-2 isoforms could increase the nuclear stiffness, 
and subsequently reduce migration potential of high grade cancer cell lines such as MDA-
MB-231 within space-restrictive scaffolds. For example, if a hypothetical lower nesprin-1 
isoform contained the sequence SR1, SR2, SR3, SR4 followed by a C-terminal KASH 
domain, constructs could be made expressing each SR alone, alongside combinations 
(i.e. SR1, or SR2+SR3). These constructs could then be inserted into MDA-MB-231 cells 
and their effects on nuclear stiffness and migration tested, to see if their insertion 
displayed a significant effect. If a positive correlation is identified between specific regions 
and reduced migration potential/increased nuclear stiffness, following investigations would 
aim to assess the functional roles played by these SR regions, through yeast two-hybrid 
screening. This would then allow the full characterisation of the roles played by these 
lower-isoforms, and provide an indication as to their potential roles in the development of 
cancer phenotypes, either verifying or contradicting views within this thesis and the 
literature [496], suggesting that nuclear stiffness may constitute a rate limiting step in 3D 
cell migration, and that these properties are regulated through LINC complex connections.  
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7.5.4    Further experiments arising from Chapter 6. 
 
     In Chapter 6, it was shown that Nup88 displays physical interacting potential with the 
C-terminal region of nesprin-2, alongside further suggestions that Nup88 may acts as an 
upstream regulator of nesprin-2. However, the mechanism by which Nup88 regulates 
nesprin-2 is still unclear. One suggested hypothesis is that the physical interaction of 
Nup88 may stimulate the degradation of nesprin-2 through decreasing the proximity of 
Nup88s binding partner Nup358 and nesprin-2. It was suggested that due to Nup358s role 
as a small ubiquitin-like modifier (SUMO), it may be responsible for the degradation of 
nesprin-2 upon Nup88 upregulation. Follow on investigations would test this through 
transfections of Nup358 into cellular systems such as HaCaT cells, followed by 
subsequent western blot protein analysis. If a marked decrease in nesprin-2 levels is 
observed, then it provides supporting evidence for this hypothesis that Nup88 
overexpression may induce increased Nup358 degradation activity on nesprin-2 within the 
cells.       
 
 
 
 
 
 
 
 
 
 
 
349 | P a g e  
 
8. References 
[1] J. M. Berg, J. L. Tymoczko, and L. Stryer, “Eukaryotic Transcription and Translation 
Are Separated in Space and Time.” W H Freeman, 2002. 
[2] S. G. Brohawn, J. R. Partridge, J. R. R. Whittle, and T. U. Schwartz, “The nuclear 
pore complex has entered the atomic age.,” Structure, vol. 17, no. 9, pp. 1156–68, 
Sep. 2009. 
[3] D. Görlich and U. Kutay, “Transport between the cell nucleus and the cytoplasm.,” 
Annu. Rev. Cell Dev. Biol., vol. 15, pp. 607–60, Jan. 1999. 
[4] S. D. Speese, J. Ashley, V. Jokhi, J. Nunnari, R. Barria, Y. Li, B. Ataman, A. Koon, 
Y.-T. Chang, Q. Li, M. J. Moore, and V. Budnik, “Nuclear envelope budding enables 
large ribonucleoprotein particle export during synaptic Wnt signaling.,” Cell, vol. 
149, no. 4, pp. 832–46, May 2012. 
[5] A. Rose and C. Schlieker, “Alternative nuclear transport for cellular protein quality 
control.,” Trends Cell Biol., vol. 22, no. 10, pp. 509–14, Oct. 2012. 
[6] D. E. Ingber, “Tensegrity: the architectural basis of cellular mechanotransduction.,” 
Annu. Rev. Physiol., vol. 59, pp. 575–99, Jan. 1997. 
[7] S. Antoku, R. Zhu, S. Kutscheidt, O. T. Fackler, and G. G. Gundersen, “Reinforcing 
the LINC complex connection to actin filaments: the role of FHOD1 in TAN line 
formation and nuclear movement.,” Cell Cycle, pp. 1–6, Jun. 2015. 
[8] S. Alam, D. B. Lovett, R. B. Dickinson, K. J. Roux, and T. P. Lele, “Nuclear forces 
and cell mechanosensing.,” Prog. Mol. Biol. Transl. Sci., vol. 126, pp. 205–15, Jan. 
2014. 
[9] S. Neumann, M. Schneider, R. L. Daugherty, C. J. Gottardi, S. A. Eming, A. Beijer, 
A. A. Noegel, and I. Karakesisoglou, “Nesprin-2 interacts with {alpha}-catenin and 
regulates Wnt signaling at the nuclear envelope.,” J. Biol. Chem., vol. 285, no. 45, 
pp. 34932–8, Nov. 2010. 
[10] E. C. Tapley and D. A. Starr, “Connecting the nucleus to the cytoskeleton by SUN-
KASH bridges across the nuclear envelope.,” Curr. Opin. Cell Biol., vol. 25, no. 1, 
pp. 57–62, Feb. 2013. 
[11] M. L. Lombardi and J. Lammerding, “Keeping the LINC: the importance of 
nucleocytoskeletal coupling in intracellular force transmission and cellular 
function.,” Biochem. Soc. Trans., vol. 39, no. 6, pp. 1729–34, Dec. 2011. 
[12] H. J. Worman and G. Bonne, “‘Laminopathies’: a wide spectrum of human 
diseases.,” Exp. Cell Res., vol. 313, no. 10, pp. 2121–33, Jun. 2007. 
[13] I. Méndez-López and H. J. Worman, “Inner nuclear membrane proteins: impact on 
human disease.,” Chromosoma, vol. 121, no. 2, pp. 153–67, Apr. 2012. 
350 | P a g e  
 
[14] D. A. Starr and H. N. Fridolfsson, “Interactions between nuclei and the cytoskeleton 
are mediated by SUN-KASH nuclear-envelope bridges.,” Annu. Rev. Cell Dev. 
Biol., vol. 26, pp. 421–44, Jan. 2010. 
[15] W. Chang, H. J. Worman, and G. G. Gundersen, “Accessorizing and anchoring the 
LINC complex for multifunctionality.,” J. Cell Biol., vol. 208, no. 1, pp. 11–22, Jan. 
2015. 
[16] S. J. King, K. Nowak, N. Suryavanshi, I. Holt, C. M. Shanahan, and A. J. Ridley, 
“Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration.,” 
Cytoskeleton (Hoboken)., vol. 71, no. 7, pp. 423–34, Jul. 2014. 
[17] J. T. Patel, A. Bottrill, S. L. Prosser, S. Jayaraman, K. Straatman, A. M. Fry, and S. 
Shackleton, “Mitotic phosphorylation of SUN1 loosens its connection with the 
nuclear lamina while the LINC complex remains intact.,” Nucleus, vol. 5, no. 5, pp. 
462–73, Jan. . 
[18] R. de la Fuente, M. Manterola, A. Viera, M. T. Parra, M. Alsheimer, J. S. Rufas, and 
J. Page, “Chromatin organization and remodeling of interstitial telomeric sites 
during meiosis in the Mongolian gerbil (Meriones unguiculatus).,” Genetics, vol. 
197, no. 4, pp. 1137–51, Aug. 2014. 
[19] N. Stuurman, S. Heins, and U. Aebi, “Nuclear lamins: their structure, assembly, and 
interactions.,” J. Struct. Biol., vol. 122, no. 1–2, pp. 42–66, Jan. 1998. 
[20] Q. S. Padiath, K. Saigoh, R. Schiffmann, H. Asahara, T. Yamada, A. Koeppen, K. 
Hogan, L. J. Ptácek, and Y.-H. Fu, “Lamin B1 duplications cause autosomal 
dominant leukodystrophy.,” Nat. Genet., vol. 38, no. 10, pp. 1114–23, Oct. 2006. 
[21] A. Robinson, D. Partridge, A. Malhas, S. C. P. De Castro, P. Gustavsson, D. N. 
Thompson, D. J. Vaux, A. J. Copp, P. Stanier, A. G. Bassuk, and N. D. E. Greene, 
“Is LMNB1 a susceptibility gene for neural tube defects in humans?,” Birth Defects 
Res. A. Clin. Mol. Teratol., vol. 97, no. 6, pp. 398–402, Jun. 2013. 
[22] S. Sun, M. Z. Xu, R. T. Poon, P. J. Day, and J. M. Luk, “Circulating Lamin B1 
(LMNB1) biomarker detects early stages of liver cancer in patients.,” J. Proteome 
Res., vol. 9, no. 1, pp. 70–8, Jan. 2010. 
[23] L. Liu, J. Wang, L. Shi, W. Zhang, X. Du, Z. Wang, and Y. Zhang, “β-Asarone 
induces senescence in colorectal cancer cells by inducing lamin B1 expression.,” 
Phytomedicine, vol. 20, no. 6, pp. 512–20, Apr. 2013. 
[24] U. Wazir, M. H. Ahmed, J. M. Bridger, A. Harvey, W. G. Jiang, A. K. Sharma, and 
K. Mokbel, “The clinicopathological significance of lamin A/C, lamin B1 and lamin B 
receptor mRNA expression in human breast cancer.,” Cell. Mol. Biol. Lett., vol. 18, 
no. 4, pp. 595–611, Dec. 2013. 
[25] L. Li, Y. Du, X. Kong, Z. Li, Z. Jia, J. Cui, J. Gao, G. Wang, and K. Xie, “Lamin B1 is 
a novel therapeutic target of betulinic acid in pancreatic cancer.,” Clin. Cancer Res., 
vol. 19, no. 17, pp. 4651–61, Sep. 2013. 
[26] J. L. Broers, B. M. Machiels, H. J. Kuijpers, F. Smedts, R. van den Kieboom, Y. 
Raymond, and F. C. Ramaekers, “A- and B-type lamins are differentially expressed 
351 | P a g e  
 
in normal human tissues.,” Histochem. Cell Biol., vol. 107, no. 6, pp. 505–17, Jun. 
1997. 
[27] V. K. Parnaik and K. Manju, “Laminopathies: multiple disorders arising from defects 
in nuclear architecture.,” J. Biosci., vol. 31, no. 3, pp. 405–21, Sep. 2006. 
[28] H. J. Worman, “Nuclear lamins and laminopathies.,” J. Pathol., vol. 226, no. 2, pp. 
316–25, Jan. 2012. 
[29] F. Haque, D. J. Lloyd, D. T. Smallwood, C. L. Dent, C. M. Shanahan, A. M. Fry, R. 
C. Trembath, and S. Shackleton, “SUN1 interacts with nuclear lamin A and 
cytoplasmic nesprins to provide a physical connection between the nuclear lamina 
and the cytoskeleton.,” Mol. Cell. Biol., vol. 26, no. 10, pp. 3738–51, May 2006. 
[30] C. Ostlund, E. S. Folker, J. C. Choi, E. R. Gomes, G. G. Gundersen, and H. J. 
Worman, “Dynamics and molecular interactions of linker of nucleoskeleton and 
cytoskeleton (LINC) complex proteins.,” J. Cell Sci., vol. 122, no. Pt 22, pp. 4099–
108, Nov. 2009. 
[31] G. W. G. Luxton, E. R. Gomes, E. S. Folker, H. J. Worman, and G. G. Gundersen, 
“TAN lines: a novel nuclear envelope structure involved in nuclear positioning.,” 
Nucleus, vol. 2, no. 3, pp. 173–81, Jan. 2011. 
[32] V. C. Padmakumar, T. Libotte, W. Lu, H. Zaim, S. Abraham, A. A. Noegel, J. 
Gotzmann, R. Foisner, and I. Karakesisoglou, “The inner nuclear membrane protein 
Sun1 mediates the anchorage of Nesprin-2 to the nuclear envelope.,” J. Cell Sci., 
vol. 118, no. Pt 15, pp. 3419–30, Aug. 2005. 
[33] M. Crisp, Q. Liu, K. Roux, J. B. Rattner, C. Shanahan, B. Burke, P. D. Stahl, and D. 
Hodzic, “Coupling of the nucleus and cytoplasm: role of the LINC complex.,” J. Cell 
Biol., vol. 172, no. 1, pp. 41–53, Jan. 2006. 
[34] T. Sullivan, D. Escalante-Alcalde, H. Bhatt, M. Anver, N. Bhat, K. Nagashima, C. L. 
Stewart, and B. Burke, “Loss of A-type lamin expression compromises nuclear 
envelope integrity leading to muscular dystrophy.,” J. Cell Biol., vol. 147, no. 5, pp. 
913–20, Nov. 1999. 
[35] C. Coffinier, S. Y. Chang, C. Nobumori, Y. Tu, E. A. Farber, J. I. Toth, L. G. Fong, 
and S. G. Young, “Abnormal development of the cerebral cortex and cerebellum in 
the setting of lamin B2 deficiency.,” Proc. Natl. Acad. Sci. U. S. A., vol. 107, no. 11, 
pp. 5076–81, Mar. 2010. 
[36] C. Coffinier, H.-J. Jung, C. Nobumori, S. Chang, Y. Tu, R. H. Barnes, Y. Yoshinaga, 
P. J. de Jong, L. Vergnes, K. Reue, L. G. Fong, and S. G. Young, “Deficiencies in 
lamin B1 and lamin B2 cause neurodevelopmental defects and distinct nuclear 
shape abnormalities in neurons.,” Mol. Biol. Cell, vol. 22, no. 23, pp. 4683–93, Dec. 
2011. 
[37] Q. Zhang, C. Bethmann, N. F. Worth, J. D. Davies, C. Wasner, A. Feuer, C. D. 
Ragnauth, Q. Yi, J. A. Mellad, D. T. Warren, M. A. Wheeler, J. A. Ellis, J. N. 
Skepper, M. Vorgerd, B. Schlotter-Weigel, P. L. Weissberg, R. G. Roberts, M. 
Wehnert, and C. M. Shanahan, “Nesprin-1 and -2 are involved in the pathogenesis 
352 | P a g e  
 
of Emery Dreifuss muscular dystrophy and are critical for nuclear envelope 
integrity.,” Hum. Mol. Genet., vol. 16, no. 23, pp. 2816–33, Dec. 2007. 
[38] S. Osmanagic-Myers, T. Dechat, and R. Foisner, “Lamins at the crossroads of 
mechanosignaling.,” Genes Dev., vol. 29, no. 3, pp. 225–37, Feb. 2015. 
[39] J. M. . Mislow, J. M. Holaska, M. S. Kim, K. K. Lee, M. Segura-Totten, K. L. Wilson, 
and E. M. McNally, “Nesprin-1α self-associates and binds directly to emerin and 
lamin A in vitro,” FEBS Lett., vol. 525, no. 1–3, pp. 135–140, Aug. 2002. 
[40] Q. Zhang, C. D. Ragnauth, J. N. Skepper, N. F. Worth, D. T. Warren, R. G. 
Roberts, P. L. Weissberg, J. A. Ellis, and C. M. Shanahan, “Nesprin-2 is a multi-
isomeric protein that binds lamin and emerin at the nuclear envelope and forms a 
subcellular network in skeletal muscle.,” J. Cell Sci., vol. 118, no. Pt 4, pp. 673–87, 
Feb. 2005. 
[41] S. Kandert, Y. Lüke, T. Kleinhenz, S. Neumann, W. Lu, V. M. Jaeger, M. Munck, M. 
Wehnert, C. R. Müller, Z. Zhou, A. A. Noegel, M.-C. Dabauvalle, and I. 
Karakesisoglou, “Nesprin-2 giant safeguards nuclear envelope architecture in 
LMNA S143F progeria cells.,” Hum. Mol. Genet., vol. 16, no. 23, pp. 2944–59, Dec. 
2007. 
[42] M. A. Wheeler, J. D. Davies, Q. Zhang, L. J. Emerson, J. Hunt, C. M. Shanahan, 
and J. A. Ellis, “Distinct functional domains in nesprin-1alpha and nesprin-2beta 
bind directly to emerin and both interactions are disrupted in X-linked Emery-
Dreifuss muscular dystrophy.,” Exp. Cell Res., vol. 313, no. 13, pp. 2845–57, Aug. 
2007. 
[43] S. Gudise, R. A. Figueroa, R. Lindberg, V. Larsson, and E. Hallberg, “Samp1 is 
functionally associated with the LINC complex and A-type lamina networks.,” J. Cell 
Sci., vol. 124, no. Pt 12, pp. 2077–85, Jun. 2011. 
[44] J. Borrego-Pinto, T. Jegou, D. S. Osorio, F. Auradé, M. Gorjánácz, B. Koch, I. W. 
Mattaj, and E. R. Gomes, “Samp1 is a component of TAN lines and is required for 
nuclear movement.,” J. Cell Sci., vol. 125, no. Pt 5, pp. 1099–105, Mar. 2012. 
[45] C. Ostlund, T. Sullivan, C. L. Stewart, and H. J. Worman, “Dependence of 
diffusional mobility of integral inner nuclear membrane proteins on A-type lamins.,” 
Biochemistry, vol. 45, no. 5, pp. 1374–82, Feb. 2006. 
[46] D. Tunnah, C. A. Sewry, D. Vaux, E. C. Schirmer, and G. E. Morris, “The apparent 
absence of lamin B1 and emerin in many tissue nuclei is due to epitope masking.,” 
J. Mol. Histol., vol. 36, no. 5, pp. 337–44, Jun. 2005. 
[47] A. J. Koch and J. M. Holaska, “Loss of emerin alters myogenic signaling and 
miRNA expression in mouse myogenic progenitors.,” PLoS One, vol. 7, no. 5, p. 
e37262, Jan. 2012. 
[48] J. M. Holaska and K. L. Wilson, “Multiple roles for emerin: implications for Emery-
Dreifuss muscular dystrophy.,” Anat. Rec. A. Discov. Mol. Cell. Evol. Biol., vol. 288, 
no. 7, pp. 676–80, Jul. 2006. 
353 | P a g e  
 
[49] K. L. Wilson, J. M. Holaska, R. Montes de Oca, K. Tifft, M. Zastrow, M. Segura-
Totten, M. Mansharamani, and L. Bengtsson, “Nuclear membrane protein emerin: 
roles in gene regulation, actin dynamics and human disease.,” Novartis Found. 
Symp., vol. 264, pp. 51–58; discussion 58–62, 227–30, Jan. 2005. 
[50] W. Chang, E. S. Folker, H. J. Worman, and G. G. Gundersen, “Emerin organizes 
actin flow for nuclear movement and centrosome orientation in migrating 
fibroblasts.,” Mol. Biol. Cell, vol. 24, no. 24, pp. 3869–80, Dec. 2013. 
[51] I. Hagan and M. Yanagida, “The product of the spindle formation gene sad1+ 
associates with the fission yeast spindle pole body and is essential for viability.,” J. 
Cell Biol., vol. 129, no. 4, pp. 1033–47, May 1995. 
[52] C. J. Malone, W. D. Fixsen, H. R. Horvitz, and M. Han, “UNC-84 localizes to the 
nuclear envelope and is required for nuclear migration and anchoring during C. 
elegans development.,” Development, vol. 126, no. 14, pp. 3171–81, Jun. 1999. 
[53] M. J. Puckelwartz, E. Kessler, Y. Zhang, D. Hodzic, K. N. Randles, G. Morris, J. U. 
Earley, M. Hadhazy, J. M. Holaska, S. K. Mewborn, P. Pytel, and E. M. McNally, 
“Disruption of nesprin-1 produces an Emery Dreifuss muscular dystrophy-like 
phenotype in mice.,” Hum. Mol. Genet., vol. 18, no. 4, pp. 607–20, Feb. 2009. 
[54] E. Göb, J. Schmitt, R. Benavente, and M. Alsheimer, “Mammalian sperm head 
formation involves different polarization of two novel LINC complexes.,” PLoS One, 
vol. 5, no. 8, p. e12072, Jan. 2010. 
[55] C.-H. Yeh, P.-L. Kuo, Y.-Y. Wang, Y.-Y. Wu, M.-F. Chen, D.-Y. Lin, T.-H. Lai, H.-S. 
Chiang, and Y.-H. Lin, “SEPT12/SPAG4/LAMINB1 complexes are required for 
maintaining the integrity of the nuclear envelope in postmeiotic male germ cells.,” 
PLoS One, vol. 10, no. 3, p. e0120722, Jan. 2015. 
[56] E. C. Tapley, N. Ly, and D. A. Starr, “Multiple mechanisms actively target the SUN 
protein UNC-84 to the inner nuclear membrane.,” Mol. Biol. Cell, vol. 22, no. 10, pp. 
1739–52, May 2011. 
[57] A. Rothballer, T. U. Schwartz, and U. Kutay, “LINCing complex functions at the 
nuclear envelope: what the molecular architecture of the LINC complex can reveal 
about its function.,” Nucleus, vol. 4, no. 1, pp. 29–36, Jan. . 
[58] B. A. Sosa, A. Rothballer, U. Kutay, and T. U. Schwartz, “LINC complexes form by 
binding of three KASH peptides to domain interfaces of trimeric SUN proteins.,” 
Cell, vol. 149, no. 5, pp. 1035–47, May 2012. 
[59] W. Wang, Z. Shi, S. Jiao, C. Chen, H. Wang, G. Liu, Q. Wang, Y. Zhao, M. I. 
Greene, and Z. Zhou, “Structural insights into SUN-KASH complexes across the 
nuclear envelope.,” Cell Res., vol. 22, no. 10, pp. 1440–52, Oct. 2012. 
[60] E. Göb, E. Meyer-Natus, R. Benavente, and M. Alsheimer, “Expression of individual 
mammalian Sun1 isoforms depends on the cell type.,” Commun. Integr. Biol., vol. 4, 
no. 4, pp. 440–2, Jul. 2011. 
354 | P a g e  
 
[61] D. M. Hodzic, D. B. Yeater, L. Bengtsson, H. Otto, and P. D. Stahl, “Sun2 is a novel 
mammalian inner nuclear membrane protein.,” J. Biol. Chem., vol. 279, no. 24, pp. 
25805–12, Jun. 2004. 
[62] K. K. Lee, D. Starr, M. Cohen, J. Liu, M. Han, K. L. Wilson, and Y. Gruenbaum, 
“Lamin-dependent localization of UNC-84, a protein required for nuclear migration 
in Caenorhabditis elegans.,” Mol. Biol. Cell, vol. 13, no. 3, pp. 892–901, Mar. 2002. 
[63] S. Hasan, S. Güttinger, P. Mühlhäusser, F. Anderegg, S. Bürgler, and U. Kutay, 
“Nuclear envelope localization of human UNC84A does not require nuclear 
lamins.,” FEBS Lett., vol. 580, no. 5, pp. 1263–8, Feb. 2006. 
[64] D. Jahn, S. Schramm, M. Schnölzer, C. J. Heilmann, C. G. de Koster, W. Schütz, 
R. Benavente, and M. Alsheimer, “A truncated lamin A in the Lmna -/- mouse line: 
implications for the understanding of laminopathies.,” Nucleus, vol. 3, no. 5, pp. 
463–74, Jan. . 
[65] Y. Turgay, R. Ungricht, A. Rothballer, A. Kiss, G. Csucs, P. Horvath, and U. Kutay, 
“A classical NLS and the SUN domain contribute to the targeting of SUN2 to the 
inner nuclear membrane.,” EMBO J., vol. 29, no. 14, pp. 2262–75, Jul. 2010. 
[66] F. Haque, D. Mazzeo, J. T. Patel, D. T. Smallwood, J. A. Ellis, C. M. Shanahan, 
and S. Shackleton, “Mammalian SUN protein interaction networks at the inner 
nuclear membrane and their role in laminopathy disease processes.,” J. Biol. 
Chem., vol. 285, no. 5, pp. 3487–98, Jan. 2010. 
[67] Z. Zhou, X. Du, Z. Cai, X. Song, H. Zhang, T. Mizuno, E. Suzuki, M. R. Yee, A. 
Berezov, R. Murali, S.-L. Wu, B. L. Karger, M. I. Greene, and Q. Wang, “Structure 
of Sad1-UNC84 homology (SUN) domain defines features of molecular bridge in 
nuclear envelope.,” J. Biol. Chem., vol. 287, no. 8, pp. 5317–26, Feb. 2012. 
[68] B. A. Sosa, A. Rothballer, U. Kutay, and T. U. Schwartz, “LINC complexes form by 
binding of three KASH peptides to domain interfaces of trimeric SUN proteins.,” 
Cell, vol. 149, no. 5, pp. 1035–47, May 2012. 
[69] Z. Jahed, H. Shams, and M. R. K. Mofrad, “A Disulfide Bond Is Required for the 
Transmission of Forces through SUN-KASH Complexes.,” Biophys. J., vol. 109, no. 
3, pp. 501–9, Aug. 2015. 
[70] M. Schneider, A. A. Noegel, and I. Karakesisoglou, “KASH-domain proteins and the 
cytoskeletal landscapes of the nuclear envelope.,” Biochem. Soc. Trans., vol. 36, 
no. Pt 6, pp. 1368–72, Dec. 2008. 
[71] H. Xiong, F. Rivero, U. Euteneuer, S. Mondal, S. Mana-Capelli, D. Larochelle, A. 
Vogel, B. Gassen, and A. A. Noegel, “Dictyostelium Sun-1 connects the 
centrosome to chromatin and ensures genome stability.,” Traffic, vol. 9, no. 5, pp. 
708–24, May 2008. 
[72] I. Schulz, O. Baumann, M. Samereier, C. Zoglmeier, and R. Gräf, “Dictyostelium 
Sun1 is a dynamic membrane protein of both nuclear membranes and required for 
centrosomal association with clustered centromeres.,” Eur. J. Cell Biol., vol. 88, no. 
11, pp. 621–38, Nov. 2009. 
355 | P a g e  
 
[73] K. Graumann and D. E. Evans, “Plant SUN domain proteins: components of 
putative plant LINC complexes?,” Plant Signal. Behav., vol. 5, no. 2, pp. 154–6, 
Feb. 2010. 
[74] K. Zhou and W. Hanna-Rose, “Movers and shakers or anchored: Caenorhabditis 
elegans nuclei achieve it with KASH/SUN.,” Dev. Dyn., vol. 239, no. 5, pp. 1352–
64, May 2010. 
[75] W. Lu, J. Gotzmann, L. Sironi, V.-M. Jaeger, M. Schneider, Y. Lüke, M. Uhlén, C. 
A.-K. Szigyarto, A. Brachner, J. Ellenberg, R. Foisner, A. A. Noegel, and I. 
Karakesisoglou, “Sun1 forms immobile macromolecular assemblies at the nuclear 
envelope.,” Biochim. Biophys. Acta, vol. 1783, no. 12, pp. 2415–26, Dec. 2008. 
[76] D. A. Starr and J. A. Fischer, “KASH ’n Karry: the KASH domain family of cargo-
specific cytoskeletal adaptor proteins.,” Bioessays, vol. 27, no. 11, pp. 1136–46, 
Nov. 2005. 
[77] M. Schneider, W. Lu, S. Neumann, A. Brachner, J. Gotzmann, A. A. Noegel, and I. 
Karakesisoglou, “Molecular mechanisms of centrosome and cytoskeleton 
anchorage at the nuclear envelope.,” Cell. Mol. Life Sci., vol. 68, no. 9, pp. 1593–
610, May 2011. 
[78] K. J. Roux, M. L. Crisp, Q. Liu, D. Kim, S. Kozlov, C. L. Stewart, and B. Burke, 
“Nesprin 4 is an outer nuclear membrane protein that can induce kinesin-mediated 
cell polarization.,” Proc. Natl. Acad. Sci. U. S. A., vol. 106, no. 7, pp. 2194–9, Feb. 
2009. 
[79] E. D. Apel, R. M. Lewis, R. M. Grady, and J. R. Sanes, “Syne-1, a dystrophin- and 
Klarsicht-related protein associated with synaptic nuclei at the neuromuscular 
junction.,” J. Biol. Chem., vol. 275, no. 41, pp. 31986–95, Oct. 2000. 
[80] N. T. Duong, G. E. Morris, L. T. Lam, Q. Zhang, C. A. Sewry, C. M. Shanahan, and 
I. Holt, “Nesprins: tissue-specific expression of epsilon and other short isoforms.,” 
PLoS One, vol. 9, no. 4, p. e94380, Jan. 2014. 
[81] J. A. Mellad, D. T. Warren, and C. M. Shanahan, “Nesprins LINC the nucleus and 
cytoskeleton.,” Curr. Opin. Cell Biol., vol. 23, no. 1, pp. 47–54, Feb. 2011. 
[82] J. M. K. Mislow, J. M. Holaska, M. S. Kim, K. K. Lee, M. Segura-Totten, K. L. 
Wilson, and E. M. McNally, “Nesprin-1alpha self-associates and binds directly to 
emerin and lamin A in vitro.,” FEBS Lett., vol. 525, no. 1–3, pp. 135–40, Aug. 2002. 
[83] M. H. Wilson and E. L. F. Holzbaur, “Nesprins anchor kinesin-1 motors to the 
nucleus to drive nuclear distribution in muscle cells.,” Development, vol. 142, no. 1, 
pp. 218–28, Jan. 2015. 
[84] M. H. Wilson and E. L. F. Holzbaur, “Nesprins anchor kinesin-1 motors to the 
nucleus to drive nuclear distribution in muscle cells.,” Development, vol. 142, no. 1, 
pp. 218–28, Jan. 2015. 
[85] A. Morimoto, H. Shibuya, X. Zhu, J. Kim, K. Ishiguro, M. Han, and Y. Watanabe, “A 
conserved KASH domain protein associates with telomeres, SUN1, and dynactin 
during mammalian meiosis.,” J. Cell Biol., vol. 198, no. 2, pp. 165–72, Jul. 2012. 
356 | P a g e  
 
[86] K. Wilhelmsen, S. H. M. Litjens, I. Kuikman, N. Tshimbalanga, H. Janssen, I. van 
den Bout, K. Raymond, and A. Sonnenberg, “Nesprin-3, a novel outer nuclear 
membrane protein, associates with the cytoskeletal linker protein plectin.,” J. Cell 
Biol., vol. 171, no. 5, pp. 799–810, Dec. 2005. 
[87] R. Gräf, P. Batsios, and I. Meyer, “Evolution of centrosomes and the nuclear 
lamina: Amoebozoan assets.,” Eur. J. Cell Biol., vol. 94, no. 6, pp. 249–56, Apr. 
2015. 
[88] A. Méjat and T. Misteli, “LINC complexes in health and disease.,” Nucleus, vol. 1, 
no. 1, pp. 40–52, Jan. 2010. 
[89] H. Lodish, A. Berk, S. L. Zipursky, P. Matsudaira, D. Baltimore, and J. Darnell, 
“Molecular Cell Biology.” W. H. Freeman, 2000. 
[90] A. O. Sperry, “The dynamic cytoskeleton of the developing male germ cell.,” Biol. 
Cell, vol. 104, no. 5, pp. 297–305, May 2012. 
[91] S. V Strelkov, H. Herrmann, and U. Aebi, “Molecular architecture of intermediate 
filaments.,” Bioessays, vol. 25, no. 3, pp. 243–51, Mar. 2003. 
[92] D. A. Starr and M. Han, “Role of ANC-1 in tethering nuclei to the actin 
cytoskeleton.,” Science, vol. 298, no. 5592, pp. 406–9, Oct. 2002. 
[93] G. W. G. Luxton, E. R. Gomes, E. S. Folker, E. Vintinner, and G. G. Gundersen, 
“Linear arrays of nuclear envelope proteins harness retrograde actin flow for 
nuclear movement.,” Science, vol. 329, no. 5994, pp. 956–9, Aug. 2010. 
[94] S. Kutscheidt, R. Zhu, S. Antoku, G. W. G. Luxton, I. Stagljar, O. T. Fackler, and G. 
G. Gundersen, “FHOD1 interaction with nesprin-2G mediates TAN line formation 
and nuclear movement.,” Nat. Cell Biol., vol. 16, no. 7, pp. 708–15, Jul. 2014. 
[95] E. R. Gomes, S. Jani, and G. G. Gundersen, “Nuclear movement regulated by 
Cdc42, MRCK, myosin, and actin flow establishes MTOC polarization in migrating 
cells.,” Cell, vol. 121, no. 3, pp. 451–63, May 2005. 
[96] G. W. G. Luxton, E. R. Gomes, E. S. Folker, H. Worman, and G. G. Gundersen, 
“TAN lines,” Nucleus, vol. 2, no. 3, pp. 173–181, Oct. 2014. 
[97] G. G. Gundersen and H. J. Worman, “Nuclear positioning.,” Cell, vol. 152, no. 6, pp. 
1376–89, Mar. 2013. 
[98] D. Rajgor, J. A. Mellad, D. Soong, J. B. Rattner, M. J. Fritzler, and C. M. Shanahan, 
“Mammalian microtubule P-body dynamics are mediated by nesprin-1.,” J. Cell 
Biol., vol. 205, no. 4, pp. 457–75, May 2014. 
[99] H. F. Horn, D. I. Kim, G. D. Wright, E. S. M. Wong, C. L. Stewart, B. Burke, and K. 
J. Roux, “A mammalian KASH domain protein coupling meiotic chromosomes to 
the cytoskeleton.,” J. Cell Biol., vol. 202, no. 7, pp. 1023–39, Sep. 2013. 
[100] X. Zhang, K. Lei, X. Yuan, X. Wu, Y. Zhuang, T. Xu, R. Xu, and M. Han, “SUN1/2 
and Syne/Nesprin-1/2 complexes connect centrosome to the nucleus during 
357 | P a g e  
 
neurogenesis and neuronal migration in mice.,” Neuron, vol. 64, no. 2, pp. 173–87, 
Oct. 2009. 
[101] W. Lu, M. Schneider, S. Neumann, V.-M. Jaeger, S. Taranum, M. Munck, S. 
Cartwright, C. Richardson, J. Carthew, K. Noh, M. Goldberg, A. A. Noegel, and I. 
Karakesisoglou, “Nesprin interchain associations control nuclear size.,” Cell. Mol. 
Life Sci., vol. 69, no. 20, pp. 3493–509, Oct. 2012. 
[102] M. L. Lombardi, D. E. Jaalouk, C. M. Shanahan, B. Burke, K. J. Roux, and J. 
Lammerding, “The interaction between nesprins and sun proteins at the nuclear 
envelope is critical for force transmission between the nucleus and cytoskeleton.,” 
J. Biol. Chem., vol. 286, no. 30, pp. 26743–53, Jul. 2011. 
[103] J. T. Morgan, E. R. Pfeiffer, T. L. Thirkill, P. Kumar, G. Peng, H. N. Fridolfsson, G. 
C. Douglas, D. A. Starr, and A. I. Barakat, “Nesprin-3 regulates endothelial cell 
morphology, perinuclear cytoskeletal architecture, and flow-induced polarization.,” 
Mol. Biol. Cell, vol. 22, no. 22, pp. 4324–34, Nov. 2011. 
[104] R. B. Dickinson, S. Neelam, and T. P. Lele, “Dynamic, mechanical integration 
between nucleus and cell- where physics meets biology.,” Nucleus, Sep. 2015. 
[105] A. L. Olins, M. Zwerger, H. Herrmann, H. Zentgraf, A. J. Simon, M. Monestier, and 
D. E. Olins, “The human granulocyte nucleus: Unusual nuclear envelope and 
heterochromatin composition.,” Eur. J. Cell Biol., vol. 87, no. 5, pp. 279–90, May 
2008. 
[106] J. Lammerding, J. Hsiao, P. C. Schulze, S. Kozlov, C. L. Stewart, and R. T. Lee, 
“Abnormal nuclear shape and impaired mechanotransduction in emerin-deficient 
cells.,” J. Cell Biol., vol. 170, no. 5, pp. 781–91, Aug. 2005. 
[107] J. Liu, T. Rolef Ben-Shahar, D. Riemer, M. Treinin, P. Spann, K. Weber, A. Fire, 
and Y. Gruenbaum, “Essential roles for Caenorhabditis elegans lamin gene in 
nuclear organization, cell cycle progression, and spatial organization of nuclear 
pore complexes.,” Mol. Biol. Cell, vol. 11, no. 11, pp. 3937–47, Nov. 2000. 
[108] M. Eriksson, W. T. Brown, L. B. Gordon, M. W. Glynn, J. Singer, L. Scott, M. R. 
Erdos, C. M. Robbins, T. Y. Moses, P. Berglund, A. Dutra, E. Pak, S. Durkin, A. B. 
Csoka, M. Boehnke, T. W. Glover, and F. S. Collins, “Recurrent de novo point 
mutations in lamin A cause Hutchinson-Gilford progeria syndrome.,” Nature, vol. 
423, no. 6937, pp. 293–8, May 2003. 
[109] A. E. Rusiñol and M. S. Sinensky, “Farnesylated lamins, progeroid syndromes and 
farnesyl transferase inhibitors.,” J. Cell Sci., vol. 119, no. Pt 16, pp. 3265–72, Aug. 
2006. 
[110] M. P. Mallampalli, G. Huyer, P. Bendale, M. H. Gelb, and S. Michaelis, “Inhibiting 
farnesylation reverses the nuclear morphology defect in a HeLa cell model for 
Hutchinson-Gilford progeria syndrome.,” Proc. Natl. Acad. Sci. U. S. A., vol. 102, 
no. 40, pp. 14416–21, Oct. 2005. 
[111] B. C. Capell, M. R. Erdos, J. P. Madigan, J. J. Fiordalisi, R. Varga, K. N. Conneely, 
L. B. Gordon, C. J. Der, A. D. Cox, and F. S. Collins, “Inhibiting farnesylation of 
progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria 
358 | P a g e  
 
syndrome.,” Proc. Natl. Acad. Sci. U. S. A., vol. 102, no. 36, pp. 12879–84, Sep. 
2005. 
[112] A. Kaufmann, F. Heinemann, M. Radmacher, and R. Stick, “Amphibian oocyte 
nuclei expressing lamin A with the progeria mutation E145K exhibit an increased 
elastic modulus.,” Nucleus, vol. 2, no. 4, pp. 310–9, Jan. 2011. 
[113] J. Lammerding, L. G. Fong, J. Y. Ji, K. Reue, C. L. Stewart, S. G. Young, and R. T. 
Lee, “Lamins A and C but not lamin B1 regulate nuclear mechanics.,” J. Biol. 
Chem., vol. 281, no. 35, pp. 25768–80, Sep. 2006. 
[114] D. Ferrera, C. Canale, R. Marotta, N. Mazzaro, M. Gritti, M. Mazzanti, S. Capellari, 
P. Cortelli, and L. Gasparini, “Lamin B1 overexpression increases nuclear rigidity in 
autosomal dominant leukodystrophy fibroblasts.,” FASEB J., vol. 28, no. 9, pp. 
3906–18, Sep. 2014. 
[115] Y. Lüke, H. Zaim, I. Karakesisoglou, V. M. Jaeger, L. Sellin, W. Lu, M. Schneider, 
S. Neumann, A. Beijer, M. Munck, V. C. Padmakumar, J. Gloy, G. Walz, and A. A. 
Noegel, “Nesprin-2 Giant (NUANCE) maintains nuclear envelope architecture and 
composition in skin.,” J. Cell Sci., vol. 121, no. Pt 11, pp. 1887–98, Jun. 2008. 
[116] S. Kandert, Y. Lüke, T. Kleinhenz, S. Neumann, W. Lu, V. M. Jaeger, M. Munck, M. 
Wehnert, C. R. Müller, Z. Zhou, A. A. Noegel, M.-C. Dabauvalle, and I. 
Karakesisoglou, “Nesprin-2 giant safeguards nuclear envelope architecture in 
LMNA S143F progeria cells.,” Hum. Mol. Genet., vol. 16, no. 23, pp. 2944–59, Dec. 
2007. 
[117] N. E. Cain, E. C. Tapley, K. L. McDonald, B. M. Cain, and D. A. Starr, “The SUN 
protein UNC-84 is required only in force-bearing cells to maintain nuclear envelope 
architecture.,” J. Cell Biol., vol. 206, no. 2, pp. 163–72, Jul. 2014. 
[118] N. E. Cain and D. A. Starr, “SUN proteins and nuclear envelope spacing.,” Nucleus, 
vol. 6, no. 1, pp. 2–7, Jan. 2015. 
[119] N. R. Morris, “Nuclear Migration: From Fungi to the Mammalian Brain,” J. Cell Biol., 
vol. 148, no. 6, pp. 1097–1102, Mar. 2000. 
[120] A. Yamamoto and Y. Hiraoka, “Cytoplasmic dynein in fungi: insights from nuclear 
migration.,” J. Cell Sci., vol. 116, no. Pt 22, pp. 4501–12, Nov. 2003. 
[121] R. B. Vallee and J.-W. Tsai, “The cellular roles of the lissencephaly gene LIS1, and 
what they tell us about brain development.,” Genes Dev., vol. 20, no. 11, pp. 1384–
93, Jun. 2006. 
[122] S. Reinsch and P. Gönczy, “Mechanisms of nuclear positioning.,” J. Cell Sci., vol. 
111 ( Pt 1, pp. 2283–95, Aug. 1998. 
[123] K. L. Weber, A. M. Sokac, J. S. Berg, R. E. Cheney, and W. M. Bement, “A 
microtubule-binding myosin required for nuclear anchoring and spindle assembly.,” 
Nature, vol. 431, no. 7006, pp. 325–9, Sep. 2004. 
359 | P a g e  
 
[124] R. M. Grady, D. A. Starr, G. L. Ackerman, J. R. Sanes, and M. Han, “Syne proteins 
anchor muscle nuclei at the neuromuscular junction.,” Proc. Natl. Acad. Sci. U. S. 
A., vol. 102, no. 12, pp. 4359–64, Mar. 2005. 
[125] X. Zhang, R. Xu, B. Zhu, X. Yang, X. Ding, S. Duan, T. Xu, Y. Zhuang, and M. Han, 
“Syne-1 and Syne-2 play crucial roles in myonuclear anchorage and motor neuron 
innervation.,” Development, vol. 134, no. 5, pp. 901–8, Mar. 2007. 
[126] M. Maninová, Z. Klímová, J. T. Parsons, M. J. Weber, M. P. Iwanicki, and T. 
Vomastek, “The reorientation of cell nucleus promotes the establishment of front-
rear polarity in migrating fibroblasts.,” J. Mol. Biol., vol. 425, no. 11, pp. 2039–55, 
Jun. 2013. 
[127] W. Chang, S. Antoku, C. Östlund, H. J. Worman, and G. G. Gundersen, “Linker of 
nucleoskeleton and cytoskeleton (LINC) complex-mediated actin-dependent 
nuclear positioning orients centrosomes in migrating myoblasts.,” Nucleus, vol. 6, 
no. 1, pp. 77–88, Jan. 2015. 
[128] J. R. Sims, S. Karp, and D. E. Ingber, “Altering the cellular mechanical force 
balance results in integrated changes in cell, cytoskeletal and nuclear shape.,” J. 
Cell Sci., vol. 103 ( Pt 4, pp. 1215–22, Dec. 1992. 
[129] A. J. Maniotis, C. S. Chen, and D. E. Ingber, “Demonstration of mechanical 
connections between integrins, cytoskeletal filaments, and nucleoplasm that 
stabilize nuclear structure.,” Proc. Natl. Acad. Sci. U. S. A., vol. 94, no. 3, pp. 849–
54, Feb. 1997. 
[130] N. Wang, K. Naruse, D. Stamenović, J. J. Fredberg, S. M. Mijailovich, I. M. Tolić-
Nørrelykke, T. Polte, R. Mannix, and D. E. Ingber, “Mechanical behavior in living 
cells consistent with the tensegrity model.,” Proc. Natl. Acad. Sci. U. S. A., vol. 98, 
no. 14, pp. 7765–70, Jul. 2001. 
[131] D. Stamenović, S. M. Mijailovich, I. M. Tolić-Nørrelykke, J. Chen, and N. Wang, 
“Cell prestress. II. Contribution of microtubules.,” Am. J. Physiol. Cell Physiol., vol. 
282, no. 3, pp. C617–24, Mar. 2002. 
[132] N. Wang, I. M. Tolić-Nørrelykke, J. Chen, S. M. Mijailovich, J. P. Butler, J. J. 
Fredberg, and D. Stamenović, “Cell prestress. I. Stiffness and prestress are closely 
associated in adherent contractile cells.,” Am. J. Physiol. Cell Physiol., vol. 282, no. 
3, pp. C606–16, Mar. 2002. 
[133] Y.-C. Poh, S. P. Shevtsov, F. Chowdhury, D. C. Wu, S. Na, M. Dundr, and N. 
Wang, “Dynamic force-induced direct dissociation of protein complexes in a nuclear 
body in living cells.,” Nat. Commun., vol. 3, p. 866, Jan. 2012. 
[134] K. Burridge, K. Fath, T. Kelly, G. Nuckolls, and C. Turner, “Focal adhesions: 
transmembrane junctions between the extracellular matrix and the cytoskeleton.,” 
Annu. Rev. Cell Biol., vol. 4, pp. 487–525, Jan. 1988. 
[135] N. Wang, J. P. Butler, and D. E. Ingber, “Mechanotransduction across the cell 
surface and through the cytoskeleton.,” Science, vol. 260, no. 5111, pp. 1124–7, 
May 1993. 
360 | P a g e  
 
[136] D. N. Simon and K. L. Wilson, “The nucleoskeleton as a genome-associated 
dynamic ‘network of networks,’” Nat. Rev. Mol. Cell Biol., vol. 12, no. 11, pp. 695–
708, Oct. 2011. 
[137] W. F. Liu, “Mechanical regulation of cellular phenotype: implications for vascular 
tissue regeneration.,” Cardiovasc. Res., vol. 95, no. 2, pp. 215–22, Jul. 2012. 
[138] R. M. Stewart, A. E. Zubek, K. A. Rosowski, S. M. Schreiner, V. Horsley, and M. C. 
King, “Nuclear-cytoskeletal linkages facilitate cross talk between the nucleus and 
intercellular adhesions.,” J. Cell Biol., vol. 209, no. 3, pp. 403–18, May 2015. 
[139] T. Anno, N. Sakamoto, and M. Sato, “Role of nesprin-1 in nuclear deformation in 
endothelial cells under static and uniaxial stretching conditions.,” Biochem. Biophys. 
Res. Commun., vol. 424, no. 1, pp. 94–9, Jul. 2012. 
[140] T. J. Chancellor, J. Lee, C. K. Thodeti, and T. Lele, “Actomyosin tension exerted on 
the nucleus through nesprin-1 connections influences endothelial cell adhesion, 
migration, and cyclic strain-induced reorientation.,” Biophys. J., vol. 99, no. 1, pp. 
115–23, Jul. 2010. 
[141] S. B. Khatau, C. M. Hale, P. J. Stewart-Hutchinson, M. S. Patel, C. L. Stewart, P. C. 
Searson, D. Hodzic, and D. Wirtz, “A perinuclear actin cap regulates nuclear 
shape.,” Proc. Natl. Acad. Sci. U. S. A., vol. 106, no. 45, pp. 19017–22, Nov. 2009. 
[142] D.-H. Kim, S. B. Khatau, Y. Feng, S. Walcott, S. X. Sun, G. D. Longmore, and D. 
Wirtz, “Actin cap associated focal adhesions and their distinct role in cellular 
mechanosensing.,” Sci. Rep., vol. 2, p. 555, Jan. 2012. 
[143] S. B. Khatau, R. J. Bloom, S. Bajpai, D. Razafsky, S. Zang, A. Giri, P.-H. Wu, J. 
Marchand, A. Celedon, C. M. Hale, S. X. Sun, D. Hodzic, and D. Wirtz, “The distinct 
roles of the nucleus and nucleus-cytoskeleton connections in three-dimensional cell 
migration.,” Sci. Rep., vol. 2, p. 488, Jan. 2012. 
[144] S. B. Khatau, S. Kusuma, D. Hanjaya-Putra, P. Mali, L. Cheng, J. S. H. Lee, S. 
Gerecht, and D. Wirtz, “The differential formation of the LINC-mediated perinuclear 
actin cap in pluripotent and somatic cells.,” PLoS One, vol. 7, no. 5, p. e36689, Jan. 
2012. 
[145] D. Splinter, M. E. Tanenbaum, A. Lindqvist, D. Jaarsma, A. Flotho, K. Lou Yu, I. 
Grigoriev, D. Engelsma, E. D. Haasdijk, N. Keijzer, J. Demmers, M. Fornerod, F. 
Melchior, C. C. Hoogenraad, R. H. Medema, and A. Akhmanova, “Bicaudal D2, 
dynein, and kinesin-1 associate with nuclear pore complexes and regulate 
centrosome and nuclear positioning during mitotic entry.,” PLoS Biol., vol. 8, no. 4, 
p. e1000350, Jan. 2010. 
[146] J. Wu, K. C. Lee, R. B. Dickinson, and T. P. Lele, “How dynein and microtubules 
rotate the nucleus.,” J. Cell. Physiol., vol. 226, no. 10, pp. 2666–74, Oct. 2011. 
[147] J. Lammerding, P. C. Schulze, T. Takahashi, S. Kozlov, T. Sullivan, R. D. Kamm, 
C. L. Stewart, and R. T. Lee, “Lamin A/C deficiency causes defective nuclear 
mechanics and mechanotransduction.,” J. Clin. Invest., vol. 113, no. 3, pp. 370–8, 
Feb. 2004. 
361 | P a g e  
 
[148] C. Y. Ho, D. E. Jaalouk, M. K. Vartiainen, and J. Lammerding, “Lamin A/C and 
emerin regulate MKL1-SRF activity by modulating actin dynamics.,” Nature, vol. 
497, no. 7450, pp. 507–11, May 2013. 
[149] E. Markiewicz, K. Tilgner, N. Barker, M. van de Wetering, H. Clevers, M. Dorobek, 
I. Hausmanowa-Petrusewicz, F. C. S. Ramaekers, J. L. V Broers, W. M. 
Blankesteijn, G. Salpingidou, R. G. Wilson, J. A. Ellis, and C. J. Hutchison, “The 
inner nuclear membrane protein emerin regulates beta-catenin activity by restricting 
its accumulation in the nucleus.,” EMBO J., vol. 25, no. 14, pp. 3275–85, Jul. 2006. 
[150] E. D. Tulgren, S. M. Turgeon, K. J. Opperman, and B. Grill, “The Nesprin family 
member ANC-1 regulates synapse formation and axon termination by functioning in 
a pathway with RPM-1 and β-Catenin.,” PLoS Genet., vol. 10, no. 7, p. e1004481, 
Jul. 2014. 
[151] P. Isermann and J. Lammerding, “Nuclear mechanics and mechanotransduction in 
health and disease.,” Curr. Biol., vol. 23, no. 24, pp. R1113–21, Dec. 2013. 
[152] G. Uzer, W. R. Thompson, B. Sen, Z. Xie, S. S. Yen, S. Miller, G. Bas, M. Styner, 
C. T. Rubin, S. Judex, K. Burridge, and J. Rubin, “Cell Mechanosensitivity to 
Extremely Low-Magnitude Signals Is Enabled by a LINCed Nucleus.,” Stem Cells, 
vol. 33, no. 6, pp. 2063–76, Jun. 2015. 
[153] C. Guilluy, L. D. Osborne, L. Van Landeghem, L. Sharek, R. Superfine, R. Garcia-
Mata, and K. Burridge, “Isolated nuclei adapt to force and reveal a 
mechanotransduction pathway in the nucleus.,” Nat. Cell Biol., vol. 16, no. 4, pp. 
376–81, Apr. 2014. 
[154] J. Schmitt, R. Benavente, D. Hodzic, C. Höög, C. L. Stewart, and M. Alsheimer, 
“Transmembrane protein Sun2 is involved in tethering mammalian meiotic 
telomeres to the nuclear envelope.,” Proc. Natl. Acad. Sci. U. S. A., vol. 104, no. 
18, pp. 7426–31, May 2007. 
[155] A. M. Penkner, A. Fridkin, J. Gloggnitzer, A. Baudrimont, T. Machacek, A. Woglar, 
E. Csaszar, P. Pasierbek, G. Ammerer, Y. Gruenbaum, and V. Jantsch, “Meiotic 
chromosome homology search involves modifications of the nuclear envelope 
protein Matefin/SUN-1.,” Cell, vol. 139, no. 5, pp. 920–33, Nov. 2009. 
[156] D. J. Wynne, O. Rog, P. M. Carlton, and A. F. Dernburg, “Dynein-dependent 
processive chromosome motions promote homologous pairing in C. elegans 
meiosis.,” J. Cell Biol., vol. 196, no. 1, pp. 47–64, Jan. 2012. 
[157] D. Jahn, S. Schramm, R. Benavente, and M. Alsheimer, “Dynamic properties of 
meiosis-specific lamin C2 and its impact on nuclear envelope integrity.,” Nucleus, 
vol. 1, no. 3, pp. 273–83, Jan. 2010. 
[158] J. Link, D. Jahn, J. Schmitt, E. Göb, J. Baar, S. Ortega, R. Benavente, and M. 
Alsheimer, “The meiotic nuclear lamina regulates chromosome dynamics and 
promotes efficient homologous recombination in the mouse.,” PLoS Genet., vol. 9, 
no. 1, p. e1003261, Jan. 2013. 
362 | P a g e  
 
[159] P. Oza, S. L. Jaspersen, A. Miele, J. Dekker, and C. L. Peterson, “Mechanisms that 
regulate localization of a DNA double-strand break to the nuclear periphery.,” 
Genes Dev., vol. 23, no. 8, pp. 912–27, Apr. 2009. 
[160] R. K. Swartz, E. C. Rodriguez, and M. C. King, “A role for nuclear envelope-
bridging complexes in homology-directed repair.,” Mol. Biol. Cell, vol. 25, no. 16, 
pp. 2461–71, Aug. 2014. 
[161] K. Lei, X. Zhu, R. Xu, C. Shao, T. Xu, Y. Zhuang, and M. Han, “Inner nuclear 
envelope proteins SUN1 and SUN2 play a prominent role in the DNA damage 
response.,” Curr. Biol., vol. 22, no. 17, pp. 1609–15, Sep. 2012. 
[162] I. Sur, S. Neumann, and A. A. Noegel, “Nesprin-1 role in DNA damage response.,” 
Nucleus, vol. 5, no. 2, pp. 173–91, Jan. 2014. 
[163] N. Cabanelas and V. P. Martins, “Laminopathies: a Pandora’s box of heart failure, 
bradyarrhythmias and sudden death.,” Rev. Port. Cardiol., vol. 34, no. 2, pp. 
139.e1–5, Feb. 2015. 
[164] D. Camozzi, C. Capanni, V. Cenni, E. Mattioli, M. Columbaro, S. Squarzoni, and G. 
Lattanzi, “Diverse lamin-dependent mechanisms interact to control chromatin 
dynamics. Focus on laminopathies.,” Nucleus, vol. 5, no. 5, pp. 427–40, Jan. 2014. 
[165] Y. Gruenbaum and O. Medalia, “Lamins: the structure and protein complexes.,” 
Curr. Opin. Cell Biol., vol. 32, pp. 7–12, Feb. 2015. 
[166] F. Gros-Louis, N. Dupré, P. Dion, M. A. Fox, S. Laurent, S. Verreault, J. R. Sanes, 
J.-P. Bouchard, and G. A. Rouleau, “Mutations in SYNE1 lead to a newly 
discovered form of autosomal recessive cerebellar ataxia.,” Nat. Genet., vol. 39, no. 
1, pp. 80–5, Jan. 2007. 
[167] Y. Izumi, R. Miyamoto, H. Morino, A. Yoshizawa, K. Nishinaka, F. Udaka, M. 
Kameyama, H. Maruyama, and H. Kawakami, “Cerebellar ataxia with SYNE1 
mutation accompanying motor neuron disease.,” Neurology, vol. 80, no. 6, pp. 600–
1, Feb. 2013. 
[168] N. Dupré, F. Gros-Louis, J.-P. Bouchard, A. Noreau, and G. A. Rouleau, “SYNE1-
Related Autosomal Recessive Cerebellar Ataxia.” University of Washington, 
Seattle, 13-Oct-2011. 
[169] A. Noreau, C. V. Bourassa, A. Szuto, A. Levert, S. Dobrzeniecka, J. Gauthier, S. 
Forlani, A. Durr, M. Anheim, G. Stevanin, A. Brice, J.-P. Bouchard, P. A. Dion, N. 
Dupré, and G. A. Rouleau, “SYNE1 Mutations in Autosomal Recessive Cerebellar 
Ataxia,” JAMA Neurol., vol. 70, no. 10, pp. 1296–31, Aug. 2013. 
[170] D. Razafsky and D. Hodzic, “A variant of Nesprin1 giant devoid of KASH domain 
underlies the molecular etiology of autosomal recessive cerebellar ataxia type I.,” 
Neurobiol. Dis., vol. 78, pp. 57–67, Jun. 2015. 
[171] Y. Lüke, H. Zaim, I. Karakesisoglou, V. M. Jaeger, L. Sellin, W. Lu, M. Schneider, 
S. Neumann, A. Beijer, M. Munck, V. C. Padmakumar, J. Gloy, G. Walz, and A. A. 
Noegel, “Nesprin-2 Giant (NUANCE) maintains nuclear envelope architecture and 
composition in skin.,” J. Cell Sci., vol. 121, no. Pt 11, pp. 1887–98, Jun. 2008. 
363 | P a g e  
 
[172] J.-Y. Wang, I.-S. Yu, C.-C. Huang, C.-Y. Chen, W.-P. Wang, S.-W. Lin, K.-T. 
Jeang, and Y.-H. Chi, “Sun1 deficiency leads to cerebellar ataxia in mice.,” Dis. 
Model. Mech., vol. 8, no. 8, pp. 957–67, Aug. 2015. 
[173] B. J. O’Roak, L. Vives, S. Girirajan, E. Karakoc, N. Krumm, B. P. Coe, R. Levy, A. 
Ko, C. Lee, J. D. Smith, E. H. Turner, I. B. Stanaway, B. Vernot, M. Malig, C. Baker, 
B. Reilly, J. M. Akey, E. Borenstein, M. J. Rieder, D. A. Nickerson, R. Bernier, J. 
Shendure, and E. E. Eichler, “Sporadic autism exomes reveal a highly 
interconnected protein network of de novo mutations,” Nature, vol. 485, no. 7397, 
pp. 246–250, Apr. 2012. 
[174] T. W. Yu, M. H. Chahrour, M. E. Coulter, S. Jiralerspong, K. Okamura-Ikeda, B. 
Ataman, K. Schmitz-Abe, D. A. Harmin, M. Adli, A. N. Malik, A. M. D’Gama, E. T. 
Lim, S. J. Sanders, G. H. Mochida, J. N. Partlow, C. M. Sunu, J. M. Felie, J. 
Rodriguez, R. H. Nasir, J. Ware, R. M. Joseph, R. S. Hill, B. Y. Kwan, M. Al-Saffar, 
N. M. Mukaddes, A. Hashmi, S. Balkhy, G. G. Gascon, F. M. Hisama, E. LeClair, A. 
Poduri, O. Oner, S. Al-Saad, S. A. Al-Awadi, L. Bastaki, T. Ben-Omran, A. S. Teebi, 
L. Al-Gazali, V. Eapen, C. R. Stevens, L. Rappaport, S. B. Gabriel, K. Markianos, 
M. W. State, M. E. Greenberg, H. Taniguchi, N. E. Braverman, E. M. Morrow, and 
C. A. Walsh, “Using whole-exome sequencing to identify inherited causes of 
autism.,” Neuron, vol. 77, no. 2, pp. 259–73, Jan. 2013. 
[175] E. K. Green, D. Grozeva, L. Forty, K. Gordon-Smith, E. Russell, A. Farmer, M. 
Hamshere, I. R. Jones, L. Jones, P. McGuffin, J. L. Moran, S. Purcell, P. Sklar, M. 
J. Owen, M. C. O’Donovan, and N. Craddock, “Association at SYNE1 in both 
bipolar disorder and recurrent major depression.,” Mol. Psychiatry, vol. 18, no. 5, 
pp. 614–7, May 2013. 
[176] S. Taranum, E. Vaylann, P. Meinke, S. Abraham, L. Yang, S. Neumann, I. 
Karakesisoglou, M. Wehnert, and A. A. Noegel, “LINC complex alterations in DMD 
and EDMD/CMT fibroblasts.,” Eur. J. Cell Biol., vol. 91, no. 8, pp. 614–28, Aug. 
2012. 
[177] D. Rajgor and C. M. Shanahan, “Nesprins: from the nuclear envelope and beyond.,” 
Expert Rev. Mol. Med., vol. 15, p. e5, Jan. 2013. 
[178] R. Attali, N. Warwar, A. Israel, I. Gurt, E. McNally, M. Puckelwartz, B. Glick, Y. 
Nevo, Z. Ben-Neriah, and J. Melki, “Mutation of SYNE-1, encoding an essential 
component of the nuclear lamina, is responsible for autosomal recessive 
arthrogryposis.,” Hum. Mol. Genet., vol. 18, no. 18, pp. 3462–9, Sep. 2009. 
[179] J. L. V Broers, F. C. S. Ramaekers, G. Bonne, R. Ben Yaou, and C. J. Hutchison, 
“Nuclear lamins: laminopathies and their role in premature ageing.,” Physiol. Rev., 
vol. 86, no. 3, pp. 967–1008, Jul. 2006. 
[180] C.-Y. Chen, Y.-H. Chi, R. A. Mutalif, M. F. Starost, T. G. Myers, S. A. Anderson, C. 
L. Stewart, and K.-T. Jeang, “Accumulation of the inner nuclear envelope protein 
Sun1 is pathogenic in progeric and dystrophic laminopathies.,” Cell, vol. 149, no. 3, 
pp. 565–77, Apr. 2012. 
[181] Z.-J. Chen, W.-P. Wang, Y.-C. Chen, J.-Y. Wang, W.-H. Lin, L.-A. Tai, G.-G. Liou, 
C.-S. Yang, and Y.-H. Chi, “Dysregulated interactions between lamin A and SUN1 
induce abnormalities in the nuclear envelope and endoplasmic reticulum in progeric 
laminopathies.,” J. Cell Sci., vol. 127, no. Pt 8, pp. 1792–804, Apr. 2014. 
364 | P a g e  
 
[182] M. Ketema, K. Wilhelmsen, I. Kuikman, H. Janssen, D. Hodzic, and A. Sonnenberg, 
“Requirements for the localization of nesprin-3 at the nuclear envelope and its 
interaction with plectin.,” J. Cell Sci., vol. 120, no. Pt 19, pp. 3384–94, Oct. 2007. 
[183] M. Ketema, M. Kreft, P. Secades, H. Janssen, and A. Sonnenberg, “Nesprin-3 
connects plectin and vimentin to the nuclear envelope of Sertoli cells but is not 
required for Sertoli cell function in spermatogenesis.,” Mol. Biol. Cell, vol. 24, no. 
15, pp. 2454–66, Aug. 2013. 
[184] H. F. Horn, Z. Brownstein, D. R. Lenz, S. Shivatzki, A. A. Dror, O. Dagan-
Rosenfeld, L. M. Friedman, K. J. Roux, S. Kozlov, K.-T. Jeang, M. Frydman, B. 
Burke, C. L. Stewart, and K. B. Avraham, “The LINC complex is essential for 
hearing.,” J. Clin. Invest., vol. 123, no. 2, pp. 740–50, Feb. 2013. 
[185] M. Schwander, B. Kachar, and U. Müller, “Review series: The cell biology of 
hearing.,” J. Cell Biol., vol. 190, no. 1, pp. 9–20, Jul. 2010. 
[186] H. J. Worman and N. Segil, “Nucleocytoplasmic connections and deafness.,” J. 
Clin. Invest., vol. 123, no. 2, pp. 553–5, Feb. 2013. 
[187] G. P. Richardson, J. B. de Monvel, and C. Petit, “How the genetics of deafness 
illuminates auditory physiology.,” Annu. Rev. Physiol., vol. 73, pp. 311–34, Jan. 
2011. 
[188] P. Dallos, “Cochlear amplification, outer hair cells and prestin.,” Curr. Opin. 
Neurobiol., vol. 18, no. 4, pp. 370–6, Aug. 2008. 
[189] I. Sziklai, M. Szõnyi, and P. Dallos, “Phosphorylation mediates the influence of 
acetylcholine upon outer hair cell electromotility.,” Acta Otolaryngol., vol. 121, no. 2, 
pp. 153–6, Jan. 2001. 
[190] P. Dallos, X. Wu, M. A. Cheatham, J. Gao, J. Zheng, C. T. Anderson, S. Jia, X. 
Wang, W. H. Y. Cheng, S. Sengupta, D. Z. Z. He, and J. Zuo, “Prestin-based outer 
hair cell motility is necessary for mammalian cochlear amplification.,” Neuron, vol. 
58, no. 3, pp. 333–9, May 2008. 
[191] G. I. Frolenkov, F. Mammano, and B. Kachar, “Regulation of outer hair cell 
cytoskeletal stiffness by intracellular Ca2+: underlying mechanism and implications 
for cochlear mechanics.,” Cell Calcium, vol. 33, no. 3, pp. 185–95, Mar. 2003. 
[192] C. L. Stewart and B. Burke, “The missing LINC: a mammalian KASH-domain 
protein coupling meiotic chromosomes to the cytoskeleton.,” Nucleus, vol. 5, no. 1, 
pp. 3–10, Jan. 2013. 
[193] M. Plessner and R. Grosse, “Extracellular signaling cues for nuclear actin 
polymerization,” Eur. J. Cell Biol., Jun. 2015. 
[194] A. Rothballer and U. Kutay, “The diverse functional LINCs of the nuclear envelope 
to the cytoskeleton and chromatin.,” Chromosoma, vol. 122, no. 5, pp. 415–29, Oct. 
2013. 
[195] S. Yachida, S. Jones, I. Bozic, T. Antal, R. Leary, B. Fu, M. Kamiyama, R. H. 
Hruban, J. R. Eshleman, M. A. Nowak, V. E. Velculescu, K. W. Kinzler, B. 
365 | P a g e  
 
Vogelstein, and C. A. Iacobuzio-Donahue, “Distant metastasis occurs late during 
the genetic evolution of pancreatic cancer.,” Nature, vol. 467, no. 7319, pp. 1114–7, 
Oct. 2010. 
[196] A. Marmé, H.-P. Zimmermann, G. Moldenhauer, M. Schorpp-Kistner, C. Müller, O. 
Keberlein, A. Giersch, J. Kretschmer, B. Seib, E. Spiess, A. Hunziker, F. Merchán, 
P. Möller, U. Hahn, R. Kurek, F. Marmé, G. Bastert, D. Wallwiener, and H. 
Ponstingl, “Loss of Drop1 expression already at early tumor stages in a wide range 
of human carcinomas.,” Int. J. Cancer, vol. 123, no. 9, pp. 2048–56, Nov. 2008. 
[197] C. Turnbull, S. Ahmed, J. Morrison, D. Pernet, A. Renwick, M. Maranian, S. Seal, 
M. Ghoussaini, S. Hines, C. S. Healey, D. Hughes, M. Warren-Perry, W. Tapper, D. 
Eccles, D. G. Evans, M. Hooning, M. Schutte, A. van den Ouweland, R. Houlston, 
G. Ross, C. Langford, P. D. P. Pharoah, M. R. Stratton, A. M. Dunning, N. Rahman, 
and D. F. Easton, “Genome-wide association study identifies five new breast 
cancer susceptibility loci.,” Nat. Genet., vol. 42, no. 6, pp. 504–7, Jun. 2010. 
[198] S. P. Shah, A. Roth, R. Goya, A. Oloumi, G. Ha, Y. Zhao, G. Turashvili, J. Ding, K. 
Tse, G. Haffari, A. Bashashati, L. M. Prentice, J. Khattra, A. Burleigh, D. Yap, V. 
Bernard, A. McPherson, K. Shumansky, A. Crisan, R. Giuliany, A. Heravi-Moussavi, 
J. Rosner, D. Lai, I. Birol, R. Varhol, A. Tam, N. Dhalla, T. Zeng, K. Ma, S. K. Chan, 
M. Griffith, A. Moradian, S.-W. G. Cheng, G. B. Morin, P. Watson, K. Gelmon, S. 
Chia, S.-F. Chin, C. Curtis, O. M. Rueda, P. D. Pharoah, S. Damaraju, J. Mackey, 
K. Hoon, T. Harkins, V. Tadigotla, M. Sigaroudinia, P. Gascard, T. Tlsty, J. F. 
Costello, I. M. Meyer, C. J. Eaves, W. W. Wasserman, S. Jones, D. Huntsman, M. 
Hirst, C. Caldas, M. A. Marra, and S. Aparicio, “The clonal and mutational evolution 
spectrum of primary triple-negative breast cancers.,” Nature, vol. 486, no. 7403, pp. 
395–9, Jun. 2012. 
[199] M. Tessema, R. Willink, K. Do, Y. Y. Yu, W. Yu, E. O. Machida, M. Brock, L. Van 
Neste, C. A. Stidley, S. B. Baylin, and S. A. Belinsky, “Promoter methylation of 
genes in and around the candidate lung cancer susceptibility locus 6q23-25.,” 
Cancer Res., vol. 68, no. 6, pp. 1707–14, Mar. 2008. 
[200] T. Sjöblom, S. Jones, L. D. Wood, D. W. Parsons, J. Lin, T. D. Barber, D. 
Mandelker, R. J. Leary, J. Ptak, N. Silliman, S. Szabo, P. Buckhaults, C. Farrell, P. 
Meeh, S. D. Markowitz, J. Willis, D. Dawson, J. K. V Willson, A. F. Gazdar, J. 
Hartigan, L. Wu, C. Liu, G. Parmigiani, B. H. Park, K. E. Bachman, N. 
Papadopoulos, B. Vogelstein, K. W. Kinzler, and V. E. Velculescu, “The consensus 
coding sequences of human breast and colorectal cancers.,” Science, vol. 314, no. 
5797, pp. 268–74, Oct. 2006. 
[201] M. Zwerger, C. Y. Ho, and J. Lammerding, “Nuclear mechanics in disease.,” Annu. 
Rev. Biomed. Eng., vol. 13, pp. 397–428, Aug. 2011. 
[202] A. C. Rowat, D. E. Jaalouk, M. Zwerger, W. L. Ung, I. A. Eydelnant, D. E. Olins, A. 
L. Olins, H. Herrmann, D. A. Weitz, and J. Lammerding, “Nuclear envelope 
composition determines the ability of neutrophil-type cells to passage through 
micron-scale constrictions.,” J. Biol. Chem., vol. 288, no. 12, pp. 8610–8, Mar. 
2013. 
[203] A. Matsumoto, M. Hieda, Y. Yokoyama, Y. Nishioka, K. Yoshidome, M. Tsujimoto, 
and N. Matsuura, “Global loss of a nuclear lamina component, lamin A/C, and LINC 
366 | P a g e  
 
complex components SUN1, SUN2, and nesprin-2 in breast cancer.,” Cancer Med., 
Jul. 2015. 
[204] A. Wang, X. Ma, M. A. Conti, C. Liu, S. Kawamoto, and R. S. Adelstein, 
“Nonmuscle myosin II isoform and domain specificity during early mouse 
development,” Proc. Natl. Acad. Sci., vol. 107, no. 33, pp. 14645–14650, Aug. 
2010. 
[205] R. S. Fischer, M. Gardel, X. Ma, R. S. Adelstein, and C. M. Waterman, “Local 
cortical tension by myosin II guides 3D endothelial cell branching.,” Curr. Biol., vol. 
19, no. 3, pp. 260–5, Mar. 2009. 
[206] M. Vicente-Manzanares, K. Newell-Litwa, A. I. Bachir, L. A. Whitmore, and A. R. 
Horwitz, “Myosin IIA/IIB restrict adhesive and protrusive signaling to generate front-
back polarity in migrating cells.,” J. Cell Biol., vol. 193, no. 2, pp. 381–96, Apr. 
2011. 
[207] A. M. Pasapera, I. C. Schneider, E. Rericha, D. D. Schlaepfer, and C. M. 
Waterman, “Myosin II activity regulates vinculin recruitment to focal adhesions 
through FAK-mediated paxillin phosphorylation,” J. Cell Biol., vol. 188, no. 6, pp. 
877–890, Mar. 2010. 
[208] J. R. Beach, L. Shao, K. Remmert, D. Li, E. Betzig, and J. A. Hammer, “Nonmuscle 
Myosin II Isoforms Coassemble in Living Cells,” Curr. Biol., vol. 24, no. 10, pp. 
1160–1166, May 2014. 
[209] J. R. Beach, G. S. Hussey, T. E. Miller, A. Chaudhury, P. Patel, J. Monslow, Q. 
Zheng, R. A. Keri, O. Reizes, A. R. Bresnick, P. H. Howe, and T. T. Egelhoff, 
“Myosin II isoform switching mediates invasiveness after TGF-β-induced epithelial-
mesenchymal transition.,” Proc. Natl. Acad. Sci. U. S. A., vol. 108, no. 44, pp. 
17991–6, Nov. 2011. 
[210] D. G. Thomas, A. Yenepalli, C. M. Denais, A. Rape, J. R. Beach, Y.-L. Wang, W. P. 
Schiemann, H. Baskaran, J. Lammerding, and T. T. Egelhoff, “Non-muscle myosin 
IIB is critical for nuclear translocation during 3D invasion.,” J. Cell Biol., vol. 210, no. 
4, pp. 583–94, Aug. 2015. 
[211] O.-Y. Revach, A. Weiner, K. Rechav, I. Sabanay, A. Livne, and B. Geiger, 
“Mechanical interplay between invadopodia and the nucleus in cultured cancer 
cells.,” Sci. Rep., vol. 5, p. 9466, Jan. 2015. 
[212] L. G. Griffith and M. A. Swartz, “Capturing complex 3D tissue physiology in vitro.,” 
Nat. Rev. Mol. Cell Biol., vol. 7, no. 3, pp. 211–24, Mar. 2006. 
[213] W. Mueller-Klieser, “Three-dimensional cell cultures: from molecular mechanisms 
to clinical applications.,” Am. J. Physiol., vol. 273, no. 4 Pt 1, pp. C1109–23, Oct. 
1997. 
[214] J. Bin Kim, “Three-dimensional tissue culture models in cancer biology.,” Semin. 
Cancer Biol., vol. 15, no. 5, pp. 365–77, Oct. 2005. 
367 | P a g e  
 
[215] A. Birgersdotter, R. Sandberg, and I. Ernberg, “Gene expression perturbation in 
vitro--a growing case for three-dimensional (3D) culture systems.,” Semin. Cancer 
Biol., vol. 15, no. 5, pp. 405–12, Oct. 2005. 
[216] P. A. Kenny, G. Y. Lee, C. A. Myers, R. M. Neve, J. R. Semeiks, P. T. Spellman, K. 
Lorenz, E. H. Lee, M. H. Barcellos-Hoff, O. W. Petersen, J. W. Gray, and M. J. 
Bissell, “The morphologies of breast cancer cell lines in three-dimensional assays 
correlate with their profiles of gene expression.,” Mol. Oncol., vol. 1, no. 1, pp. 84–
96, Jun. 2007. 
[217] Y.-M. Wu, J. Tang, P. Zhao, Z.-N. Chen, and J.-L. Jiang, “Morphological changes 
and molecular expressions of hepatocellular carcinoma cells in three-dimensional 
culture model.,” Exp. Mol. Pathol., vol. 87, no. 2, pp. 133–40, Oct. 2009. 
[218] H. R. Kalhor, F. Shahin V, M. H. Fouani, and H. Hosseinkhani, “Self-assembly of 
tissue transglutaminase into amyloid-like fibrils using physiological concentration of 
Ca2+.,” Langmuir, vol. 27, no. 17, pp. 10776–84, Sep. 2011. 
[219] S. Mohajeri, H. Hosseinkhani, N. G. Ebrahimi, L. Nikfarjam, M. Soleimani, and A.-
M. Kajbafzadeh, “Proliferation and differentiation of mesenchymal stem cell on 
collagen sponge reinforced with polypropylene/polyethylene terephthalate blend 
fibers.,” Tissue Eng. Part A, vol. 16, no. 12, pp. 3821–30, Dec. 2010. 
[220] W. Li, D. Machule, C. Gao, and P. K. DenBesten, “Growth of ameloblast-lineage 
cells in a three-dimensional Matrigel environment.,” Eur. J. Oral Sci., vol. 114 Suppl 
, pp. 159–63; discussion 164–5, 380–1, May 2006. 
[221] R. B. Trinca, G. A. Abraham, and M. I. Felisberti, “Electrospun nanofibrous 
scaffolds of segmented polyurethanes based on PEG, PLLA and PTMC blocks: 
Physico-chemical properties and morphology,” Mater. Sci. Eng. C, vol. 56, pp. 511–
517, Nov. 2015. 
[222] J. Lee, M. J. Cuddihy, and N. A. Kotov, “Three-dimensional cell culture matrices: 
state of the art.,” Tissue Eng. Part B. Rev., vol. 14, no. 1, pp. 61–86, Mar. 2008. 
[223] C. R. Langford, D. W. Johnson, and N. R. Cameron, “Preparation of hybrid thiol-
acrylate emulsion-templated porous polymers by interfacial copolymerization of 
high internal phase emulsions.,” Macromol. Rapid Commun., vol. 36, no. 9, pp. 
834–9, May 2015. 
[224] H.-J. Stark, K. Boehnke, N. Mirancea, M. J. Willhauck, A. Pavesio, N. E. Fusenig, 
and P. Boukamp, “Epidermal homeostasis in long-term scaffold-enforced skin 
equivalents.,” J. Investig. Dermatol. Symp. Proc., vol. 11, no. 1, pp. 93–105, Sep. 
2006. 
[225] B. Inanç, A. E. Elçin, and Y. M. Elçin, “Human embryonic stem cell differentiation on 
tissue engineering scaffolds: effects of NGF and retinoic acid induction.,” Tissue 
Eng. Part A, vol. 14, no. 6, pp. 955–64, Jun. 2008. 
[226] H.-T. Liao, Y.-Y. Chen, Y.-T. Lai, M.-F. Hsieh, and C.-P. Jiang, “The osteogenesis 
of bone marrow stem cells on mPEG-PCL-mPEG/hydroxyapatite composite 
scaffold via solid freeform fabrication.,” Biomed Res. Int., vol. 2014, p. 321549, Jan. 
2014. 
368 | P a g e  
 
[227] K.-C. Hung, C.-S. Tseng, and S.-H. Hsu, “Synthesis and 3D printing of 
biodegradable polyurethane elastomer by a water-based process for cartilage 
tissue engineering applications.,” Adv. Healthc. Mater., vol. 3, no. 10, pp. 1578–87, 
Oct. 2014. 
[228] Y. Ouyang, C. Huang, Y. Zhu, C. Fan, and Q. Ke, “Fabrication of seamless 
electrospun collagen/PLGA conduits whose walls comprise highly longitudinal 
aligned nanofibers for nerve regeneration.,” J. Biomed. Nanotechnol., vol. 9, no. 6, 
pp. 931–43, Jul. 2013. 
[229] M. Eichhorn, C. Stannard, K. Anselme, and J. Rühe, “Nucleus deformation of 
SaOs-2 cells on rhombic µ-pillars.,” J. Mater. Sci. Mater. Med., vol. 26, no. 2, p. 
108, Feb. 2015. 
[230] Y. C. Lussi, I. Hügi, E. Laurell, U. Kutay, and B. Fahrenkrog, “The nucleoporin 
Nup88 is interacting with nuclear lamin A.,” Mol. Biol. Cell, vol. 22, no. 7, pp. 1080–
90, Apr. 2011. 
[231] E. Knight, B. Murray, R. Carnachan, and S. Przyborski, “Alvetex®: polystyrene 
scaffold technology for routine three dimensional cell culture.,” Methods Mol. Biol., 
vol. 695, pp. 323–340, 2011. 
[232] V. C. Padmakumar, S. Abraham, S. Braune, A. A. Noegel, B. Tunggal, I. 
Karakesisoglou, and E. Korenbaum, “Enaptin, a giant actin-binding protein, is an 
element of the nuclear membrane and the actin cytoskeleton.,” Exp. Cell Res., vol. 
295, no. 2, pp. 330–9, May 2004. 
[233] T. Libotte, H. Zaim, S. Abraham, V. C. Padmakumar, M. Schneider, W. Lu, M. 
Munck, C. Hutchison, M. Wehnert, B. Fahrenkrog, U. Sauder, U. Aebi, A. A. 
Noegel, and I. Karakesisoglou, “Lamin A/C-dependent localization of Nesprin-2, a 
giant scaffolder at the nuclear envelope.,” Mol. Biol. Cell, vol. 16, no. 7, pp. 3411–
24, Jul. 2005. 
[234] Y.-Y. Zhen, T. Libotte, M. Munck, A. A. Noegel, and E. Korenbaum, “NUANCE, a 
giant protein connecting the nucleus and actin cytoskeleton.,” J. Cell Sci., vol. 115, 
no. Pt 15, pp. 3207–22, Aug. 2002. 
[235] A. Sandilands, X. Wang, A. M. Hutcheson, J. James, A. R. Prescott, A. Wegener, 
M. Pekny, X. Gong, and R. A. Quinlan, “Bfsp2 mutation found in mouse 129 strains 
causes the loss of CP49 and induces vimentin-dependent changes in the lens fibre 
cell cytoskeleton,” Exp. Eye Res., vol. 78, no. 1, pp. 109–123, Jan. 2004. 
[236] M. Tanno, “Tumor necrosis factor-induced protection of the murine heart is 
independent of p38-MAPK activation,” J. Mol. Cell. Cardiol., vol. 35, no. 12, pp. 
1523–1527, Dec. 2003. 
[237] J. L. Elliott, M. Der Perng, A. R. Prescott, K. A. Jansen, G. H. Koenderink, and R. A. 
Quinlan, “The specificity of the interaction between αB-crystallin and desmin 
filaments and its impact on filament aggregation and cell viability.,” Philos. Trans. R. 
Soc. Lond. B. Biol. Sci., vol. 368, no. 1617, p. 20120375, May 2013. 
369 | P a g e  
 
[238] X. Wu, B. Currall, T. Yamashita, L. L. Parker, R. Hallworth, and J. Zuo, “Prestin-
prestin and prestin-GLUT5 interactions in HEK293T cells.,” Dev. Neurobiol., vol. 67, 
no. 4, pp. 483–97, Mar. 2007. 
[239] B. Thaa, A. Herrmann, and M. Veit, “Intrinsic cytoskeleton-dependent clustering of 
influenza virus M2 protein with hemagglutinin assessed by FLIM-FRET.,” J. Virol., 
vol. 84, no. 23, pp. 12445–9, Dec. 2010. 
[240] C. R. Bone, E. C. Tapley, M. Gorjánácz, and D. A. Starr, “The Caenorhabditis 
elegans SUN protein UNC-84 interacts with lamin to transfer forces from the 
cytoplasm to the nucleoskeleton during nuclear migration.,” Mol. Biol. Cell, vol. 25, 
no. 18, pp. 2853–65, Sep. 2014. 
[241] B. Burke and K. J. Roux, “Nuclei take a position: managing nuclear location.,” Dev. 
Cell, vol. 17, no. 5, pp. 587–97, Nov. 2009. 
[242] J. L. V. Broers, “Decreased mechanical stiffness in LMNA-/- cells is caused by 
defective nucleo-cytoskeletal integrity: implications for the development of 
laminopathies,” Hum. Mol. Genet., vol. 13, no. 21, pp. 2567–2580, Sep. 2004. 
[243] J. W. Foster, R. R. Jones, C. A. Bippes, R. M. Gouveia, and C. J. Connon, 
“Differential nuclear expression of Yap in basal epithelial cells across the cornea 
and substrates of differing stiffness.,” Exp. Eye Res., vol. 127, pp. 37–41, Oct. 
2014. 
[244] S. C. Wei, L. Fattet, J. H. Tsai, Y. Guo, V. H. Pai, H. E. Majeski, A. C. Chen, R. L. 
Sah, S. S. Taylor, A. J. Engler, and J. Yang, “Matrix stiffness drives epithelial-
mesenchymal transition and tumour metastasis through a TWIST1-G3BP2 
mechanotransduction pathway.,” Nat. Cell Biol., vol. 17, no. 5, pp. 678–688, Apr. 
2015. 
[245] S. Prauzner-Bechcicki, J. Raczkowska, E. Madej, J. Pabijan, J. Lukes, J. Sepitka, 
J. Rysz, K. Awsiuk, A. Bernasik, A. Budkowski, and M. Lekka, “PDMS substrate 
stiffness affects the morphology and growth profiles of cancerous prostate and 
melanoma cells.,” J. Mech. Behav. Biomed. Mater., vol. 41, pp. 13–22, Jan. 2015. 
[246] J. Ahringer, “Control of cell polarity and mitotic spindle positioning in animal cells,” 
Curr. Opin. Cell Biol., vol. 15, no. 1, pp. 73–81, Feb. 2003. 
[247] I. Dupin and S. Etienne-Manneville, “Nuclear positioning: mechanisms and 
functions.,” Int. J. Biochem. Cell Biol., vol. 43, no. 12, pp. 1698–707, Dec. 2011. 
[248] M. A. Chapman, J. Zhang, I. Banerjee, L. T. Guo, Z. Zhang, G. D. Shelton, K. 
Ouyang, R. L. Lieber, and J. Chen, “Disruption of both nesprin 1 and desmin results 
in nuclear anchorage defects and fibrosis in skeletal muscle.,” Hum. Mol. Genet., 
vol. 23, no. 22, pp. 5879–92, Nov. 2014. 
[249] J. Zhang, A. Felder, Y. Liu, L. T. Guo, S. Lange, N. D. Dalton, Y. Gu, K. L. 
Peterson, A. P. Mizisin, G. D. Shelton, R. L. Lieber, and J. Chen, “Nesprin 1 is 
critical for nuclear positioning and anchorage.,” Hum. Mol. Genet., vol. 19, no. 2, 
pp. 329–41, Jan. 2010. 
370 | P a g e  
 
[250] K. Lei, X. Zhang, X. Ding, X. Guo, M. Chen, B. Zhu, T. Xu, Y. Zhuang, R. Xu, and 
M. Han, “SUN1 and SUN2 play critical but partially redundant roles in anchoring 
nuclei in skeletal muscle cells in mice.,” Proc. Natl. Acad. Sci. U. S. A., vol. 106, no. 
25, pp. 10207–12, Jun. 2009. 
[251] R. N. Rashmi, B. Eckes, G. Glöckner, M. Groth, S. Neumann, J. Gloy, L. Sellin, G. 
Walz, M. Schneider, I. Karakesisoglou, L. Eichinger, and A. A. Noegel, “The nuclear 
envelope protein Nesprin-2 has roles in cell proliferation and differentiation during 
wound healing.,” Nucleus, vol. 3, no. 2, pp. 172–86, Mar. 2012. 
[252] D. T. Warren, T. Tajsic, J. A. Mellad, R. Searles, Q. Zhang, and C. M. Shanahan, 
“Novel nuclear nesprin-2 variants tether active extracellular signal-regulated 
MAPK1 and MAPK2 at promyelocytic leukemia protein nuclear bodies and act to 
regulate smooth muscle cell proliferation.,” J. Biol. Chem., vol. 285, no. 2, pp. 
1311–20, Jan. 2010. 
[253] G. Mazzoleni, D. Di Lorenzo, and N. Steimberg, “Modelling tissues in 3D: the next 
future of pharmaco-toxicology and food research?,” Genes Nutr., vol. 4, no. 1, pp. 
13–22, Dec. 2008. 
[254] D. Bazou, “Biochemical properties of encapsulated high-density 3-D HepG2 
aggregates formed in an ultrasound trap for application in hepatotoxicity studies : 
Biochemical responses of encapsulated 3-D HepG2 aggregates.,” Cell Biol. 
Toxicol., vol. 26, no. 2, pp. 127–41, Apr. 2010. 
[255] G. Y. Lee, P. A. Kenny, E. H. Lee, and M. J. Bissell, “Three-dimensional culture 
models of normal and malignant breast epithelial cells.,” Nat. Methods, vol. 4, no. 4, 
pp. 359–65, Apr. 2007. 
[256] A. S. Salimath and A. J. García, “Biofunctional hydrogels for skeletal muscle 
constructs.,” J. Tissue Eng. Regen. Med., Mar. 2014. 
[257] H. Taketa, G. A. Sathi, M. Farahat, K. A. Rahman, T. Sakai, Y. Hirano, T. Kuboki, 
Y. Torii, and T. Matsumoto, “Peptide-modified Substrate for Modulating Gland 
Tissue Growth and Morphology In Vitro.,” Sci. Rep., vol. 5, p. 11468, Jan. 2015. 
[258] M. Sušec, S. C. Ligon, J. Stampfl, R. Liska, and P. Krajnc, “Hierarchically porous 
materials from layer-by-layer photopolymerization of high internal phase 
emulsions.,” Macromol. Rapid Commun., vol. 34, no. 11, pp. 938–43, Jul. 2013. 
[259] C. Decaestecker, O. Debeir, P. Van Ham, and R. Kiss, “Can anti-migratory drugs 
be screened in vitro? A review of 2D and 3D assays for the quantitative analysis of 
cell migration.,” Med. Res. Rev., vol. 27, no. 2, pp. 149–76, Mar. 2007. 
[260] N. Kramer, A. Walzl, C. Unger, M. Rosner, G. Krupitza, M. Hengstschläger, and H. 
Dolznig, “In vitro cell migration and invasion assays.,” Mutat. Res., vol. 752, no. 1, 
pp. 10–24, Jan. 2013. 
[261] J. Marshall, “Transwell(®) invasion assays.,” Methods Mol. Biol., vol. 769, pp. 97–
110, Jan. 2011. 
371 | P a g e  
 
[262] A. L. Olins, T. V Hoang, M. Zwerger, H. Herrmann, H. Zentgraf, A. A. Noegel, I. 
Karakesisoglou, D. Hodzic, and D. E. Olins, “The LINC-less granulocyte nucleus.,” 
Eur. J. Cell Biol., vol. 88, no. 4, pp. 203–14, Apr. 2009. 
[263] X. M. Xu, “A Molecular Basis Accounted for the Malignant Features of Breast 
Cancer Cells,” Apr. 2012. 
[264] K. N. Dahl, A. J. S. Ribeiro, and J. Lammerding, “Nuclear shape, mechanics, and 
mechanotransduction.,” Circ. Res., vol. 102, no. 11, pp. 1307–18, Jun. 2008. 
[265] M. Nagayama, H. Haga, and K. Kawabata, “Drastic change of local stiffness 
distribution correlating to cell migration in living fibroblasts.,” Cell Motil. 
Cytoskeleton, vol. 50, no. 4, pp. 173–9, Dec. 2001. 
[266] P. M. Davidson, C. Denais, M. C. Bakshi, and J. Lammerding, “Nuclear 
deformability constitutes a rate-limiting step during cell migration in 3-D 
environments.,” Cell. Mol. Bioeng., vol. 7, no. 3, pp. 293–306, Sep. 2014. 
[267] T. Harada, J. Swift, J. Irianto, J.-W. Shin, K. R. Spinler, A. Athirasala, R. Diegmiller, 
P. C. D. P. Dingal, I. L. Ivanovska, and D. E. Discher, “Nuclear lamin stiffness is a 
barrier to 3D migration, but softness can limit survival.,” J. Cell Biol., vol. 204, no. 5, 
pp. 669–82, Mar. 2014. 
[268] G. Giannone, “Super-resolution links vinculin localization to function in focal 
adhesions,” Nat. Cell Biol., vol. 17, no. 7, pp. 845–847, Jun. 2015. 
[269] M.-F. Carlier, S. Wiesner, C. Le Clainche, and D. Pantaloni, “Actin-based motility as 
a self-organized system: mechanism and reconstitution in vitro.,” C. R. Biol., vol. 
326, no. 2, pp. 161–70, Feb. 2003. 
[270] J. Qiu, L. Zhong, M. Zhou, D. Chen, X. Huang, J. Chen, M. Chen, H. Ni, and Z. Cai, 
“Establishment and characterization of a reconstructed Chinese human epidermis 
model.,” Int. J. Cosmet. Sci., Jun. 2015. 
[271] R. L. Eckert, “Structure, function, and differentiation of the keratinocyte.,” Physiol. 
Rev., vol. 69, no. 4, pp. 1316–46, Oct. 1989. 
[272] P. M. Davidson, C. Denais, M. C. Bakshi, and J. Lammerding, “Nuclear 
deformability constitutes a rate-limiting step during cell migration in 3-D 
environments.,” Cell. Mol. Bioeng., vol. 7, no. 3, pp. 293–306, Sep. 2014. 
[273] R. Chiotaki, H. Polioudaki, and P. A. Theodoropoulos, “Differential nuclear shape 
dynamics of invasive andnon-invasive breast cancer cells are associated with actin 
cytoskeleton organization and stability,” Biochem. Cell Biol., vol. 92, no. 4, pp. 287–
295, Aug. 2014. 
[274] K. Richter, M. Nessling, and P. Lichter, “Experimental evidence for the influence of 
molecular crowding on nuclear architecture.,” J. Cell Sci., vol. 120, no. Pt 9, pp. 
1673–80, May 2007. 
[275] E. Louvet, A. Yoshida, M. Kumeta, and K. Takeyasu, “Probing the stiffness of 
isolated nucleoli by atomic force microscopy.,” Histochem. Cell Biol., vol. 141, no. 4, 
pp. 365–81, Apr. 2014. 
372 | P a g e  
 
[276] X. Sui, N. Kong, L. Ye, W. Han, J. Zhou, Q. Zhang, C. He, and H. Pan, “p38 and 
JNK MAPK pathways control the balance of apoptosis and autophagy in response 
to chemotherapeutic agents.,” Cancer Lett., vol. 344, no. 2, pp. 174–9, Mar. 2014. 
[277] F. van Roy and G. Berx, “The cell-cell adhesion molecule E-cadherin.,” Cell. Mol. 
Life Sci., vol. 65, no. 23, pp. 3756–88, Nov. 2008. 
[278] F. M. Watt, “Terminal differentiation of epidermal keratinocytes.,” Curr. Opin. Cell 
Biol., vol. 1, no. 6, pp. 1107–15, Dec. 1989. 
[279] Y. Li, D. Lovett, Q. Zhang, S. Neelam, R. A. Kuchibhotla, R. Zhu, G. G. Gundersen, 
T. P. Lele, and R. B. Dickinson, “Moving Cell Boundaries Drive Nuclear Shaping 
during Cell Spreading.,” Biophys. J., vol. 109, no. 4, pp. 670–86, Aug. 2015. 
[280] W. H. Ziegler, R. C. Liddington, and D. R. Critchley, “The structure and regulation of 
vinculin.,” Trends Cell Biol., vol. 16, no. 9, pp. 453–60, Sep. 2006. 
[281] M. Brosig, J. Ferralli, L. Gelman, M. Chiquet, and R. Chiquet-Ehrismann, 
“Interfering with the connection between the nucleus and the cytoskeleton affects 
nuclear rotation, mechanotransduction and myogenesis.,” Int. J. Biochem. Cell 
Biol., vol. 42, no. 10, pp. 1717–28, Oct. 2010. 
[282] K. N. Randles, L. T. Lam, C. A. Sewry, M. Puckelwartz, D. Furling, M. Wehnert, E. 
M. McNally, and G. E. Morris, “Nesprins, but not sun proteins, switch isoforms at 
the nuclear envelope during muscle development.,” Dev. Dyn., vol. 239, no. 3, pp. 
998–1009, Mar. 2010. 
[283] E. Faurobert, A.-P. Bouin, and C. Albiges-Rizo, “Microenvironment, tumor cell 
plasticity, and cancer.,” Curr. Opin. Oncol., vol. 27, no. 1, pp. 64–70, Jan. 2015. 
[284] M. Krause, J. Te Riet, and K. Wolf, “Probing the compressibility of tumor cell nuclei 
by combined atomic force-confocal microscopy.,” Phys. Biol., vol. 10, no. 6, p. 
065002, Dec. 2013. 
[285] B. Hampoelz and T. Lecuit, “Nuclear mechanics in differentiation and 
development.,” Curr. Opin. Cell Biol., vol. 23, no. 6, pp. 668–75, Dec. 2011. 
[286] N. Caille, O. Thoumine, Y. Tardy, and J.-J. Meister, “Contribution of the nucleus to 
the mechanical properties of endothelial cells.,” J. Biomech., vol. 35, no. 2, pp. 
177–87, Feb. 2002. 
[287] F. Guilak, J. R. Tedrow, and R. Burgkart, “Viscoelastic properties of the cell 
nucleus.,” Biochem. Biophys. Res. Commun., vol. 269, no. 3, pp. 781–6, Mar. 2000. 
[288] A. C. Rowat, L. J. Foster, M. M. Nielsen, M. Weiss, and J. H. Ipsen, 
“Characterization of the elastic properties of the nuclear envelope.,” J. R. Soc. 
Interface, vol. 2, no. 2, pp. 63–9, Mar. 2005. 
[289] E. Tinois, M. Faure, P. Chatelain, P. Vallier, and D. Schmitt, “Growth and 
differentiation of human keratinocytes on extracellular matrix.,” Arch. Dermatol. 
Res., vol. 279, no. 4, pp. 241–6, Jan. 1987. 
373 | P a g e  
 
[290] N. Haddad and M. Paulin-Levasseur, “Effects of heat shock on the distribution and 
expression levels of nuclear proteins in HeLa S3 cells.,” J. Cell. Biochem., vol. 105, 
no. 6, pp. 1485–500, Dec. 2008. 
[291] C. Capanni, R. Del Coco, S. Squarzoni, M. Columbaro, E. Mattioli, D. Camozzi, A. 
Rocchi, K. Scotlandi, N. Maraldi, R. Foisner, and G. Lattanzi, “Prelamin A is 
involved in early steps of muscle differentiation.,” Exp. Cell Res., vol. 314, no. 20, 
pp. 3628–37, Dec. 2008. 
[292] E. Mattioli, M. Columbaro, C. Capanni, N. M. Maraldi, V. Cenni, K. Scotlandi, M. T. 
Marino, L. Merlini, S. Squarzoni, and G. Lattanzi, “Prelamin A-mediated recruitment 
of SUN1 to the nuclear envelope directs nuclear positioning in human muscle.,” Cell 
Death Differ., vol. 18, no. 8, pp. 1305–15, Aug. 2011. 
[293] A. E. Boggs, M. I. Vitolo, R. A. Whipple, M. S. Charpentier, O. G. Goloubeva, O. B. 
Ioffe, K. C. Tuttle, J. Slovic, Y. Lu, G. B. Mills, and S. S. Martin, “α-Tubulin 
acetylation elevated in metastatic and basal-like breast cancer cells promotes 
microtentacle formation, adhesion, and invasive migration.,” Cancer Res., vol. 75, 
no. 1, pp. 203–15, Jan. 2015. 
[294] A. B. Chambliss, S. B. Khatau, N. Erdenberger, D. K. Robinson, D. Hodzic, G. D. 
Longmore, and D. Wirtz, “The LINC-anchored actin cap connects the extracellular 
milieu to the nucleus for ultrafast mechanotransduction.,” Sci. Rep., vol. 3, p. 1087, 
Jan. 2013. 
[295] M. Brosig, J. Ferralli, L. Gelman, M. Chiquet, and R. Chiquet-Ehrismann, 
“Interfering with the connection between the nucleus and the cytoskeleton affects 
nuclear rotation, mechanotransduction and myogenesis.,” Int. J. Biochem. Cell 
Biol., vol. 42, no. 10, pp. 1717–28, Oct. 2010. 
[296] Y.-H. Chi, K. Haller, J.-M. Peloponese, and K.-T. Jeang, “Histone acetyltransferase 
hALP and nuclear membrane protein hsSUN1 function in de-condensation of 
mitotic chromosomes.,” J. Biol. Chem., vol. 282, no. 37, pp. 27447–58, Sep. 2007. 
[297] Y. Gruenbaum, A. Margalit, R. D. Goldman, D. K. Shumaker, and K. L. Wilson, 
“The nuclear lamina comes of age.,” Nat. Rev. Mol. Cell Biol., vol. 6, no. 1, pp. 21–
31, Jan. 2005. 
[298] B. Mitmaker, L. R. Begin, and P. H. Gordon, “Nuclear shape as a prognostic 
discriminant in colorectal carcinoma,” Dis. Colon Rectum, vol. 34, no. 3, pp. 249–
259, Mar. 1991. 
[299] K. L. Wydner, J. A. McNeil, F. Lin, H. J. Worman, and J. B. Lawrence, 
“Chromosomal Assignment of Human Nuclear Envelope Protein Genes LMNA, 
LMNB1, and LBR by Fluorescencein SituHybridization,” Genomics, vol. 32, no. 3, 
pp. 474–478, Mar. 1996. 
[300] M. Giacca, L. Zentilin, P. Norio, S. Diviacco, D. Dimitrova, G. Contreas, G. 
Biamonti, G. Perini, F. Weighardt, and S. Riva, “Fine mapping of a replication origin 
of human DNA.,” Proc. Natl. Acad. Sci. U. S. A., vol. 91, no. 15, pp. 7119–23, Jul. 
1994. 
374 | P a g e  
 
[301] L. Vergnes, M. Péterfy, M. O. Bergo, S. G. Young, and K. Reue, “Lamin B1 is 
required for mouse development and nuclear integrity.,” Proc. Natl. Acad. Sci. U. S. 
A., vol. 101, no. 28, pp. 10428–33, Jul. 2004. 
[302] V. Butin-Israeli, S. A. Adam, N. Jain, G. L. Otte, D. Neems, L. Wiesmüller, S. L. 
Berger, and R. D. Goldman, “Role of lamin b1 in chromatin instability.,” Mol. Cell. 
Biol., vol. 35, no. 5, pp. 884–98, Mar. 2015. 
[303] G. Bonne, M. R. Di Barletta, S. Varnous, H. M. Bécane, E. H. Hammouda, L. 
Merlini, F. Muntoni, C. R. Greenberg, F. Gary, J. A. Urtizberea, D. Duboc, M. 
Fardeau, D. Toniolo, and K. Schwartz, “Mutations in the gene encoding lamin A/C 
cause autosomal dominant Emery-Dreifuss muscular dystrophy.,” Nat. Genet., vol. 
21, no. 3, pp. 285–8, Mar. 1999. 
[304] S. Quijano-Roy, B. Mbieleu, C. G. Bönnemann, P.-Y. Jeannet, J. Colomer, N. F. 
Clarke, J.-M. Cuisset, H. Roper, L. De Meirleir, A. D’Amico, R. Ben Yaou, A. 
Nascimento, A. Barois, L. Demay, E. Bertini, A. Ferreiro, C. A. Sewry, N. B. 
Romero, M. Ryan, F. Muntoni, P. Guicheney, P. Richard, G. Bonne, and B. 
Estournet, “De novo LMNA mutations cause a new form of congenital muscular 
dystrophy.,” Ann. Neurol., vol. 64, no. 2, pp. 177–86, Aug. 2008. 
[305] Z. Wu, L. Wu, D. Weng, D. Xu, J. Geng, and F. Zhao, “Reduced expression of 
lamin A/C correlates with poor histological differentiation and prognosis in primary 
gastric carcinoma.,” J. Exp. Clin. Cancer Res., vol. 28, p. 8, Jan. 2009. 
[306] J. L. Broers, Y. Raymond, M. K. Rot, H. Kuijpers, S. S. Wagenaar, and F. C. 
Ramaekers, “Nuclear A-type lamins are differentially expressed in human lung 
cancer subtypes.,” Am. J. Pathol., vol. 143, no. 1, pp. 211–20, Jul. 1993. 
[307] B. Stadelmann, E. Khandjian, A. Hirt, A. Lüthy, R. Weil, and H. P. Wagner, 
“Repression of nuclear lamin A and C gene expression in human acute 
lymphoblastic leukemia and non-Hodgkin’s lymphoma cells.,” Leuk. Res., vol. 14, 
no. 9, pp. 815–21, Jan. 1990. 
[308] C. D. Capo-chichi, K. Q. Cai, F. Simpkins, P. Ganjei-Azar, A. K. Godwin, and X.-X. 
Xu, “Nuclear envelope structural defects cause chromosomal numerical instability 
and aneuploidy in ovarian cancer.,” BMC Med., vol. 9, p. 28, Jan. 2011. 
[309] C. D. Capo-chichi, K. Q. Cai, J. Smedberg, P. Ganjei-Azar, A. K. Godwin, and X.-X. 
Xu, “Loss of A-type lamin expression compromises nuclear envelope integrity in 
breast cancer.,” Chin. J. Cancer, vol. 30, no. 6, pp. 415–25, Jun. 2011. 
[310] M. E. Hudson, I. Pozdnyakova, K. Haines, G. Mor, and M. Snyder, “Identification of 
differentially expressed proteins in ovarian cancer using high-density protein 
microarrays.,” Proc. Natl. Acad. Sci. U. S. A., vol. 104, no. 44, pp. 17494–9, Oct. 
2007. 
[311] N. D. Willis, T. R. Cox, S. F. Rahman-Casañs, K. Smits, S. A. Przyborski, P. van 
den Brandt, M. van Engeland, M. Weijenberg, R. G. Wilson, A. de Bruïne, and C. J. 
Hutchison, “Lamin A/C is a risk biomarker in colorectal cancer.,” PLoS One, vol. 3, 
no. 8, p. e2988, Jan. 2008. 
375 | P a g e  
 
[312] L. Kong, G. Schäfer, H. Bu, Y. Zhang, Y. Zhang, and H. Klocker, “Lamin A/C 
protein is overexpressed in tissue-invading prostate cancer and promotes prostate 
cancer cell growth, migration and invasion through the PI3K/AKT/PTEN pathway.,” 
Carcinogenesis, vol. 33, no. 4, pp. 751–9, Apr. 2012. 
[313] C. M. L. J. Tilli, F. C. S. Ramaekers, J. L. V Broers, C. J. Hutchison, and H. A. M. 
Neumann, “Lamin expression in normal human skin, actinic keratosis, squamous 
cell carcinoma and basal cell carcinoma.,” Br. J. Dermatol., vol. 148, no. 1, pp. 
102–9, Jan. 2003. 
[314] L. Crabbe, A. J. Cesare, J. M. Kasuboski, J. A. J. Fitzpatrick, and J. Karlseder, 
“Human telomeres are tethered to the nuclear envelope during postmitotic nuclear 
assembly.,” Cell Rep., vol. 2, no. 6, pp. 1521–9, Dec. 2012. 
[315] V. Nikolova-Krstevski, C. Leimena, X.-H. Xiao, S. Kesteven, J. C. Tan, L. S. Yeo, 
Z.-Y. Yu, Q. Zhang, A. Carlton, S. Head, C. Shanahan, M. P. Feneley, and D. 
Fatkin, “Nesprin-1 and actin contribute to nuclear and cytoskeletal defects in lamin 
A/C-deficient cardiomyopathy.,” J. Mol. Cell. Cardiol., vol. 50, no. 3, pp. 479–86, 
Mar. 2011. 
[316] T. W. Chittenden, E. A. Howe, A. C. Culhane, R. Sultana, J. M. Taylor, C. Holmes, 
and J. Quackenbush, “Functional classification analysis of somatically mutated 
genes in human breast and colorectal cancers.,” Genomics, vol. 91, no. 6, pp. 508–
11, Jun. 2008. 
[317] J. A. Doherty, M. A. Rossing, K. L. Cushing-Haugen, C. Chen, D. J. Van Den Berg, 
A. H. Wu, M. C. Pike, R. B. Ness, K. Moysich, G. Chenevix-Trench, J. Beesley, P. 
M. Webb, J. Chang-Claude, S. Wang-Gohrke, M. T. Goodman, G. Lurie, P. J. 
Thompson, M. E. Carney, E. Hogdall, S. K. Kjaer, C. Hogdall, E. L. Goode, J. M. 
Cunningham, B. L. Fridley, R. A. Vierkant, A. Berchuck, P. G. Moorman, J. M. 
Schildkraut, R. T. Palmieri, D. W. Cramer, K. L. Terry, H. P. Yang, M. Garcia-
Closas, S. Chanock, J. Lissowska, H. Song, P. D. P. Pharoah, M. Shah, B. Perkins, 
V. McGuire, A. S. Whittemore, R. A. Di Cioccio, A. Gentry-Maharaj, U. Menon, S. A. 
Gayther, S. J. Ramus, A. Ziogas, W. Brewster, H. Anton-Culver, and C. L. Pearce, 
“ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an 
Ovarian Cancer Association Consortium study.,” Cancer Epidemiol. Biomarkers 
Prev., vol. 19, no. 1, pp. 245–50, Jan. 2010. 
[318] S. Cartwright and I. Karakesisoglou, “Nesprins in health and disease.,” Semin. Cell 
Dev. Biol., vol. 29, pp. 169–79, May 2014. 
[319] “WHO breast cancer statistics.” [Online]. Available: http://www.iarc.fr/en/media-
centre/pr/2013/pdfs/pr223_E.pdf. [Accessed: 13-Sep-2015]. 
[320] S. Oved and Y. Yarden, “Signal transduction: molecular ticket to enter cells.,” 
Nature, vol. 416, no. 6877, pp. 133–6, Mar. 2002. 
[321] A. D. Thor, I. I. Moore DH, S. M. Edgerton, E. S. Kawasaki, E. Reihsaus, H. T. 
Lynch, J. N. Marcus, L. Schwartz, L. C. Chen, and B. H. Mayall, “Accumulation of 
p53 tumor suppressor gene protein: an independent marker of prognosis in breast 
cancers.,” J. Natl. Cancer Inst., vol. 84, no. 11, pp. 845–55, Jun. 1992. 
[322] A. Ioakim-Liossi, P. Karakitsos, C. Markopoulos, K. Aroni, P. Athanassiadou, K. 
Delivelioti, P. Athanassiades, and G. Vaiopoulos, “p53 protein expression and 
376 | P a g e  
 
oestrogen and progesterone receptor status in invasive ductal breast carcinomas.,” 
Cytopathology, vol. 12, no. 3, pp. 197–202, Jun. 2001. 
[323] K. Vermeulen, D. R. Van Bockstaele, and Z. N. Berneman, “The cell cycle: a review 
of regulation, deregulation and therapeutic targets in cancer.,” Cell Prolif., vol. 36, 
no. 3, pp. 131–49, Jun. 2003. 
[324] P. S. Steeg and Q. Zhou, “Cyclins and breast cancer.,” Breast Cancer Res. Treat., 
vol. 52, no. 1–3, pp. 17–28, Jan. 1998. 
[325] M. Lodén, M. Stighall, N. H. Nielsen, G. Roos, S. O. Emdin, H. Ostlund, and G. 
Landberg, “The cyclin D1 high and cyclin E high subgroups of breast cancer: 
separate pathways in tumorogenesis based on pattern of genetic aberrations and 
inactivation of the pRb node.,” Oncogene, vol. 21, no. 30, pp. 4680–90, Jul. 2002. 
[326] S. Zhao, M. Yi, Y. Yuan, W. Zhuang, D. Zhang, X. Yu, X. Chen, B. Teng, Z. Guan, 
and Y. Zhang, “Expression of AKAP95, Cx43, CyclinE1 and CyclinD1 in 
esophageal cancer and their association with the clinical and pathological 
parameters.,” Int. J. Clin. Exp. Med., vol. 8, no. 5, pp. 7324–32, Jan. 2015. 
[327] R. Siegel, D. Naishadham, and A. Jemal, “Cancer statistics, 2013.,” CA. Cancer J. 
Clin., vol. 63, no. 1, pp. 11–30, Jan. 2013. 
[328] J. H. Tsai and J. Yang, “Epithelial-mesenchymal plasticity in carcinoma 
metastasis.,” Genes Dev., vol. 27, no. 20, pp. 2192–206, Oct. 2013. 
[329] B. T. Hennessy, A.-M. Gonzalez-Angulo, K. Stemke-Hale, M. Z. Gilcrease, S. 
Krishnamurthy, J.-S. Lee, J. Fridlyand, A. Sahin, R. Agarwal, C. Joy, W. Liu, D. 
Stivers, K. Baggerly, M. Carey, A. Lluch, C. Monteagudo, X. He, V. Weigman, C. 
Fan, J. Palazzo, G. N. Hortobagyi, L. K. Nolden, N. J. Wang, V. Valero, J. W. Gray, 
C. M. Perou, and G. B. Mills, “Characterization of a naturally occurring breast 
cancer subset enriched in epithelial-to-mesenchymal transition and stem cell 
characteristics.,” Cancer Res., vol. 69, no. 10, pp. 4116–24, May 2009. 
[330] A. Prat and C. M. Perou, “Deconstructing the molecular portraits of breast cancer.,” 
Mol. Oncol., vol. 5, no. 1, pp. 5–23, Feb. 2011. 
[331] N. R. Bertos and M. Park, “Breast cancer - one term, many entities?,” J. Clin. 
Invest., vol. 121, no. 10, pp. 3789–96, Oct. 2011. 
[332] B. E. Gould Rothberg and M. B. Bracken, “E-cadherin immunohistochemical 
expression as a prognostic factor in infiltrating ductal carcinoma of the breast: a 
systematic review and meta-analysis.,” Breast Cancer Res. Treat., vol. 100, no. 2, 
pp. 139–48, Nov. 2006. 
[333] P. J. Kowalski, M. A. Rubin, and C. G. Kleer, “E-cadherin expression in primary 
carcinomas of the breast and its distant metastases.,” Breast Cancer Res., vol. 5, 
no. 6, pp. R217–22, Jan. 2003. 
[334] C. Gaggioli, S. Hooper, C. Hidalgo-Carcedo, R. Grosse, J. F. Marshall, K. 
Harrington, and E. Sahai, “Fibroblast-led collective invasion of carcinoma cells with 
differing roles for RhoGTPases in leading and following cells.,” Nat. Cell Biol., vol. 
9, no. 12, pp. 1392–400, Dec. 2007. 
377 | P a g e  
 
[335] K. J. Cheung, E. Gabrielson, Z. Werb, and A. J. Ewald, “Collective invasion in 
breast cancer requires a conserved basal epithelial program.,” Cell, vol. 155, no. 7, 
pp. 1639–51, Dec. 2013. 
[336] S. P. Carey, A. Starchenko, A. L. McGregor, and C. A. Reinhart-King, “Leading 
malignant cells initiate collective epithelial cell invasion in a three-dimensional 
heterotypic tumor spheroid model.,” Clin. Exp. Metastasis, vol. 30, no. 5, pp. 615–
30, Jun. 2013. 
[337] J. Condeelis and J. W. Pollard, “Macrophages: obligate partners for tumor cell 
migration, invasion, and metastasis.,” Cell, vol. 124, no. 2, pp. 263–6, Jan. 2006. 
[338] R. Guiet, E. Van Goethem, C. Cougoule, S. Balor, A. Valette, T. Al Saati, C. A. 
Lowell, V. Le Cabec, and I. Maridonneau-Parini, “The process of macrophage 
migration promotes matrix metalloproteinase-independent invasion by tumor cells.,” 
J. Immunol., vol. 187, no. 7, pp. 3806–14, Oct. 2011. 
[339] M. Roh-Johnson, J. J. Bravo-Cordero, A. Patsialou, V. P. Sharma, P. Guo, H. Liu, 
L. Hodgson, and J. Condeelis, “Macrophage contact induces RhoA GTPase 
signaling to trigger tumor cell intravasation.,” Oncogene, vol. 33, no. 33, pp. 4203–
12, Aug. 2014. 
[340] V. Masola, A. Carraro, G. Zaza, G. Bellin, U. Montin, P. Violi, A. Lupo, and U. 
Tedeschi, “Epithelial to mesenchymal transition in the liver field: the double face of 
Everolimus in vitro.,” BMC Gastroenterol., vol. 15, no. 1, p. 118, Jan. 2015. 
[341] M. M. Vantangoli, S. J. Madnick, S. M. Huse, P. Weston, and K. Boekelheide, 
“MCF-7 Human Breast Cancer Cells Form Differentiated Microtissues in Scaffold-
Free Hydrogels.,” PLoS One, vol. 10, no. 8, p. e0135426, Jan. 2015. 
[342] W. Kamphuis, C. Mamber, M. Moeton, L. Kooijman, J. A. Sluijs, A. H. P. Jansen, M. 
Verveer, L. R. de Groot, V. D. Smith, S. Rangarajan, J. J. Rodríguez, M. Orre, and 
E. M. Hol, “GFAP isoforms in adult mouse brain with a focus on neurogenic 
astrocytes and reactive astrogliosis in mouse models of Alzheimer disease.,” PLoS 
One, vol. 7, no. 8, p. e42823, Jan. 2012. 
[343] A. Batistatou, D. Stefanou, E. Arkoumani, and N. J. Agnantis, “The usefulness of 
p63 as a marker of breast myoepithelial cells.,” In Vivo, vol. 17, no. 6, pp. 573–6, 
Jan. 2003. 
[344] A. A. McDonough, L. C. Veiras, J. N. Minas, and D. L. Ralph, “Considerations when 
quantitating protein abundance by immunoblot.,” Am. J. Physiol. Cell Physiol., vol. 
308, no. 6, pp. C426–33, Mar. 2015. 
[345] C. Albiges-Rizo, O. Destaing, B. Fourcade, E. Planus, and M. R. Block, “Actin 
machinery and mechanosensitivity in invadopodia, podosomes and focal 
adhesions.,” J. Cell Sci., vol. 122, no. Pt 17, pp. 3037–49, Sep. 2009. 
[346] R. Poincloux, F. Lizárraga, and P. Chavrier, “Matrix invasion by tumour cells: a 
focus on MT1-MMP trafficking to invadopodia.,” J. Cell Sci., vol. 122, no. Pt 17, pp. 
3015–24, Sep. 2009. 
378 | P a g e  
 
[347] V. Marchesin, G. Montagnac, and P. Chavrier, “ARF6 Promotes the Formation of 
Rac1 and WAVE-Dependent Ventral F-Actin Rosettes in Breast Cancer Cells in 
Response to Epidermal Growth Factor,” PLoS One, vol. 10, no. 3, p. e0121747, 
Mar. 2015. 
[348] S. J. Heasman and A. J. Ridley, “Mammalian Rho GTPases: new insights into their 
functions from in vivo studies.,” Nat. Rev. Mol. Cell Biol., vol. 9, no. 9, pp. 690–701, 
Sep. 2008. 
[349] E. D. Hay, “The mesenchymal cell, its role in the embryo, and the remarkable 
signaling mechanisms that create it.,” Dev. Dyn., vol. 233, no. 3, pp. 706–20, Jul. 
2005. 
[350] M. G. Mendez, S.-I. Kojima, and R. D. Goldman, “Vimentin induces changes in cell 
shape, motility, and adhesion during the epithelial to mesenchymal transition.,” 
FASEB J., vol. 24, no. 6, pp. 1838–51, Jun. 2010. 
[351] Y.-S. Chou and M.-H. Yang, “Epithelial-mesenchymal transition-related factors in 
solid tumor and hematological malignancy.,” J. Chin. Med. Assoc., vol. 78, no. 8, 
pp. 438–45, Aug. 2015. 
[352] E. Gladilin, P. Gonzalez, and R. Eils, “Dissecting the contribution of actin and 
vimentin intermediate filaments to mechanical phenotype of suspended cells using 
high-throughput deformability measurements and computational modeling.,” J. 
Biomech., vol. 47, no. 11, pp. 2598–605, Aug. 2014. 
[353] G. Gong, P. Chen, L. Li, H. Tan, J. Zhou, Y. Zhou, X. Yang, and X. Wu, “Loss of 
lamin A but not lamin C expression in epithelial ovarian cancer cells is associated 
with metastasis and poor prognosis.,” Pathol. Res. Pract., vol. 211, no. 2, pp. 175–
82, Feb. 2015. 
[354] T.-H. Hsieh, C.-L. Chien, Y.-H. Lee, C.-I. Lin, J.-Y. Hsieh, M.-E. Chao, D.-J. Liu, S.-
S. Chu, W. Chen, S.-C. Lin, D. M.-T. Ho, R.-S. Liu, C.-H. Lin, T.-T. Wong, and H.-
W. Wang, “Downregulation of SUN2, a novel tumor suppressor, mediates miR-
221/222-induced malignancy in central nervous system embryonal tumors.,” 
Carcinogenesis, vol. 35, no. 10, pp. 2164–74, Oct. 2014. 
[355] G. A. Pihan, A. Purohit, J. Wallace, R. Malhotra, L. Liotta, and S. J. Doxsey, 
“Centrosome defects can account for cellular and genetic changes that characterize 
prostate cancer progression.,” Cancer Res., vol. 61, no. 5, pp. 2212–9, Mar. 2001. 
[356] G. Pihan and S. J. Doxsey, “Mutations and aneuploidy: co-conspirators in cancer?,” 
Cancer Cell, vol. 4, no. 2, pp. 89–94, Aug. 2003. 
[357] B. Delaval and S. J. Doxsey, “Pericentrin in cellular function and disease.,” J. Cell 
Biol., vol. 188, no. 2, pp. 181–90, Jan. 2010. 
[358] N. Martínez, A. Alonso, M. D. Moragues, J. Pontón, and J. Schneider, “The nuclear 
pore complex protein Nup88 is overexpressed in tumor cells.,” Cancer Res., vol. 
59, no. 21, pp. 5408–11, Nov. 1999. 
379 | P a g e  
 
[359] L. Martignetti, B. Tesson, A. Almeida, A. Zinovyev, G. C. Tucker, T. Dubois, and E. 
Barillot, “Detection of miRNA regulatory effect on triple negative breast cancer 
transcriptome.,” BMC Genomics, vol. 16, p. S4, Jan. 2015. 
[360] A. A. Thike, T. Puay Hoon, M. Ikeda, and J. Iqbal, “Increased ID4 expression, 
accompanied by mutant p53 accumulation and loss of BRCA1/2 proteins in triple 
negative breast cancer adversely affects survival.,” Histopathology, Aug. 2015. 
[361] K. Milde-Langosch, T. Löning, and A.-M. Bamberger, “Expression of the 
CCAAT/enhancer-binding proteins C/EBPalpha, C/EBPbeta and C/EBPdelta in 
breast cancer: correlations with clinicopathologic parameters and cell-cycle 
regulatory proteins.,” Breast Cancer Res. Treat., vol. 79, no. 2, pp. 175–85, May 
2003. 
[362] J. V Moyano, J. R. Evans, F. Chen, M. Lu, M. E. Werner, F. Yehiely, L. K. Diaz, D. 
Turbin, G. Karaca, E. Wiley, T. O. Nielsen, C. M. Perou, and V. L. Cryns, “AlphaB-
crystallin is a novel oncoprotein that predicts poor clinical outcome in breast 
cancer.,” J. Clin. Invest., vol. 116, no. 1, pp. 261–70, Jan. 2006. 
[363] A. J. M. Campbell-Lloyd, J. Mundy, R. Deva, G. Lampe, C. Hawley, G. Boyle, R. 
Griffin, C. Thompson, and P. Shah, “Is alpha-B crystallin an independent marker for 
prognosis in lung cancer?,” Heart. Lung Circ., vol. 22, no. 9, pp. 759–66, Sep. 
2013. 
[364] M. Kabbage, M. Trimeche, H. Ben Nasr, P. Hammann, L. Kuhn, B. Hamrita, A. 
Chaieb, L. Chouchane, and K. Chahed, “Expression of the molecular chaperone 
αB-crystallin in infiltrating ductal breast carcinomas and the significance thereof: an 
immunohistochemical and proteomics-based strategy.,” Tumour Biol., vol. 33, no. 6, 
pp. 2279–88, Dec. 2012. 
[365] Z. Chen, Q. Ruan, S. Han, L. Xi, W. Jiang, H. Jiang, D. A. Ostrov, and J. Cai, 
“Discovery of structure-based small molecular inhibitor of αB-crystallin against 
basal-like/triple-negative breast cancer development in vitro and in vivo.,” Breast 
Cancer Res. Treat., vol. 145, no. 1, pp. 45–59, May 2014. 
[366] W. Ma, Y. Teng, H. Hua, J. Hou, T. Luo, and Y. Jiang, “Upregulation of heat shock 
protein 27 confers resistance to actinomycin D-induced apoptosis in cancer cells.,” 
FEBS J., vol. 280, no. 18, pp. 4612–24, Sep. 2013. 
[367] C.-H. Lee, Y.-T. Wu, H.-C. Hsieh, Y. Yu, A. L. Yu, and W.-W. Chang, “Epidermal 
growth factor/heat shock protein 27 pathway regulates vasculogenic mimicry 
activity of breast cancer stem/progenitor cells.,” Biochimie, vol. 104, pp. 117–26, 
Sep. 2014. 
[368] G. Viale, M. Gambacorta, G. Coggi, P. Dell’Orto, M. Milani, and C. Doglioni, “Glial 
fibrillary acidic protein immunoreactivity in normal and diseased human breast.,” 
Virchows Arch. A. Pathol. Anat. Histopathol., vol. 418, no. 4, pp. 339–48, Jan. 
1991. 
[369] S. S. Banerjee and M. Harris, “Morphological and immunophenotypic variations in 
malignant melanoma.,” Histopathology, vol. 36, no. 5, pp. 387–402, May 2000. 
380 | P a g e  
 
[370] R. D. Abbott and D. L. Kaplan, “Strategies for improving the physiological relevance 
of human engineered tissues.,” Trends Biotechnol., vol. 33, no. 7, pp. 401–7, Apr. 
2015. 
[371] “Epidermal Structure and Function,” J. Invest. Dermatol., vol. 132, no. S2, pp. S75–
S88, Sep. 2012. 
[372] H. J. Wearing and J. A. Sherratt, “Keratinocyte growth factor signalling: a 
mathematical model of dermal–epidermal interaction in epidermal wound healing,” 
Math. Biosci., vol. 165, no. 1, pp. 41–62, May 2000. 
[373] R. Moll, W. W. Franke, D. L. Schiller, B. Geiger, and R. Krepler, “The catalog of 
human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured 
cells,” Cell, vol. 31, no. 1, pp. 11–24, Nov. 1982. 
[374] E. Fuchs and H. Green, “Changes in keratin gene expression during terminal 
differentiation of the keratinocyte,” Cell, vol. 19, no. 4, pp. 1033–1042, Apr. 1980. 
[375] L. Ma, S. Yamada, D. Wirtz, and P. A. Coulombe, “A ‘hot-spot’ mutation alters the 
mechanical properties of keratin filament networks.,” Nat. Cell Biol., vol. 3, no. 5, 
pp. 503–6, May 2001. 
[376] P. A. Coulombe, M. L. Kerns, and E. Fuchs, “Epidermolysis bullosa simplex: a 
paradigm for disorders of tissue fragility.,” J. Clin. Invest., vol. 119, no. 7, pp. 1784–
93, Jul. 2009. 
[377] V. Vasca, E. Vasca, P. Freiman, D. Marian, A. Luce, M. Mesolella, M. Caraglia, F. 
Ricciardiello, and T. Duminica, “Keratin 5 expression in squamocellular carcinoma 
of the head and neck.,” Oncol. Lett., vol. 8, no. 6, pp. 2501–2504, Dec. 2014. 
[378] F. Otterbach, A. Bankfalvi, S. Bergner, T. Decker, R. Krech, and W. Boecker, 
“Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical 
proliferations of the breast,” Histopathology, vol. 37, no. 3, pp. 232–240, Sep. 2000. 
[379] a. Stoler, R. Kopan, M. Duvic, and E. Fuchs, “Use of monospecific antisera and 
cRNA probes to localize the major changes in keratin expression during normal and 
abnormal epidermal differentiation,” Journal of Cell Biology, vol. 107, no. 2. The 
Rockefeller University Press, pp. 427–446, 01-Aug-1988. 
[380] R. A. Weiss, R. Eichner, and T. T. Sun, “Monoclonal antibody analysis of keratin 
expression in epidermal diseases: a 48- and 56-kdalton keratin as molecular 
markers for hyperproliferative keratinocytes.,” J. Cell Biol., vol. 98, no. 4, pp. 1397–
406, Apr. 1984. 
[381] P. J. Koch and D. R. Roop, “The role of keratins in epidermal development and 
homeostasis--going beyond the obvious.,” J. Invest. Dermatol., vol. 123, no. 5, pp. 
x–xi, Nov. 2004. 
[382] J. Reichelt, G. Furstenberger, and T. M. Magin, “Loss of keratin 10 leads to 
mitogen-activated protein kinase (MAPK) activation, increased keratinocyte 
turnover, and decreased tumor formation in mice.,” J. Invest. Dermatol., vol. 123, 
no. 5, pp. 973–81, Nov. 2004. 
381 | P a g e  
 
[383] E. Proksch, J. M. Brandner, and J.-M. Jensen, “The skin: an indispensable barrier.,” 
Exp. Dermatol., vol. 17, no. 12, pp. 1063–72, Dec. 2008. 
[384] D. Keswell, S. H. Kidson, and L. M. Davids, “Melanocyte migration is influenced by 
E-cadherin-dependent adhesion of keratinocytes in both two- and three-
dimensional in vitro wound models.,” Cell Biol. Int., vol. 39, no. 2, pp. 169–76, Feb. 
2015. 
[385] A. Kobielak and E. Fuchs, “Alpha-catenin: at the junction of intercellular adhesion 
and actin dynamics.,” Nat. Rev. Mol. Cell Biol., vol. 5, no. 8, pp. 614–25, Aug. 2004. 
[386] S. Kuphal and A. K. Bosserhoff, “E-cadherin cell-cell communication in 
melanogenesis and during development of malignant melanoma.,” Arch. Biochem. 
Biophys., vol. 524, no. 1, pp. 43–7, Aug. 2012. 
[387] T. Sun, S. Jackson, J. W. Haycock, and S. MacNeil, “Culture of skin cells in 3D 
rather than 2D improves their ability to survive exposure to cytotoxic agents.,” J. 
Biotechnol., vol. 122, no. 3, pp. 372–81, Apr. 2006. 
[388] M. Li, A. Moeen Rezakhanlou, C. Chavez-Munoz, A. Lai, and A. Ghahary, 
“Keratinocyte-releasable factors increased the expression of MMP1 and MMP3 in 
co-cultured fibroblasts under both 2D and 3D culture conditions.,” Mol. Cell. 
Biochem., vol. 332, no. 1–2, pp. 1–8, Dec. 2009. 
[389] S. Frank, G. H bner, G. Breier, M. T. Longaker, D. G. Greenhalgh, and S. Werner, 
“Regulation of Vascular Endothelial Growth Factor Expression in Cultured 
Keratinocytes,” J. Biol. Chem., vol. 270, no. 21, pp. 12607–12613, May 1995. 
[390] A. Elkhal, L. Tunggal, and M. Aumailley, “Fibroblasts contribute to the deposition of 
laminin 5 in the extracellular matrix.,” Exp. Cell Res., vol. 296, no. 2, pp. 223–30, 
Jun. 2004. 
[391] D. T. Woodley, J. R. Stanley, M. J. Reese, and E. J. O’keefe, “Human Dermal 
Fibroblasts Synthesize Laminin.,” J. Invest. Dermatol., vol. 90, no. 5, pp. 679–683, 
May 1988. 
[392] M. Kawamoto, D. J. Romberger, Y. Nakamura, Y. Adachi, L. Tate, R. F. Ertl, J. R. 
Spurzem, and S. I. Rennard, “Modulation of fibroblast type I collagen and 
fibronectin production by bovine bronchial epithelial cells.,” Am. J. Respir. Cell Mol. 
Biol., vol. 12, no. 4, pp. 425–33, Apr. 1995. 
[393] A. Saalbach, T. Janik, M. Busch, D. Herbert, U. Anderegg, and J. C. Simon, 
“Fibroblasts support migration of monocyte-derived dendritic cells by secretion of 
PGE2 and MMP-1.,” Exp. Dermatol., vol. 24, no. 8, pp. 598–604, Aug. 2015. 
[394] E. A. O’Toole, “Extracellular matrix and keratinocyte migration.,” Clin. Exp. 
Dermatol., vol. 26, no. 6, pp. 525–30, Sep. 2001. 
[395] S. Guo and L. A. Dipietro, “Factors affecting wound healing.,” J. Dent. Res., vol. 89, 
no. 3, pp. 219–29, Mar. 2010. 
382 | P a g e  
 
[396] A. el-Ghalbzouri, S. Gibbs, E. Lamme, C. A. Van Blitterswijk, and M. Ponec, “Effect 
of fibroblasts on epidermal regeneration.,” Br. J. Dermatol., vol. 147, no. 2, pp. 230–
43, Aug. 2002. 
[397] S. Aoki, S. Toda, T. Ando, and H. Sugihara, “Bone marrow stromal cells, 
preadipocytes, and dermal fibroblasts promote epidermal regeneration in their 
distinctive fashions.,” Mol. Biol. Cell, vol. 15, no. 10, pp. 4647–57, Oct. 2004. 
[398] I. Boxman, C. Löwik, L. Aarden, and M. Ponec, “Modulation of IL-6 production and 
IL-1 activity by keratinocyte-fibroblast interaction.,” J. Invest. Dermatol., vol. 101, 
no. 3, pp. 316–24, Sep. 1993. 
[399] C. Marchese, A. Felici, V. Visco, G. Lucania, M. Igarashi, M. Picardo, L. Frati, and 
M. R. Torrisi, “Fibroblast growth factor 10 induces proliferation and differentiation of 
human primary cultured keratinocytes.,” J. Invest. Dermatol., vol. 116, no. 4, pp. 
623–8, Apr. 2001. 
[400] S. Werner and H. Smola, “Paracrine regulation of keratinocyte proliferation and 
differentiation.,” Trends Cell Biol., vol. 11, no. 4, pp. 143–6, Apr. 2001. 
[401] E. A. Blomme, Y. Sugimoto, Y. C. Lin, C. C. Capen, and T. J. Rosol, “Parathyroid 
hormone-related protein is a positive regulator of keratinocyte growth factor 
expression by normal dermal fibroblasts.,” Mol. Cell. Endocrinol., vol. 152, no. 1–2, 
pp. 189–97, Jun. 1999. 
[402] N. Maas-Szabowski, A. Shimotoyodome, and N. E. Fusenig, “Keratinocyte growth 
regulation in fibroblast cocultures via a double paracrine mechanism.,” J. Cell Sci., 
vol. 112 ( Pt 1, pp. 1843–53, Jun. 1999. 
[403] G. Imokawa, “Mechanism of UVB-induced wrinkling of the skin: paracrine cytokine 
linkage between keratinocytes and fibroblasts leading to the stimulation of 
elastase.,” J. Investig. Dermatol. Symp. Proc., vol. 14, no. 1, pp. 36–43, Aug. 2009. 
[404] N. Nath, S. K. Saraswat, S. Jain, and S. Koteshwar, “Inhibition of proliferation and 
migration of stricture fibroblasts by epithelial cell-conditioned media.,” Indian J. 
Urol., vol. 31, no. 2, pp. 111–5, Jan. 2015. 
[405] P. Huang, J. Bi, G. R. Owen, W. Chen, A. Rokka, L. Koivisto, J. Heino, L. Häkkinen, 
and H. Larjava, “Keratinocyte Microvesicles Regulate the Expression of Multiple 
Genes in Dermal Fibroblasts.,” J. Invest. Dermatol., Aug. 2015. 
[406] R. J. Pelham and Y. l Wang, “Cell locomotion and focal adhesions are regulated by 
substrate flexibility.,” Proc. Natl. Acad. Sci. U. S. A., vol. 94, no. 25, pp. 13661–5, 
Dec. 1997. 
[407] M. Chiquet, A. S. Renedo, F. Huber, and M. Flück, “How do fibroblasts translate 
mechanical signals into changes in extracellular matrix production?,” Matrix Biol., 
vol. 22, no. 1, pp. 73–80, Mar. 2003. 
[408] K. R. Levental, H. Yu, L. Kass, J. N. Lakins, M. Egeblad, J. T. Erler, S. F. T. Fong, 
K. Csiszar, A. Giaccia, W. Weninger, M. Yamauchi, D. L. Gasser, and V. M. 
Weaver, “Matrix crosslinking forces tumor progression by enhancing integrin 
signaling.,” Cell, vol. 139, no. 5, pp. 891–906, Nov. 2009. 
383 | P a g e  
 
[409] J. Rautela, N. Baschuk, C. Y. Slaney, K. M. Jayatilleke, K. Xiao, B. N. Bidwell, E. C. 
Lucas, E. D. Hawkins, P. Lock, C. S. Wong, W. Chen, R. L. Anderson, P. J. 
Hertzog, D. M. Andrews, A. Möller, and B. S. Parker, “Loss of Host Type-I IFN 
Signaling Accelerates Metastasis and Impairs NK-Cell Antitumor Function in 
Multiple Models of Breast Cancer.,” Cancer Immunol. Res., Jul. 2015. 
[410] G. Venugopalan, D. B. Camarillo, K. D. Webster, C. D. Reber, J. A. Sethian, V. M. 
Weaver, D. A. Fletcher, H. El-Samad, and C. H. Rycroft, “Multicellular Architecture 
of Malignant Breast Epithelia Influences Mechanics,” PLoS One, vol. 9, no. 8, p. 
e101955, Aug. 2014. 
[411] R. W. Tilghman, C. R. Cowan, J. D. Mih, Y. Koryakina, D. Gioeli, J. K. Slack-Davis, 
B. R. Blackman, D. J. Tschumperlin, and J. T. Parsons, “Matrix rigidity regulates 
cancer cell growth and cellular phenotype.,” PLoS One, vol. 5, no. 9, p. e12905, 
Jan. 2010. 
[412] S. L. Schor, A. M. Schor, and G. W. Bazill, “The effects of fibronectin on the 
adhesion and migration of chinese hamster ovary cells on collagen substrata.,” J. 
Cell Sci., vol. 49, pp. 299–310, Jun. 1981. 
[413] T. A. Ulrich, A. Jain, K. Tanner, J. L. MacKay, and S. Kumar, “Probing cellular 
mechanobiology in three-dimensional culture with collagen–agarose matrices,” 
Biomaterials, vol. 31, no. 7, pp. 1875–1884, Mar. 2010. 
[414] J. N. Beck, A. Singh, A. R. Rothenberg, J. H. Elisseeff, and A. J. Ewald, “The 
independent roles of mechanical, structural and adhesion characteristics of 3D 
hydrogels on the regulation of cancer invasion and dissemination.,” Biomaterials, 
vol. 34, no. 37, pp. 9486–95, Dec. 2013. 
[415] M. P. Schwartz, B. D. Fairbanks, R. E. Rogers, R. Rangarajan, M. H. Zaman, and 
K. S. Anseth, “A synthetic strategy for mimicking the extracellular matrix provides 
new insight about tumor cell migration.,” Integr. Biol. (Camb)., vol. 2, no. 1, pp. 32–
40, Jan. 2010. 
[416] R. C. Siegel, “Biosynthesis of collagen crosslinks: increased activity of purified lysyl 
oxidase with reconstituted collagen fibrils.,” Proc. Natl. Acad. Sci. U. S. A., vol. 71, 
no. 12, pp. 4826–30, Dec. 1974. 
[417] W. M. Elbjeirami, E. O. Yonter, B. C. Starcher, and J. L. West, “Enhancing 
mechanical properties of tissue-engineered constructs via lysyl oxidase crosslinking 
activity.,” J. Biomed. Mater. Res. A, vol. 66, no. 3, pp. 513–21, Sep. 2003. 
[418] K. Wolf, I. Mazo, H. Leung, K. Engelke, U. H. von Andrian, E. I. Deryugina, A. Y. 
Strongin, E.-B. Bröcker, and P. Friedl, “Compensation mechanism in tumor cell 
migration: mesenchymal-amoeboid transition after blocking of pericellular 
proteolysis.,” J. Cell Biol., vol. 160, no. 2, pp. 267–77, Jan. 2003. 
[419] D. Kedrin, B. Gligorijevic, J. Wyckoff, V. V Verkhusha, J. Condeelis, J. E. Segall, 
and J. van Rheenen, “Intravital imaging of metastatic behavior through a mammary 
imaging window.,” Nat. Methods, vol. 5, no. 12, pp. 1019–21, Dec. 2008. 
384 | P a g e  
 
[420] L. Gibot, T. Galbraith, J. Huot, and F. A. Auger, “A preexisting microvascular 
network benefits in vivo revascularization of a microvascularized tissue-engineered 
skin substitute.,” Tissue Eng. Part A, vol. 16, no. 10, pp. 3199–206, Oct. 2010. 
[421] L. Gibot, T. Galbraith, J. Huot, and F. A. Auger, “Development of a tridimensional 
microvascularized human skin substitute to study melanoma biology.,” Clin. Exp. 
Metastasis, vol. 30, no. 1, pp. 83–90, Jan. 2013. 
[422] V. M. Schoop, N. Mirancea, and N. E. Fusenig, “Epidermal organization and 
differentiation of HaCaT keratinocytes in organotypic coculture with human dermal 
fibroblasts.,” J. Invest. Dermatol., vol. 112, no. 3, pp. 343–53, Mar. 1999. 
[423] G. Sriram, P. L. Bigliardi, and M. Bigliardi-Qi, “Fibroblast heterogeneity and its 
implications for engineering organotypic skin models in vitro.,” Eur. J. Cell Biol., 
Aug. 2015. 
[424] E. Tamariz and F. Grinnell, “Modulation of fibroblast morphology and adhesion 
during collagen matrix remodeling.,” Mol. Biol. Cell, vol. 13, no. 11, pp. 3915–29, 
Nov. 2002. 
[425] C. Ballestrem, B. Hinz, B. A. Imhof, and B. Wehrle-Haller, “Marching at the front 
and dragging behind: differential alphaVbeta3-integrin turnover regulates focal 
adhesion behavior.,” J. Cell Biol., vol. 155, no. 7, pp. 1319–32, Dec. 2001. 
[426] J. J. Christiansen and A. K. Rajasekaran, “Reassessing epithelial to mesenchymal 
transition as a prerequisite for carcinoma invasion and metastasis.,” Cancer Res., 
vol. 66, no. 17, pp. 8319–26, Sep. 2006. 
[427] Z.-H. Zheng, X.-J. Sun, H.-T. Zhou, C. Shang, H. Ji, and K.-L. Sun, “Analysis of 
metastasis suppressing function of E-cadherin in gastric cancer cells by RNAi.,” 
World J. Gastroenterol., vol. 11, no. 13, pp. 2000–3, Apr. 2005. 
[428] S. H. Lang, C. Hyde, I. N. Reid, I. S. Hitchcock, C. A. Hart, A. A. G. Bryden, J.-M. 
Villette, M. J. Stower, and N. J. Maitland, “Enhanced expression of vimentin in 
motile prostate cell lines and in poorly differentiated and metastatic prostate 
carcinoma.,” Prostate, vol. 52, no. 4, pp. 253–63, Sep. 2002. 
[429] K. Boehnke, N. Mirancea, A. Pavesio, N. E. Fusenig, P. Boukamp, and H.-J. Stark, 
“Effects of fibroblasts and microenvironment on epidermal regeneration and tissue 
function in long-term skin equivalents.,” Eur. J. Cell Biol., vol. 86, no. 11–12, pp. 
731–46, Dec. 2007. 
[430] R. D. Lillie, R. E. Tracy, P. Pizzolato, P. T. Donaldson, and C. Reynolds, 
“Differential staining of collagen types in paraffin sections: A color change in 
degraded forms,” Virchows Arch. A Pathol. Anat. Histol., vol. 386, no. 2, pp. 153–
159, Apr. 1980. 
[431] P. N. Marshall, “Papanicolaou staining--a review.,” Microsc. Acta, vol. 87, no. 3, pp. 
233–43, May 1983. 
[432] P. Friedl and K. Wolf, “Plasticity of cell migration: a multiscale tuning model.,” J. 
Cell Biol., vol. 188, no. 1, pp. 11–9, Jan. 2010. 
385 | P a g e  
 
[433] A. A. Khalil and P. Friedl, “Determinants of leader cells in collective cell migration,” 
Integr. Biol., vol. 2, no. 11–12, p. 568, Nov. 2010. 
[434] A. J. Ewald, A. Brenot, M. Duong, B. S. Chan, and Z. Werb, “Collective epithelial 
migration and cell rearrangements drive mammary branching morphogenesis.,” 
Dev. Cell, vol. 14, no. 4, pp. 570–81, Apr. 2008. 
[435] J. Notbohm, A. Lesman, D. A. Tirrell, and G. Ravichandran, “Quantifying cell-
induced matrix deformation in three dimensions based on imaging matrix fibers.,” 
Integr. Biol. (Camb)., May 2015. 
[436] R. P. Martins, J. D. Finan, F. Guilak, and D. A. Lee, “Mechanical regulation of 
nuclear structure and function.,” Annu. Rev. Biomed. Eng., vol. 14, pp. 431–55, 
Jan. 2012. 
[437] T. Sun, D. Norton, A. J. Ryan, S. MacNeil, and J. W. Haycock, “Investigation of 
fibroblast and keratinocyte cell-scaffold interactions using a novel 3D cell culture 
system,” J. Mater. Sci. Mater. Med., vol. 18, no. 2, pp. 321–328, Feb. 2007. 
[438] L. N. Castor, “Contact regulation of cell division in an epithelial-like cell line.,” J. 
Cell. Physiol., vol. 72, no. 3, pp. 161–72, Dec. 1968. 
[439] A. Puliafito, L. Hufnagel, P. Neveu, S. Streichan, A. Sigal, D. K. Fygenson, and B. I. 
Shraiman, “Collective and single cell behavior in epithelial contact inhibition.,” Proc. 
Natl. Acad. Sci. U. S. A., vol. 109, no. 3, pp. 739–44, Jan. 2012. 
[440] C. A. Heckman, “Contact inhibition revisited.,” J. Cell. Physiol., vol. 220, no. 3, pp. 
574–5, Sep. 2009. 
[441] S.-I. Iwasaki and H. Aoyagi, “Expression of keratin 14 in the basal cells of the 
lingual epithelium of mice during the morphogenesis of filiform papillae: 
visualization by fluorescent immunostaining and confocal laser-scanning 
microscopy in the transmission mode.,” Odontology, vol. 95, no. 1, pp. 61–5, Jul. 
2007. 
[442] H. Zarkoob, S. Bodduluri, S. V Ponnaluri, J. C. Selby, and E. A. Sander, “Substrate 
Stiffness Affects Human Keratinocyte Colony Formation.,” Cell. Mol. Bioeng., vol. 8, 
no. 1, pp. 32–50, Mar. 2015. 
[443] K. Wang, C. Degerny, M. Xu, and X.-J. Yang, “YAP, TAZ, and Yorkie: a conserved 
family of signal-responsive transcriptional coregulators in animal development and 
human disease.,” Biochem. Cell Biol., vol. 87, no. 1, pp. 77–91, Feb. 2009. 
[444] M. Liu, S. Zhao, Q. Lin, and X.-P. Wang, “YAP regulates the expression of Hoxa1 
and Hoxc13 in mouse and human oral and skin epithelial tissues.,” Mol. Cell. Biol., 
vol. 35, no. 8, pp. 1449–61, Apr. 2015. 
[445] A. G. Clark and D. M. Vignjevic, “Modes of cancer cell invasion and the role of the 
microenvironment,” Curr. Opin. Cell Biol., vol. 36, pp. 13–22, Oct. 2015. 
[446] F. Nallet-Staub, V. Marsaud, L. Li, C. Gilbert, S. Dodier, V. Bataille, M. Sudol, M. 
Herlyn, and A. Mauviel, “Pro-invasive activity of the Hippo pathway effectors YAP 
386 | P a g e  
 
and TAZ in cutaneous melanoma.,” J. Invest. Dermatol., vol. 134, no. 1, pp. 123–
32, Jan. 2014. 
[447] J. E. Kim, G. J. Finlay, and B. C. Baguley, “The role of the hippo pathway in 
melanocytes and melanoma.,” Front. Oncol., vol. 3, p. 123, Jan. 2013. 
[448] Q. Zeng and W. Hong, “The emerging role of the hippo pathway in cell contact 
inhibition, organ size control, and cancer development in mammals.,” Cancer Cell, 
vol. 13, no. 3, pp. 188–92, Mar. 2008. 
[449] J. Arnemann, K. H. Sullivan, A. I. Magee, I. A. King, and R. S. Buxton, 
“Stratification-related expression of isoforms of the desmosomal cadherins in 
human epidermis.,” J. Cell Sci., vol. 104 ( Pt 3, pp. 741–50, Mar. 1993. 
[450] M. Plessner, M. Melak, P. Chinchilla, C. Baarlink, and R. Grosse, “Nuclear F-actin 
formation and reorganization upon cell spreading.,” J. Biol. Chem., vol. 290, no. 18, 
pp. 11209–16, May 2015. 
[451] Z. Jahed, H. Shams, M. Mehrbod, and M. R. K. Mofrad, “Mechanotransduction 
pathways linking the extracellular matrix to the nucleus.,” Int. Rev. Cell Mol. Biol., 
vol. 310, pp. 171–220, Jan. 2014. 
[452] Q. Zhang, J. N. Skepper, F. Yang, J. D. Davies, L. Hegyi, R. G. Roberts, P. L. 
Weissberg, J. A. Ellis, and C. M. Shanahan, “Nesprins: a novel family of spectrin-
repeat-containing proteins that localize to the nuclear membrane in multiple 
tissues.,” J. Cell Sci., vol. 114, no. Pt 24, pp. 4485–98, Dec. 2001. 
[453] A. Schönichen, H. G. Mannherz, E. Behrmann, A. J. Mazur, S. Kühn, U. Silván, C.-
A. Schoenenberger, O. T. Fackler, S. Raunser, L. Dehmelt, and M. Geyer, “FHOD1 
is a combined actin filament capping and bundling factor that selectively associates 
with actin arcs and stress fibers.,” J. Cell Sci., vol. 126, no. Pt 8, pp. 1891–901, Apr. 
2013. 
[454] D. Stoffler, B. Feja, B. Fahrenkrog, J. Walz, D. Typke, and U. Aebi, “Cryo-electron 
tomography provides novel insights into nuclear pore architecture: implications for 
nucleocytoplasmic transport.,” J. Mol. Biol., vol. 328, no. 1, pp. 119–30, Apr. 2003. 
[455] M. Beck, F. Förster, M. Ecke, J. M. Plitzko, F. Melchior, G. Gerisch, W. Baumeister, 
and O. Medalia, “Nuclear pore complex structure and dynamics revealed by 
cryoelectron tomography.,” Science, vol. 306, no. 5700, pp. 1387–90, Nov. 2004. 
[456] R. Bernad, H. van der Velde, M. Fornerod, and H. Pickersgill, “Nup358/RanBP2 
attaches to the nuclear pore complex via association with Nup88 and Nup214/CAN 
and plays a supporting role in CRM1-mediated nuclear protein export.,” Mol. Cell. 
Biol., vol. 24, no. 6, pp. 2373–84, Mar. 2004. 
[457] R. Bernad, D. Engelsma, H. Sanderson, H. Pickersgill, and M. Fornerod, “Nup214-
Nup88 nucleoporin subcomplex is required for CRM1-mediated 60 S preribosomal 
nuclear export.,” J. Biol. Chem., vol. 281, no. 28, pp. 19378–86, Jul. 2006. 
[458] M. Capelson, Y. Liang, R. Schulte, W. Mair, U. Wagner, and M. W. Hetzer, 
“Chromatin-bound nuclear pore components regulate gene expression in higher 
eukaryotes.,” Cell, vol. 140, no. 3, pp. 372–83, Feb. 2010. 
387 | P a g e  
 
[459] T. U. Schwartz, “Modularity within the architecture of the nuclear pore complex.,” 
Curr. Opin. Struct. Biol., vol. 15, no. 2, pp. 221–6, Apr. 2005. 
[460] M. Fornerod, J. van Deursen, S. van Baal, A. Reynolds, D. Davis, K. G. Murti, J. 
Fransen, and G. Grosveld, “The human homologue of yeast CRM1 is in a dynamic 
subcomplex with CAN/Nup214 and a novel nuclear pore component Nup88.,” 
EMBO J., vol. 16, no. 4, pp. 807–16, Feb. 1997. 
[461] E. R. Griffis, S. Xu, and M. A. Powers, “Nup98 localizes to both nuclear and 
cytoplasmic sides of the nuclear pore and binds to two distinct nucleoporin 
subcomplexes.,” Mol. Biol. Cell, vol. 14, no. 2, pp. 600–10, Feb. 2003. 
[462] P. Roth, N. Xylourgidis, N. Sabri, A. Uv, M. Fornerod, and C. Samakovlis, “The 
Drosophila nucleoporin DNup88 localizes DNup214 and CRM1 on the nuclear 
envelope and attenuates NES-mediated nuclear export.,” J. Cell Biol., vol. 163, no. 
4, pp. 701–6, Nov. 2003. 
[463] N. Xylourgidis, P. Roth, N. Sabri, V. Tsarouhas, and C. Samakovlis, “The 
nucleoporin Nup214 sequesters CRM1 at the nuclear rim and modulates 
NFkappaB activation in Drosophila.,” J. Cell Sci., vol. 119, no. Pt 21, pp. 4409–19, 
Nov. 2006. 
[464] N. Takahashi, J. W. J. van Kilsdonk, B. Ostendorf, R. Smeets, S. W. M. 
Bruggeman, A. Alonso, F. van de Loo, M. Schneider, W. B. van den Berg, and G. 
W. M. Swart, “Tumor marker nucleoporin 88 kDa regulates nucleocytoplasmic 
transport of NF-kappaB.,” Biochem. Biophys. Res. Commun., vol. 374, no. 3, pp. 
424–30, Sep. 2008. 
[465] V. B. Andela, A. H. Gordon, G. Zotalis, R. N. Rosier, J. J. Goater, G. D. Lewis, E. 
M. Schwarz, J. E. Puzas, and R. J. O’Keefe, “NFkappaB: a pivotal transcription 
factor in prostate cancer metastasis to bone.,” Clin. Orthop. Relat. Res., no. 415 
Suppl, pp. S75–85, Oct. 2003. 
[466] H. Zhang, J. Schneider, and I. Rosdahl, “Expression of p16, p27, p53, p73 and 
Nup88 proteins in matched primary and metastatic melanoma cells.,” Int. J. Oncol., 
vol. 21, no. 1, pp. 43–8, Jul. 2002. 
[467] J. Schneider, F. Martínez-Arribas, and R. Torrejón, “Nup88 expression is 
associated with myometrial invasion in endometrial carcinoma.,” Int. J. Gynecol. 
Cancer, vol. 20, no. 5, pp. 804–8, Jul. 2010. 
[468] D. Agudo, F. Gómez-Esquer, F. Martínez-Arribas, M. J. Núñez-Villar, M. Pollán, 
and J. Schneider, “Nup88 mRNA overexpression is associated with high 
aggressiveness of breast cancer.,” Int. J. Cancer, vol. 109, no. 5, pp. 717–20, May 
2004. 
[469] Z.-Y. Zhang, Z.-R. Zhao, L. Jiang, J.-C. Li, Y.-M. Gao, D.-S. Cui, C.-J. Wang, J. 
Schneider, M.-W. Wang, and X.-F. Sun, “Nup88 expression in normal mucosa, 
adenoma, primary adenocarcinoma and lymph node metastasis in the colorectum.,” 
Tumour Biol., vol. 28, no. 2, pp. 93–9, Jan. 2007. 
388 | P a g e  
 
[470] Z.-R. Zhao, L.-J. Zhang, Y.-Y. Wang, F. Li, M.-W. Wang, and X.-F. Sun, “Increased 
serum level of Nup88 protein is associated with the development of colorectal 
cancer.,” Med. Oncol., vol. 29, no. 3, pp. 1789–95, Sep. 2012. 
[471] R. E. Hewitt, A. McMarlin, D. Kleiner, R. Wersto, P. Martin, M. Tsokos, G. W. 
Stamp, W. G. Stetler-Stevenson, and M. Tsoskas, “Validation of a model of colon 
cancer progression.,” J. Pathol., vol. 192, no. 4, pp. 446–54, Dec. 2000. 
[472] S. Xu and M. A. Powers, “Nuclear pore proteins and cancer.,” Semin. Cell Dev. 
Biol., vol. 20, no. 5, pp. 620–30, Jul. 2009. 
[473] Y. Lüke, H. Zaim, I. Karakesisoglou, V. M. Jaeger, L. Sellin, W. Lu, M. Schneider, 
S. Neumann, A. Beijer, M. Munck, V. C. Padmakumar, J. Gloy, G. Walz, and A. A. 
Noegel, “Nesprin-2 Giant (NUANCE) maintains nuclear envelope architecture and 
composition in skin.,” J. Cell Sci., vol. 121, no. Pt 11, pp. 1887–98, Jun. 2008. 
[474] W. Shu, Y. Chen, Q. Wu, R. Li, and G. Cui, “Deguelin represses both the 
expression of nucleophosmin and some nucleoporins: Nup88 and Nup214 in Jurkat 
cells.,” Biol. Pharm. Bull., vol. 31, no. 1, pp. 27–32, Jan. 2008. 
[475] Q. Liu, N. Pante, T. Misteli, M. Elsagga, M. Crisp, D. Hodzic, B. Burke, and K. J. 
Roux, “Functional association of Sun1 with nuclear pore complexes.,” J. Cell Biol., 
vol. 178, no. 5, pp. 785–98, Aug. 2007. 
[476] C. Hashizume, H. Nakano, K. Yoshida, and R. W. Wong, “Characterization of the 
role of the tumor marker Nup88 in mitosis.,” Mol. Cancer, vol. 9, p. 119, Jan. 2010. 
[477] H. Brustmann and M. Hager, “Nucleoporin 88 expression in normal and neoplastic 
squamous epithelia of the uterine cervix.,” Ann. Diagn. Pathol., vol. 13, no. 5, pp. 
303–7, Oct. 2009. 
[478] Y. C. Lussi, I. Hügi, E. Laurell, U. Kutay, and B. Fahrenkrog, “The nucleoporin 
Nup88 is interacting with nuclear lamin A.,” Mol. Biol. Cell, vol. 22, no. 7, pp. 1080–
90, Apr. 2011. 
[479] M. Sakaki, H. Koike, N. Takahashi, N. Sasagawa, S. Tomioka, K. Arahata, and S. 
Ishiura, “Interaction between emerin and nuclear lamins.,” J. Biochem., vol. 129, no. 
2, pp. 321–7, Feb. 2001. 
[480] S. Wang, A. Reuveny, and T. Volk, “Nesprin provides elastic properties to muscle 
nuclei by cooperating with spectraplakin and EB1,” J. Cell Biol., vol. 209, no. 4, pp. 
529–538, May 2015. 
[481] H. N. Kha, B. K. Chen, G. M. Clark, and R. Jones, “Stiffness properties for Nucleus 
standard straight and contour electrode arrays,” Med. Eng. Phys., vol. 26, no. 8, pp. 
677–685, Oct. 2004. 
[482] A. Vaziri and M. R. K. Mofrad, “Mechanics and deformation of the nucleus in 
micropipette aspiration experiment.,” J. Biomech., vol. 40, no. 9, pp. 2053–62, Jan. 
2007. 
[483] J. Swift, I. L. Ivanovska, A. Buxboim, T. Harada, P. C. D. P. Dingal, J. Pinter, J. D. 
Pajerowski, K. R. Spinler, J.-W. Shin, M. Tewari, F. Rehfeldt, D. W. Speicher, and 
389 | P a g e  
 
D. E. Discher, “Nuclear lamin-A scales with tissue stiffness and enhances matrix-
directed differentiation.,” Science, vol. 341, no. 6149, p. 1240104, Aug. 2013. 
[484] B. A. Sosa, U. Kutay, and T. U. Schwartz, “Structural insights into LINC 
complexes.,” Curr. Opin. Struct. Biol., vol. 23, no. 2, pp. 285–91, Apr. 2013. 
[485] T. P. Driscoll, B. D. Cosgrove, S.-J. Heo, Z. E. Shurden, and R. L. Mauck, 
“Cytoskeletal to Nuclear Strain Transfer Regulates YAP Signaling in Mesenchymal 
Stem Cells,” Biophys. J., vol. 108, no. 12, pp. 2783–2793, Jun. 2015. 
[486] A. L. Olins, T. V Hoang, M. Zwerger, H. Herrmann, H. Zentgraf, A. A. Noegel, I. 
Karakesisoglou, D. Hodzic, and D. E. Olins, “The LINC-less granulocyte nucleus.,” 
Eur. J. Cell Biol., vol. 88, no. 4, pp. 203–14, Apr. 2009. 
[487] D. Rajgor, J. A. Mellad, F. Autore, Q. Zhang, and C. M. Shanahan, “Multiple novel 
nesprin-1 and nesprin-2 variants act as versatile tissue-specific intracellular 
scaffolds.,” PLoS One, vol. 7, no. 7, p. e40098, Jan. 2012. 
[488] J. G. Simpson and R. G. Roberts, “Patterns of evolutionary conservation in the 
nesprin genes highlight probable functionally important protein domains and 
isoforms.,” Biochem. Soc. Trans., vol. 36, no. Pt 6, pp. 1359–67, Dec. 2008. 
[489] E. J. Vlug, R. A. H. van de Ven, J. F. Vermeulen, P. Bult, P. J. van Diest, and P. W. 
B. Derksen, “Nuclear localization of the transcriptional coactivator YAP is 
associated with invasive lobular breast cancer.,” Cell. Oncol. (Dordr)., vol. 36, no. 5, 
pp. 375–84, Oct. 2013. 
[490] M. Demetriou, I. R. Nabi, M. Coppolino, S. Dedhar, and J. W. Dennis, “Reduced 
contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-
transferase V.,” J. Cell Biol., vol. 130, no. 2, pp. 383–92, Jul. 1995. 
[491] S. Strunze, M. F. Engelke, I.-H. Wang, D. Puntener, K. Boucke, S. Schleich, M. 
Way, P. Schoenenberger, C. J. Burckhardt, and U. F. Greber, “Kinesin-1-Mediated 
Capsid Disassembly and Disruption of the Nuclear Pore Complex Promote Virus 
Infection,” Cell Host Microbe, vol. 10, no. 3, pp. 210–223, Sep. 2011. 
[492] Z.-R. Zhao, Z.-Y. Zhang, X.-Q. He, Y.-M. Hu, Y.-F. Tian, L.-J. Zhang, and X.-F. 
Sun, “Nup88 mRNA overexpression in colorectal cancers and relationship with 
p53.,” Cancer Biomark., vol. 8, no. 2, pp. 73–80, Jan. 2010. 
[493] S. Wälde, K. Thakar, S. Hutten, C. Spillner, A. Nath, U. Rothbauer, S. Wiemann, 
and R. H. Kehlenbach, “The nucleoporin Nup358/RanBP2 promotes nuclear import 
in a cargo- and transport receptor-specific manner.,” Traffic, vol. 13, no. 2, pp. 218–
33, Feb. 2012. 
[494] W. Jahr, B. Schmid, C. Schmied, F. O. Fahrbach, and J. Huisken, “Hyperspectral 
light sheet microscopy.,” Nat. Commun., vol. 6, p. 7990, Jan. 2015. 
[495] F. Pampaloni, B.-J. Chang, and E. H. K. Stelzer, “Erratum to: Light sheet-based 
fluorescence microscopy (LSFM) for the quantitative imaging of cells and tissues.,” 
Cell Tissue Res., vol. 362, no. 1, p. 265, Oct. 2015. 
390 | P a g e  
 
[496] L. A. Lautscham, C. Kämmerer, J. R. Lange, T. Kolb, C. Mark, A. Schilling, P. L. 
Strissel, R. Strick, C. Gluth, A. C. Rowat, C. Metzner, and B. Fabry, “Migration in 
Confined 3D Environments Is Determined by a Combination of Adhesiveness, 
Nuclear Volume, Contractility, and Cell Stiffness,” Biophys. J., vol. 109, no. 5, pp. 
900–913, Sep. 2015. 
[497] C. Zhu, X. Wang, H. Hagberg, and K. Blomgren, “Correlation Between Caspase-3 
Activation and Three Different Markers of DNA Damage in Neonatal Cerebral 
Hypoxia-Ischemia,” J. Neurochem., vol. 75, no. 2, pp. 819–829, Jan. 2002. 
[498] M. W. Carlson, A. Alt-Holland, C. Egles, and J. A. Garlick, “Three-dimensional 
tissue models of normal and diseased skin.,” Curr. Protoc. Cell Biol., vol. Chapter 
19, p. Unit 19.9, Dec. 2008. 
[499] S. Levenberg, A. Yarden, Z. Kam, and B. Geiger, “p27 is involved in N-cadherin-
mediated contact inhibition of cell growth and S-phase entry,” Oncogene, vol. 18, 
no. 4, pp. 869–876, Feb. 1999. 
[500] K. Polyak, J. Y. Kato, M. J. Solomon, C. J. Sherr, J. Massague, J. M. Roberts, and 
A. Koff, “p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and 
contact inhibition to cell cycle arrest.,” Genes Dev., vol. 8, no. 1, pp. 9–22, Jan. 
1994. 
[501] C. Dietrich, K. Wallenfang, F. Oesch, and R. Wieser, “Differences in the 
mechanisms of growth control in contact-inhibited and serum-deprived human 
fibroblasts.,” Oncogene, vol. 15, no. 22, pp. 2743–7, Nov. 1997. 
[502] T. Fuse, M. Tanikawa, M. Nakanishi, K. Ikeda, T. Tada, H. Inagaki, K. Asai, T. Kato, 
and K. Yamada, “p27Kip1 expression by contact inhibition as a prognostic index of 
human glioma.,” J. Neurochem., vol. 74, no. 4, pp. 1393–9, Apr. 2000. 
[503] H. R. Gatla, B. Singha, V. Persaud, and I. Vancurova, “Evaluating cytoplasmic and 
nuclear levels of inflammatory cytokines in cancer cells by western blotting.,” 
Methods Mol. Biol., vol. 1172, pp. 271–83, Jan. 2014. 
[504] S. Piccolo, S. Dupont, and M. Cordenonsi, “The biology of YAP/TAZ: hippo 
signaling and beyond.,” Physiol. Rev., vol. 94, no. 4, pp. 1287–312, Oct. 2014. 
[505] B. A. Sosa, A. Rothballer, U. Kutay, and T. U. Schwartz, “LINC complexes form by 
binding of three KASH peptides to domain interfaces of trimeric SUN proteins.,” 
Cell, vol. 149, no. 5, pp. 1035–47, May 2012. 
[506] “The Cytoplasm and Cellular Organelles · Anatomy & Physiology.” [Online]. 
Available: http://philschatz.com/anatomy-book/contents/m46023.html. [Accessed: 
15-Sep-2015]. 
[507] J. A. Segre, “Epidermal barrier formation and recovery in skin disorders.,” J. Clin. 
Invest., vol. 116, no. 5, pp. 1150–8, May 2006. 
[508] S. Cartwright and I. Karakesisoglou, “Nesprins in health and disease.,” Semin. Cell 
Dev. Biol., vol. 29, pp. 169–79, May 2014. 
391 | P a g e  
 
[509] J. Pascual, M. Pfuhl, D. Walther, M. Saraste, and M. Nilges, “Solution structure of 
the spectrin repeat: a left-handed antiparallel triple-helical coiled-coil.,” J. Mol. Biol., 
vol. 273, no. 3, pp. 740–51, Oct. 1997.  
 
 
 
 
